fluconazole has been researched along with amphotericin b in 1920 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (1.25) | 18.7374 |
| 1990's | 519 (27.03) | 18.2507 |
| 2000's | 645 (33.59) | 29.6817 |
| 2010's | 580 (30.21) | 24.3611 |
| 2020's | 152 (7.92) | 2.80 |
| Authors | Studies |
|---|---|
| Allaudeen, HS; Dolle, RE; Kruse, LI | 1 |
| Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 1 |
| Fujie, A; Furuta, T; Hashimoto, S; Hino, M; Hori, Y; Iwamoto, T; Kasahara, C; Muramatsu, H; Sato, B | 1 |
| Barrett, D; Harada, K; Ikeda, F; Maki, K; Ohki, H; Tanaka, A; Watabe, E | 1 |
| Ecker, DM; McAlpine, J; Rogers, B; Stafford, A; Talbot, MK; Ubillas, R; Yang, SW | 1 |
| Barrett, D; Harada, K; Ikeda, F; Maki, K; Tanaka, A; Watabe, E | 1 |
| Buchta, V; Fáková, H; Koudelka, P; Kubanová, P; Pour, M; Pourová, H; Schiller, R; Spulák, M; Voprsalová, M; Wsól, V | 1 |
| MacMillan, JB; Molinski, TF; Moon, SS; Olmstead, MM; Pessah, IN; Ta, TA | 1 |
| Li, R; MacMillan, JB; Molinski, TF; Nicholas, GM | 1 |
| Malan, SF; Swart, H; Van Dyk, S | 1 |
| Bennani, YL; Dickman, DA; Ding, H; Frost, D; Goldman, RC; Hasvold, L; Lartey, P; Li, Q; Meulbroek, JA; Nilius, AM; Plattner, JJ; Steiner, B; Wang, W | 1 |
| Clark, AM; ElSohly, HN; Jacob, MR; Li, XC; Nagle, DG; Smillie, TJ; Walker, LA | 1 |
| Bamba-Nagano, R; Hashizume, T; Imamura, H; Jona, H; Morishima, H; Sakoh, H; Sakuraba, S; Sugimoto, Y; Yamada, K | 1 |
| Clark, AM; Hossain, CF; Jacob, MR; Mohammed, KA; Nagle, DG; Smillie, TJ; Walker, LA | 1 |
| Chaturvedi, AK; Shukla, PK; Tandon, VK; Yadav, DB | 1 |
| Chaturvedi, AK; Shukla, PK; Singh, RV; Tandon, VK; Yadav, DB | 1 |
| Cardellina, JH; McCloud, TG; Meragelman, TL; Shoemaker, RH; Tucker, KD | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Katzhendler, J; Oren, G; Polacheck, I; Shalom, E; Sionov, E; Srebnik, M; Takrouri, K | 1 |
| Kumar, M; Maurya, HK; Shukla, PK; Tandon, VK; Tripathi, A; Yadav, DB | 1 |
| Andes, D; Hoff, B; Holoyda, K; Lincoln, L; Marchillo, K; Massey, R; Nett, J; VanHandel, M | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Babu, KS; Clark, AM; Ferreira, D; Jacob, MR; Khan, SI; Li, XC; Zhang, Q | 1 |
| Abbasoglu, U; Aki-Sener, E; Ertan, T; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yalcin, I; Yildiz, I | 1 |
| Alves, SH; Bonacorso, HG; Borchhardt, DM; Coelho, HS; da Silva, FM; Flores, KM; Machado, P; Martins, MA; Santurio, JM; Spader, TB; Zanatta, N | 1 |
| Liu, T; Lv, J; Wang, Y; Yin, L | 1 |
| Colombo, AL; Costa, SF; da Matta, VL; de Souza Carvalho Melhem, M; dos Anjos Martins, M; Duboc de Almeida, GM; Levin, AS; Moretti, ML; Nucci, M; Rodero, L; Souza Dias, MB | 1 |
| Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
| Adamec, J; Beckert, R; Buchta, V; Kaustová, J; Klimesová, V; Möllmann, U; Waisser, K; Weiss, D | 1 |
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| Cao, YB; Jiang, YY; Sun, QY; Wu, QY; Xu, JM; Zhang, DZ; Zhang, J; Zhang, WN; Zhao, HQ | 1 |
| Kang, TH; Kim, S; Park, JS; Suh, YG; Yu, KA | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Duflos, M; Le Baut, G; Le Borgne, M; Le Pape, P; Lebouvier, N; Na, YM; Pagniez, F | 1 |
| Chaffin, WL; Mekala, S; Perumal, P | 1 |
| Liu, T; Lv, J; Wang, Y | 1 |
| Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF | 1 |
| Calderone, R; Chauhan, N; Kruppa, M | 1 |
| Daneshtalab, M; Hattori, M; Khan, JK; Kully, M; Ma, CM | 1 |
| Cao, Y; Chen, J; Ji, H; Jiang, Y; Li, Y; Liang, R; Lü, J; Tang, H; Yao, B; Zheng, C; Zhou, Y; Zhu, J | 1 |
| Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P | 1 |
| Gesztelyi, R; Kardos, G; Kelentey, B; Majoros, L; Sóczó, G; Varga, I | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Aki-Sener, E; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yalçin, I; Yildiz, I | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Barchiesi, F; Maida, CM; Milici, ME; Scalise, G; Spreghini, E | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Albert, ND; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
| Hashimoto, K; Kaeriyama, M; Kimura, A; Mitsuyama, J; Narita, H; Nishikawa, H; Nomura, N; Todo, Y; Yamada, E | 1 |
| Chavan, PS; Deshpande, MV; Hazra, BG; Pore, VS; Shirazi, F; Vatmurge, NS | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Aki, E; Alper-Hayta, S; Arisoy, M; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yildiz, I | 1 |
| Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Miyazaki, Y; Seki, M; Senda, H; Tashiro, T; Yamamoto, Y; Yanagihara, K | 1 |
| Meletiadis, J; Papaioannidou, P; Roilides, E; Sein, T; Stergiopoulou, T; Tsiouris, I; Walsh, TJ | 1 |
| Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS | 1 |
| Barchiesi, F; Giannini, D; Maida, CM; Milici, ME; Orlando, F; Scalise, G; Spreghini, E; Tomassetti, S | 1 |
| Agarwal, AK; Ashfaq, MK; Babu, KS; Clark, AM; Elsohly, HN; Jacob, MR; Khan, SI; Li, XC; Manly, SP | 1 |
| Chu, CC; Hsueh, PR; Ruan, SY | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Aki, E; Bolelli, K; Ertan, T; Kaynak, F; Ozkan, S; Tekiner-Gulbas, B; Temiz-Arpaci, O; Yalcin, I; Yildiz, I | 1 |
| Coleman, DC; Dudley, E; Kelly, DE; Kelly, SL; Lamb, DC; Melo, NR; Moran, GP; Smith, SN; Sullivan, DJ; Warrilow, AG | 1 |
| Begouin, A; Begouin, JM; Kirsch, G; Oliveira, JF; Pinto, E; Queiroz, MJ; Vale-Silva, LA | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Ernoult, E; Larcher, G; Tronchin, G; Vandeputte, P | 1 |
| Maurya, HK; Panda, D; ShivaKeshava, GB; Shukla, PK; Srivastava, P; Tandon, VK; Tripathi, A | 1 |
| Bavikar, SN; Chattopadhyay, S; Deshpande, MV; Dodd, RH; Hazra, BG; Kadreppa, S; Pore, VS; Salunke, DB; Shirazi, F; Thierry, J | 1 |
| Cocco, MT; Congiu, C; De Logu, A; Fadda, R; Meleddu, R; Onnis, V | 1 |
| Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP | 1 |
| Hata, M; Kitamura, A; Nakajima, R; Someya, K; Takemura, M | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Bol'shakov, OI; Konstantinova, LS; Laborie, H; Lanneluc, I; Obruchnikova, NV; Picot, L; Rakitin, OA; Sablé, S; Sopéna, V; Tanga, A; Thiéry, V | 1 |
| Jakus, PB; Kerekes, S; Kilár, F; Kocsis, B; Kustos, I; Lóránd, T; Nyul, A; Prókai, L; Villarreal, V | 1 |
| Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
| Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
| Aher, NG; Bhat, MK; Kumar, A; Mishra, NN; Pore, VS; Sharma, A; Shukla, PK | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, J; Sheehan, DJ | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
| Rahkhoodaee, F; Raymond, M; Tsao, S | 1 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Chaudhary, PM; Chavan, SR; Deshpande, MV; Deshpande, SR; Gonnade, R; Hazara, BG; Likhite, AP; Maybhate, SP; Nimkar, P; Razdan, M; Shirazi, F | 1 |
| Maurya, HK; Mishra, NN; Shukla, PK; Tandon, VK | 2 |
| Bergès, T; Bouchara, JP; Chabasse, D; Renier, G; Rocher, F; Tronchin, G; Vandeputte, P | 1 |
| Botta, M; Castagnolo, D; Cona, A; D'Arezzo, S; Doria, D; Fadda, G; Fracasso, ME; Manetti, F; Posteraro, B; Raffi, F; Rajamäki, S; Sanguinetti, M; Visca, P; Zizzari, AT | 1 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Boikov, D; Nagappan, V; Vazquez, JA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Borate, HB; Chandavarkar, MA; Chavan, SP; Iyer, R; Joshi, VA; Kelkar, RG; Kunte, SS; Maujan, SR; Sawargave, SP; Vaiude, SR; Wakharkar, RD | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
| Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K | 1 |
| Buchta, V; Krenk, O; Kunes, J; Nobilis, M; Pour, M; Senel, P; Spulák, M; Tichotová, L; Votruba, I | 1 |
| Billack, B; Fronczek, FR; Graham, SM; Kocsis, B; Kocsis, E; Nicholson, SM; Patel, MR; Patel, PD; Talele, TT; Warren, AR | 1 |
| Kumar, R; Maurya, HK; Shukla, PK; Tandon, VK; Verma, MK | 1 |
| Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M | 1 |
| Mitsuyama, J; Nishikawa, H; Nomura, N; Yamada, E | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Abe, S; Asada, M; Haneda, T; Hata, K; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Tanaka, K; Tsukada, I; Ueda, N; Watanabe, N; Yoshimatsu, K | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| D'Ursi, AM; De Rosa, M; Di Marino, S; Fadda, G; Grimaldi, M; Posteraro, B; Sanguinetti, M; Scrima, M; Soriente, A | 1 |
| Afeltra, J; Moglioni, AG; Moltrasio, GY; Sarmiento, GP; Vitale, RG | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Cao, Y; Chai, X; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Aiello, S; Borghi, E; Boschi, D; Fruttero, R; Guglielmo, S; Morace, G | 1 |
| Deshpande, MV; Hazra, BG; Pore, VS; Salunke, DB; Shingate, BB; Shirazi, F | 1 |
| Bauer, J; Burger-Kentischer, A; Eickhoff, H; Finkelmeier, D; Jung, G; Kinast, S; Kleymann, G; Rayyan, WA; Rupp, S; Schröppel, K; Singh, A; Wiesmüller, KH | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y | 1 |
| Agarwal, AK; Babu, KS; Clark, AM; Jacob, MR; Khan, SI; Li, XC | 1 |
| Borate, HB; Chandavarkar, MA; Chavan, SP; Deore, JV; Iyer, R; Kangire, GS; Kudale, AS; Mahajan, PS; Rao, D; Sawargave, SP; Tawte, A | 1 |
| Camps, I; Coelho, LF; D' Dego, JL; Dias, AL; Dias, KS; dos Santos, MH; Januário, JP; Viegas, C | 1 |
| Chai, X; Hu, H; Liao, J; Wu, Q; Xu, M; Yu, S; Zhao, Q; Zou, Y | 1 |
| Bittker, JA; Dandapani, S; Dockendorff, C; Hartland, CL; Lindquist, S; Munoz, B; Palmer, M; Schreiber, SL; Vincent, B; Whitesell, L; Youngsaye, W | 1 |
| Hu, Y; Shen, F; Wang, K; Wang, L; Yang, W; Zhu, J | 1 |
| Ganesh Kumar, C; Poornima, M; Prabhavathi Devi, BL; Prasad, RB; Reddy, TV | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Akalin, G; Bertout, S; Demirci, F; Fulcrand, P; Maillard, LT; Martinez, J; Masurier, N; Quinonéro, O; Turan-Zitouni, G | 1 |
| Ablordeppey, SY; Boateng, C; Bolden, S; Etukala, JR; Flores-Rozas, H; Jacob, MR; Khan, SI; Mazu, T; Walker, LA; Zhu, XY | 1 |
| Araújo, AJ; Costa-Lotufo, LV; de Assis, PA; de Paula, JE; Espindola, LS; Grougnet, R; Kritsanida, M; Michel, S; Theodoro, PN | 1 |
| Cai, T; Cao, X; Cao, Y; Chu, W; Hu, W; Sun, Z; Wang, R; Yang, Y | 1 |
| Batchu, H; Batra, S; Mishra, A; Shukla, PK; Singh, P; Srivastava, K | 1 |
| Abruzzo, G; Card, D; Chen, T; Dreikorn, S; Flattery, A; Gill, C; Hornak, V; Kelly, R; Kurtz, M; Li, X; Liu, W; Meinz, M; Onishi, JC; Rosenbach, M; Shafiee, A; Singh, SB; Thompson, JR | 1 |
| Botta, M; Castagnolo, D; Donzellini, G; Posteraro, B; Sanfilippo, S; Sanglard, D; Sanguinetti, M | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Krátký, M; Novotná, E; Stolaříková, J; Trejtnar, F; Vinšová, J; Volková, M | 1 |
| Liang, GC; Song, YL; Wu, F; Yu, JJ; Zhang, CC; Zhou, G | 1 |
| Bardiot, D; Cammue, BP; Chaltin, P; Cos, P; De Brucker, K; Maes, L; Marchand, A; McNaughton, M; Peeters, A; Taborda, CP; Thevissen, K | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chopra, S; Kushwaha, P; Modukuri, RK; Pasupuleti, M; Rao, KB; Sashidhara, KV; Shukla, PK; Singh, P; Soni, I | 1 |
| Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD | 1 |
| Barbosa de Oliveira, R; Borelli, BM; Fonseca, NC; Johann, S; Lino, CI; Pereira de Sá, N; Ramos, JP; Rosa, CA; Santos, DA; Souza-Fagundes, EM | 1 |
| Akdemir, A; Bizzarri, B; Bolasco, A; Caprara, F; Carradori, S; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zicari, A | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Green, KD; Shrestha, SK | 1 |
| Krátký, M; Vinšová, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aktumsek, A; Bizzarri, B; Carradori, S; Chimenti, P; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zengin, G; Zicari, A | 1 |
| Chandrika, NT; Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Agarwal, AK; Jacob, MR; Khan, SI; Li, XC; Ravu, RR; Yu, BY; Yu, Q | 1 |
| Bondaryk, M; Mierzejewska, J; Milner-Krawczyk, M; Staniszewska, M; Łukowska-Chojnacka, E | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Benková, M; Hrabálek, A; Karabanovich, G; Kavková, V; Klimešová, V; Konečná, K; Macháček, M; Němeček, J; Roh, J; Soukup, O; Stolaříková, J; Sychra, P; Vávrová, K | 1 |
| Garneau-Tsodikova, S; Garzan, A; Shrestha, SK | 1 |
| Chauhan, CS; Dandia, A; Indora, A; Khan, S; Mahawar, DK; Pandya, P; Soni, P | 1 |
| Jacob, MR; Jain, R; Khan, SI; Kumar, V; Maurya, IK; Sharma, KK; Tikoo, K | 1 |
| Bizzarri, B; Carradori, S; D'Ascenzio, M; De Monte, C; Grande, R; Mari, E; Patsilinakos, A; Ragno, R; Rivanera, D; Sabatino, M; Secci, D; Zicari, A | 1 |
| Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J | 1 |
| Garneau-Tsodikova, S; Howard, KC; Ngo, HX; Shrestha, SK; Thamban Chandrika, N; Tsodikov, OV | 1 |
| Garneau-Tsodikova, S; Howard, KC; Ngo, HX; Shrestha, SK; Thamban Chandrika, N | 1 |
| Adamus, K; Gizińska, M; Koronkiewicz, M; Mikulak, E; Staniszewska, M; Łukowska-Chojnacka, E | 1 |
| Borelli, BM; de Oliveira Fernandes, P; de Oliveira, RB; Gonçalves de Souza, I; Johann, S; Lino, CI; Maltarollo, VG; Maria de Souza Fagundes, E; Ramos, JP; Santos Teixeira, IN; Silvério Matos, TT | 1 |
| Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z | 1 |
| Chen, S; He, S; Liu, X; Qiu, G; Shi, J; Tang, W; Wu, X; Xu, K; Zhang, J | 1 |
| Blundell, R; Butler, MS; Cooper, MA; Fraser, JA; Furlong, E; Kappler, U; Kobe, B; Kummari, LK; Nouwens, A; Robertson, AAB; Silva, AB | 1 |
| Gao, JY; Li, M; Niu, CW; Ren, T; Ruan, WB; Song, FH; Song, GQ; Wang, JG; Wang, L; Wu, RJ; Yao, Z; Yu, Q; Zhang, LX | 1 |
| Han, G; Ji, C; Li, Z; Liu, N; Sheng, C; Tu, J; Wang, Y | 1 |
| Zhang, B | 1 |
| Lombardo, M; Ortalli, M; Quintavalla, A; Rosso, C; Trombini, C; Varani, S | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Cacciatore, I; Ciulla, M; Di Stefano, A; Epifano, F; Eusepi, P; Fiorito, S; Fornasari, E; Genovese, S; Marinelli, L; Mingoia, M; Örtücü, S; Pugnaloni, A; Simoni, S; Turkez, H | 1 |
| Dalkara, S; Eşsiz, Ş; Gencel, M; Karakurt, A; Kart, D; Kaynak, FB; Öztürk, N; Saraç, S; Sari, S; Taşkor, G | 1 |
| Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
| Jin, YS | 1 |
| Braga, SS | 1 |
| Bai, H; Chen, L; Zhang, J; Zheng, S; Zhou, X; Zhu, R | 1 |
| Jaisingh, A; Maurya, IK; Salunke, DB; Singh, R | 1 |
| Abutaleb, NS; Hagras, M; Kotb, A; Mayhoub, AS; Salama, EA; Sayed, AM; Seleem, MN | 1 |
| Gazzola, S; Guillon, R; Le Pape, P; Logé, C; Montoir, D; Ourliac-Garnier, I; Pagniez, F; Picot, C; Planchat, A; Soklou, KE; Tonnerre, A | 1 |
| Mani Chandrika, KVS; Sharma, S | 1 |
| Ahmad, A; Al-Bogami, AS; Aqlan, FM; Wani, MY | 1 |
| Gabriel, I; Paluszkiewicz, E; Rząd, K | 1 |
| Razzaghi-Abyaneh, M; Shams-Ghahfarokhi, M; Teymuri, M | 1 |
| Cojean, S; Ferrié, L; Figadère, B; Le Pape, P; Loiseau, PM; Maciuk, A; Nguyen, LT; Pinet, A; Vásquez-Ocmín, P | 1 |
| Bahn, YS; Cheong, E; Choi, JW; Jang, BK; Kim, D; Kim, HJ; Kim, S; Lee, DG; Lee, JS; Lee, KT; Lee, MH; Lee, YR; Park, JH; Park, KD; Park, SJ; Seo, KJ; Yeon, SK | 1 |
| Ji, C; Li, J; Li, W; Liu, N; Sheng, C; Tu, J; Yang, W; Yun, Z | 1 |
| Cai, J; Fu, T; Hu, CH; Liao, G; Peng, Y; Wang, M; Zhang, X; Zhu, X | 1 |
| Masoodi, KZ; Padder, SA; Prasad, R; Ramzan, A; Rehman, RU; Shafi, S; Shah, AH; Tahir, I | 1 |
| Wingard, JR | 3 |
| Ariza, J; Carratalà, J; Martos, A; Mascaró, J; Podzamczer, D; Santín, M | 1 |
| Wheat, LJ | 1 |
| Van Cutsem, J | 1 |
| Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
| Lesher, JL | 1 |
| Bava, AJ; Negroni, R | 1 |
| Büchner, T; Roos, N | 1 |
| Lode, H; Schaberg, T | 1 |
| Lozano, MC; Martín, E; Parras, P | 1 |
| Wilson, DC | 1 |
| Hashino, S; Higa, T; Kasai, M; Kiyama, Y; Masauzi, N; Matsuura, A; Morii, K; Naohara, T; Tanaka, J; Watanabe, M | 1 |
| Rabaw, MY; Siegman-Igra, Y | 1 |
| Bordone, G; Colledan, M; Malaspina, C; Pagano, A; Paone, G; Rossi, G; Tortorano, AM; Viviani, MA | 1 |
| Mocsny, N | 1 |
| Bartholomew, WR; Goldstein, E; Penn, CC | 1 |
| Edwards, JE; Filler, SG; Fu, Y; Ghannoum, MA; Ibrahim, AS | 1 |
| Anaissie, E; Bodey, G; Gokaslan, A; Griffin, G; Hachem, R; Robinson, R; Rubin, R; Sobel, J | 1 |
| Bannatyne, RM; Cheng, PC; Fong, IW | 1 |
| Denning, DW | 1 |
| Foleno, B; Fu, KP; Isaacson, D; LoCoco, J | 1 |
| Cloud, GA; Follansbee, SE; Graybill, JR; Jacobson, JM; McAuliffe, VJ; Meyer, RD; Powderly, WG; Robinson, P; Saag, MS; Sugar, AM | 1 |
| Laatikainen, L; Tuominen, M; von Dickhoff, K | 1 |
| Bernacer, B; Carrasco, R; Navarro, V; Nieto, A; Rodríguez, M; Roig, P; Salavert, M | 1 |
| Edwards, JE; Filler, SG | 1 |
| Powderly, WG | 7 |
| Santamaría, JM; Zubero, Z | 1 |
| Tolins, JP | 1 |
| Dupont, B; Pialoux, G | 1 |
| Chevalier, MC; Damay, M; Gouraud, F; Jabado, N; Landman-Parker, J; Leverger, G; Varache, C | 1 |
| Dermoumi, H | 1 |
| Riggs, D; Santeiro, ML; Weibley, RE | 1 |
| Borregón Carretero, SJ; González Quijada, S; Pedrajas Navas, JM; Téllez Molina, J | 1 |
| Blade, J; Bordas, J; Bruguera, M; Carreras, E; Cervantes, F; Grañena, A; Lopez-Guillermo, A; Montserrat, E; Rozman, C; Sierra, J | 1 |
| Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J | 1 |
| Lange, JM; Reiss, P | 1 |
| Larsen, RA | 2 |
| Williams, KW | 1 |
| Johnson, TR; Karp, JE; Merz, WG; Rinaldi, MG; Saral, R; Wingard, JR | 1 |
| Soutar, RL | 1 |
| Colville, A; Wale, MC | 1 |
| Gerarden, T; Hollis, R; Isenberg, HD; Levenson, D; Pfaller, MA; Smith, MA; Tucci, CB | 1 |
| Cloud, GA; Fisher, JF; Grieco, MH; Powderly, WG; Robinson, P; Saag, MS; Sharkey, PK; Sugar, AM; Thompson, SE; Tuazon, CU | 1 |
| Glück, T; Weber, P; Wiedmann, KH | 1 |
| Bakker-Woudenberg, IA; van de Rhee, NE; van Etten, EW; van Kampen, KM | 1 |
| Bayer, AS; Witt, MD | 1 |
| Fernández-Nogués, F; Maña, J; Martinez-Lacasa, J; Niubó, R; Rufi, G; Saez, A | 1 |
| Brockmeyer, NH; Goos, M; Hantschke, D; Hengge, UA; Olbricht, T | 1 |
| Bozzette, SA; Chiu, J; Larsen, RA; Leal, MA; Leedom, JM; McCutchan, JA; Richman, DD; Tilles, JG | 1 |
| Bradley, SF; Kauffman, CA; Ross, SC; Weber, DR | 1 |
| Anaissie, E; Barnett, K; Bodey, GP; Bow, E; David, C; Defelice, R; Downs, N; File, T; Kantarjian, H; Karam, G | 1 |
| Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR | 1 |
| Sugar, AM | 1 |
| Akalin, HE; Akova, M; Gür, D; Uzun, O | 1 |
| Carroll, K; Classen, D; Cohen, S; Evans, TG; Mayer, J | 1 |
| Benson, JD; Padhye, AA; Sides, EH | 1 |
| Bianchi Porro, G; Cernuschi, M; Lazzarin, A; Parente, F; Rizzardini, G; Valsecchi, L | 1 |
| Graybill, JR; Sharkey, PK | 1 |
| Shindo, K | 1 |
| Jakab, K; Kelemen, E; Prinz, G; Török, I | 1 |
| Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM | 1 |
| Good, CB; Leeper, HF | 1 |
| Jakab, K; Kelemen, E; Török, I; Váradi, G | 1 |
| Dettori, G; Manzara, S; Morace, G | 1 |
| Andrac, L; Bonerandi, JJ; Dhiver, C; Fournerie, JR; Gastaut, JA; Grob, JJ; Poizot-Martin, I | 1 |
| Crislip, MA; Edwards, JE; Filler, SG; Mayer, CL | 1 |
| Chan, PC; Chau, SP; Cheng, IK; Lim, W | 1 |
| Aggarwal, R; Gibb, AP; Swainson, CP | 1 |
| Branger, J; Dekker, AW; Rozenberg-Arska, M; Verhoef, J | 1 |
| Bercy, P; De Beule, F; Ferrant, A | 1 |
| Allendoerfer, R; Graybill, JR; Marquis, AJ; Rinaldi, MG | 1 |
| Ikemoto, H | 1 |
| Finke, R | 1 |
| Ruf, B | 1 |
| Aoki, S; Bacher, J; Lee, J; Mechinaud, F; Pizzo, PA; Rubin, M; Walsh, TJ | 1 |
| Lucey, CR; Lucey, DR | 1 |
| Hector, RF; Yee, E | 1 |
| Linde, I; Mattie, H; Meynaar, I; Poell, R; Van 't Wout, JW; Van Furth, R | 1 |
| Meunier, F | 3 |
| Chan, LS; Larsen, RA; Leal, MA | 1 |
| Defaveri, J; Graybill, JR; Rinaldi, MG; Salazar, MH | 1 |
| Bacher, J; Kelly, P; Lecciones, J; Lee, JW; Peter, J; Pizzo, PA; Thomas, V; Walsh, TJ | 1 |
| Fukuchi, K; Gomi, K; Oguro, T; Sugita, M; Takagi, Y; Tanaka, Y; Wakuta, R | 1 |
| Powell, G; Reents, SB | 1 |
| Cavanna, C; Gramegna, G; Lombardi, G; Michelone, G | 1 |
| Watanabe, K | 2 |
| Fujita, S; Hisazumi, H; Nishikawa, T; Ohkawa, M; Takashima, M; Tokunaga, S; Wheat, RW | 1 |
| Lambert, C; Meunier, F; Van der Auwera, P | 1 |
| Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G | 1 |
| Kobayashi, GS; Medoff, G; Rinaldi, MG; Travis, SJ | 1 |
| Boettger, DW; Miedzinski, LJ; Taylor, GD; Tyrrell, DL | 1 |
| Gutman, LT; Moncino, MD | 1 |
| Noble, L; Picard, M; Sugar, AM | 1 |
| Mattie, H; van Furth, R; Van t Wout, JW | 1 |
| Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD | 1 |
| Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F | 1 |
| Fisher, MA; Lee, PG; Tarry, WF | 1 |
| Ahrens, J; Graybill, JR; Restrepo, BI | 1 |
| Dupont, B | 3 |
| Fisher, MA; Haddad, J; Shen, SH; Tarry, WF | 1 |
| Franzmann, M; Mathiesen, LR; Smith, E | 1 |
| Burns, RJ; Cochius, JI; Willoughby, JO | 1 |
| Polak, A | 1 |
| Byrne, WR; Wajszczuk, CP | 1 |
| Kobayashi, GS; Medoff, G; Travis, SJ | 1 |
| Walsh, TJ | 1 |
| de Graeff-Meeder, ER; Kuis, W; Paul, LC; van 't Wout, JW; van Furth, R | 1 |
| Saunders, C; Sugar, AM | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
| Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
| Kobayashi, GS; Medoff, G; Travis, S | 1 |
| Ahrens, J; Graybill, JR; Sun, SH | 1 |
| Diamond, RD; Lyman, CA; Sugar, AM | 1 |
| Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH | 1 |
| Dixon, DM; Polak, A | 1 |
| Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF | 1 |
| Huang, CT; Leu, HS | 2 |
| Kitamura, A; Nakajima, R; Sato, K; Someya, K; Tanaka, M | 1 |
| Castiglia, M; Fisher, MA; Smego, RA | 1 |
| Abramowsky, C; Ehrett, S; Friedland, I; Jafari, HS; McCracken, GH; Olsen, KD; Parras, F; Rinderknecht, S; Sáez-Llorens, X; Severien, C | 1 |
| Hussein, A; Meisenberg, B; Mudad, R; Paulson, EK; Peters, WP; Ross, M; Vredenburgh, J | 1 |
| Ito, H; Kawakami, N; Nishizaki, T; Sugiyama, S | 1 |
| Arning, M; Aul, C | 1 |
| Schaffner, A; Schaffner, M | 1 |
| Fothergill, AW; McGough, DA; Peter, J; Pizzo, PA; Rinaldi, MG; Walsh, TJ | 1 |
| Osborne, PJ; Quirk, PC; Walsh, LJ | 1 |
| Härtl, A; Hillesheim, HG; Künkel, W; Schrinner, EJ | 1 |
| Atkinson, BA; Bocanegra, R; Bouthet, C; Correa, A; Graybill, JR; Luther, MF | 1 |
| Conrad, PD; Kamitsuka, MD; Nugent, NA; Swanson, TN | 1 |
| Bale, M; Buschelman, B; Cooper, CR; Espinel-Ingroff, A; Lancaster, M; McGinnis, MR; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Hahn, K; Scheven, Ch; Scheven, M; Senf, A | 1 |
| Ehninger, G; Mölle, M; Schuler, U | 1 |
| De Cock, KM; Hay, RJ; Lucas, SB; Miller, RF | 1 |
| Baillie, F; Clink, H; Ellis, ME; Ernst, P; Greer, W; Halim, MA; Kalin, M; Spence, D | 1 |
| Hoeprich, PD | 1 |
| Boeschoten, EW; Krediet, RT; Kuijper, EJ; Struijk, DG | 1 |
| Berenguer, J; Bouza, E; Fernández-Baca, V; Sánchez, R | 1 |
| Ahearn, DG; Kalya, AV | 1 |
| Hall, MA; Hitchcock, RJ; Malone, PS; Pallett, A | 1 |
| Barry, AL; Pfaller, MA | 2 |
| Acritidou, E; Bibashi, E; Gompakis, N; Karpouzas, JG; Koliouskas, D; Roilides, E; Trahana, M | 1 |
| Ennis, DM; Saag, MS | 1 |
| Barry, AL; Nelson, PW; Pfaller, MA; Rex, JH; Webb, CD | 1 |
| Denning, DW; Ganguli, LA; Keaney, MG; Law, D; Moore, CB; Wardle, HM | 1 |
| Kreis, H; Legendre, C; Page, B; Thervet, E | 1 |
| Bonner, DP; Fung-Tomc, JC; Huczko, E; Kessler, RE; Kolek, B; Minassian, B | 1 |
| Itoh, T; Kakei, M; Kawamata, N; Nozoe, S; Tanaka, H; Yamada, H; Yamaguchi, A | 1 |
| Basset, D; Dubois, N; Fourgeaud, M; Herrmann, JL; Lagrange, PH | 1 |
| Baltch, AL; Franke, MA; Gordon, MA; Louie, A; Smith, RP | 1 |
| Cross, JT; Hickerson, SL; Yamauchi, T | 1 |
| de Lalla, F; Fabris, P; Franzetti, M; Manfrin, V; Pellizzer, G; Stecca, C; Vaglia, A | 1 |
| Bhakdi, S; Jahn, B; Martin, E; Stueben, A | 1 |
| Akler, ME; Gold, WL; McNeely, DM; Vellend, H; Walmsley, SL | 1 |
| Adams, R; Bowden, RA; Feldman, AR; Levenstein, MJ; Meyers, JD; Osborne, B; Schoch, HG; Slavin, MA | 1 |
| Hay, RJ | 1 |
| Boillot, F; Fournier, C; Gaspar, A; Villard, J | 1 |
| Hollis, RJ; Messer, SA; Pfaller, MA | 1 |
| Hitchcock, CA; Picard, M; Sugar, AM; Troke, PF | 1 |
| Anaissie, EJ; Dignani, MC; Karyotakis, NC | 1 |
| Ninane, J | 1 |
| Belcher, KE; Law, EJ; Spencer, SA; Still, JM | 1 |
| Mangino, JE; Moser, SA; Waites, KB | 1 |
| Goetz, MB; White, A | 1 |
| Kitamura, S; Shibuya, Y | 1 |
| Adrados, M; Laguna, F; Martínez-Suárez, JV | 1 |
| Elewski, BE; Woods, SG | 1 |
| Baltch, AL; Franke, MA; Gordon, MA; Louie, A; Ritz, WJ; Singh, JK; Smith, RP | 1 |
| Dewsnup, DH; Stevens, DA | 1 |
| Teira, R | 1 |
| Montalvo, JA; Montaner, A; Morales, L; Ribó, JM; Torino, JR | 1 |
| Joly, V | 1 |
| Boccanera, M; Cassone, A; De Bernardis, F; Girmenia, C; Martino, P; Micozzi, A | 1 |
| Chapman, A; Piecuch, R; Weintrub, PS | 1 |
| DiNubile, MJ | 2 |
| Cofsky, RD | 1 |
| Girmenia, C; Martino, P | 2 |
| Crook, DW; Howe, P; Tang, CM | 1 |
| Arias-Díaz, J; Balibrea, JL; Barrientos, A; García, C; Marañés, JP; Rabadán, PM; Vara, E | 1 |
| Solomkin, JS | 1 |
| Espinel-Ingroff, A; Fothergill, A; Grant, C; Lancaster, M; McGinnis, MR; Pasarell, L; Pfaller, MA; Rinaldi, MG; Steele-Moore, L; Vu, Q | 1 |
| Bale, M; Buschelman, B; Espinel-Ingroff, A; Lancaster, M; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Bennett, JE; Dine, AP; Edwards, JE; Karchmer, AW; Pappas, PG; Rex, JH; Scheld, WM; Sugar, AM; van der Horst, CM; Washburn, RG | 1 |
| Becherer, PR; Joist, JH; Milligan, T; Sokol-Anderson, M | 1 |
| Wheat, J | 1 |
| Dekker, AW; Rozenberg-Arska, M; Verdonck, LF | 1 |
| Bale, MJ; Buschelman, B; Espinel-Ingroff, A; Lancaster, M; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Atkinson, BA; Bocanegra, R; Colombo, AL; Graybill, JR | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
| Pahls, S; Schaffner, A | 1 |
| Ichihara, T; Katayama, K; Koizumi, S; Konishi, M; Maekawa, S; Seki, H; Tamaru, Y; Taniguchi, N; Yamagami, M | 1 |
| Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC; Paetznick, V; Rex, JH | 1 |
| Dan, M; Priel, I | 1 |
| Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B | 1 |
| Cartledge, J; Fisher, M; Gazzard, BG; Nelson, MR; Rogers, T | 1 |
| Bille, J; Boerlin, P; Boerlin-Petzold, F; Chave, JP; Durussel, C; Glauser, MP; Vuffray, A | 1 |
| DeGregorio, R; Esperanza, LE; Greene, JN; Haight, DO; Sandin, RL; Spiers, AS | 1 |
| Cloud, GA; Dismukes, WE; Powderly, WG; Saag, MS | 1 |
| Stevens, DA | 1 |
| Bickers, DR | 1 |
| Furuse, F; Hara, N; Ikeda, T; Inoue, H; Kotoh, H; Nakanishi, Y; Yatsunami, J | 1 |
| Chan, CY; Chan, TM; Cheng, IK; Cheng, SW; Lo, CY; Lo, WK | 1 |
| Bhakdi, S; Maier, F; Martin, E | 1 |
| Demajo, WA; Devenyi, RG; Menezes, AV; Sigesmund, DA | 1 |
| Alcouloumre, MS; Edwards, JE; Ghannoum, MA; Ibrahim, AS; Selsted, ME | 1 |
| Bakker-Woudenberg, IA; van den Heuvel-de Groot, C; van Etten, EW | 1 |
| Alvarez Blanco, A; Alvarez, C; Floristán, F; Hernández, I; Hernández, J; Ponton, J; Sarcía-Ruiz, JC | 1 |
| Holubka, J; Khatib, R; Sarmiento, R | 1 |
| Cannon, L; Cherukuri, R; Kahn, RN; Skelcy, KM; Thakur, RK | 1 |
| Anaissie, EJ; Bodey, GP; Elting, LS; Estey, E; Kantarjian, H; O'Brien, S | 1 |
| Maher, D; Mwandumba, H | 1 |
| Ko, KF | 1 |
| Aznar, C; Boccon-Gibod, L; Landman, J; Lasfargues, G; Leverger, G; Tabone, MD | 1 |
| Barbui, T; Bucaneve, G; Carotenuto, M; D'Antonio, D; Del Favero, A; Fasola, G; Liso, V; Mandelli, F; Martino, P; Menichetti, F; Micozzi, A; Nosari, AM; Ricci, P | 1 |
| Akiyama, H; Mori, S; Onozawa, Y; Sakamaki, H; Tanikawa, S | 1 |
| Hinthorn, DR; Klotz, SA; Zahid, MA | 1 |
| Alter, SJ; Farley, J | 1 |
| Klein, HG; Kumar, P; Sloand, EM; Yu, M | 1 |
| Bailey, CJ; Cartledge, JM; Morris, SA | 1 |
| Altés, A; Brunet, S; Domingo-Albós, A; Martínez, C; Martino, R; Nomdedéu, J; Sureda, A | 1 |
| Cabezudo, E; Cancelas, JA; Diz, P; Garcia Laraña, J; Jimenez Mena, M; Lopez, J; Navas, E; Perez de Oteyza, J; Sanchez-Sousa, A; Villalon, L | 1 |
| Blaauwgeers, JL; Dirks-Go, S; Kok, I; Rietra, PJ; Veenstra, J; Weigel, HM | 1 |
| Borne, MJ; Elliott, JH; O'Day, DM | 1 |
| Flynn, PM; Hughes, WT; Marina, NM; Rivera, GK | 1 |
| Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC; Samonis, G | 1 |
| Uchida, K; Yamaguchi, H | 1 |
| Agrawal, RM; Ashok, PS; Brodmerkel, GJ; Girgis, RM; Ravi, J; Reed, PA | 1 |
| Karp, JE; Merz, WG; Miller, CB; Rinaldi, MG; Saral, R; Wingard, JR | 1 |
| Bayer, AS; Imhoff, T; Li, C; Witt, MD | 1 |
| Koga, H; Kono, S | 1 |
| Johnson, JR | 1 |
| Edwards, JE; Filler, SG; Swerdloff, JN | 1 |
| Nomura, J; Ruskin, J | 1 |
| Huijgens, PC; Sibinga, L; Zweegman, S | 1 |
| Drew, RH | 1 |
| Garg, AK; Hamir, Z; Padhye, AA; Sekhon, AS | 1 |
| Buchanan, WE; Hasbargen, JA; Quinn, MJ | 1 |
| Casadevall, A; Rinaldi, MG; Spitzer, ED; Webb, D | 1 |
| Bissell, V; Felix, DH; Wray, D | 1 |
| Andriole, VT; George, D; Kordick, D; Miniter, P; Patterson, TF | 1 |
| Ivatury, RR; Jabbour, N; Nassoura, Z; Simon, RJ; Stahl, WM | 1 |
| Erbslöh-Möller, B; Sack, K; Steinhoff, J | 1 |
| Menon, T; Ponnuvel, KM; Rama, CP | 1 |
| Brammer, KW; Ehninger, G; Mufti, GJ; Philpott-Howard, JN; Wade, JJ | 1 |
| Fetchick, R; Graybill, JR; Sharkey-Mathis, PK; Velez, J | 1 |
| Klauss, V; Lund, OE; Miño de Kaspar, H | 1 |
| Bozzette, SA | 1 |
| Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV | 1 |
| Conejo, C; García, I; Pascual, A; Perea, EJ | 1 |
| Tang, C | 1 |
| Kaku, M; Koga, H; Kohno, S; Maesaki, S; Yamada, H | 1 |
| Beaulieu, D; Parr, TR; Tang, J; Zeckner, DJ | 1 |
| Douketis, JD; Kesten, S | 1 |
| Drummond, DC; McCormack, JG; Whitman, LM; Wong, CW | 1 |
| Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
| Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM | 1 |
| Claeys, G; Colardyn, F; De Deyne, C; de Hemptinne, B; Decruyenaere, J; Hesse, U; Hoste, E; Lutz-Dettinger, N; Vandewoude, K; Vogelaers, D | 1 |
| Casadevall, A; Currie, B; Edwards, JE; Ghannoum, MA; Ibrahim, AS; Sanati, H | 1 |
| Althaus, BL; Lam, HH | 1 |
| Fothergill, AW; Rinaldi, MG; To, WK | 1 |
| Albisetti, M; Braegger, CP; Nadal, D | 1 |
| Hof, H; Kretschmar, M | 1 |
| Criddle, RS; Edwards, JE; Fu, Y; Ghannoum, MA; Ibrahim, AS; Mortara, LA; Shafiq, MC | 1 |
| Mills, K; Nelson, PW; Rex, JH; Wanger, A | 1 |
| Chandna, A; Haslett, RS; McGalliard, JN; Moriarty, AP; Vijayadurai, P | 1 |
| Finlay, PM; Richardson, MD; Robertson, AG | 1 |
| Bamberger, M; Eng, RH; Fan-Havard, P; O'Donovan, C; Oh, J; Smith, SM | 1 |
| Bennett, JE; Edwards, JE; Pappas, PG; Rex, JH; Serody, J; Sugar, AM; Washburn, RG | 1 |
| Engstrom, RE; Glasgow, BJ; Holland, GN; Kreiger, AE; Wool, MG | 1 |
| Kralovic, SM; Rhodes, JC | 1 |
| Morris, AJ; Nguyen, MH; Nguyen, ML; Peacock, JE; Rinaldi, MG; Snydman, DR; Tanner, DC; Wagener, MM; Yu, VL | 1 |
| Okazawa, Y; Tosaka, M; Yamane, N | 1 |
| Dunne, D; Finkelstein, FO; Goldie, SJ; Gorban-Brennan, N; Kiernan-Tridle, L; Kliger, AS; Torres, C | 1 |
| Chanock, SJ; Gonzalez, C; Lyman, CA; Pizzo, PA; Walsh, TJ | 1 |
| Anaissie, EJ; Uzun, O | 1 |
| Brugiere, O; Dromer, F; Dupont, B; Letenneur, L; Mathoulin, S | 1 |
| Martinez-Suarez, JV; Rodriguez-Tudela, JL | 2 |
| Liu, XP; Sugar, AM | 1 |
| Arranz-Caso, JA; García-Altozano, J; Gomez-Herruz, P; Lopez-Pizarro, VM; Martinez-Martinez, J | 1 |
| Medoff, G | 1 |
| Manne, RK; Ramirez, FC; Sanowski, RA; Stone, HH; Walker, GJ | 1 |
| Belcher, K; Law, EJ; Still, JM | 1 |
| Barry, AL; Pfaller, MA; Rex, JH; Rhine-Chalberg, J | 1 |
| De Rojas Silva, MV; Fente Sampayo, B; Gallegos Chamas, G; Pereiro, M; Rodriguez-Ares, MT; S-Salorio, M | 1 |
| Kume, H; Murase, S | 1 |
| Abi-Said, D; Anaissie, EJ; Bodey, GP; Gardner, A; Gilbreath, J; Khoury, P; Kontoyiannis, DP; Papadakis, K; Pinczowski, H; Raad, II; Uzun, O; Vartivarian, SE | 1 |
| Blaschke-Hellmessen, R; Kabus, M; Kaulen, F; Schwarze, R; Wendisch, J | 1 |
| Bramnert, M; Castor, B; Dejmek, A; Klingspor, L; Lorén, I; Papadopoulos, KI | 1 |
| Choo, KE; Hanifah, MJ; Wahab, JA | 1 |
| Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
| Berrouane, YF; Hollis, RJ; Pfaller, MA | 1 |
| Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P | 1 |
| Hashimoto, S; Horie, T; Inami, T; Nakayama, T; Nishinarita, S; Tomita, Y | 1 |
| Joosten, L; Surmont, I; van Eldere, J; Verhaeghe, V | 1 |
| Fox, N; Freeman, K; Jacobs, LG; Lipschultz, D; Skidmore, EA | 1 |
| Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD | 1 |
| Bollens, D; Deluol, AM; Frottier, J; Mayaud, C; Meynard, JL; Meyohas, MC; Poirot, JL; Roux, P; Rozenbaum, W | 1 |
| Benedetti, E; Dunn, DL; Gruessner, AC; Gruessner, RW; Papalois, BE; Sutherland, DE; Troppmann, C | 1 |
| Bartlett, ST | 1 |
| Cox, GM; Dodge, RK; Perfect, JR; Schell, WA | 1 |
| Fujita, S | 1 |
| Capobianco, JO; Goldman, RC; Griffin, JH; Sharpe, BA; Zakula, D | 1 |
| Martins, MD; Rex, JH | 1 |
| Bryant, KK; Lewis, JJ; Rabalais, GP; Samiec, TD | 1 |
| Friedland, IR | 1 |
| Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU | 1 |
| Berenguer, J; Martínez-Suárez, JV; Rodríguez-Tudela, JL; Sanchez, R | 1 |
| Denning, DW; Law, D; Wardle, HM | 1 |
| Borum, M; Le, TP; Levine, M; Rollhauser, C; Tuazon, CU | 1 |
| Anaissie, EJ; Ensign, LG; Espinel-Ingroff, A; Galgiani, JN; Hitchcock, CA; LaRocco, M; Paetznick, VL; Patterson, T; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Hara, N; Hashimoto, S; Kawasaki, M; Nakanishi, Y; Nomoto, Y; Takayama, K; Tsuruta, N; Wakamatsu, K; Yatsunami, J | 1 |
| Galgiani, JN; Ghannoum, MA; Rex, JH | 1 |
| Casadevall, A; Feldmesser, M; Harris, C; Khan, S; Reichberg, S | 1 |
| Fujimoto, K; Kubo, K; Sekiguchi, M; Tsushima, K | 1 |
| Abi-Said, D; Anaissie, EJ; Bodey, GP; Darouiche, RO; Gentry, LO; Karl, CL; Kontoyiannis, DP; Mera, J; Uzun, O; Williams, T | 1 |
| Love, DN; Malik, R; Medeiros, C; Wigney, DI | 1 |
| Einsele, H; Kelly, DE; Kelly, SL; Lamb, DC; Loeffler, J | 1 |
| Djeu, JY; Greene, JN; Hiemenz, JW; Rosemurgy, AS; Sweeney, JF; Wei, S | 1 |
| García, MT; Lima, JE; Llorente, MT; Mínguez, F; Prieto, J | 1 |
| Clark, AB; Gelfand, MS; Lobo, BL | 1 |
| Cooper, PA; De Villiers, FP; Driessen, M; Ellis, JB; Gous, H; Hahn, D; Muwazi, F; Wainer, S | 1 |
| Barson, WJ; Marcon, MJ | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Dix, S; Falconer, DJ; Geller, R; Gilmore, C; Nolte, FS; Parkinson, T; Williams, J; Wingard, JR | 1 |
| Goto, Y; Hashimoto, A; Nagai, H; Nasu, M; Perparim, K; Tashiro, T | 1 |
| Alonso, J; Iglesias, L; Rodriguez-Peralto, JL; Romero, G; Sanchez-Albisua, B; Vanaclocha, F | 1 |
| Einsele, H; Hebart, H; Kelly, DE; Kelly, SL; Lamb, DC; Loeffler, J; Manning, NJ; Schumacher, U | 1 |
| Bregenzer, T; Evison-Eckstein, AC; Frei, R; Zimmerli, W | 1 |
| Jones, RN; Messer, S; Pfaller, MA | 1 |
| Casadevall, A; Franzot, SP | 1 |
| Bastide, JM; Mallié, M | 1 |
| Ibáñez-Lucía, P; León-Gil, C; León-Regidor, MA; Martínez-González, J; Nolla-Salas, J; Sitges-Serra, A; Torres-Rodríguez, JM | 1 |
| Inouye, S; Kondo, S; Ohtsuka, K; Orikasa, Y; Takeuchi, T; Uchida, K; Watanabe, M; Yamaguchi, H | 1 |
| Goldman, M; Lee, YP | 1 |
| al Soub, H; Estinoso, W | 1 |
| Cao, B; Samaranayake, LP; Tsang, DN; Tsang, PW; Wang, J | 1 |
| Mirels, LF; Stevens, DA | 1 |
| Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 3 |
| Caselli, D; Castagnola, E; Congiu, M; Fanci, R; Garaventa, A; Giacchino, M; Menichetti, F; Moroni, C; Rossi, MR; Van Lint, MT; Viscoli, C | 1 |
| Kelly, SL; Manning, NJ; Rinaldi, MG; Taylor, M; Venkateswarlu, K | 1 |
| Afschrift, M; Claessens, Y; Deroo, M; Naeyaert, JM; Petrovic, M; Verplancke, P; Vogelaers, D | 1 |
| Busuttil, RW; Goldstein, L; Holt, CD; Imagawa, DK; Kubak, B; Martin, P; Millis, JM; Olthoff, K; Shackleton, CR; Shaked, A; Winston, DJ | 1 |
| Igari, J; Yamane, N | 1 |
| Colin, S; Dannaoui, E; Pichot, J; Piens, MA | 1 |
| González-Lahoz, JM; Laguna, F; Moreno, V; Polo, R; Valencia, E | 1 |
| Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
| Arikan, S; Cetinkaya, Y; Kocagöz, S; Unal, S; Uzun, O | 1 |
| Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
| Eagle, RC; Rodriguez, A; Tasman, W; Wong, VK | 1 |
| Gøtzsche, PC; Johansen, HK | 6 |
| Bowden, RA; Einsele, H; Engelhard, D; Hebart, H; Kanz, L; Löffler, J; Müller, CA; Roller, G; Rothenhofer, I; Schumacher, U; van Burik, J | 1 |
| Hacek, DM; Noskin, GA; Obias, AA; Peterson, LR; Tornatore, MA | 1 |
| Bayer, AS; Ghannoum, MA; Ramos, CF; Sanati, H | 1 |
| Digranes, A; Lassen, J; Nilsen, K; Sandven, P; Tjade, T | 1 |
| Jones, RN; Klepser, ME; Nightingale, CH; Pfaller, MA; Wolfe, EJ | 1 |
| Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
| André, P; Baud, O; Boithias, C; Chabernaud, JL; Dehan, M; Frydman, R; Guibert, M; Lacaze-Masmonteil, T; Nordmann, P; Ville, Y; Zupan, V | 1 |
| Cloud, GA; Dismukes, WE; Graybill, JR; Hamill, RJ; Johnson, PC; Kerkering, T; Moskovitz, BL; Powderly, WG; Saag, MS; Sobel, JD; Tuazon, CU; van der Horst, CM | 1 |
| Bistoni, F; Cenci, E; Del Sero, G; Mencacci, A; Romani, L | 1 |
| White, TC | 1 |
| Conly, JM; Fong, I; Garber, G; Ioannou, S; Miller, M; Phillips, P; Rotstein, C; Salit, I; Shafran, S; Singer, J; Smaill, F; Williams, K | 1 |
| Jaruratanasirikul, S | 1 |
| Ramani, A; Ramani, R; Wong, SJ | 1 |
| Kozelj, M; Lejko-Zupanc, T | 1 |
| Lai, PH; Lin, SM; Pan, HB; Yang, CF | 1 |
| Evans, S; Leake, H; Ustianowski, AP | 1 |
| Casado, JL; Cobo, J; Corral, I; Moreno, A; Navas, E; Oliva, J; Pintado, V; Quereda, C | 1 |
| Lee, K; Scherer, WJ | 1 |
| Balza, R; Barros, J; Bianchi, G; Cáceres, AM; Guevara, R; Marcano, C; Nuñez, M; Redondo, MC; Rosario, V; Sardiñas, C; Silva, M | 1 |
| Aleck, KA; Bartley, DL | 1 |
| Hedderwick, S; Kauffman, CA | 1 |
| Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U | 1 |
| Allworth, T; Borleffs, JC; Clezy, K; de Marie, S; Hop, WC; Hoy, J; Jones, P; Kauffmann, RH; Kroon, FP; Leenders, AC; Portegies, P; Reiss, P; Verbrugh, HA | 1 |
| Castagnola, E; Machetti, M; Viscoli, C | 1 |
| Chen, RJ; Liu, XP; Sugar, AM | 1 |
| Yamaguchi, H | 3 |
| Asari, S; Endo, T; Shimomura, Y; Tahara, K; Yanagihara, T | 1 |
| Bone, WD; Gray, GC; Martin, CR; Oldfield, EC; Olson, P; Schillaci, RF | 1 |
| Kauffman, CA; Spiegel, JE; Tiballi, RN; Zarins, LT | 1 |
| Espinel-Ingroff, A | 2 |
| Haberreiter, A; Paule, I; Seidl, HP; Wildfeuer, A | 1 |
| Bouza, E | 1 |
| Graybill, JR | 2 |
| Burgaleta, C | 1 |
| Bouza, E; Muñoz, P | 1 |
| Fortun Abete, J | 1 |
| Berenguer Berenguer, J | 1 |
| Kumar, BR; Kumar, RR; Lakshmaiah, KC; Shafiulla, M; Sridhar, H | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Barnes, RA; Flanagan, PG | 1 |
| Hamdan, JS; Oréfice, F; Sena, CM; Tanure, MA; Vieira-Dias, D | 1 |
| Akova, M; Arikan, S; Gür, D | 1 |
| Muñoz García de Paredes, P | 1 |
| Aguado García, JM; Caballero Cubedo, R; Cobo Reinoso, P; Lumbreras Bermejo, C; Noriega Rodríguez, AR; Pérez Vela, JL; Sanz Sanz, F | 1 |
| Eagle, RC; Frayer, WC; Orlin, SE; Sulewski, ME; Weissgold, DJ | 1 |
| Chen, CJ; Chen, YC; Kuo, NW; Sheu, SJ; Wang, JH | 1 |
| Balloul, E; Cahite, I; Caubarrère, I; Couderc, LJ; Molina, JM; Saimot, AG; Wolff, M | 1 |
| Elzi, M; Reusser, P; Tolnay, M | 1 |
| Glasmacher, A; Just-Nübling, G; Molitor, E | 1 |
| Arzeni, D; Barchiesi, F; Compagnucci, P; Di Francesco, LF; Giacometti, A; Scalise, G | 1 |
| Bader, D; Hershman-Sarafov, M; Srugo, I; Tubi, O | 1 |
| Bauer, M; Daniel, BE; Diamond, DM; Ding, JC; Graybill, JR; Johnson, D; Larsen, RA; Leal, MA; Najvar, L; Thomas, AM; Williams, BK | 1 |
| Seaton, RA | 1 |
| Gould, IM; Kunova, A; Milne, K; Wood, W | 1 |
| Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
| Demitrovicova, A; Kralovicova, K; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Mrazova-Studena, M; Oravcova, E; Spanik, S; Stopkova-Grey, K; Trupl, J | 1 |
| Klepser, ME; Pfaller, MA; Wolfe, EJ | 1 |
| Lorenz, KJ; Maier, H; Wallner, F | 1 |
| Berger, TG; Cunningham, ET; Horton, JC; Howes, EL; Lizotte, PE; Seiff, SR | 1 |
| Bentata, M; Bouges-Michel, C; Guillevin, L; Jarrousse, B; Launay, O; Lortholary, O | 1 |
| Blumberg, HM; Dibb, JC; Edwards, JE; Houston, A; Jarvis, W; Martin, MA; Messer, SA; Neu, HC; Patterson, JE; Pfaller, MA; Rangel-Frausto, MS; Rinaldi, MG; Roldan, CM; Saiman, L; Wenzel, RP; Wiblin, T | 1 |
| Bacci, A; Bistoni, F; Cenci, E; Del Sero, G; Fé d'Ostiani, C; Mencacci, A; Montagnoli, C; Romani, L | 1 |
| Beloborodova, NV; Boĭko, NB; Demina, AM; Kurchavov, VA; Pozdorovkina, VV; Rogatina, EA | 1 |
| Blaschke-Hellmessen, R; Schwarze, R; Seebacher, C | 1 |
| Aguado, JM; Colina, F; del Palacio, A; Gómez, R; Herrero, JA; Lizasoain, M; Lumbreras, C; Miguélez, M; Moreno, E; Rodríguez-Noriega, A | 1 |
| Fowler, SL; Hollis, RJ; Messer, SA; Pfaller, MA; Rhoton, B; Springer, SC | 1 |
| Suzuka, T; Umemura, A | 1 |
| Ernst, EJ; Klepser, ME; Lewis, RE; Lund, BC; Pfaller, MA | 1 |
| Ainbinder, DJ; Mader, TH; Nelson, ML; Parmley, VC | 1 |
| Badrinath, SS; Biswas, J; Gopal, L; Madhavan, HN; Parikh, S; Sharma, T | 1 |
| Alvarez Marcos, R; Fernández Gutiérrez, F; Guzmán Cabañas, J; Huertas Muñoz, MD; Jaraba Caballero, MP; Jaraba Caballero, S; Muriel Zafra, I; Zapatero Martínez, M | 1 |
| Behre, G; Büchner, T; Eimermacher, H; Grote-Metke, A; Hiddemann, W; Kerkhoff, A; Kern, W; Kubica, U; Rudolf, T; Wörmann, B | 1 |
| Arsura, EL; Caldwell, JW; Einstein, HE; Freeman, JC; Johnson, RH; Kilgore, WB | 1 |
| Ellepola, AN; Samaranayake, LP | 5 |
| Aiyar, S; Haq, JA; Menon, BS; Noh, LM; Shuaib, IL; Zamari, M | 1 |
| Arikan, S; Chen, Y; Coffman, S; Heffner, T; Lozano-Chiu, M; Messer, SA; Pfaller, MA; Rennie, R; Rex, JH; Sand, C; Wang, J; Yamane, N | 1 |
| Bruno, C; Curone, M; Finquelievich, J; Gamba, A; Pescio, A; Roel, JE | 1 |
| Warnock, DW | 1 |
| Arceneaux, KA; Hosgood, G; Taboada, J | 1 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Hinthorn, D; Luchi, M; Saberhagen, C | 1 |
| Fothergill, AW; Graybill, JR; Najvar, LK; Restrepo, MI | 1 |
| Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA | 1 |
| Johnson, EM; Rogers, TR; Warnock, DW | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| Matsumura, M; Mori, T; Oguri, T | 1 |
| Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
| Carbon, C; Joly, V | 1 |
| Davis, RD; Howell, DN; Lawrence, CM; Miralles, AP; Palmer, SM; Perfect, JR; Tapson, VF | 1 |
| Bordón, J; de la Fuente, J; Fernández-Ulloa, J; Martínez-Vázquez, C; Ocampo, A; Rubianes, M; Sopeña, B | 1 |
| Barza, M | 1 |
| Nguyen, MH; Yu, CY | 1 |
| Aziz, Z; Khan, S; Malik, IA; Moid, I; Suleman, M | 1 |
| Graninger, W; Presterl, E | 1 |
| Ernst, EJ; Klepser, ME; Pfaller, MA | 2 |
| Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Grausová, S; Krcméry, V; Krupová, I; Mardiak, J; Roidová, A; Sálek, T; Spánik, S; Sufliarsky, J; Trupl, J | 1 |
| Casadevall, A; Cleare, W; Franzot, SP; Nosanchuk, JD | 1 |
| Berrouane, YF; Herwaldt, LA; Pfaller, MA | 1 |
| Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Grausova, S; Hanzen, J; Krcmery, V; Kunova, A; Mateicka, F | 1 |
| Amerongen, AV; Helmerhorst, EJ; Reijnders, IM; Simoons-Smit, I; van't Hof, W; Veerman, EC | 1 |
| Nielsen, H; Rössel, P; Schønheyder, HC | 1 |
| Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H | 1 |
| Johnson, SA; Rule, SA; Turner, DL | 1 |
| Alva, EM; Khayr, W | 1 |
| Antrum, J; Hewetson, M; Mehta, J; Powles, R; Richardson, C; Stewart, A | 1 |
| Conly, J; Dranitsaris, G; Garber, G; Ioannou, S; Miller, M; Phillips, P; Puodziunas, A; Rotstein, C; Salit, I; Shafran, S; Singer, J; Smaill, F; Williams, K | 1 |
| Alonso, M; García, F; Gatell, JM; Mallolas, J; Miró, JM; Ortega, M; Soriano, A; Soriano, E | 1 |
| Grausova, S; Grey, E; Krcmery, V; Krupova, I; Kunova, A; Mateicka, F; Pichnova, E; Sabo, A; Spanik, S; Trupl, J | 1 |
| Belhadj, S; Ben Abid, H; Boussen, N; Chaker, E; Kallel, K; Kilani, B; Mejri, H; Zouiten, F; Zribi, A | 1 |
| Borro, JM; Calvo, V; Morales, P; Morcillo, A; París, F; Tarrazona, V; Vicente, R | 1 |
| Ayagiri, A; Bansal, R; Kalita, J; Misra, UK | 1 |
| Bocanegra, R; de las Heras, FG; Fothergill, A; Graybill, JR; Najvar, L | 1 |
| de Pauw, BE; Meunier, F | 1 |
| Sobel, JD | 1 |
| Ambroise-Thomas, P; Brion, JP; Grillot, R; Lebeau, B; Pavese, P | 1 |
| Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
| Ayeni, O; Khatib, R; Riederer, KM; Wilson, FM | 1 |
| Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I | 1 |
| Cuenca-Estrella, M; Rodríguez-Tudela, JL | 1 |
| Fujimori, Y; Kakishita, E; Kanamaru, A; Okada, M; Okamoto, T; Takatsuka, H; Takemoto, Y; Tamura, S; Wada, H | 1 |
| Anaissie, EJ; Arikan, S; Lozano-Chiu, M; Paetznick, VL; Rex, JH | 1 |
| Aquino, VR; Dargél, AA; Goldani, LZ | 1 |
| Bila, J; Bogdanović, A; Colović, M; Colović, R; Janković, G; Lazarević, V; Suvajdzić, N | 1 |
| Chang, HW; Chang, WN; Chuang, YC; Lu, CH | 1 |
| Bacher, J; Bell, A; Candelario, M; Groll, AH; Lyman, CA; McMillian, CL; Petraitiene, R; Petraitis, V; Sein, T; Walsh, TJ | 1 |
| El-Menyawi, I; Graninger, W; Lassnigg, A; Mueller-Uri, P; Presterl, E | 1 |
| Adachi, A; Horikawa, T; Ichihashi, M; Komura, A; Takashima, T | 1 |
| Martín Dávila, P; Muñoz Labián, V; Pintado García, V; Quereda Rodríguez-Navarro, C | 1 |
| Bacher, J; Calendario, M; Field-Ridley, A; Groll, AH; Petraitiene, R; Petraitis, V; Piscitelli, SC; Walsh, TJ | 1 |
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Bujdáková, H; Dierich, MP; Gruber, A; Klobusický, M; Kurisková, S; Langgartner, M; Lell, CP; Spötl, L; Würzner, R | 1 |
| Grey, E; Jurga, L; Krcmery, V; Kunova, A; Mardiak, J; Mateicka, F; Mrazova, M; Novotny, J; Sabo, A; Sevcikova, L; Sorkovska, D; Sufliarsky, J; Trupl, J; West, D | 1 |
| de Vries, HG; Eikelboom, MC; Kuipers, ME; Meijer, DK; Swart, PJ | 1 |
| Gubbins, PO; McConnell, SA; Penzak, SR | 1 |
| Alonso-Vargas, R; Arévalo, P; Bornay-Llinares, FJ; Carrillo-Muñoz, AJ; del Valle, O; Gasser, I; Quindós, G; Ruesga, MT; Santos, P; Tur-Tur, C | 1 |
| Gotzsche, PC; Johansen, HK | 2 |
| Ariffin, H; Ariffin, W; de Bruyne, J; Lin, HP; Omar, A; Tharam, S | 1 |
| Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC | 1 |
| Banerjee, P; Drusano, GL; Louie, A; Miller, MH; Shayegani, M | 1 |
| Al-Abdely, HM; Graybill, JR; Loebenberg, D; Melby, PC | 1 |
| Brown, P; Jandourek, A; Vazquez, JA | 1 |
| Bash, E; Giladi, M; Izkhakov, E; Orni-Wasserlauf, R; Polacheck, I; Siegman-Igra, Y | 1 |
| Lin, KJ; Tzen, KY; Yen, TC | 1 |
| Kuhara, T; Uchida, K; Yamaguchi, H | 1 |
| Deville, JG; Equils, O; Sanchez, CP; Shapiro, AM | 1 |
| Cutler, JE; Hazen, KC; Riesselman, MH | 1 |
| Schiller, GJ; Winston, DJ | 1 |
| Boots, R; Crerar-Gilbert, A; Fraenkel, D; MacDonald, GA | 1 |
| Wierzbicka, M | 1 |
| Blowey, DL; Garg, UC; Kearns, GL; Warady, BA | 1 |
| Abitbol, C; Coakley, S; Diaz, R; Mazza, I; Montane, BS; Strauss, J; Zilleruelo, G | 1 |
| Cahn, P; Canteros, C; Córdoba, S; Davel, G; Guelfand, L; Hochenfellner, F; Kaufman, S; Rodero, L | 1 |
| Aragón, G; De la Torre, A; De Prados, F; Montero, A; Regueiro, CA; Romero, J; Sánchez-Aloz, G; Vargas, JA | 1 |
| Bacci, A; Bistoni, F; Cenci, E; Mencacci, A; Romani, L | 1 |
| Arsura, EL; Kilgore, WB | 1 |
| Mirón, M; Richart, C; Sirvent, JJ; Vidal, F | 1 |
| Chang, HC; Chang, JJ; Chang, TC; Huang, AH | 1 |
| Agarwal, J; Ayyagari, A; Dhole, TN; Dixit, AK; Prasad, KN; Tiwari, DP | 1 |
| Chang, SC; Chen, YC; Hsieh, WC; Hung, CC; Luhbd, KT; Pan, YS; Shih, CC | 1 |
| Burgess, DS; Hardin, TC; Hastings, RW; Rinaldi, MG; Summers, KK | 1 |
| Arnavielhe, S; Bastide, JM; Blancard, A; Mallie, M | 1 |
| Chadha, DS; Kalra, SP; Mohapatra, AK; Sanchetee, PC; Singh, AP | 1 |
| Chang, SC; Chen, YC; Hsieh, WC; Luh, KT; Shih, CC | 1 |
| Alemanni, M; Esnault, Y; Taillandier, J | 1 |
| Bolwell, B; Collins, R; Dummer, S; Ericson, S; Fay, J; Freytes, CO; Goodman, SA; Greer, J; Herzig, RH; LeMaistre, F; Lynch, J; Pineiro, L; Pohlman, B; Stein, R; Stevens, D; Wolff, SN | 1 |
| Huijgens, PC; Simoons-Smit, AM; Timmers, GJ; Touw, D; van Loenen, AC; Zweegman, S | 1 |
| Braxton, GR; Cawley, MJ; Guilday, RE; Haith, LR; Patton, ML; Reilly, KJ | 1 |
| Arantes, MR; Malta, MH; Martinez, R; Verceze, AV | 1 |
| Ciblak, MA; Clayton, GE; Elie, CM; Li, RK | 1 |
| Ashida, T; Hasegawa, H; Kanamaru, A; Tsubaki, K | 1 |
| Bernhardt, H | 1 |
| Panzer, H | 1 |
| Fichtenbaum, CJ; Powderly, WG; Rajicic, N; Wheat, LJ; Zackin, R; Zingman, BS | 1 |
| Hahn, RC; Hamdan, JS | 1 |
| Hartmann, M; Kappe, R; Prariyachatigul, C; Rimek, D; Zimmermann, T | 1 |
| Büchner, T; Essink, M; Fegeler, W; Roos, N; Silling, G | 1 |
| Cicale, MJ; Mergo, P; Zander, DS | 1 |
| Cahn, P; Canteros, C; Córdoba, S; Davel, G; Guelfand, L; Kaufman, S; Lucarini, M; Rodero, L; Soria, M | 1 |
| Niki, Y | 1 |
| Anndo, T | 1 |
| Kawana, A | 1 |
| Akgün, Y; Anğ, O; Erturan, Z; Kiraz, N | 1 |
| Kohler, SM; LeMonte, AM; Schnizlein-Bick, C; Smedema, ML; Washum, KE; Wheat, LJ | 1 |
| Colombo, AL | 1 |
| Arzeni, D; Barchiesi, F; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Fallani, S; Fortuna, M; Giacometti, A; Giannini, D; Mazzei, T; Novelli, A; Scalise, G; Schimizzi, AM | 1 |
| Hasliza, M; Hussain, IH; Lim, CB; Nur Atiqah, NA | 1 |
| Gallacher, K; Helenius, H; Issakainen, J; Lehtonen, OP; Nikoskelainen, J; Richardson, MD; Salonen, JH | 1 |
| Ellis, RW; Fisher, NC; Hastings, JG; Jones, SG; Miller, SJ; Mutimer, DJ; Singhal, S | 1 |
| Clemons, KV; Lutz, JE; Stevens, DA | 1 |
| Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 1 |
| Denning, DW; Moore, CB; Morrissey, J; Warn, PA | 1 |
| Chaturvedi, V; Ramani, R | 1 |
| Abbas, J; Abi-Said, D; Bodey, GP; Girgawy, E; Hachem, R; Hanna, HA; Mardani, M; Raad, I; Whimbey, E | 1 |
| Chapman, RL; Faix, RG | 1 |
| Berger, TM; Caduff, JH; Spalinger, J; Stocker, M | 1 |
| Hathorn, JW; Schiller, GJ; Schuster, MG; Territo, MC; Winston, DJ | 1 |
| Bodey, GP | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
| Burgess, DS; Hastings, RW | 1 |
| Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
| Masci, JR | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín-Mazuelos, E; Recio, FJ | 1 |
| Haapasalo, MP; Meurman, JH; Samaranayake, LP; Waltimo, TM; Ørstavik, D | 1 |
| Bacher, J; Francesconi, A; Groll, AH; Lyman, CA; Petraitiene, R; Petraitis, V; Piscitelli, SC; Schaufele, RL; Sein, T; Walsh, TJ | 1 |
| Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH | 1 |
| Kibbler, CC; McWhinney, PH; Paterson, PJ; Potter, M; Prentice, HG | 1 |
| Hachem, R; Minari, A; Raad, I | 1 |
| Chandrasekar, PH | 1 |
| Brankovic, L; Hindler, J; Muehlbauer, L; Steele-Moore, L; Wong-Beringera, A | 1 |
| al-Uzri, AY; Barton, LL; Rewari, M; Scott, KM; Theodorou, AA; Yorgin, PD | 1 |
| García, MT; Llorente, MT; Mínguez, F; Prieto, J | 2 |
| Harada, H; Hashimoto, C; Kato, K; Kodama, F; Maruta, A; Oba, R; Omine, M; Takahashi, N; Tanabe, J | 1 |
| Chithrathara, K; Gangadharan, VP; Preetha, S; Sasidharan, K | 1 |
| Amerongen, AV; Helmerhorst, EJ; Reijnders, IM; Simoons-Smit, IM; van't Hof, W; Veerman, EC; Walgreen-Weterings, E | 1 |
| Meis, JF; Verweij, PE | 1 |
| Buslaeva, GN | 1 |
| Birinci, A; Durupinar, B; Saniç, A | 1 |
| Argenziano, M; Naka, Y; Nurozler, F; Oz, MC | 1 |
| Brownjohn, AM; Chang, B; Dedi, R; Kumar, A; Wright, MJ | 1 |
| Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
| Busowski, JD; Safdar, A | 1 |
| Leitner, I; Ryder, NS | 1 |
| Denning, DW; Moore, CB; Oakley, KL | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Kox, WJ; Tietz, HJ; Wauer, HJ; West, C | 1 |
| Minamoto, GY; Segal, RE | 1 |
| Arendrup, M; Frimodt-Møller, N; Hansen, BS; Jensen, IM; Lundgren, B | 1 |
| Jurga, L; Krcmery, V; Mateicka, F; Sulcová, M | 1 |
| Brooks, JT; Wheat, LJ | 1 |
| Chandra, J; Douglas, LJ; Faddoul, FF; Ghannoum, MA; Hoyer, LL; Leidich, SD; Mukherjee, PK | 1 |
| Briand, V; Lortholary, O | 1 |
| André, MH; Lortholary, O | 1 |
| Dupont, H | 1 |
| Ikeda, U; Katsuki, T; Saito, Y; Sato, A; Shimada, K; Takahashi, M | 1 |
| Bojtarova, E; Ilavska, I; Krcmery, V; Krupova, Y; Mistrik, M; Sejnova, D | 1 |
| Babela, R; Gogova, M; Hanzen, J; Horn, J; Kovacicova, G; Krcmery, V; Lovaszova, M; Pisarcikova, M; Sejnova, D; Svetlansky, I | 1 |
| Huang, YC; Kao, HT; Kuo, AJ; Lin, TY | 1 |
| Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Rodríguez-Tudela, JL | 1 |
| Cutrona, AF; File, TM; Flechner, SM; Kapoor, A; O'Malley, K; Paolone, D | 1 |
| Bleicher, JJ; Davenport, DS; Kauffman, CA; Malani, PN | 1 |
| Kempley, ST; Melville, C | 1 |
| Chappell, ET; Taylor, W; Wrobel, CJ | 1 |
| Samaranayake, LP; Samaranayake, YH; Tsang, PC; Wong, KH; Yeung, KW | 1 |
| Boyle, K; Espinel-Ingroff, A; Sheehan, DJ | 1 |
| Bodey, GP; Kontoyiannis, DP; Mantzoros, CS | 1 |
| Chang, SC; Chen, YC; Fang, CT; Liang, JD; Luh, KT | 1 |
| López-Ribot, JL; Ramage, G; Vande Walle, K; Wickes, BL | 1 |
| Bossi, P; Bricaire, F; Caumes, E; Katlama, C; Rollot, F; Tubiana, R; Zeller, V | 1 |
| Bonito, AJ; Patton, LL; Shugars, DA | 1 |
| Butt, AA; Kleinpeter, MA | 1 |
| Skelton, H; Smith, KJ; Welsh, M | 1 |
| Anil, S; Ellepola, AN; Samaranayake, LP | 1 |
| Chang, KC; Kou, HK; Lin, JW | 1 |
| Groll, AH; Müller, FM; Ritter, J | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Torres-Rodríguez, JM; Vivas, JR | 1 |
| Chow, LP; Hall, AJ; McKelvie, PA; Wong, EY | 1 |
| Katusić, D; Sarić, B; Sikić, J; Vukojević, N | 1 |
| Marr, KA | 2 |
| Muller, RJ | 1 |
| Gompakis, N; Kanakoudi-Tsakalidou, F; Kanellopoulou, K; Mpantouraki, M; Roilides, E; Trachana, M | 1 |
| Gómez, C; López, C; Mateo, A; Mathurín, S; Ramos, L | 1 |
| Liao, W; Wen, H; Yao, Z | 1 |
| Ahmad, H; Lechin, AE; Lewis, RE; Pietrucha-Dilanchian, P | 1 |
| Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K | 1 |
| Kam, LW; Lin, JD | 1 |
| Diekema, DJ; Klepser, ME; Lewis, RE; Messer, SA; Pfaller, MA | 1 |
| Mantovani, L; Virgili, A; Zampino, MR | 1 |
| Buchta, V; Kohout, A; Otcenásek, M; Zák, P | 1 |
| Arzeni, D; Barchiesi, F; D'Angelo, M; Falconi Di Francesco, L; Giuliana, G; Milici, ME; Pizzo, G; Scalise, G | 1 |
| Hong, JW; Kim, HM; Shin, JY | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín Mazuelos, E; Quindós, G; Serrano, C; Valverde, A | 1 |
| Abbas, J; Bodey, GP; Boktour, M; Girgawy, E; Hachem, RY; Hanna, HA; Kontoyiannis, DP; Mardani, M; Raad, II | 1 |
| Arikan, S; Gordon, D; Lozano-Chiu, M; Ostrosky-Zeichner, L; Paetznick, V; Rex, JH; Wallace, T | 1 |
| Alexandridou, A; Kirkby, GR; Reginald, AY; Stavrou, P | 1 |
| Nakanishi, T; Sekimizu, K | 1 |
| Kontoyiannis, DP | 1 |
| Colombo, AL; Nucci, M | 1 |
| Alvarez, ME; Barcena, R; Candelas, A; de Vicente, E; Fortun, J; Honrubia, A; Lopez-San roman, A; Martin-Davila, P; Moreno, S; Navas, E; Nuño, J; Sanchez-Sousa, A | 1 |
| Bennett, JE; Holland, SM; Ju, JY; Marr, KA; Polhamus, C | 1 |
| Chiu, YW; Tan, AL; Wang, GC | 1 |
| Bukharie, HA | 1 |
| Bovey, EH; Guex-Crosier, Y; Mora, P | 1 |
| Irvine, J; Smith, R; Wu, Z; Ying, H; Yiu, S | 1 |
| Domenge, C; Lefebvre, JL | 1 |
| Brizendine, E; Connolly, PA; Durkin, MM; Haynes, RR; LeMonte, AM; Smedema, ML; Wheat, LJ | 1 |
| Arikan, S; Hasçelik, G | 1 |
| Capilla, J; Fernández-Torres, B; Guarro, J; Ortoneda, M; Pujol, I | 1 |
| Alvarado, D; Díaz, MC; Silva, V | 2 |
| Batisse, D; Karmochkine, M; Kazatchkine, MD; Mikol, J; Mrejen, S; Piketty, C; Rambeloarisoa, J; Thiebaut, JB; Weiss, L | 1 |
| Clarke, MA; Hedderwick, SA; Jones, JM; Sarsam, MA | 1 |
| Itoh, S; Kajiwara, M; Kumagai, J; Nagasawa, M; Sugimoto, T; Tomizawa, D | 1 |
| Goodman, D; Jakubowski, A; Morris, C; Pamer, E; Sepkowitz, K | 1 |
| Baldassarri, R; Biancofiore, G; Bindi, ML; Catalano, G; Filipponi, F; Mosca, F; Romanelli, AM; Vagelli, A | 1 |
| Denning, DW; Moore, CB; Mosquera, J; Sharp, A; Warn, PA | 1 |
| Bergervoet, M; Meis, JF; Meletiadis, J; Mouton, JW; Punt, NC; Te Dorsthorst, DT; Verweij, PE | 1 |
| Bayik, M; Cerikcioğlu, N; Cetiner, M; Karti, S; Korten, V; Odabaşi, Z; Ratip, S; Yeğen, C | 1 |
| Ferranti, S; Gemignani, G; Menichetti, F; Messina, F; Tascini, C | 1 |
| Paterson, DL; Singh, N | 1 |
| López-Ribot, JL; Ramage, G; VandeWalle, K; Wickes, BL | 1 |
| Anil, S; Samaranayake, LP | 1 |
| Gehrs, KM; Heilskov, TW; Kherani, A; Kherani, F; Sutphin, JE; Wagoner, MD | 1 |
| Acus, R; Askew, M; Dipersio, J; Kodali, P; Silverberg, D | 1 |
| Demir, M; Kaldir, M; Turgut, B; Vural, O | 1 |
| Berrouschot, J; Günther, P; Hermann, W; Kühn, HJ; Wagner, A | 1 |
| Chen, HY; Fung, CP; Hung, YB; Jwo, SC; Lee, JC; Lee, SC; Li, CT; Liao, HC; Loke, SS; See, LC; Wang, FL | 1 |
| Darouiche, RO; Kontoyiannis, DP; Lewis, RE; Prince, RA; Raad, II | 1 |
| Bachmann, SP; López-Ribot, JL; Ramage, G; VandeWalle, K; Wickes, BL | 1 |
| Ghannoum, MA; Hossain, MA; Long, L; Mukherjee, PK; Reyes, G | 1 |
| Li, T; Liu, Z; Qin, S; Sheng, R; Wang, A | 1 |
| Cuenca-Estrella, M; Mellado, E; Rodríguez-Tudela, JL | 1 |
| Fook-Chong, SM; Goh, YT; Koh, LP; Kurup, A; Tan, PH | 1 |
| Chan, TK; Chee, SP; Cheng, CL; Song, KP | 1 |
| Arikan, S; Ergin, C; Ergin, S | 1 |
| Paya, CV | 1 |
| Fishman, JA; Kubak, BM | 1 |
| Kurowski, R; Ostapchuk, M | 1 |
| Beran, M; Cortes, J; Estey, E; Giles, F; Kantarjian, H; Koller, C; Kontoyiannis, D; Mattiuzzi, GN; Munsell, M; Raad, I; Shen, Y | 1 |
| Baddour, LM; Hawkins, JL | 1 |
| Cartelle, M; Cuenca-Estrella, M; Durán, MT; Gil, E; Guerrero, A; Molina, F; Rodríguez-Tudela, JL | 1 |
| Cantón, E; Gobernado, M; López-Ribot, JL; Pemán, J; Viudes, A | 1 |
| Ergon, C; Ozkutuk, A; Yulug, N | 1 |
| Alvarez-Lerma, F; León, MA; Nolla, J; Palomar, M | 1 |
| Islam, S; Wilson, J; Zaidi, AK | 1 |
| Audeh, YM; Cherrington, A; Gruszecki, AC; Reddy, VV | 1 |
| Bernet, C; de Torrenté, A; Genné, D; Marchetti, O; Porchet, F; Seravalli, L; Van Linthoudt, D | 1 |
| Al-Anezi, AA; Chandy, R; Khan, ZU; Xu, J | 1 |
| Brown, AL; Greig, JR | 1 |
| Kaur, T; Sandhu, S | 1 |
| Cerikcioglu, N; Kaygusuz, I; Korten, V; Mulazimoglu, L; Oktay, A; Toprak, A | 1 |
| Esen, N; Yücesoy, M; Yuluğ, N | 1 |
| Murase, S; Sakai, N; Shinoda, J; Yano, H; Yasokawa, YT | 1 |
| Kohno, S; Miyazaki, Y | 1 |
| Blin, P; Chevalier, E; Cohen, Y; Dupont, H; Gauzit, R; Hennequin, C; Montravers, P; Palestro, B; Timsit, JF; Veber, B | 1 |
| Babinchak, T; Booth, J; Bradsher, RW; Brass, C; Chapman, SW; Chu, TC; Cleary, JD; Cohen, DM; Danziger, L; Edwards, JE; Goldman, M; Goodman, J; Hadley, S; Hilton, E; Horowitz, HW; Hyslop, NE; Karchmer, AW; Kett, DH; Lee, J; Lutz, J; Mautner, L; McKinsey, D; Panzer, H; Pappas, PG; Rex, JH; Rosenstein, RB; Rubin, RH; Scheld, WM; Schuster, M; Simmons, B; Sobel, J; Stein, DK; Vazquez, JA; Washburn, RG; Zervos, M | 1 |
| Odds, FC | 1 |
| Fujihara, M; Kohara, T; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 1 |
| Avery, RK; Bolwell, BJ; Mossad, SB | 1 |
| McGee, WT; Tereso, GJ | 1 |
| León, E; Palavecino, E; Tapia, C | 1 |
| Garcia, CA; King, RT; Miller, JW; Rex, JH; Rodríguez-Adrián, LJ; Tamayo-Derat, LG | 1 |
| Ikeda, R; Jacobson, ES; Shinoda, T; Sugita, T | 1 |
| Hamdan, JS; Moraes, EM; Prímola, NS | 1 |
| Dar-Odeh, NS; Shehabi, AA | 1 |
| Abe, S; Ishibashi, H; Oshima, H; Sato, Y; Takakura, N; Uchida, K; Yamaguchi, H | 1 |
| Alvareda, D; Silva, V; Zepeda, G | 1 |
| Busick, NP; Dunn, DL; Everett, JE; Sielaff, T; Wahoff, DC | 1 |
| Kretzer, V; Lawrenz, K; Pollak, A; Pumberger, W; Wald, M; Weninger, M; Zaknun, D | 1 |
| Campa, M; Danesi, R; Del Tacca, M; Lupetti, A; Nibbering, PH | 1 |
| Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Rohner, P; Schnyder, I | 1 |
| Chi, C; Chiu, C; Fu, L; Liou, J; Tseng, C | 1 |
| Aaron, L; Dupont, B; Lahoulou, R; Therby, A; Viard, JP | 1 |
| González, P; Noriega, LM; Palavecino, E; Pereira, A; Pérez, J; Tapia, C | 1 |
| Daneshtalab, M; Kurosawa, T; Mori, Y; Sardari, S | 1 |
| Fang, K; Sun, QN | 1 |
| Bétis, F; Gastaud, P; Hofman, P; Leguay, JM; Zur, C | 1 |
| Zielińska, E | 1 |
| Grooters, AM; Taboada, J | 1 |
| Momoff, N; Parrish, A | 1 |
| Chapman, S; Dismukes, WE; Edwards, JE; Hamill, RJ; Horowitz, HW; Hyslop, N; Kauffman, CA; Larsen, RA; Lee, J; Mangino, JE; Pappas, PG; Powderly, W; Rex, JH | 1 |
| Gökahmetoglu, S; Nedret Koç, A; Patiroglu, T | 1 |
| Dosekun, AK; Serna, JH; Wanger, A | 1 |
| Branchini, ML; Colombo, AL; Kussano, EJ; Nakagawa, Z; Nucci, M; Valdetaro, F | 1 |
| De Hoog, GS; Verweij, PE; Vitale, RG | 1 |
| Erdem, U; Gonlum, A; Saracli, MA; Yildiran, ST | 1 |
| Ikeda, F | 1 |
| Berman, J | 1 |
| Mikamo, H; Ninomiya, M; Tamaya, T | 1 |
| Banker, DD; Iyer, RS | 1 |
| Fehér, J; Lengyel, G | 1 |
| Antoniadou, A; Bodey, GP; Han, XY; Kontoyiannis, DP; Lewis, RE; Raad, II; Rolston, KV; Safdar, A; Tarrand, JP; Thornby, J; Torres, HA | 1 |
| Barbetseas, J; Filiotou, A; Goumas, G; Kaloterakis, A; Papathanasiou, S; Rizos, I; Toutouzas, P | 1 |
| Bachmann, SP; López-Ribot, JL; Patterson, TF; Ramage, G; VandeWalle, K; Wickes, BL | 1 |
| Cerqueira, CH; de F L Fernandes, O; Miranda, AT; Passos, XS; Silva, Mdo R; Souza, LK | 1 |
| Bansal, AK; Garg, P; Gopinathan, U; Mahesh, S; Rao, GN | 1 |
| Ai, ZL; Chen, JW; He, YM; Jiang, CQ; Lei, DX; Liu, ZS; Lv, XS; Qian, Q; Sun, Q; Yuan, YF | 1 |
| Kirk, KL; Kuklo, TR | 1 |
| Barrett, T; Viglione, M; Yoo, SS | 1 |
| Antony, S; Dominguez, DC; Sotelo, E | 1 |
| Bliss, JM; Gigliotti, F; Wellington, M | 1 |
| Kullberg, BJ; Netea, MG; van der Meer, JW; van Krieken, JH; Verweij, PE; Vonk, AG | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Ao, J; Li, R; Song, K; Wang, D; Wang, W; Yang, R | 1 |
| Junnu, V; Suvoutho, S; Tiewcharoen, S | 1 |
| Driebe, WT; Goldstein, MH; Lim, M | 1 |
| Karpov, OI; Klimko, NN; Kolbin, AS | 1 |
| Joseph Wheat, L | 1 |
| Muzyka-Woźniak, M; Oficjalska-Młyńczak, J; Teklak, D; Turno-Krecicka, A | 1 |
| Cheng, HH; Ho, M; Ho, YA; Lo, HJ; Yang, YL | 1 |
| Cheng, MF; Fan, YH; Ho, M; Hsieh, KS; Lo, HJ; Tang, RB; Yang, YL; Yu, KW | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Clerihew, L; McGuire, W | 2 |
| Bauer, M; Graybill, JR; Larsen, RA; Thomas, AM | 1 |
| Battagliotti, C; Galíndez, J; Greca, A; Kilstein, J; Negro-Marquínez, L; Pietrobon, D | 1 |
| Baddley, JW; Cobbs, CS; Pappas, PG | 1 |
| Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K | 1 |
| Höhl, R | 1 |
| Al Hedaithy, SS; Fotedar, R | 1 |
| Aranda, JV; Frattarelli, DA; Giacoia, GP; Reed, MD | 1 |
| Chen, A; Epstein, JB; Epstein, JD; Fritsche, TR; Hanson-Huggins, K; Mancl, LA; Petersdorf, SH; Press, OW; Truelove, EL | 1 |
| Chaturvedi, V; Pfaller, MA; Ramani, R | 1 |
| Adou-Bryn, KD; Buisson, Y; Chandenier, J; Douchet, C; Kombila, M; Richard-Lenoble, D; Sar, B; Swinne, D; Thérizol-Ferly, M | 1 |
| Brouwer, AE; Chierakul, W; Griffin, GE; Harrison, TS; Larsen, RA; Rajanuwong, A; White, NJ | 1 |
| Chen, CM; Ho, MW; Wang, JH; Yu, WL | 1 |
| Rao, AG; Rao, CV; Thool, BA | 1 |
| Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M | 1 |
| Dhaliwal, HS; Oliver, RJ; Pemberton, MN; Theaker, ED | 1 |
| Barbuch, R; Bard, M; Bareither, B; Barker, KS; Crisp, S; Eckstein, J; Lewis, RE; Rogers, PD; Wiederhold, N | 1 |
| García Agudo, L; Garcia Martos, P; Marín, P; Montes de Oca, M; Puerto, JL; Ruiz Aragón, J; Saldarreaga, A | 1 |
| Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK | 1 |
| Chang, CS; Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lee, PY; Lei, CB; Lu, CH | 1 |
| Cortés, JA; Cuervo, SI; Hernández, LF; Potdevin, G; Urdaneta, AM | 1 |
| Atogami, S; Eishi, K; Noguchi, M; Takai, H | 1 |
| López-Ribot, JL; Ramage, G; Redding, SW; Tomsett, K; Wickes, BL | 1 |
| Banovac, K; Conaughty, JM; Eismont, FJ; Khurana, S; Martinez, OV | 1 |
| Buisson, Y; Keo, C; Monchy, D; Sar, B; Sarthou, JL; Vann, M | 1 |
| Biser, SA; Donnenfeld, ED; Doshi, SJ; Lee, CC; Perry, HD; Solomon, R | 1 |
| Abbasoğlu, U; Cesur, S; Citak, S; Içli, F; Ozçelik, B | 1 |
| Bujdáková, H; Melkusová, S; Mikami, Y; Myoken, Y; Volleková, A | 1 |
| Archer, J; Lane, M; McBride, J | 1 |
| Al-Fattani, MA; Douglas, LJ | 2 |
| Booton, GC; Dunnebacke, TH; Schuster, FL; Yagi, S | 1 |
| Bonasser Filho, F; Leite, AG; Nogueira, RS; Oliveira, AC; Vidal, JE | 1 |
| Archer, S; Bothun, ED; Del Monte, M; Johnson, MW; Singh-Parikshak, R; Superstein, R | 1 |
| Naito, Y | 1 |
| Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
| Orenstein, R; Prabhu, RM | 1 |
| Asako, E; Harada, S; Majoros, L; Nishikawa, A; Ohkusu, M; Ohshima, F; Sipiczki, M; Sugita, T; Takashima, M; Takeo, K; Virtudazo, E; Yanaka, C | 1 |
| D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
| Yoshida, M | 1 |
| MacCallum, DM; Odds, FC | 1 |
| Pandit, AN; Shinde, SM; Vanarse, KS | 1 |
| Behari, M; Goel, V; Sarkar, C; Sharma, MC; Singh, P; Singh, S; Srivastava, T | 1 |
| Burnie, JP; Matthews, RC; Nooney, L | 1 |
| Marr, K | 1 |
| Gilgado, F; Guarro, J; Mayayo, E; Pastor, FJ; Serena, C | 1 |
| Perfect, JR | 1 |
| Rommes, JH; Saene, HK; Spronk, PE | 1 |
| Cheung, BP; Samaranayake, LP; Samaranayake, YH; Yau, JY; Ye, J | 1 |
| Baur, AS; Bellini, C; Cavassini, M; Fournier, Y; Waeber, G | 1 |
| Alonso, R; Carrillo-Muñoz, AJ; del Valle, O; Hernández-Molina, JM; Loebenberg, D; McNicholas, P; Quindós, G; Ruesga, M; Santos, P | 1 |
| Alfaro, B; Avila-Aguero, ML; Canas-Coto, A; Caro, MA; Paris, MM; Ulloa-Gutierrez, R | 1 |
| Adamski, H; Arvieux, C; Chevrant-Breton, J; Chevrier, S; Droitcourt, C; Le Gall, F; Michelet, C | 1 |
| Jenny-Avital, E; Musial, CE; Wheat, LJ | 1 |
| Ergon, MC; Gülay, Z | 1 |
| Masood, A; Sallah, S | 1 |
| Cheng, HH; Li, SY; Lo, HJ; Yang, YL | 2 |
| Borgna, R; Cardia, MC; De Logu, A; Maccioni, E; Saddi, B; Saddi, M; Sanna, C | 1 |
| Chang, CW; Lin, CP; Su, CY | 1 |
| Almond, H; Alvarnas, J; Sarkadee-Adoo, C; Schriber, J | 1 |
| Yasuda, MA | 1 |
| Nolard, N; Swinne, D; Watelle, M | 1 |
| Cheng, HH; Ho, YA; Lo, HJ; Yang, YL | 1 |
| Kamatani, T; Osaki, T; Ueta, E; Yamamoto, T | 1 |
| Burnier, MN; Deschênes, J; Souza Filho, JP; Vianna, RN | 1 |
| Cuadrado, JM; Jover, F; Martínez-Baltanás, A; Roig, P | 1 |
| Arikan, S; Hascelik, G; Sancak, B | 1 |
| Bicanic, T; Harrison, TS | 1 |
| Dolapci, I; Guven, GS; Koyuncu, E; Sahin, GO; Tekeli, A; Uzun, O | 1 |
| Hsieh, WB; Leung, C | 1 |
| Erturan, Z; Kucukates, E; Susever, S; Yegenoglu, Y | 1 |
| Coche, E; Gressens, B; Hantson, P; Leonard, I; Liolios, A | 1 |
| Ahumada-Mendoza, H; Campos-Rivera, T; Martínez-Barbabosa, I; Rondán-Zárate, A; Vázquez-Tsuji, O | 1 |
| Blair, M; Graham, BS; O'Neill, JT | 1 |
| Arayawichanont, A; Chotmongkol, V; Sawanyawisuth, K; Thavornpitak, Y | 1 |
| Feiszt, P; Kardos, G; Majoros, L; Szabó, B | 1 |
| Abdullah, NA; Othman, N; Wahab, ZA | 1 |
| Devkatte, AN; Karuppayil, SM; Zore, GB | 1 |
| Steinbach, WJ | 1 |
| McGirt, MJ; Rigamonti, D; Williams, MA; Woodworth, GF | 1 |
| Ai'e, X; Xiujiao, X | 1 |
| Avorn, J; Fischer, MA; Rubin, RH; Winkelmayer, WC | 1 |
| Leather, H; Wingard, JR | 1 |
| de Górgolas, M; Erice, A; Gil, A; Gutiérrez, J; Hernando, C; Rivas, P; Rodríguez, MC | 1 |
| Denning, DW; Morrissey, G; Sharp, A; Warn, PA | 1 |
| Benjamin, DK; Smith, PB; Tiffany, KF | 1 |
| Carrel, T; Gamma, R; Hullin, R; Mohacsi, PJ; Schmidli, J; Tanner, H; Zimmerli, S | 1 |
| Abbasoglu, U; Kalkanci, A; Kaynak, F; Kustimur, S; Ozkan, S | 1 |
| Glasmacher, A; Prentice, AG | 1 |
| Ayala-Lugo, R; Barbosa, L; de Kaspar, HM; Sanchez-Di Martino, D; Sonego-Krone, S; Ta, CN; Torres-Alvariza, G | 1 |
| Chen, WL; Ho, TL; Lee, HJ; Lee, KW | 1 |
| Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
| Amsden, JR; Gubbins, PO | 1 |
| Bedard, M; Lulic-Botica, M; Natarajan, G; Pappas, A; Rongkavilit, C | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Angel-Moreno, A; Bolaños, M; Boronat, M; Carrillo, A; González, S; Pérez Arellano, JL | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Ito, S; Katayama, K; Kikkawa, Y; Nakata, M | 1 |
| Fernández-Torres, B; Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Athan, E; Hughes, A; Lye, DC; O'Brien, D | 1 |
| Kiertiburanakul, S; Pracharktam, R; Sungkanuparph, S; Wirojtananugoon, S | 1 |
| Bicanic, T; Brouwer, AE; Harrison, TS; Macallan, DC; Macsween, KF; Marsh, H | 1 |
| Karabetsos, D; Koutentakis, D; Ntouros, D; Vakis, A | 1 |
| Aldigier, JC; Diaconita, M; Le Meur, Y; Paraf, F; Rerolle, JP; Szelag, JC | 1 |
| Hector, RF | 1 |
| Hardy, RD; Hester, LJ; Skiest, DJ | 1 |
| Cheeks, C; Fidel, PL; Leigh, JE; Lilly, EA; Shetty, KV | 1 |
| Chiang, PC; Huang, CC; Huang, SF; Lee, CH; Lin, CM; Liu, HP; Tsai, YH | 1 |
| Al-Assiri, A; Al-Fraikh, H; Al-Jastaneiah, S; Al-Khalaf, A; Wagoner, MD | 1 |
| Azeredo, J; Cerca, N; Henriques, M; Oliveira, R | 1 |
| Golan, Y; Hadley, S; Pauker, SG; Wolf, MP; Wong, JB | 1 |
| Arend, SM; de Fijter, JW; de Vaal, BJ; Kuijper, EJ; van't Wout, JW | 1 |
| Díaz, MC; Giusiano, G; Gómez, V; Mangiaterra, M; Rojas, F; Saito, VG | 1 |
| Beretz, L; Entz-Werlé, N; Herbrecht, R; Kara, F; Koffel, JC; Letscher-Bru, V; Levêque, D; Lioure, B; Lutun, P; Nivoix, Y; Remy, V; Rigolot, JC; Waller, J; Zamfir, A | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Srivastava, L; Verma, PK | 1 |
| Abbagnato, L; Di Carlo, P; Giordano, S; Lazzaro, G; Romano, A; Sapuppo, F; Tetamo, R; Titone, L | 1 |
| Darwich, R; Giannetti, AV; Pedroso, ER; Pianetti Filho, G | 1 |
| Brouwer, N; Jamie, J; Kohen, J; Vemulpad, S | 1 |
| Colome-Grimmer, M; Fridlington, E; Kelly, BC; Kelly, E | 1 |
| Gasnier, O; Lortholary, O; Malvy, D; Mienniel, B; Receveur, MC; Rivière, JP; Roussin, C | 1 |
| Beytout, J; Corbain, V; Ferrier, A; Gibold, X; Gourdon, F; Husson, A; Irthum, P; Laurichesse, H; Lesens, O; Vidal, M | 1 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Craig, JC; Playford, EG; Sorrell, TC; Webster, AC | 1 |
| Bell, JD; Bun Navy, K; Harwell, JI; Lynen, L; Prem Prey, S; Sovanna, P | 1 |
| Kawasugi, K; Morimoto, T; Nomura, K | 1 |
| Marik, PE | 1 |
| Casadevall, A; Martinez, LR | 1 |
| Ali, U; Rao, S | 1 |
| Budak, F; Ozcan, SK; Susever, S; Willke, A; Yucesoy, G | 1 |
| Nakamura, K; Nakasone, I; Ohta, C; Onaga, S; Yamane, N | 1 |
| Kilár, F; Kocsis, B; Kustos, I; Lóránd, T; Nyul, A | 1 |
| Chen, CH; Cheng, YR; Lin, LC; Liu, CE; Tsay, RW; Young, TG | 1 |
| Addison, RM; Alexander, BD; Alspaugh, JA; Chao, NJ; Dodds Ashley, ES; Perfect, JR | 1 |
| Shetty, K | 1 |
| Ahmed, E; Manzoor, K; Qadir, F | 1 |
| Dambrauskiene, A; Skrodeniene, E; Vitkauskiene, A | 1 |
| Cheng, HH; Lo, HJ; Yang, YL | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Akova, M; Sahin, GO | 1 |
| Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
| Mekha, N; Poonwan, N; Sugita, T; Takashima, M | 1 |
| Cheng, WY; Shen, CC; Yang, MY | 1 |
| Abdul, M; Arpin, M; Dannaoui, E; Dromer, F; Favel, A; Lortholary, O; Michel-Nguyen, A; Piens, MA | 1 |
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Chumpathat, N; Eampokalap, B; Foongladda, S; Manosuthi, W; Sungkanuparph, S; Thawornwan, U; Thongyen, S | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Arcaya, NM; Beltrán-Luengo, H; Mesa, LM; Milagros Calvo, B; Pineda, MR | 1 |
| Candido, RC; Ferreira, JC; Pedroso, RS | 1 |
| Borowska-Rybus, B; Grzegorczyk, W; Kupś, J; Woźniakowska-Gesicka, T | 1 |
| Chowdhary, A; Dharmshale, SN; Gohil, A; Oberoi, C; Patil, SA | 1 |
| Aoun, M; Beguin, H; Georgala, A; Husson, M; Meuleman, N; Nolard, N; Vekemans, M | 1 |
| Khyriem, AB; Parija, SC; Sujatha, S | 1 |
| Bakir, M; Barton, R; Cerikcioglu, N; Yagci, A | 1 |
| Deziel, MR; Drusano, GL; Drusano, MF; Gumbo, T; Liu, W; Louie, A; Ma, L | 1 |
| Bicanic, T; Dyakopu, N; Harrison, T; Meintjes, G; Niepieklo, A | 1 |
| Hamill, RJ | 1 |
| Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S | 1 |
| Manfredi, R; Sabbatani, S | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Gopal, L; Sen, P; Sen, PR | 1 |
| de Souza, JA | 1 |
| Krockenberger, MB; Malik, R; Martin, P; O'Brien, CR; Wigney, DI | 1 |
| Decembrino, L; Stronati, M | 1 |
| Boonpokbn, L; Maek-a-Nantawat, W; Mctm, AG; Phonrat, B; Pitisuttithum, P; Tansuphaswadikul, S | 1 |
| Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Chaturvedi, AK; Duggineni, S; Kumar, M; Kundu, B; Shukla, PK; Srivastava, G | 1 |
| Farjo, AA; Farjo, QA; Farjo, RS | 1 |
| Malecha, MA; Malecha, MJ; Tarigopula, S | 1 |
| Bagyalakshmi, R; Deepa, P; Madhavan, HN; Therese, KL | 1 |
| Hashinaga, K; Hiramatsu, K; Ishii, H; Kadota, J; Kishi, K; Kushima, H; Ohama, M; Tokimatsu, I; Umeki, K | 1 |
| Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A | 1 |
| Ichikawa, D; Kimura, K; Sato, T; Shima, Y; Tsuchida, H; Yasuda, T | 1 |
| Sipp, JA; Sobol, SE; Wise, SK; Yellin, SA | 1 |
| Bruch-Gerharz, D; Hengge, U; Homey, B; Marini, A; Meller, S; Ruzicka, T | 1 |
| Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R | 1 |
| Williams, PL | 1 |
| Cañal, J; Farinas, MC; Fernández-Sampedro, M; García-Palomo, D; Horcajada, JP; Salesa, R | 1 |
| Antoine, MG; Jackson, ST; Roberts, GD; Smikle, MF | 1 |
| del Palacio, A; Moragues, MD; Pazos, C; Pontón, J; Quindós, G | 1 |
| Azimi, AR; Hasan Paknejad, SM; Motamedi, M; Sahraian, MA | 1 |
| Ahmad, S; Al-Kazemi, N; Al-Sweih, NA; Chandy, R; Joseph, L; Khan, S; Khan, ZU | 1 |
| Bae, EH; Bae, WK; Cho, HH; Cho, YB; Choi, KC; Kim, NH; Kim, SW; Lee, KS; Ma, SK; Park, JW; Shin, JH | 1 |
| Frentiu, E; May, T; Petitfrere, M; Rabaud, C | 1 |
| Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S | 1 |
| Bederson, JB; Eloy, JA; Smouha, EE | 1 |
| Harada, AS; Lau, W | 1 |
| Caron, F; Etienne, M | 1 |
| Bekker, LG; Bicanic, T; Harrison, T; Hayes, M; Meintjes, G; Rebe, K; Wood, R | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Hirata, Y; Kobayashi, K; Miyoshi, T; Oka, S; Tsuji, M; Yokote, T | 1 |
| Kaufman, DA | 1 |
| Beltrame, A; Cerana, M; De Maria, A; Di Biagio, A; Pacini, D | 1 |
| Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C | 1 |
| Capilla, J; Clemons, KV; Sobel, RA; Stevens, DA | 1 |
| Guilhermetti, E; Shinobu, CS; Svidzinski, TI; Takahachi, G | 1 |
| Creutzig, U; Groll, AH; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Ritter, J; Schwabe, D; Varwig, D | 1 |
| Arikan, S; Hüseyin, A; Sancak, B | 1 |
| Arslan, H; Azap, O; Can, F; Demirbileki, M; Timurkaynak, F | 1 |
| Abbruzzetti, A; Arzeni, D; Barchiesi, F; Cirioni, O; Giacometti, A; Kamysz, E; Kamysz, W; Riva, A; Scalise, G; Silvestri, C | 1 |
| Ahmad, S; Jeragh, A; Khan, ZU; Naseem, J | 1 |
| Abouelfath, A; Depont, F; Dupon, M; Dutronc, H; Galpérine, T; Giauque, E; Hébert, G; Moore, N; Ragnaud, JM; Valentino, R; Vargas, F | 1 |
| Dutta, TK; Harish, BN; Parija, SC; Sivasangeetha, K; Sujatha, S | 1 |
| Santra, G | 1 |
| Holmes, AR; Iguchi, Y; Ikeda, F; Maki, K; Matsumoto, S; Mutoh, S; Tawara, S; Watabe, E | 1 |
| Chamroonswasdi, K; Chottanapund, S; Kaewkungwal, J; Manosuthi, W; Singhasivanon, P | 1 |
| Khakoo, RA; Khan, FA; Slain, D | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Jin, H; Li, S; Liu, M; Shi, W; Xie, L | 1 |
| Arzeni, D; Barchiesi, F; Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Licci, A; Marigliano, A; Nadolski, P; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
| Marol, S; Yücesoy, M | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Rawat, D | 1 |
| Abrahamsen, TG; Gaustad, P; Warris, A; Winn, RM | 1 |
| Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V | 1 |
| Bizerra, FC; Borsato Quesada, RM; de Poersch, C; Estivalet Svidzinski, TI; Goldenberg, S; Krieger, MA; Nakamura, CV; Yamada-Ogatta, SF | 1 |
| Araiza, J; Arias, P; Bonifaz, A; Macias, B; Paredes-Farrera, F; Ponce, RM | 1 |
| Auer, I; Conly, J; Cox, H; Debru, E; Dupre, M; Hollaar, G; Lategan, J; Medlicott, SA | 1 |
| Cheng, WT; Li, SY; Lo, HJ; Wang, AH; Wang, CW; Yang, YL | 1 |
| Abdelkefi, M; Belcadhi, M; Ben Said, M; Bouzouita, K; Krifa, N; Mani, R | 1 |
| Carrillo-Muñoz, AJ; Eraso, E; Espinel-Ingroff, A; Quindós, G; Ruesga, M; Villar-Vidal, M | 1 |
| Dempsey, EM; O'Grady, MJ | 1 |
| Choi, JD; Friedman, AH; Powers, CJ; Sampson, JH; Vredenburgh, JJ | 1 |
| Aggarwal, P; Banerjee, U; Capoor, MR; Deb, M; Mandal, P | 1 |
| Hachem, R; Hanna, H; Jiang, Y; Kontoyiannis, D; Raad, I | 1 |
| Atalay, S; Ciftçi, E; Düzenli, F; Ekim, M; Galip, N; Güriz, H; Kendirli, T; Ozçakar, ZB; Tapisiz, A; Tutar, E; Uçar, T | 1 |
| Akşit, F; Kiraz, N; Kiremitçi, A; Oz, Y | 1 |
| Chavasco, JK; Claudino, AL; Franco, MC; Lyon, JP; Melhem, MS; Peixoto, RF; Szeszs, MW | 1 |
| Carter, JE; Estrada, B; Evans, TN; Laurini, JA | 1 |
| Campbell, B; Chan, K; Kim, J; Mahoney, N; May, G; Molyneux, R | 1 |
| Hermann, P; Miszti, C; Rozgonyi, F; Sóczó, G; Szabó, Z | 1 |
| Cuenca-Estrella, M; Dos Anjos Martins, M; Gomez-Lopez, A; Melhem, MC; Rodriguez-Tudela, JL; Zaragoza, O | 1 |
| Perheentupa, J; Pfaller, MA; Rautemaa, R; Richardson, M; Saxén, H | 1 |
| Ayala, J; Elizondo, M; González, GM | 1 |
| Bekker, A; Greeff, S; Perkins, DR; Swe Han, KS | 1 |
| Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Jeong, SH; Jung, SI; Kim, EC; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, MK; Lee, WG; Park, KH; Ryang, DW; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
| Arendse, T; Orth, H | 1 |
| Li, L; Li, R; Luo, S; Sun, X; Wang, Z | 1 |
| Bustamante, B; Campos, PE; Chávez, VM; Dammert, P; Huaroto, L; Llanos-Cuentas, A; Ticona, E | 1 |
| Hollenbach, E | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
| Candido, RC; da Costa, KR; Ferreira, JC; Komesu, MC | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
| Boone, E; De Laere, E; Surmont, I; Swinne, D; Vandamme, K; Vervaeke, S | 1 |
| Pasqualotto, AC | 1 |
| Akduman, D; Aydemir, H; Celebi, G; Oztoprak, N; Pişkin, N; Tekin, IO | 1 |
| Brecht, M; Clerihew, L; McGuire, W | 1 |
| Dedicoat, M; Dlamini, S; Paul, N; Sloan, D | 1 |
| Aktas, E; Cizmeci, Z; Durmaz, R; Gulcan, H; Kuzucu, C; Otlu, B | 1 |
| Chen, YS; Chi, NH; Chou, NK; Tsai, HE; Wang, JL; Wang, SS | 1 |
| Chabasse, D; Coulibaly, I; Dembélé, M; Diarra, AS; Diarra, M; Doumbo, OK; Konaté, A; Maïga, II; Maïga, MY; Minta, DK; Pichard, E; Sidibé, AT; Traoré, AK; Traoré, HA | 1 |
| Diop, AG; Mapoure, YN; Ndiaye, IP; Ndiaye, M; Ndiaye, MM; Ngom, NF; Sène, MS; Sène-Diouf, F; Seydi, M; Soumaré, M; Sow, AD; Sow, PS | 1 |
| Arendrup, MC; Auzinger, G; Azoulay, E; Borges Sá, M; Guery, BP; Johnson, EM; Kullberg, BJ; Müller, E; Putensen, C; Rotstein, C; Sganga, G; Venditti, M; Zaragoza Crespo, R | 1 |
| Borro, JM; de la Torre, M; Delgado, M; Fernandez, R; Gonzalez, D; Monte, E; Pastor, A; Saura, A; Solé, A | 1 |
| Imamura, Y; Izumikawa, K; Kohno, S | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
| dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
| Cisalpino, PS; da Costa César, G; de Carvalho, IR; dos Anjos Martins, M; Kohler, LM; Santos, DA; Soares, BM | 1 |
| Delgado-Jiménez, Y; Fernández-Herrera, J; García-Diez, A; Nam-Cha, S; Pedraz, J; Pérez-Gala, S | 1 |
| Jung, IS; Kim, ES; Kim, SK; Park, HJ; Song, JC; Song, YG; Yu, JS | 1 |
| Harris, BP; Koerner, IL | 1 |
| Amato, VS; Penteado Filho, SR; Tuon, FF | 1 |
| Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L | 1 |
| Liu, PY; Shi, ZY; Yang, Y | 1 |
| Huang, J; Liu, H; Wu, B; Zhang, T; Zhang, W | 1 |
| Ao, JH; Hao, ZF; Wang, CM; Wang, WL; Yang, RY; Zhang, J | 1 |
| Ahammed, SK; Chakrabarti, A; Dutta, U; Kochhar, R; Ray, P; Singh, K; Sinha, SK; Wig, JD | 1 |
| Anderson, JB; Lafayette, S; Sirjusingh, C; Syed, N | 1 |
| Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
| Menezes, Y; Muller, RP; Pádua, SS; Park, MV; Passos, RM; Pereira, GH | 1 |
| Fauzi, AR; How, SH; Kuan, YC; Ng, TH; Ramachandram, K | 1 |
| Corbett, EL; Ferrand, RA; Mangeya, N; Miller, RF; Seddon, J | 1 |
| Cruz, AR; Gallin, JI; Huang, CY; Zarember, KA | 1 |
| Maheshwari, S; Rao, S; Shah, S; Suresh, PV | 1 |
| Anane, S; Belhadj, S; Ben Châabane, T; Ben Fadhl, K; Ben Lakhal, S; Chaker, E; Kallel, K; Kaouech, E; Khedher, A; Meddeb, B | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Callaghan, JJ; Johannsson, B | 1 |
| Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F | 1 |
| Bosshard, PP; Calligaris-Maibach, RC; Georgi, A; Meyer, S; Schneemann, M; Tintelnot, K; Weber, R | 1 |
| Chen, L; He, SM; He, ZY; Huang, B; Jiang, YK; Li, YZ; Tu, YY; Zhang, HX; Zhang, L | 1 |
| Blyth, CC; Chen, SC; Ellis, D; Marriott, D; Meyer, W; Nguyen, Q; Serena, C; Slavin, MA; Sorrell, TC | 1 |
| Billack, B; Lau-Cam, C; Santoro, M | 1 |
| Albini, TA; Couvillion, SS; Davis, JL; Dubovy, SR; Wykoff, CC | 1 |
| Harrison, TS | 1 |
| Anekthananon, T; Chetchotisakd, P; Filler, SG; Johnson, P; Kendrick, AS; Larsen, RA; Manosuthi, W; Morris, MI; Nolen, TL; Pappas, PG; Sobel, JD; Sungkanuparph, S; Supparatpinyo, K; Zimmer, LO | 1 |
| Anaissie, EJ; Chang, CH; Fishman, JA; Horn, DL; Marr, KA; Neofytos, D; Olyaei, AJ; Pfaller, MA; Steinbach, WJ; Webster, KM | 1 |
| Bernardo, SM; Lee, SA; Miceli, MH | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Kolaczkowska, A; Kolaczkowski, M; Kubiak, A; Miecznikowska, H; Polanowski, A; Rolka, K; Sokolowska, A | 1 |
| Cooper, C; Mills, EJ; Nachega, JB; Perri, D; Phillips, P; Tleyjeh, I; Wu, P | 1 |
| Borges Sá, M; Garnacho Montero, J | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Dedicoat, MJ; Lalloo, DG; Sloan, DJ | 1 |
| Arechavala, AI; Borgnia, MD; Ochiuzzi, ME; Santiso, GM | 1 |
| Fermín, S; González-Guevara, L; Guevara-Campos, J; Urbéz-Cano, J | 1 |
| Anekthananon, T; Chetchotisakd, P; Filler, SG; Johnson, PC; Kendrick, AS; Kopetskie, H; Larsen, RA; Manosuthi, W; Morris, MI; Nolen, TL; Pappas, PG; Sobel, JD; Sungkanuparph, S; Supparatpinyo, K | 1 |
| Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Azeredo, J; Henriques, M; Martins, M; Negri, M; Oliveira, R; Svidzinski, TI | 1 |
| Bertout, S; Bourgeois, N; Bousquet, PJ; Dehandschoewercker, L; Lachaud, L; Rispail, P | 1 |
| Chetchotisakd, P; Nolen, TL; Pappas, P; Pramanpol, S; Walker, ME; Wallace, D; Zimmer, LO | 1 |
| Gao, F; Jiang, PF; Shen, SX; Shui, QX; Xia, ZZ; Yu, HM; Zhou, BL | 1 |
| Gambhir, IS; Gulati, AK; Nigam, C; Prakash, P; Tilak, R; Tilak, V | 1 |
| Hu, G; Kronstad, JW | 1 |
| Binning, MJ; Lee, J; Riva-Cambrin, JK; Thorell, EA | 1 |
| Crogan, J; Gunasekera, H; Isaacs, D; Sheikh, M; Wood, N | 1 |
| Bundrant, N; Cotton, M; Donoghue, M; Fransesconi, A; Hardwick, M; Kim, SY; Mickiene, D; Mizrahi, I; Pyrgos, V; Sein, T; Shoham, S; Walsh, TJ | 1 |
| Andes, D; Anekthananon, T; Chetchotisakd, P; Filler, SG; Larsen, RA; Manosuthi, W; Nolen, TL; Pappas, PG; Sungkanuparph, S; Supparatpinyo, K; Wallace, D | 1 |
| Bagheri, F; Cervellione, KL; Marino, W; Maruf, M; Santucci, T | 1 |
| Chen, Y; Fan, W; Li, L; Li, Y; Liu, L; Sheng, J; Tan, JP; Wang, H; Wei, Z; Xu, K; Yang, YY | 1 |
| Erasmus, J; Mattiuzzi, GN; Sever, M; Verstovsek, S | 1 |
| Abr Ao, MS; Auler, ME; Margarido, PF; Matsumoto, FE; Morreira, D; Paula, CR; Rodrigues, FF; Schneider, RP; Silva, BC; Silva, EG | 1 |
| Cooke, GS; Dedicoat, M; Lessells, RJ; Lightowler, JV; Mutevedzi, P; Newell, ML | 1 |
| Cheng, MF; Cheng, WT; Hospitals, T; Lo, HJ; Wang, AH; Wang, CW; Yang, YL | 1 |
| Coenye, T; Deforce, D; Nailis, H; Nelis, HJ; Vandenbosch, D | 1 |
| Corti, M; Negroni, R; Yampolsky, C | 1 |
| Choi, SW; Jung, JH; Kim, MK; Lee, M; Lee, TJ | 1 |
| d'Enfert, C; Rossignol, T; Vediyappan, G | 1 |
| Francis-Rogers, S; Patel, R; Persad, P; Stephens, J; Talat, P | 1 |
| Müller, FM; Salvenmoser, S; Seidler, M | 1 |
| Arechavala, AI; Ochiuzzi, ME; Santiso, GM | 1 |
| Chen, ZJ; Gao, CW; Pang, GR; Sun, ST; Wang, BL; Xu, Y; Zhao, DQ; Zhou, LT | 1 |
| Huang, H; Lan, F; Tong, YZ; Xiong, SD; Xiong, WN; Xu, YJ | 1 |
| Alswad, MM; Kader, MA; Mahdy, RA; Nada, WM; Saleh, MM; Wageh, MM | 1 |
| Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
| Chen, HT; Cheng, WT; Leaw, SN; Lo, HJ; Wang, AH; Yang, YL | 1 |
| Brilhante, RS; Cordeiro, RA; Maia, DC; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Soares, GD | 1 |
| de Hoog, GS; Delair, S; Deville, JG; Fothergill, AW; Lewinski, MA; Mershon-Shier, KL; Sutton, DA; Wickes, B | 1 |
| Benharref, A; Bouaziz, M; Fadli, M; Hassani, L; Mezrioui, NE; Saad, A | 1 |
| Boel, A; Cartuyvels, R; Magerman, K; Naesens, R; Nys, S; Vijgen, S | 1 |
| Mahdy, RA; Nada, WM; Wageh, MM | 1 |
| Atella, GC; da Silva Almeida, M; Domitrovic, T; Freire, JC; Gehring, K; Kozlov, G; Kurtenbach, E; Masuda, CA; Matta-Camacho, E; Montero-Lomeli, M | 1 |
| Lazzaro, C | 1 |
| Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R | 1 |
| Hsu, KY; Wu, MH | 1 |
| Alkmim-Teixeira, GC; Auxiliadora-Martins, M; Basile-Filho, A; Bellissimo-Rodrigues, F; Carlotti, CG; Machado-Viana, J; Martins-Filho, OA; Nicolini, EA | 1 |
| Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L | 1 |
| Beltrame Júnior, M; da Costa, AC; Jorge, AO; Junqueira, JC; Machado, AK; Pereira, CA; Zöllner, MS | 1 |
| Krzyściak, P; Macura, AB | 1 |
| Aydin, F; Bayramoglu, G; Guler, NC; Kaklikkaya, N; Tosun, I | 1 |
| Mahida, P; Mitha, M; Naicker, P | 1 |
| Mathisen, G; Shelub, A; Truong, J; Wigen, C | 1 |
| Chen, MC; Li, HT; Li, Z; Liu, JH; Luo, DQ | 1 |
| Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
| Chai, LY; Denning, DW; Warn, P | 1 |
| Chang, MR; Dias, AL; Gambale, V; Paula, CR; Prates, RA; Ribeiro, MS; Ruiz, Lda S; Silva, EG | 1 |
| Arthington-Skaggs, BA; Bizerra, FC; Colombo, AL; Freymüller, E; Melo, AS | 1 |
| Arzeni, D; Barchiesi, F; Campanati, A; Cirioni, O; Gabrielli, E; Ganzetti, G; Giacometti, A; Kamysz, E; Kamysz, W; Offidani, A; Silvestri, C; Simonetti, O | 1 |
| Akman, I; Altuncu, E; Bakır, M; Bilgen, H; Cerikçioğlu, N; Ilki, A; Ozek, E; Ulger, N | 1 |
| Kityo, C; Kizito, H; Mugyenyi, P; Musiime, V; Natukunda, E; Ssali, F | 1 |
| Almyroudis, NG; Segal, BH | 1 |
| Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
| Abbes, S; Ayadi, A; Ben Jemaa, M; Bouaziz, M; Cheikhrouhou, F; Chelly, H; Hammami, B; Khaled, S; Makni, F; Néji, S; Sellami, A; Sellami, H | 1 |
| Hajdú, J; Harmath, A; Janik, L; Komka, K; Kristóf, K; Nagy, K; Nobilis, A; Rigó, J; Rozgonyi, F; Szabó, D | 1 |
| Ando, T; Ikushima, S; Masunaga, A; Morimoto, K; Oritsu, M; Takemura, T | 1 |
| de Souza, W; Ishida, K; Rodrigues, JC; Rozental, S; Urbina, JA; Visbal, G | 1 |
| Kim, S; Ko, KS; Lee, MS; Lee, MY; Moon, SY; Son, JS | 1 |
| Aoki, T; Karakida, K; Ota, Y; Otsuru, M; Sasaki, M; Yamazaki, H | 1 |
| Campbell, BC; Chan, KL; Faria, NC; Gonçalves, LA; Kim, JH; Martins, Mde L | 1 |
| Arslan, U; Fındık, D; Yüksekkaya, S | 1 |
| Gonçalves-Pereira, J; Póvoa, P | 1 |
| Cunha, FA; de Vasconcelos, AA; Menezes, EA | 1 |
| Chiller, TM; Govender, NP; Lockhart, SR; Patel, J; van Wyk, M | 1 |
| Kato, K; Kojima, S; Matsumoto, K; Watanabe, N | 1 |
| Ainoda, Y; Fujita, T; Hirai, Y; Mori, N; Motoji, T; Shiseki, M; Shoji, T; Teramura, M; Totsuka, K; Yoshinaga, K | 1 |
| Fisher, JF; Kauffman, CA; Newman, CA; Sobel, JD | 1 |
| Lopez-Ribot, JL; Ramasubramanian, A; Srinivasan, A; Uppuluri, P | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM | 1 |
| Lopez-Ribot, J; Ramasubramanian, AK; Srinivasan, A; Uppuluri, P | 1 |
| Brissaud, O; Guichoux, J; Tandonnet, O | 1 |
| Abele-Horn, M; Beer, M; Hebestreit, H; Kunzmann, S; Radike, K | 1 |
| Henriques, M; Lopez-Ribot, JL; Martins, M; Oliveira, R | 1 |
| Aruch, DB; Bhusal, Y; Hamill, RJ | 1 |
| Barrios-Fernández, A; Borobia, AM; Carcas, AJ; de la Puente, JM; Frías, J; García-Rodríguez, J; Herrero, A; Lei, S; Ortega, JM; Ramírez, E; Sánchez, M | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Eller, AW; Mayercik, VA; Pihlblad, MS | 1 |
| Ahmad, I; Khan, MS; Malik, A | 1 |
| Hai, W; Jianghan, C; Julin, G; Nan, X; Wanqing, L; Xiaojun, W; Yuanjie, Z | 1 |
| Kullberg, BJ; Oborska, IT; Oude Lashof, AM; Pappas, PG; Rex, JH; Rothova, A; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C | 1 |
| Prasad, R; Sharma, M | 1 |
| Heller, T; Lessells, RJ; Mutevedzi, PC; Newell, ML | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| Kamegaya, C; Kido, N; Makimura, K; Omiya, T; Shibata, E; Shindo, I; Yamamoto, Y | 1 |
| Al-Nawas, B; Karbach, J; Walter, C | 1 |
| Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
| Celebi, S; Hacimustafaoglu, M | 1 |
| Hamoud, S; Hayek, T; Keidar, Z | 1 |
| Martins, CH; Mendes-Giannini, MJ; Pires, RH; Santos, JM; Zaia, JE | 1 |
| Batoni, G; Del Gaudio, G; Maisetta, G; Petruzzelli, R; Sanguinetti, M; Senesi, S; Tavanti, A | 1 |
| Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
| Katayama, N; Kohara, T; Kyo, T; Nakase, K; Sugawara, Y; Suzuki, K | 1 |
| Harrison, TS; Hearn, P; Jaffar, S; Jarvis, JN; Kabanda, T; Longley, N; Muzoora, CK; Mwesigye, J; Ortu, G; Ssentamu, J | 1 |
| Calışkan, E; Calışkan, S; Cınar, S; Corakçı, A; Keçeli Özcan, S | 1 |
| Anekthananon, T; Chetchotisakd, P; Filler, SG; Kendrick, AS; Kiertiburanakul, S; Kopetskie, HA; Larsen, RA; Manosuthi, W; Nolen, TL; Pappas, PG; Ratanasuwan, W; Supparatpinyo, K | 1 |
| Hyndman, ME; Marr, KA; Mullins, JK; Sundi, D; Tseng, K | 1 |
| Arpi, M; Brorson, S; Jensen, PE; Kaldau, NC; Schultz, C | 1 |
| Ahmad, I; Khan, MS | 2 |
| Ascher, SB; Benjamin, DK; Clark, RH; Cohen-Wolkowiez, M; Moran, C; Smith, PB; Watt, K | 1 |
| César, IC; Gouveia, LF; Pianetti, GA; Resende-Stoianoff, MA; Santos, DA; Santos, JR; Taylor, EL | 1 |
| Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K | 1 |
| Cheng, MF; Hsieh, LY; Liou, CH; Lo, HJ; Lu, DC; Shi, ZY; Tsai, MS; Wang, AH; Wang, LS; Wu, CJ; Yang, YL | 1 |
| Bauer, M; Larsen, RA; Thomas, AM | 1 |
| Bonfietti, LX; Martins, MA; Matos, D; Melhem, MS; Silva, DC; Szeszs, MW | 1 |
| Kombila, U; Magne, C; Mandji, LJ; Mounguengui, D; Nzenze, JR; Nziengui, MM; Ondounda, M | 1 |
| Chakrabarti, A; Randev, S; Sachdeva, RK; Sharma, A; Singh, S; Varma, S; Wanchu, A | 1 |
| Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S | 1 |
| Dietz, A; Geginat, G; Kilian, AK; Reinshagen, K; Schroten, H; Tenenbaum, T; Weichert, S; Zahn, K | 1 |
| Celis-Aguilar, E; Coutinho-De Toledo, H; Macias-Valle, L | 1 |
| Espinosa-Heidmann, D; Harper, T; Jamie Miller, G; Kresch, ZA | 1 |
| Alvarez-Lerma, F; Gimeno-Costa, R; Gracia-Arnillas, MP; Insausti-Ordeñana, J; López-Pueyo, MJ; Olaechea-Astigarraga, PM; Otal-Entraigas, JJ; Palomar-Martínez, M; Seijas-Betolaza, I | 1 |
| Ford, N; Milani, B | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Agarwal, H; Butoli, J; Dubey, T; Joshi, K; Kulshresth, M; Mathur, A; Mathur, S | 1 |
| Angarone, M; Theodoropoulos, N | 1 |
| Ghannoum, MA; Isham, N; Richie, DL; Ryder, NS; Thompson, KV | 1 |
| Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC | 1 |
| Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R | 1 |
| Chikasema, M; Harrison, TS; Hosseinipour, MC; Jackson, AT; Jaffar, S; Jarvis, JN; Kanyemba, C; Namarika, D; Nussbaum, JC; Phulusa, J; van der Horst, C | 1 |
| Caggiano, G; Carone, A; Corbo, F; Franchini, C; Montagna, MT; Muraglia, M; Piarulli, M; Rosato, A; Schiavone, BI | 1 |
| Garg, A; Goyal, VK; Jajoo, M; Kumar, V | 1 |
| Kim, HR; Lee, MK; Yu, N | 1 |
| Kim, JS; Lee, JH; Park, YH | 1 |
| Horn, DL; Keith, SW; Slenker, AK | 1 |
| Bader, O; Gross, U; Hull, CM; Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG; Weig, M | 2 |
| Bayegan, S; Földi, R; Gesztelyi, R; Juhász, B; Kardos, G; Majoros, L; Szilágyi, J | 1 |
| Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
| Antonucci, R; Fanos, V; Farina, D; Franco, C; Galletto, P; Gallo, E; Manzoni, P; Rizzollo, S | 1 |
| Gárate, C; García, P; Guzmán, AM; Labarca, J; León, P; Porte, L | 1 |
| Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
| Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Giffoni Leite, JJ; Lima, DT; Monteiro, AJ; Paiva, MA; Rocha, MF; Sidrim, JJ; Teixeira, CE | 1 |
| Chander, J; Gulati, N; Kaistha, N; Singla, N | 1 |
| Conesa, A; Gebbia, M; Giaever, G; Heisler, LE; Jaime, MD; Lee, AY; Lopez-Llorca, LV; Nislow, C; Proctor, M; Westwood, JT | 1 |
| Jackson, A; van der Horst, C | 1 |
| Ait Ben Haddou, EH; Benomar, A; Lachhab, L; Maamar, M; Rasmouni, K; Regragui, W; Seffar, M; Yahyaoui, M | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Guerra, CR; Ishida, K; Nucci, M; Rozental, S | 1 |
| Bielecki, J; Jagielski, T; Kwiatkowski, S; Zak, I | 1 |
| Cho, T; Imayoshi, R; Kaminishi, H; Kodama, J; Morotomi, T; Nagao, J | 1 |
| Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW | 1 |
| de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS | 1 |
| Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
| Ho, CM; Ho, MW; Hsieh, HY; Hwang, KP; Lee, CY; Li, TC; Lin, HC; Lin, HY; Lin, MH; Lu, JJ; Su, BH | 1 |
| Birkenkamp, KE; Boulware, DR; Meya, DB; Rajasingham, R; Rolfes, MA | 1 |
| Bohjanen, P; Lukande, R; Mayanja-Kizza, H; Meya, BD; Musubire, AK; R Boulware, RD; Wiesner, LD | 1 |
| Friedman, D; Kongthavonsakul, K; Oberdorfer, P | 1 |
| Furukawa, K; Kazama, I | 1 |
| Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
| Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Sorrell, TC; Wiederhold, NP | 1 |
| Parija, SC; Singh, R | 1 |
| Arzeni, D; Astolfi, D; Catavitello, C; D'Antonio, D; Farina, C; Favaro, M; Fazii, P; Fontana, C; Hendrickx, M; Masciarelli, G; Pitzurra, L; Polilli, E; Savini, V; Sisti, M; Stubbe, D | 1 |
| Klause, S; Meyer, W; Pye, GW; Stadler, CK; Sykes, JE; Wynne, J | 1 |
| Bouquet, O; Kilár, F; Kocsis, B; Kustos, I | 1 |
| Anandaswamy, V; Chaya, R; Moin, A; Padmanabhan, S | 1 |
| Baršić, B; Mlinarić Missoni, E | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Aziz, MN; Khaithir, TM; Leong, MC; Loons, LC; Rafia, MH; Ramli, SR | 1 |
| Hamada, Y; Hirayama, T; Ichibe, Y; Katori, Y; Kuroyama, M; Okuma, R; Takahashi, S | 1 |
| Bratton, EW; Chastain, CA; El Husseini, N; Juliano, JJ; Lee, MS; Perfect, JR; Poole, C; Stürmer, T; Weber, DJ | 1 |
| Cardile, AP; Patel, SS | 1 |
| Dreyfuss, D; Gaudry, S; Ricard, JD | 1 |
| Hasegawa, C; Ishiwatari, T; Kaneko, T; Mitsuda, A; Murayama, SY; Nemoto, T; Okubo, Y; Sasai, D; Shibuya, K; Shimamura, T; Shinozaki, M; Sugita, T; Tochigi, N; Wakayama, M | 1 |
| Arsić Arsenijević, V; Barać, A; Crnčević Radović, L; Pekmezović, M; Trpković, A | 1 |
| Carvalho, RR; Dias, AL; Dias, KS; Ferreira, AV; Prado, CG | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Dyląg, M; Goffeau, A; Ko, YH; Lis, P; Niedźwiecka, K; Pedersen, PL; Ułaszewski, S | 1 |
| García-Vázquez, E; Gómez-Gómez, J; Hernández-Torres, A; Herrero-Martínez, JA; Laso-Ortiz, A | 1 |
| Cuenca-Estrella, M; de Lucas, MP; Fusco-Almeida, AM; Lozano, E; Mendes-Giannini, MJ; Mesa-Arango, AC; Scorzoni, L; Zaragoza, O | 1 |
| Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL | 1 |
| Coste, A; Eddouzi, J; Ischer, F; Kelly, S; Manai, M; Parker, JE; Sanglard, D; Vale-Silva, LA | 1 |
| Michal, W; Olena, W; Wojciech, O | 1 |
| DeSimone, JA; Fennelly, AM; Moussouttas, M; Murphy, LC; Slenker, AK | 1 |
| Hauben, M; Hung, EY | 1 |
| Bak, N; Byth, K; Chen, SC; Currie, BJ; Hajkowicz, K; Heath, CH; Kidd, S; Korman, TM; Marriott, D; McBride, WJ; Meyer, W; Murray, R; Playford, EG; Slavin, MA; Sorrell, TC | 1 |
| Agudelo, CI; Bello, S; Castañeda, E; de Bedout, C; Escandón, P; Lizarazo, J; Restrepo, A; Tobón, A | 1 |
| Arslan, F; Mert, A; Mete, B; Ozaras, R; Ozkara, C; Ozturk, R; Saltoglu, N; Tabak, F; Vanli, E | 1 |
| Day, J; Dromer, F; Harrison, TS; Lortholary, O; Loyse, A | 1 |
| Alves, SH; de Loreto, ES; Denardi, LB; Mario, DA; Nogueira, CW; Santurio, JM | 1 |
| Benjamin, DK; Ericson, J; Manzoni, P | 1 |
| Nicolle, LE | 1 |
| Bachmann, A; Bonkat, G; Braissant, O; Gasser, TC; Wernli, L | 1 |
| Bethlendy, G; Kravets, A; Rustchenko, E; Welle, S; Yang, F | 1 |
| Monod, M; Pot, SA; Spiess, BM; Unger, L; Voelter-Ratson, K | 1 |
| Lu, Q; Zhao, DY | 1 |
| Abbasi, K; Anvari, MS; Badali, H; Boroumand, M; Fesharaki, SH; Haghani, I; Kargar, ML; Meis, JF; Mousavi, B | 1 |
| Garcia, J; Horseman, MA; Matthew, E; Soch, K; Surani, S | 1 |
| Basso, LR; Bruzual, I; Gast, CE; Wong, B | 1 |
| Deng, L; Hu, DD; Hu, GH; Jiang, YY; Li, DD; Wang, Y; Zhao, LX | 1 |
| Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
| Chander, J; Gombar, S; Sidhu, SK; Singla, N | 1 |
| Jorge, JH; Machado, AL; Mima, EG; Pavarina, AC; Sanitá, PV; Vergani, CE | 1 |
| Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
| Arendrup, MC | 1 |
| Balci, I; Eksi, F; Gayyurhan, ED | 1 |
| González, GM; González, JG; Hernández-Bello, R; López, LJ; Palma-Nicolás, JP; Treviño-Rangel, Rde J | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Pastor, FJ; Sandoval-Denis, M; Sutton, DA | 1 |
| Blennow, O; Ljungman, P; Mattsson, J; Remberger, M; Sparrelid, E | 1 |
| Li, M; Liu, J; Peng, FH; Tan, F; Wang, X; Yuan, Y; Zhong, XF; Zhong, YH | 1 |
| Bradshaw, WT; Lollis, TR | 1 |
| Lin, DF; Lu, X; Shen, C; Yao, ZW | 1 |
| Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K | 1 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Borens, O; Furustrand Tafin, U; Maiolo, EM; Trampuz, A | 1 |
| Barone, G; Costa, S; Perelli, S; Romagnoli, C; Tirone, C; Vento, G | 1 |
| Luo, Z; Shi, D | 1 |
| Chowdhury, W; Rwegerera, GM; Setime, MA; Vento, S | 1 |
| Fujimoto, K; Hirayama, A; Itami, Y; Saka, T; Yoneda, T; Yoshida, K | 1 |
| Bulut, E; Esgin, H; Orüm, C | 1 |
| Fang, F; Shu, S; Wang, Y; Xu, S; Ye, F; Zhou, H | 1 |
| Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
| Assi, M; Chaaban, S; Wheat, LJ | 1 |
| Alvarado-Matute, T; Colombo, AL; Cornejo-Juarez, P; Cortes, J; Corzo-Leon, DE; Echevarria, JI; Guzman-Blanco, M; Macias, AE; Nucci, M; Ostrosky-Zeichner, L; Ponce-de-Leon, A; Queiroz-Telles, F; Santolaya, ME; Sifuentes-Osornio, J; Thompson-Moya, L; Tiraboschi, IN; Zurita, J | 1 |
| Chandy, R; Ellepola, AN; Khan, ZU | 1 |
| Brillowska-Dabrowska, A; Dzierzanowska-Fangrat, K; Gucwa, K; Milewski, S; Naumiuk, L; Romanowska, E; Szweda, P; Wojciechowska-Koszko, I | 1 |
| Chae, JD; Cho, YU; Hwang, YH; Im, H; Lee, SY; Shin, JH; Song, EJ; Sung, SA; Yoo, M | 1 |
| Cotton, MF; Hassan, H; Rabie, H | 1 |
| Anjiki, H; Arichi, N; Hiraoka, T; Mitsui, Y; Nagami, T; Nakamura, S; Ogawa, K; Shiina, H; Sumura, M; Yasumoto, H | 1 |
| Chavez-Dozal, AA; Jahng, M; Lee, SA; Lown, L; Walraven, CJ | 1 |
| Hou, J; Tu, EY | 1 |
| Assaly, R; Elgafy, H; Meyers, S; Miller, J | 1 |
| Anil, S; Bandara, HM; Hashem, M; Patil, S; Samaranayake, LP; Vellappally, S | 1 |
| Abraham, M; Babu, R; Bijulal, S; Chowdhary, A; Kathuria, S; Kumar, A; Meis, JF; Sasidharan, P; Sharma, C | 1 |
| Dufour, DR | 1 |
| Charlier, C; Jullien, V; Lecuit, M; Lortholary, O; Pilmis, B; Sobel, J | 1 |
| Agarwal, SK; Bagchi, S; Dinda, A; Kumar, MV; Panda, S; Singh, G | 1 |
| Huang, X; Li, D; Mylonakis, E; Xi, L | 1 |
| Chang, CC; Coovadia, Y; Dorasamy, A; French, M; Lewin, S; Mahabeer, Y; Mlisana, K; Moosa, MY; Naidu, D; Ndung'u, T | 1 |
| Bezerra, GF; da Silva, MA; Filho, WE; Nascimento, AC; Nascimento, Mdo D; Segundo, JB; Viana, GM; Vidal, FC | 1 |
| DeVanna, JC; Neel, JA; Stowe, DM; Uchiumi, K; Willcox, JL | 1 |
| Bernardo, SM; Chavez-Dozal, A; Jahng, M; Kulkarny, VV; Lee, SA; Parra, KJ; Rane, HS | 1 |
| Alexander, EL; Antachopoulos, C; Jabra-Rizk, MA; Katragkou, A; McCarthy, M; Meletiadis, J; Petraitis, V; Roilides, E; Walsh, TJ | 1 |
| Gomes, CC; Gomez, RS; Pereira, Tdos S; Rocha do Nascimento, A; Silva Alves, Jde F; Stoianoff, MA | 1 |
| Abrantes, M; Baptista, MI; Barroso, R; Ferreira, M; Neto, MT; Nona, J; Sampaio, I; Serelha, M; Tomé, MT; Virella, D | 1 |
| Bax, M; Cammue, BP; Cools, TL; Cos, P; De Brucker, K; De Cremer, K; Lanckacker, E; Thevissen, K | 1 |
| Bandara, HM; Ellepola, AN; Joseph, BK; Khan, ZU; Samaranayake, LP | 1 |
| Bielicki, J; Doerholt, K; Goossens, H; Lestner, JM; Roilides, E; Sharland, M; Versporten, A; Warris, A | 1 |
| Agrawal, D; Gupta, V; Karnik, ND; Tiwari, DK | 1 |
| Goff, TA; Kanakaris, NK | 1 |
| Ishiguro, T; Odashima, K; Shimizu, Y; Sugita, Y; Takayanagi, N | 1 |
| Flynn, HW; Miller, D; Silva, RA; Sridhar, J; Wykoff, CC | 1 |
| Ahmed, Y; Albrecht, H; Siddiqui, W; Weissman, S | 1 |
| Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S | 1 |
| Covey, S; Tam, W; Wu, WW; Yigit, N | 1 |
| Rughwani, N; Sangarlangkarn, A | 1 |
| Raspor, P; Tomičić, Z; Zupan, J | 1 |
| Kumar, A; Kumar, D; Singh, S; Tilak, R | 1 |
| Lewis, M | 1 |
| Monk, HM; Wade, KC | 1 |
| Agban, MN; Ahmed, SH; Hassan, EA; Sabet, MA; Zahran, KM | 1 |
| Ahmed, FU; Garg, A; Gupta, A; Mahapatra, AK; Naik, V; Sarkar, C; Sharma, B | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Choudhary, M; Sharma, D; Sharma, PK; Shastri, S | 1 |
| Amano, H; Arikawa, T; Fukuda, R; Hishinuma, A; Inami, S; Inoue, T; Masawa, T; Tajima, E; Toyoda, S; Yoshida, A | 1 |
| Bom, VL; Brown, NA; de Castro, PA; Goldman, GH; Mariné, M; Ramalho, LN; Winkelstroter, LK | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Alencar, LP; Bandeira, TJ; Brilhante, RS; Castelo-Branco, DS; Cordeiro, Rde A; de Oliveira, JS; Monteiro, AJ; Moreira, JL; Rocha, MF; Sidrim, JJ; Teixeira, CE | 1 |
| Kao, YY; Lo, HJ; Lo, HL; Tsao, MY; Tseng, KY; Yang, YL | 1 |
| He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY | 1 |
| Dugar, J; Miller, D; OʼBrien, TP; Spierer, O | 1 |
| Aliredjo, RP; de Jong, PY; de Sévaux, RG; Nooijen, S; van Spil, WE; Verhave, JC | 1 |
| Ding, CH; Muttaqillah, NA; Tzar, MN; Wahab, AA | 1 |
| Amin, RM; Hamdy, I; Osman, IM | 1 |
| de Mello, JC; Ishida, K; Luiz, RL; Nakamura, CV; Rozental, S; Vila, TV | 1 |
| Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
| Boucherit, K; Boucherit-Otmani, Z; Kunkel, D; Seddiki, SM | 1 |
| Grancini, A; Guanziroli, E; Menicanit, C; Merlo, V; Nazzaro, G; Tortorano, A; Venegoni, L; Veraldi, S | 1 |
| Ellepola, AN; Jayathilake, JA; Khan, ZU; Sharma, PN | 1 |
| Bisson, GP; Burton, R; Cainelli, F; Changalucha, JM; Chofle, AA; Fenner, L; Goldberg, DW; Harrison, TS; Haverkamp, M; Hope, W; Jarvis, JN; Kalluvya, S; Leeme, T; Lekwape, N; Letang, E; Makadzange, T; Meintjes, G; Molefi, M; Molloy, SF; Ndhlovu, CE; Perfect, JR | 1 |
| Gao, T; Huang, XS; Tian, CL; Xing, XW; Yan, B; Yao, Y; Yu, SY; Zhang, JT | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA | 1 |
| Kawai, A; Mikamo, H; Yamagishi, Y | 1 |
| Abu-Hammad, OA; Al-Omiri, MK; Al-Shayyab, MH; Dar-Odeh, NS | 1 |
| Botelho, C; Henriques, M; Moreira, A; Pais, C; Sampaio, P; Silva, S | 1 |
| Antony, SJ; Friedman, G; Parikh, MS | 1 |
| Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
| Adeyemi, BO; Ross, A | 1 |
| Ling, J; Ning, Y; Wu, CD | 1 |
| Achan, B; Akampurira, A; Alhadab, AA; Boulware, DR; Hullsiek, KH; McDonald, TR; Meya, DB; Nielsen, K; Okagaki, LH; Rhein, JR; Smith, KD | 1 |
| Bandeira, Tde J; Brilhante, RS; Castelo-Branco, Dde S; Cordeiro, Rde A; de Alencar, LP; de Oliveira, JS; Monteiro, AJ; Moreira, JL; Ribeiro, JF; Riello, GB; Rocha, MF; Rodrigues, PH; Sidrim, JJ | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Animalu, C; Cleveland, KO; Gelfand, MS; Mazumder, S | 1 |
| Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X | 1 |
| Kauffman, CA | 1 |
| Chaudhary, U; Goel, S; Mittal, S | 1 |
| Bouchrik, M; Boumhil, L; Iken, M; Lemkhente, Z; Lmimouni, B; Naoui, H; Uwingabiye, J; Zohoun, AG | 1 |
| Cortez, J; Magano, R; Ramos, E; Trindade, L | 1 |
| Al-Hayek, S; Aliyu, SH; Dev, H; Lawrentschuk, N; Papa, N; Toner, L | 1 |
| Bakhshi, S; Dabas, Y; Xess, I | 1 |
| Cauda, R; Fabbiani, M; Fantoni, M; Giovannenze, F; Milozzi, E; Murri, R; Posteraro, B; Sanguinetti, M; Scoppettuolo, G; Taccari, F; Ventura, G | 1 |
| Hall, RG; Payne, KD | 1 |
| Alencar, LP; Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Evangelista, AJJ; Franco, JDS; Marques, FJF; Melo, CVS; Oliveira, JS; Rocha, MFG; Serpa, R; Sidrim, JJC | 1 |
| Ahmed, J; Das, S; Laskar, B; Nath, R; Saikia, L; Timung, L | 1 |
| Cicora, F; Petroni, J; Roberti, J | 1 |
| Bryan, M; Damianos, A; Fisher, BT; Vendetti, N; Zaoutis, TE | 1 |
| Casadevall, A; Chatterjee, S; Fernandes, C; Gonçalves, T; Nakouzi-Naranjo, A; Prados-Rosales, R; Silva, BM; Stark, RE; Zuzarte, M | 1 |
| Akiyama, T; Haga, S; Makihara, K; Morioka, T; Sayama, T; Shimogawa, T | 1 |
| Attanasio, M; Cortegiani, A; Giarratano, A; Maggiore, A; Naro, AR; Raineri, SM; Russotto, V | 1 |
| Santiwattanakul, S; Tantisiriwat, W | 1 |
| Derevyannykh, NА; Dulaeva, EN; Filippova, LN; Klimko, NN; Klimovich, AV; Konovalenko, IB; Krasnoruzhsky, АI; Medvedeva, NV; Oksema, ЕV; Potapenko, VG | 1 |
| Dabrowski, L; Graciano, AL; Kuzmic, B; Lee, JM; Tablizo, MA | 1 |
| Capilla, J; Guarro, J; Martin-Vicente, A; Sanchis, M | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Azzam, R; Dendle, C; Graham, M; Korman, TM; Woolley, IJ; Yeung, VA | 1 |
| Ali, M; Andreoli, MT; Farooq, AV; Traish, AS; Zhou, M | 1 |
| Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M | 1 |
| Chen, S; Hu, Y; Huang, X; Jie, Q; Lin, S; Lin, Z; Zhang, H | 1 |
| Benzekri, A; Benzekri, L; Hassam, B; Ismaili, N; Lyagoubi, M; Mansouri, S; Rachadi, H; Ramli, I; Senouci, K | 1 |
| Aguado, JM; Almirante, B; Cuenca-Estrella, M; Fernández-Ruiz, M; Guinea, J; Lora-Pablos, D; Martín-Dávila, P; Merino, P; Puig-Asensio, M | 1 |
| Dunn, AL; Levy, RA; Reed, T; Stewart, C | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
| Alves, GS; Bentes, Ados S; de Souza, JV; Freire, AK; Jackisch-Matsuura, AB; Matsuura, T; Pinheiro, JF; Wanke, B | 1 |
| Boulware, DR; Merry, M | 1 |
| Badrane, H; Clancy, CJ; Nguyen, MH | 1 |
| Alfatah, M; Bhattacharyya, MS; Ganesan, K; Haque, F | 1 |
| dos Santos, LA; dos Santos, VM | 1 |
| Arendrup, MC; Hagen, F; Hare Jensen, R; Meis, JF | 1 |
| Hammoudeh, ZS; Lettieri, S | 1 |
| Campbell-Bright, S; Caylor, MM; Lin, FC; Sullivan, KA | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM | 1 |
| César, IC; Costa, MC; Freitas, GJ; Holanda, RA; Paixão, TA; Pianetti, GA; Ramos, LH; Ribeiro, NQ; Santos, DA; Santos, JR | 1 |
| Arditi, M; Bar, AS; Brown, J; Crother, TR; Funari, VA; Gargus, M; Iliev, ID; Leal, CA; Limon, JJ; Tang, J; Underhill, DM; Wang, HL; Wheeler, ML | 1 |
| Calvo, MC; Chaves Sanchez, F; de Alba Romero, C; Fernandez Rodriguez, B; Pallas Alonso, CR; Peña Gonzalez, L | 1 |
| Arslan, U; Dagi, HT; Findik, D; Senkeles, C | 1 |
| Ogundeji, AO; Pohl, CH; Sebolai, OM | 1 |
| Matos, T; Raspor, P; Tomičić, Z; Zupan, J | 1 |
| Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Durmaz, S; Toka Özer, T; Yula, E | 1 |
| Krysan, DJ | 1 |
| Acar, M; Ağaçfidan, A; Aktürk, H; Beka, H; Hançerli Törün, S; Karagöz, N; Salman, N; Somer, A; Sütçü, M; Yekeler, E | 1 |
| Cassano, R; Mellace, S; Trombino, S | 1 |
| Behan, JW; Declerck, B; Kim, GH; Rodriguez, PG; Zhu, TH | 1 |
| Alegre, LR; Carrillo-Muñoz, AJ; Cattana, ME; Córdoba, SB; de Los Ángeles Sosa, M; Fernández, MS; Giusiano, GE; Rojas, FD; Zalazar, LC | 1 |
| Capilla, J; Guarro, J; López-Fernández, L; Mayayo, E; Thomson, P | 1 |
| Ganakumar, V; Jha, S; Kakkar, A; Pawar, S; Ragesh, R; Ray, A; Sharma, MC; Sharma, SK | 1 |
| Jandaik, S; Kumar, S; Sharma, N | 1 |
| Antony, S; Cooper, LG; Heydemann, J; Misenhimer, G | 1 |
| Li, HM; Li, RY; Shimizu-Imanishi, Y; Tanaka, R; Yaguchi, T | 1 |
| Hasegawa, A; Kamata, H; Kano, R; Kimura, S; Lim, SY; Ooya, K; Yanai, T | 1 |
| Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J | 1 |
| Chen, X; He, H; He, M; Liu, H; Wu, J; Zhong, X | 1 |
| Casadevall, A; Grossman, NT | 1 |
| Ali, I; Babik, JM; Brondfield, MN; Cope, JR; DeMarco, T; Doernberg, SB; Hilts-Horeczko, A; Klein, L; Matanock, A; Reid, MJ; Ritter, JM; Rutishauser, RL; Tang, J | 1 |
| Abassi, M; Boulware, DR; Lofgren, S; Rhein, J | 1 |
| Dey, S; Shekhar, S; Singh, K; Xess, I; Yadav, Y | 1 |
| Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J | 1 |
| Aurbach, U; Cornely, OA; De Hoog, S; Demeter, J; Durán Graeff, L; Hamprecht, A; Kindo, A; Racil, Z; Seidel, D; Vehreschild, MJ; Wisplinghoff, H; Ziegler, M | 1 |
| Ma, P; Qian, J; Qu, L; Yin, Z | 1 |
| Berkowitz, AJ; Donlin, MJ; Garimallaprabhakaran, AK; Grigoryan, A; Lipnicky, A; Meyers, MJ; Murelli, RP; Tavis, JE; Zunica, A | 1 |
| Fukuda, Y; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Mitsuyama, J; Miyazaki, T; Mukae, H; Nakamura, S; Nishikawa, H; Saijo, T; Takazono, T; Tanaka, A; Tashiro, M; Yamamoto, K; Yamamoto, Y; Yanagihara, K | 1 |
| Qian, F; Wei, X; Xia, J; Xu, W; Zhang, Z | 1 |
| Arora, A; Capoor, MR; Chakrabarti, A; Chhina, D; Das, S; Ghosh, A; Kaur, H; Kindo, AJ; Marak, RSK; Patel, A; Paul, RA; Rudramurthy, SM; Sardana, R; Singh, P; Sood, P; Tarai, B; Xess, I | 1 |
| Bustamante, B; Concha-Velasco, F; González-Lagos, E; Seas, C | 1 |
| Čurová, K; Hrabovská, Z; Hrabovský, V; Pastvová, L; Schréterová, E; Siegfried, L; Takáčová, V | 1 |
| Alencar, LP; Bittencourt, PV; Brilhante, RSN; de Aguiar Cordeiro, R; de Aquino Pereira-Neto, W; de Melo Guedes, GM; de Oliveira, JS; de Souza Collares Castelo-Branco, D; Nogueira-Filho, EF; Pinheiro, M; Rocha, MFG; Sidrim, JJC | 1 |
| Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L | 1 |
| Bairy, I; Baral, BP; Gokhale, S; Hamal, D; Nayak, N; Prakash, PY; Sathian, B; Sharan, NK; Subramanya, SH | 1 |
| Abbasi, SA; Bokhari, H; Hussain, Z; Imran, M; Jamil, B; Khalid, T; Mukhtar Bokhari, MT; Mukhtar Bokhari, MZ; Saeed, A | 1 |
| Farmakiotis, D; Kontoyiannis, DP; Le, A; Tarrand, JJ | 1 |
| Jabeen, N; Naz, SA; Shafique, M; Yaseen, M | 1 |
| Bonfanti, C; Caruso, A; De Francesco, MA; Gargiulo, F; Gelmi, M; Peroni, L; Piccinelli, G; Pinsi, G; Ravizzola, G | 1 |
| Kodedová, M; Sychrová, H | 1 |
| de Medeiros, LN; Felício, MR; Gonçalves, S; Kurtenbach, E; Santos, NC; Silva, PM | 1 |
| de Carvalho Santana, R; de Gaitani, CM; Dos Santos Quaglio, AS; Martinez, R; Schiave, LA | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Almeida-Paes, R; Carregal, E; Gonçalves, MLC; Gutierrez Galhardo, MC; Lamas, CDC; Lemos, AS; Lima, MASD; Moreira, JA; Oliveira, MME; Valviesse, VRGA; Zancopé Oliveira, RM | 1 |
| Guo, JC; Li, YH; Sun, P | 1 |
| Bastos, RW; Holanda, RA; Queiroz, ER; Ribeiro, NQ; Santos, DA; Santos, JRA; Silva, LC | 1 |
| Izumikawa, K; Kohno, S; Minematsu, A; Miyazaki, T; Mukae, H; Nagayoshi, Y; Nakamura, S; Nakayama, H; Shimamura, S; Takazono, T; Yamauchi, S; Yanagihara, K | 1 |
| Bahubali, VH; Chandrashekar, N; Lahiri Mukhopadhyay, S; Maji, S; Manjunath, N; Palaniappan, M; Parthasarathy, S; Swaminathan, A | 1 |
| Bok, JW; Gellman, SH; Huang, M; Hull, CM; Keller, NP; Lim, FY; Liu, R; Rank, LA; Walsh, NM | 1 |
| Bamba, S; Guiguemde, RT; Guiguemde, T; Kone, S; Ouedraogo-Traore, R; Sangare, I; Sawadogo, M; Traore, LK; Yacouba, A; Zida, A | 1 |
| Astruc, D; Candolfi, E; Denis, J; Dillenseger, L; Gallais, F; Herbrecht, R; Koobar, O; Letscher-Bru, V; Sabou, M | 1 |
| Faryal, R; Shah, AA; Siddiqui, MT; Tasneem, U | 1 |
| Harrison, TS; Ming, DK | 1 |
| Almeida-Paes, R; Barbedo, LS; de Oliveira, JCA; Dos Santos, ALS; Figueiredo-Carvalho, MHG; Ramos, LS; Zancopé-Oliveira, RM | 1 |
| Herrera, M; Kadosh, D; Li, X; Mintz, J; Vipulanandan, G; Wickes, BL; Wiederhold, NP | 1 |
| Siew, HH | 1 |
| Carrera-Justiz, S; James, MD; Johnson, KL | 1 |
| Hatlen, TJ; Murphy, RA; Persichino, JG | 1 |
| Majmudar, PA; Tu, EY | 1 |
| Aquino, VR; de Azevedo, MI; Goldani, LZ; Neto, GW; Pilla, C; Wirth, F | 1 |
| Kamei, H; Nishioka, H; Takegawa, H | 1 |
| Díaz Idrobo, B; Lasso, FA; Potosí García, JA; Zamora Bastidas, TO | 1 |
| Bouza, E; Charlier, C; Delahaye, F; Fontanet, A; Lefort, A; Lortholary, O; Munoz, P; Rivoisy, C; Schaeffer, L; Vena, A | 1 |
| Fujimoto, F; Ikeda, M; Kaburaki, T; Koike, K; Moriya, K; Okamoto, K; Okugawa, S; Sato, T; Tatsuno, K; Wakabayashi, Y; Yamamoto, S; Yoshida, S | 1 |
| Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J | 1 |
| Arendrup, MC; Astvad, KMT; Dzajic, E; Gertsen, JB; Hare, RK; Johansen, HK; Knudsen, JD; Kristensen, L; Lemming, L; Nielsen, L; Olesen, B; Pedersen, M; Rosenvinge, FS; Røder, BL; Schønheyder, HC; Søndergaard, TS; Østergård, C | 1 |
| Aboubakar, T; Bellet, V; Bertout, S; Delaporte, E; Doumbia, A; Drakulovski, P; Kassi, FK; Kouakou, GA; Krasteva, D; Menan, HIE; Reynes, J; Roger, F; Valérie, BA; Yavo, W | 1 |
| Ahmed, D; Anwar, A; Hussain, MA; Khan, NA; Shah, MR; Siddiqui, R | 1 |
| Chao, J; Culpepper, KS; Kurtzman, DJB | 1 |
| Chang, MR; Lima, GME; Mendes, RP; Negro, GMBD; Nunes, JO; Nunes, MO; Paniago, AMM; Taira, CL; Thomaz, DY; Tsujisaki, RAS | 1 |
| Beninati, C; Biondo, C; Bonanno, R; Cordaro, S; d'Aleo, F; Mancuso, G; Midiri, A; Verduci, E; Warm, A | 1 |
| Bhattacharya, S; Fries, BC | 1 |
| Adams-Chapman, I; Autmizguine, J; Benjamin, DK; Cohen-Wolkowiez, M; Cotten, CM; Goldberg, RN; Smith, PB; Stoll, BJ; Tan, S; Wiederhold, N | 1 |
| Honda, A; Ikeda, M; Koya, J; Kurokawa, M; Misawa, Y; Morita, K; Moriya, K; Nakamura, F; Okugawa, S; Toyama, K | 1 |
| Abbas, H; Abbas, N; CiFuentes Kottkamp, A; Cindrich, R; Singh, M | 1 |
| Dawgul, MA; Grzywacz, D; Kamysz, W; Liberek, B; Myszka, H | 1 |
| Freeman, JT; McKinney, WP; Morris, AJ; Roberts, SA; Rogers, K | 1 |
| Kooshki, P; Mahmoudabadi, AZ; Rezaei-Matehkolaei, A | 1 |
| Adams, J; Bicanic, T; Bradley, J; Bright, P; Chan, AK; Chanda, D; Chawinga, C; Chen, T; Ellis, J; Gaskell, K; Harrison, TS; Heyderman, RS; Hosseinipour, MC; Jaffar, S; Kalata, N; Kanyama, C; Karunaharan, N; Kouanfack, C; Lakhi, S; Lalloo, DG; Lesikari, S; Lontsi, S; Lortholary, O; Loyse, A; Lupiya, D; Mapoure, YN; Mfinanga, S; Molloy, SF; Mwaba, P; Ndong, JG; Peirse, M; Sini, V; Stone, N; Temfack, E; van der Horst, C; van Oosterhout, JJ; Wang, D | 1 |
| Kuang, W; Li, M; Liao, J; Liu, J; Peng, F; Xu, L; Yi, H; Zhang, Q; Zhu, C | 1 |
| Blice, JP; Johnson, WJ; Lee, KK | 1 |
| Himmelreich, U; Kucharíková, S; Van Dijck, P; Vande Velde, G | 1 |
| Brilhante, RSN; Castelo-Branco, DSCM; Cordeiro, RA; Guedes, GMM; Rocha, MFG; Sidrim, JJC; Silva, MLQD | 1 |
| Alanazi, AM; Jabeen, M; Khan, AA; Khan, S; Malik, A | 1 |
| Ashrafi-Khozani, M; Falahati, M; Farahyar, S; Heidarie-Kohan, F; Majdabadi, N; Mohammadnejad, S; Rahimi-Moghaddam, P; Razavi, T | 1 |
| C, Y; Chandrashekar, N; Devi, BI; Kandregula, S; Konar, S; Raj, ARP; Shukla, D; Somanna, S; Uppar, A | 1 |
| Chiang, MC; Chu, SM; Fu, RH; Hsu, JF; Huang, HR; Lai, MY; Lee, CW; Lee, IT; Tsai, MH; Wu, IH | 1 |
| Boucherit, K; Boucherit-Otmani, Z; El Haci, IA; Ilahi, A; Mazari, W | 1 |
| Guo, R; Lv, Y; Xiang, YY; Xue, J | 1 |
| Bing, J; Du, H; Huang, G; Liu, J; Tao, L; Wang, H; Wang, X; Wang, Y; Yue, H; Zhang, F; Zheng, Q | 1 |
| Kovarik, CL; Mosojane, KI; Sowash, M; Williams, VL | 1 |
| Andrade, VS; Boniek, D; Brandão, LDS; da Mata, FMR; de Azevedo, PRM; Fernandes, JV; Resende Stoianoff, MA | 1 |
| Bonamigo, RR; Fay, VDS; Gonçalves, SMB; Gregianini, TS; Rodrigues, DMG | 1 |
| Falahati, M; Farahyar, S; Hadighi, R; Kalantari, S; Khedri, S; Khoshmirsafa, M; Roudbary, M; Santos, ALS | 1 |
| Gottlieb, T; Swan, CD | 1 |
| Bicanic, T; Eshun-Wilson, I; Okwen, MP; Richardson, M | 1 |
| Bhattacharya, S; Esquivel, BD; White, TC | 1 |
| Eshun-Wilson, I; Ford, N; Jarvis, JN; Li, T; Rouse, B; Shapiro, AE; Tenforde, MW | 1 |
| Asano, Y; Ishida, K; Kosugi, H; Mochizuki, K; Murata, K; Yamada, H; Yamada, W | 1 |
| Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA | 1 |
| Chong, LY; Head, K; Hopkins, C; Philpott, C; Sharp, S | 1 |
| Barbosa, G; Caramelli, B; Fortes, CQ; Fortes, NRQ; Golebiovski, W; Gualandro, DM; Ignoto, BG; Lamas, C; Mansur, AJ; Pierrotti, LC; Sampaio, RO; Sejas, ONE; Siciliano, RF; Strabelli, TMV; Tarasoutchi, F; Weksler, C | 1 |
| Aliyu, SH; Andrieux-Meyer, I; Bicanic, T; Boulware, DR; Burry, J; Chan, A; Chanda, D; Chiller, T; Cohn, J; Day, J; Denning, D; Doherty, M; Dromer, F; Ford, N; Gondwe-Chunda, L; Govender, N; Harrison, TS; Heyderman, R; Hosseinipour, M; Jaffar, S; Jarvis, JN; Kalata, N; Kanyama, C; Klausner, JD; Kouanfack, C; Koulla-Shiro, S; Lakhi, S; Lalloo, D; Le, T; Lesikari, S; Lortholary, O; Loyse, A; Mapoure, Y; Mfinanga, S; Mghamba, J; Migone, C; Molloy, SF; Muzoora, C; Mwaba, P; Ngoma, J; Nyirenda, R; Oladele, R; Perfect, C; Ramadhani, A; Ribeiro, I; Rodrigues, M; Schutz, C; Shimwela, M; Shroufi, A; Sini, V; Stack, M; Temfack, E; Van der Horst, C; van Oosterhout, J; Wilson, D | 1 |
| Colon, BL; Guy, RK; Kyle, DE; Rice, CA | 1 |
| Damasceno-Escoura, AH; de Oliveira Nunes, F; de Souza, ML; Florentino, DH; Gazotto, FC; Mora, DJ; Pardi, TC; Silva-Vergara, ML | 1 |
| Ahmed Khan, N; Anwar, A; Raza Shah, M; Siddiqui, R | 1 |
| Boonyawat, B; Chokephaibulkit, K; Jirapongsananuruk, O; Pacharn, P; Phongsamart, W; Visitsunthorn, N | 1 |
| Covel, J; Fierer, J; Kapoor, M; Okamoto, S; Shaw, KJ; Soltow, QA; Trzoss, M; Viriyakosol, S | 1 |
| Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L | 1 |
| Alanio, A; Alufandika, M; Boulware, DR; Boyer-Chammard, T; Chen, T; Dromer, F; Harrison, TS; Hlupeni, A; Hope, W; Hosseinipour, MC; Jaffar, S; Jarvis, JN; Kanyama, C; Lalloo, DG; Lawrence, DS; Lortholary, O; Loyse, A; Meintjes, G; Meya, DB; Molloy, SF; Mosepele, M; Muzoora, C; Mwandumba, HC; Ndhlovu, CE; Niessen, L; Schutz, C; Stott, KE; Wang, D; Youssouf, N | 1 |
| Kim, S; Lee, DG; Woo, ER | 1 |
| Kader, NA; Patil, S; Raj, AT; Seetharam, C; Sujatha, G | 1 |
| Ahmad, A; Dar, OA; Gull, P; Hashmi, AA; Lone, SA; Malik, MA; Wani, MY | 1 |
| Angkasekwinai, N; Chavapradit, N | 1 |
| Eshun-Wilson, I; Ford, N; Garner, P; Migone, C | 1 |
| Cheng, JH; Harrison, TS; Huang, LP; Jiang, YK; Wang, RY; Wang, X; Zhao, HZ; Zhou, LH; Zhu, LP | 1 |
| Milanezi, ACM; VAN DER Sand, ST; Witusk, JPD | 1 |
| Aling, E; Anywaine, Z; Ggayi, AB; Kaleebu, P; Kibengo, F; Kitonsa, J; Kiwanuka, J; Kiwanuka, N; Mayanja, Y; Namutundu, J | 1 |
| Al-Hatmi, AMS; Alves, SH; de Azevedo, MI; Loreto, ES; Rossato, L; Santurio, JM; Venturini, TP | 1 |
| Krasowska, A; Muraszko, J; Sigler, K; Suchodolski, J; Sztafrowski, D | 1 |
| Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E | 1 |
| Bay, MB; de Oliveira, AL; Freire, MG; Gomes, RMODS; Soares, RDA; Theodoro, RC; Vechi, HT | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Deger, SM; Ergin, G; Guz, G | 1 |
| Belet, N; Birinci, A; Emecen, AN; Öncü, B | 1 |
| Arastehfar, A; Boekhout, T; Brouwer, C; Charsizadeh, A; Daneshnia, F; Haas, PJ; Hagen, F; Khodavaisy, S; Najafzadeh, MJ; Pan, W; Roudbary, M; Salehi, MR; Zarrinfar, H; Zomorodian, K | 1 |
| Jandhyala, D; Sohail, MR; Stahr, DC; Tan, EM | 1 |
| Aquino, VR; Chaves, GM; Colombo, AL; de Almeida Junior, JN; de Andrade Barberino, MGM; de Queiroz Telles, F; de Tarso O Castro, P; Francisco, EC; Guimarães, T; Hahn, RC; Mendes, AVA; Padovan, ACB | 1 |
| Chaftari, AM; Hachem, R; Kontoyiannis, DP; Raad, II; Reitzel, RA; Rosenblatt, J; Vargas-Cruz, N; Wilson Dib, R | 1 |
| Chopade, BA; Nadhe, SB; Singh, R; Wadhwani, SA | 1 |
| Chong, Y; Jie, Y; Li, X; Li, Z; Liu, Y; Yan, Y; Zheng, X | 1 |
| Aouthmany, S; Cooper, AM; Rega, PP; Shah, K | 1 |
| Khattab, A; Patruni, S; Sealey, ML | 1 |
| González, GM; Gracia-Robles, G; Luna-Rodríguez, CE; Montoya, AM; Rojas, OC | 1 |
| Fujioka, K; Hamasaki, Y; Kagami, S; Kinoshita, Y; Nagai, T; Shishido, S; Urushihara, M | 1 |
| Day, JN; Hai, TP; Krysan, D; Lan, NPH; Ngan, NTT; Nhat, LTH; Thwaites, GE; Van, AD; Vinh Chau, NV | 1 |
| Bolon, MK; Clark, J; Gilley, JH; Kadakia, AR; Ko, JH; Roberts, SC; Taiwo, BO; Ward-Fore, S; Zembower, TR | 1 |
| Blatt, DB; Bobenchik, AM; Choe, YJ; Geffert, SF; Michelow, IC; Yalcindag, A | 1 |
| Chu, M; Jia, C; Li, L; Liu, J; Wang, J; Xu, K; Zhang, J; Zhuge, Y | 1 |
| Guo, Q; Hu, T; Lu, Y; Mo, L; Peng, X; Ren, B; Xu, X; Zhou, X; Zhou, Z | 1 |
| Altintop, YA; Atalay, MA; Ergul, AB; Koc, AN | 1 |
| Lockhart, SR | 1 |
| Hussein, A; Ling, JL; Muhammed, J; Saud Al-Abbas, AH | 1 |
| Alanio, A; Boyer-Chammard, T; Harrison, TS; Jarvis, JN; Lortholary, O; Temfack, E | 1 |
| Araújo Paulo de Medeiros, M; de Assis Bezerra Neto, F; Magalhães Pinto, L; Maranhão Chaves, G; Zuza Alves, DL | 1 |
| Boggild, AK; Challa, P; Kariyawasam, R; Lau, R | 1 |
| Hara, S; Nishioka, H; Shimizu, H | 1 |
| August, J; Bardwell, J; Donovan, F; Farran, S; Florita, C; Zangeneh, TT | 1 |
| Alves, MM; Barbosa, DB; Delbem, ACB; Figueiral, MH; Lopes, MM; Mira, NP; Pinto, E; Souza, JAS | 1 |
| Castanheira, M; Deshpande, LM; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Danis Vijay, D; Jayanthi, S; Meenakshi, N; Meharaj, SHS; Perumal, J; Sujhithra, A | 1 |
| Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| Chong, TYR; Lee, JSS; Singh, R; Su, PQ; Tan, GSE; Tan, JWL; Vasoo, S; Wong, KJH | 1 |
| Abassi, M; Alhadab, AA; Boulware, DR; Brundage, RC; Meya, DB; Musubire, A; Nicol, MR; Rhein, J; Tugume, L; Williams, DA | 1 |
| Andreu, D; Cavalcante, CSDP; de Aguiar, FLL; Dos Santos Fontenelle, RO; Falcão, CB; Rádis-Baptista, G | 1 |
| Alanio, A; Boyer-Chammard, T; Delliere, S; Lanternier, F; Lawrence, D; Lortholary, O; Loyse, A; Temfack, E | 1 |
| Boulware, DR; Evans, EE; Meya, DB; Muzoora, C; Nalintya, E; Ndyetukira, JF; Nuwagira, E; Pastick, KA; Rajasingham, R; Rhein, J; Skipper, C; Ssebambulidde, K; Stephens, N; Tugume, L | 1 |
| Aoufi, S; Bandadi, FZ; Lyagoubi, M; Moustachi, A; Raiss, C | 1 |
| Bellet, V; Bertout, S; Chabrol, A; Delaporte, E; Doumbia, A; Drakulovski, P; Kakou, A; Kassi, FK; Krasteva, D; Landman, R; Menan, HEI; Reynes, J; Roger, F | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Cao, Q; Cooper, B; Gui, X; Sherer, R; Zhang, Y | 1 |
| Ghaffar, M; Orr, C; Webb, G | 1 |
| Hu, J; Li, L; Yang, M; Zhang, X; Zhao, H | 1 |
| da Silva de Bastiani, FWM; de Azevedo Melo, AS; de Castro Spadari, C; Ishida, K; Pisani, PBB | 1 |
| Appendino, A; Arias, B; Castellaro, P; Córdoba, S; Monzani, V; Szusz, W; Taverna, CG; Vivot, M; Vivot, W | 1 |
| Goerge, T; Metze, D; Moeckel, SMC; Phan, NQ; Sunderkoetter, C; Tirado, M | 1 |
| Aam, BB; Eijsink, VGH; Ganan, M; Gaustad, P; Lorentzen, SB; Sørlie, M | 1 |
| Gupta, MK; Pandey, N; Paul, P; Tilak, R | 1 |
| Abassi, M; Akampurira, A; Bangdiwala, AS; Boulware, DR; Evans, EE; Hullsiek, KH; Kiggundu, R; Meintjes, G; Meya, DB; Morawski, BM; Mpoza, E; Musubire, AK; Muzoora, C; Nabeta, HW; Nuwagira, E; Pastick, KA; Pullen, MF; Rajasingham, R; Rhein, J; Schutz, C; Skipper, CP; Ssebambulidde, K; Tugume, L; Williams, DA | 1 |
| AlFouzan, W; Anastasiadis, E; Dhar, R; El Chaar, M; Ghaddar, A; Ghaddar, N; Halimeh, R; Yusef, H | 1 |
| Farquhar, C; Gertz, AM; Guthrie, BL; Jarvis, JN; Lawrence, DS; Tenforde, MW; Wills, NK | 1 |
| Adzic-Vukicevic, T; Barac, A; Cevik, M; Micic, J; Paglietti, B; Poluga, J; Rubino, S | 1 |
| Baddley, JW; Zavala, S | 1 |
| Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J | 1 |
| Chakrabarti, A; Oberoi, J; Rudramurthy, SM; Shankarnarayan, SA; Shastri, PS; Wattal, C | 1 |
| Bosch, C; Botha, A; Toplis, B; Volschenk, H; Vreulink, JM | 1 |
| Boucherit, K; Boucherit-Otmani, Z; Khoder, G; Madkour, M; Soliman, SSM; Touil, HFZ | 1 |
| Chayakulkeeree, M; Rujirachun, P; Sangwongwanich, J | 1 |
| Brock, M; Hillen, A; Himmelreich, U; Janbon, G; Lagrou, K; Poelmans, J; Vande Velde, G; Vanherp, L | 1 |
| Aksu, ED; Albayrak, Ö; Ataç, N; Aydın, M; Can, F; Çınar, G; Doğan, Ö; Ergönül, Ö; Güler, Ö; Hacıseyitoğlu, D; Kapmaz, M; Karakoç, Ç; Keske, Ş; Menekşe, Ş; Şahin, S; Tekin, S; Yalçın, D; Yeşilkaya, A | 1 |
| Jeng, A; Kalinoski, T; Malenfant, J; Yim, C | 1 |
| Hine, P; Murray, M | 1 |
| Kraft, L; Ribeiro, VST; Telles, JP; Tuon, FF | 1 |
| Ahmad, A; Srivastava, V | 1 |
| Bauab, TM; Bernegossi, J; Bonifácio, BV; Chorilli, M; de Toledo, LG; Miyashiro, CA; Ramos, MAS | 1 |
| Pea, F | 1 |
| Antoran, A; Aparicio-Fernandez, L; Buldain, I; Fuchs, BB; Ghannoum, MA; Hernando, FL; Martin-Souto, L; Mylonakis, E; Pellon, A; Ramirez-Garcia, A; Rementeria, A | 1 |
| Lacy, AJ; Murphy, LS; Shah, KS; Smith, AT | 1 |
| Chen, R; Cui, Y; Li, S; Shi, Y; Song, Y; Yao, L; Zhao, L; Zhen, Y | 1 |
| Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J | 1 |
| Byun, JH; Choi, JH; Chun, HS; Han, EH; Jeong, Y; Kim, SH; Kim, YJ; Lee, SO; Park, C; Song, KY | 1 |
| Albuquerque, P; Cabral, WF; da Glória da Silva, M; de Araújo, AR; de Holanda Veloso Júnior, PH; de Souza de Almeida Leite, JR; de Souza Silva, C; do Nascimento Dias, J; Eaton, P; Nicola, AM; Silva-Pereira, I; Souza, JMT | 1 |
| Graham, M; Hughes, C; Streitberg, R; Stuart, R; Xie, O | 1 |
| Matsumoto, Y; Sugita, T; Tateyama, Y; Yamada, T; Yamasaki, Y; Yamazaki, H | 1 |
| Crazzolara, R; Fritz, J; Hutter, J; Kropshofer, G; Lass-Flörl, C; Meryk, A; Salvador, C | 1 |
| Song, X; Wu, H; Zhang, W; Zheng, R | 1 |
| Ateş, U; Gurbanova, A; Kalkancı, A; Yiğitoğlu, FN | 1 |
| Lombardi, A; Ouanounou, A | 1 |
| Chakrabarti, A; Gaur, NA; Gow, NAR; Kumar, M; Kumar, P; Kumari, S; Mondal, AK; Prasad, R; Rudramurthy, SM; Singh, A; Wasi, M | 1 |
| Han, Y; Huang, H; Lan, K; Liang, G; Lin, J; Liu, J; Pan, J; Yang, W; Zeng, L | 1 |
| Andrade, D; Bim, FL; Macedo, AP; Oliveira, VC; Sousa, ÁFL; Souza E Silva, VC; Watanabe, E | 1 |
| Larson, L; Mejia-Chew, C; Powderly, WG; Spec, A; Sung, A | 1 |
| Montenegro-Idrogo, J; Quincho-Lopez, A; Verona-Rubio, RO | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Chang, CJ; Deng, FS; Lin, CH; Lo, WH | 1 |
| Croitor-Sava, AR; Hillen, A; Himmelreich, U; Lagrou, K; Poelmans, J; Sorrell, TC; Vande Velde, G; Vanherp, L; Weerasekera, A | 1 |
| Chen, J; Chu, Y; Han, X; Shang, H; Tian, S; Wang, Q; Zhou, B | 1 |
| Deng, X; Gan, Q; Jiang, Y; Li, M; Liu, J; Peng, F; Wang, Y; Xu, X | 1 |
| Hunt, E | 1 |
| Chen, FJ; Chen, YC; Lee, CH | 1 |
| Anywaine, Z; Day, J; Ggayi, AB; Kaleebu, P; Kibengo, FM; Kitonsa, J; Kiwanuka, J; Mayanja, Y; Nikweri, Y; Nsubuga, R; Onyango, M | 1 |
| Boulware, DR; de Albuquerque Moraes, C; de Oliveira, ACP; de Siqueira, REB; Marcusso, R; Miranda, NFB; Vidal, JE | 1 |
| Bassi, RC; Boriollo, MFG | 1 |
| Shen, Q; Sheng, L; Zhou, J | 1 |
| Itoh, K; Iwasaki, H; Negoro, E; Shigemi, H; Tokimatsu, I; Tsutani, H; Yamauchi, T | 1 |
| Berkow, EL; Damm, T; Lockhart, SR; Nunnally, NS | 1 |
| Alshahni, MM; Du, M; Hu, W; Makimura, K; Naito, T; Satoh, K; Tamura, T; Yamanishi, C | 1 |
| Bocca, AL; Brandão, F; Matos, LF; Morais, JAV; Muehlmann, LA; Poças-Fonseca, MJ; Ranjan, K; Silva-Pereira, I | 1 |
| Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP | 1 |
| Abastabar, M; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Kermani, F; Kiakojuri, K; Mahdavi Omran, S; Roodgari, S; Shokohi, T; Taghizadeh Armaki, M | 1 |
| Bernat, P; Derkacz, D; Krasowska, A; Suchodolski, J | 1 |
| Alufandika, M; Bicanic, T; Day, JN; Harrison, TS; Hope, W; Jarvis, JN; Lalloo, DG; Loyse, A; Mwandumba, HC; Perfect, JR; Stott, KE | 1 |
| Carlson, T; Chandrasekaran, S; Lupinacci, E; Moseley, K | 1 |
| Ashley, EA; Macrae, C; McLean, ARD; Smithuis, F; Tun, NN; Warrell, CE; Wilkins, E | 1 |
| Carrasco, R; Diaz, LZ; Henkel, E; Trainor, M | 1 |
| Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M | 1 |
| Bajalan, Z; Hemmat, N; Javadi, A; Mohammadi, F | 1 |
| Benelli, JL; Klafke, GB; Munhoz, LS; Poester, VR; Stevens, DA; Xavier, MO | 1 |
| Amanati, A; Badiee, P; Ghasemi, F; Haghpanah, S; Hamzavi, SS; Jafarian, H; Nematolahi, S | 1 |
| Fuchs, F; Hamprecht, A; Hof, H; Hofmann, S; Kurzai, O; Meis, JF | 1 |
| Bloch, D; Cieśla, J; Czernel, G; Florek, M; Gagoś, M; Kędzierska-Matysek, M; Matwijczuk, A | 1 |
| Aires do Nascimento, FBS; Cavalcanti, BC; de Andrade Neto, JB; Nobre Junior, HV; Odorico de Moraes, M; Pérez, L; Pinazo, A; Ramos da Silva, A; Rocha da Silva, C; Serpa Sampaio Moreno, L | 1 |
| Beardsley, J; Binh, TQ; Chau, NVV; Day, JN; Geskus, R; Hope, W; Hung, LQ; Kestelyn, E; Krysan, D; Lalloo, DG; Lan, NPH; Mai, NTH; Ngan, NTT; Phu, NH; Tai, LTH; Thanh Hoang Le, N; Thwaites, GE; Trieu, PH; Tung, NLN; Van Anh, D; Van, NTT; Vi Vi, NN; White, NJ | 1 |
| Berman, J; Gao, L; Gritsenko, V; Jiang, YY; Lu, H; Yang, F; Zhen, C | 1 |
| Chen, W; Dai, H; Hu, X; Li, H; Liu, H; Qiao, S; Sun, L; Sun, S; Wang, K; Zhang, S; Zhao, X | 1 |
| Chen, S; Chen, Y; Guan, H; Han, B; He, Q; Jiang, X; Li, C; Li, S; Li, T; Li, X; Sheng, B; Sun, L; Wang, P; Wang, Q; Wang, Y; Xiao, W; Xu, P; Yang, H; Yin, J | 1 |
| Abutaleb, NS; Hagras, M; Mayhoub, AS; Salama, EA; Sayed, AM; Seleem, MN | 1 |
| Farooqi, J; Jabeen, K; Memon, S; Naqvi, SF; Zafar, A; Zafar, U | 1 |
| Liu, L; Tu, Y; Xu, T; Yuan, G | 1 |
| Boulware, DR; Israelski, DM; Larson, BA; Meya, DB; Nalintya, E; Rajasingham, R | 1 |
| Liu, Y; Niu, X; Pan, M; Shao, J; Wang, Q; Wang, T; Wu, D; Xiao, N; Yan, G | 1 |
| Arnault, S; Brunet, K; Cateau, E; Ladram, A; Rodier, MH; Verdon, J | 1 |
| Boulware, DR; Boyer-Chammard, T; Chawinga, C; Chen, T; Comins, K; Harrison, TS; Hlupeni, A; Hope, W; Hosseinipour, MC; Jaffar, S; Jarvis, JN; Jjunju, S; Kagimu, E; Kanyama, C; Kasibante, J; Lalloo, DG; Lawrence, DS; Leeme, T; Lortholary, O; Loyse, A; Meintjes, G; Meya, DB; Molloy, SF; Mosepele, M; Moyo, M; Mpoza, E; Mutata, C; Muzoora, C; Mwandumba, HC; Mzinganjira, H; Ndhlovu, CE; Nuwagira, E; Rhein, J; Rutakingirwa, MK; Schutz, C; Siamisang, K; Singh, A; Ssebambulidde, K; Tugume, L; van Widenfelt, E; Wang, D; Youssouf, N | 1 |
| Cho, SI; Choi, SH; Kim, J; Kim, SY; Kim, WJ; Kim, YR; Koo, J; Lee, CH; Lee, H; Lee, HJ; Lee, HK; Oh, J; Ryu, SW; Shin, JH; Sohn, YH; Sung, GH | 1 |
| Paaopanchon, C; Pesee, S; Phantumvanit, P; Roytrakul, S; Samaranayake, L | 1 |
| Amiri, S; Erami, M; Fakhrehi, M; Getso, MI; Hashemi, SJ; Mehri, N; Momen-Heravi, M; Raiesi, O; Raissi, V; Yarahmadi, M | 1 |
| Alcoceba, E; Ayestarán, I; Beltrán, AF; Escribano, P; Gómez, A; Guinea, J; Lara-Esbrí, P; Muñoz, P; Oliver, A | 1 |
| Brambilla, P; Carcione, D; Intra, J; Leoni, V; Sala, MR | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Heidrich, D; Jank, L; Milani, G; Pagani, DM; Scroferneker, ML; They, NH; Tormente, F; Valente, P | 1 |
| Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
| Alegre, L; Giusiano, G; Latorre, W; Mussin, J; Rojas, FD; Sosa, MLÁ | 1 |
| Jiang, Y; Li, M; Liu, J; Peng, F; Su, X; Wang, A; Wang, Y; Xu, X; Yang, L | 1 |
| Boan, PA; Chew, SM; Dyer, JR; Heath, CH; Ingram, PR; Italiano, CM; Manning, L; Petursson, C; Robinson, JO | 1 |
| Agarwal, R; Biswal, M; Chakrabarti, A; Dhaliwal, N; Ghosh, A; Ghoshal, S; Jain, S; Kaur, H; Krishnamoorthi, S; Malhotra, P; Muthu, V; Rudramurthy, SM; Samujh, R; Singh, S | 1 |
| Falci, DR; Pasqualotto, AC | 1 |
| Harrison, TS; Jarvis, JN; Lawrence, DS | 1 |
| Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G | 1 |
| Abe, M; Hirabayashi, A; Hosaka, Y; Kajihara, T; Kitamura, N; Miyazaki, Y; Nagi, M; Sugai, M; Yahara, K | 1 |
| Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O | 1 |
| Day, JN; Flower, B; Ngan, NTT | 1 |
| Bilal, H; Hou, B; Islam, R; Khan, MN; Khan, RU; Shafiq, M; Zeng, Y | 1 |
| Chiller, TM; Ford, N; Rajasingham, R; Shapiro, AE; Tenforde, MW | 1 |
| Buapeth, KO; Chaisut, M; Chanchayanon, B; Indoung, S; Jantrakajorn, S; Morteh, R | 1 |
| Goto, N; Hida, Y; Higashi, T; Iwasaki, H; Kodawara, T; Tsukamoto, H; Watanabe, K | 1 |
| Doganer, A; Gundes, A; Mulayim, MK; Nazik, H; Nazik, S; Orak, F; Ozturk, P; Yalcinkaya, KT | 1 |
| Boulware, DR; Harrison, TS; Hosseinipour, MC; Jarvis, JN; Lawrence, DS; Lortholary, O; Meintjes, G; Mosepele, M; Mwandumba, HC | 1 |
| Matsumoto, Y; Nagamachi, T; Sugita, T; Sugiyama, Y; Yamada, T; Yoshikawa, A | 1 |
| Golubykh, K; Holleran, L; Kovalenko, I; Qurashi, S; Saleem, T | 1 |
| Cui, F; Kan, S; Li, X; Liu, W; Pang, Q | 1 |
| Bonnin, V; Butler, G; Cafarchia, C; Cassaing, S; Grenouillet, F; Hagen, F; Lavergne, RA; Le Pape, P; Moniot, M; Morio, F; Nourrisson, C; Poirier, P; Robert, E; Sabou, M | 1 |
| Harrison, TS; Jarvis, JN; Lawrence, DS; Maphane, L; Meya, DB; Moshashane, N; Nabaggala, G; Seeley, J; Ssali, A | 1 |
| Aliabadi, N; Fattahi, M; Ghasemi, R; Kouhsari, E; Lotfali, E; Madinehzad, SA; Rezaei, K; Tafti, MF | 1 |
| Abebe, W; Alemayehu, T; Ali, EE; Erku, DA; Fentie, AM; Gebremariam, GT; Gebretekle, GB; Sander, B | 1 |
| Kato, H; Kirino, Y; Kojitani, N; Nakajima, H; Samukawa, S; Soejima, Y; Takase-Minegishi, K; Uzawa, Y; Yoshimi, R | 1 |
| Balázs, B; Balogh, B; Bozó, A; Forgács, L; Kelentey, B; Kovács, R; Majoros, L; Tóth, Z | 1 |
| Ahmed, NH; Gupta, N; Naik, R; Sidhu, N; Tandon, R; Vanathi, M | 1 |
| Aguiar, ALR; da Silva, BN; de Aguiar Cordeiro, R; de Andrade, ARC; de Lima-Neto, RG; Lima, XTV; Maia, DCSC; Moura, SGB; Pereira, LMG; Portela, FVM; Reis, AT; Rocha, MFG; Sidrim, JJC | 1 |
| Howattanapanich, S; Matangkasombut, O; Satitviboon, W; Thanyasrisung, P | 1 |
| Alves, V; Araújo, GR; Frases, S | 1 |
| Gonçalves, GA; Kraft, L; Ribeiro, VST; Suss, PH; Tuon, FF | 1 |
| Aberg, JA; Badal-Faesen, S; Bukuru, A; Clifford, DB; Hogg, E; Komarow, L; Lagat, D; Lalloo, UG; Langat, D; Larsen, RA; Mave, V; McKhann, A; Pillay, S; Samaneka, W; Supparatpinyo, K; Ticona, E | 1 |
| Anversa, L; Arnoni, MV; Auler, M; Bonfietti, LX; de Camargo, BB; Dias, ALT; Garces, HG; Gimenes, VMF; Lara, BR; Leite Junior, DP; Melhem, MSC; Monari, GPM; Moreira, D; Oliveira, L; Paula, CR; Ramos, RTB; Richini-Pereira, VB; Ruiz, LDS; Silva, NC; Silveira, M | 1 |
| Baquero-Artigao, F; Capilla-Miranda, A; Garcia-Clemente, P; Plaza-López, D | 1 |
| Caza, M; César, IC; Emidio, ECP; Freitas, GJC; Gouveia-Eufrasio, L; Guimarães, GM; Kronstad, JW; Oliveira, JBS; Paixão, TA; Ribeiro, NQ; Santos, DA | 1 |
| Enersen, M; Fjeld, KG; Gay, CL; Herlofson, BB; Hove, LH; Kristoffersen, AK; Lerdal, A; Monsen, RE; Nordgarden, H; Tollisen, A | 1 |
| Alt, V; Mannala, GK; Riool, M; Rupp, M; Scholz, KJ; Simon, M; Walter, N | 1 |
| Charkhchian, M; Mirzadeh, M; Mohammadi, F | 1 |
| Abastabar, M; Badiee, P; Haghani, I; Mohammadi, R; Morovati, H; Noorbakhsh, M; Sharifi, M | 1 |
| Hong, Q; Hong, Z; Huang, Q | 1 |
| Almeida, JDR; Frickmann, H; Lacerda, MVG; Sousa, NSO; Souza, JVB | 1 |
| Alcalá, L; Cuétara, MS; Díaz-García, J; Durán-Valle, MT; Escribano, P; García-Esteban, C; Gómez-García de la Pedrosa, E; González-Romo, F; Guinea, J; Machado, M; Martínez-Quintero, GA; Merino, P; Muñoz, P; Muñoz-Algarra, M; Pérez-Ayala, A; Quiles-Melero, I; Reigadas, E; Sánchez-Carrillo, C; Sánchez-García, A; Zurita, ND | 1 |
| Bive, BZ; Bontems, S; Hayette, MP; Lelo, GM; Mudogo, CN; Sacheli, R; Zakayi, PK | 1 |
| Celis-Ramírez, AM; Contreras, A; Ehemann, K | 1 |
| Ahmad, S; Al-Sweih, N; Asadzadeh, M; Khan, Z | 1 |
| Bryk, P; Jasiura, A; Krasowska, A; Muraszko, J; Sztafrowski, D; Urbanek, AK | 1 |
261 review(s) available for fluconazole and amphotericin b
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Recent advances in natural antifungal flavonoids and their derivatives.
Topics: Antifungal Agents; Biological Products; Flavonoids; Fungi; Humans; Mycoses | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Promising antifungal agents: A minireview.
Topics: Antifungal Agents; Drug Design; Fungi; Humans; Molecular Structure; Mycoses; Structure-Activity Relationship | 2020 |
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Method; Fluconazole; Humans; Immunocompromised Host; Neoplasms; Neutropenia; Survival Rate | 1992 |
Histoplasmosis in Indianapolis.
Topics: Amphotericin B; Disease Outbreaks; Fluconazole; Histoplasmosis; Humans; Indiana; Itraconazole; Ketoconazole | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
Cryptococcal meningitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Neurologic Examination; Nursing Assessment; Patient Education as Topic | 1992 |
Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.
Topics: Amphotericin B; Animals; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans | 1992 |
Therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Animals; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 1992 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Overview: cryptococcosis in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans | 1991 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
[Mollusca contagiosa-like cutaneous cryptococcosis in AIDS: a case].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Dermatomycoses; Diagnosis, Differential; Fluconazole; Humans; Injections, Spinal; Meningitis; Molluscum Contagiosum; Opportunistic Infections; Prognosis | 1991 |
[Cryptococcosis in AIDS: therapeutic concepts].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans | 1990 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1990 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
[Prophylaxis against mycoses in neutropenic patients].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Fluconazole; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Itraconazole; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections | 1994 |
[Therapy of systemic candidiasis].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Burns; Candidiasis; Fluconazole; Humans; Incidence; Itraconazole; Neoplasms; Opportunistic Infections; Postoperative Complications; Transplantation | 1994 |
[Prophylaxis and therapy of fungal infections in oncology].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Incidence; Mycoses; Neoplasms; Triazoles | 1995 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
Acremonium fungemia in two immunocompromised children.
Topics: Acremonium; Amphotericin B; Catheterization, Central Venous; Child, Preschool; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Humans; Immunocompromised Host; Male | 1995 |
Cryptococcal meningitis in AIDS.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Carbon; Coloring Agents; Cryptococcus neoformans; Drug Administration Schedule; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Prognosis; Serotyping; Spinal Puncture; Staining and Labeling; Tomography, X-Ray Computed | 1993 |
Antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1995 |
Use of fluconazole in the treatment of candidal endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Drug Administration Schedule; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 1995 |
[Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Topics: Aerosols; Amphotericin B; Aspergillosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male | 1994 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fungemia; Gastrointestinal Diseases; Humans; Intensive Care Units; Risk Factors | 1993 |
Histoplasmosis: recognition and treatment.
Topics: Amphotericin B; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Serologic Tests | 1994 |
Aspergillus fumigatus pneumonia in neutropenic patients receiving fluconazole for infection due to Candida species: is amphotericin B combined with fluconazole the appropriate answer?
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Drug Interactions; Drug Therapy, Combination; Fluconazole; Humans; Lung Diseases, Fungal; Neutropenia | 1994 |
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Fluconazole; Fungemia; Humans; Itraconazole; London; Meningitis, Cryptococcal; Recurrence; Retrospective Studies; Survival Analysis | 1994 |
Management of systemic manifestations of fungal disease in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Coccidioidomycosis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Histoplasmosis; Humans; Itraconazole; Meningitis, Cryptococcal | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Diagnosis and treatment of invasive fungal infections in cancer patients.
Topics: Amphotericin B; Aspergillosis; Fluconazole; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Neoplasms; Serologic Tests; Tomography, X-Ray Computed; Ultrasonography | 1993 |
Disseminated Penicillium marneffei infection as an imported disease in HIV-1 infected patients. Description of two cases and a review of the literature.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Asia, Southeastern; Diagnosis, Differential; Fatal Outcome; Fluconazole; HIV-1; Humans; Male; Mycoses; Netherlands; Penicillium; Travel | 1994 |
Candida tropicalis infections in children with leukemia.
Topics: Abscess; Adolescent; Amphotericin B; Candida; Candidiasis; Cerebrospinal Fluid; Child; Child, Preschool; Combined Modality Therapy; Drainage; Female; Fluconazole; Fungemia; Humans; Infant; Leukemia; Male; Meningitis, Fungal; Neutropenia; Parenteral Nutrition, Total; Retrospective Studies; Risk Factors; Superinfection; Tennessee | 1993 |
Cryptococcal meningitis and AIDS.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; HIV-1; Humans; Meningitis, Cryptococcal; Prognosis | 1993 |
Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; United States | 1993 |
The management of cryptococcal disease in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Cryptococcosis; Eye Infections, Fungal; Fluconazole; Humans; Lung Diseases, Fungal; Male; Prostatic Diseases | 1993 |
Antifungal prophylaxis in bone marrow transplant.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Fluconazole; Humans; Mycoses | 1995 |
[Rational use of antimycotics against yeast infections].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Chemistry, Pharmaceutical; Drug Resistance, Microbial; Ergosterol; Fluconazole; Humans; Mycoses; Yeasts | 1995 |
Phaeohyphomycosis caused by Dactylaria (human dactylariosis): report of a case with review of the literature.
Topics: Amphotericin B; Antifungal Agents; Brain Diseases; Fluconazole; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Mitosporic Fungi; Mycoses | 1995 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole; Mucormycosis; Mycoses; Prognosis | 1996 |
Problems and controversies in the management of hematogenous candidiasis.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Colony-Stimulating Factors; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Fungemia; Humans; Leukocyte Transfusion; Liposomes; Neutropenia; Randomized Controlled Trials as Topic | 1996 |
Recent advances in the management of cryptococcal meningitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Combined Modality Therapy; Fluconazole; Humans; Intracranial Pressure; Itraconazole; Meningitis, Cryptococcal | 1996 |
New challenges to the therapy of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Mycoses; Sterols | 1996 |
[Antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole | 1995 |
Resistance to antifungal agents in the critical care setting: problems and perspectives.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Intensive Care Units | 1996 |
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.
Topics: Amphotericin B; Animals; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses | 1996 |
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Female; Fluconazole; Humans; Male; Prospective Studies; Treatment Failure; Treatment Outcome | 1996 |
Successful therapy of Candida albicans arthritis with a sequential intravenous amphotericin B and oral fluconazole regimen.
Topics: Amphotericin B; Antifungal Agents; Arthritis, Infectious; Candidiasis; Child; Drug Administration Schedule; Fluconazole; Follow-Up Studies; Humans; Injections, Intravenous; Knee Injuries; Male | 1996 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
The role of azole antifungal agents for systemic antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Costs; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole | 1997 |
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 1997 |
Candidal meningitis in HIV-infected patients: analysis of 14 cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Fungal; Middle Aged; Risk Factors | 1997 |
Opportunistic fungal infections: filamentous fungi and cryptococcosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptococcosis; Fluconazole; Humans; Middle Aged; Mucormycosis; Opportunistic Infections | 1997 |
Antifungal treatment in patients with cancer.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Mycoses; Neoplasms | 1997 |
[Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Quality Control; Saccharomyces cerevisiae | 1997 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[New aspects of infections caused by Aspergillus and Mucor and other filamentous fungi in immunosuppressed patients].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Clinical Trials as Topic; Female; Fluconazole; Fungi; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Mucormycosis; Multicenter Studies as Topic; Mycoses; Peritoneal Dialysis, Continuous Ambulatory | 1995 |
[Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Cryptococcosis; Fluconazole; Flucytosine; Humans; Immunotherapy; Itraconazole; Meningitis, Cryptococcal; Mice; Multicenter Studies as Topic; Vaccination | 1995 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mucormycosis; Mycoses; Neutropenia; Nystatin; Primary Prevention; Recurrence; Retrospective Studies | 1995 |
[Prevention and treatment of fungal infections in solid-organ transplant recipients].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Multicenter Studies as Topic; Mycoses; Pancreas Transplantation; Risk Factors; Transplantation | 1995 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Clinical Trials as Topic; Cryptococcosis; Drug Resistance, Microbial; Esophageal Diseases; Female; Fluconazole; Fungi; Humans; Ketoconazole; Male; Retrospective Studies | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
Ocular and concomitant cutaneous sporotrichosis.
Topics: Amphotericin B; Anterior Chamber; Brazil; Child; Eye Infections, Fungal; Female; Fluconazole; Humans; Paracentesis; Potassium Iodide; Sporotrichosis; Timolol; Uveitis | 1997 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazole; Flucytosine; Hematologic Diseases; Humans; Itraconazole; Mycoses | 1998 |
The management of cryptococcal meningitis in Papua New Guinea.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Cause of Death; Drug Combinations; Drug Monitoring; Fluconazole; Flucytosine; Humans; Hydrocortisone; Immunocompetence; Intracranial Hypertension; Intracranial Pressure; Itraconazole; Meningitis, Cryptococcal; Multicenter Studies as Topic; Papua New Guinea | 1996 |
[Candida infections in infancy and early childhood].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male; Risk Factors | 1998 |
[New aspects in treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Mycoses; Opportunistic Infections; Treatment Outcome | 1998 |
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycoses | 1998 |
Invasive infections due to Clavispora lusitaniae.
Topics: Adult; Amphotericin B; Antifungal Agents; Child, Preschool; Fluconazole; Fungemia; Humans; Meningitis, Fungal; Neoplasms; Saccharomycetales | 1999 |
Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Fungemia; Humans; Incidence; Male; Middle Aged; Neoplasms; Risk Assessment; Treatment Outcome | 1999 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Fungemia; Histoplasmosis; Humans; Immunocompromised Host; Mycoses; Zygomycosis | 1999 |
[The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
Topics: Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 1999 |
Molecular and biochemical mechanisms of drug resistance in fungi.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Flucytosine; Fungi | 1999 |
Current management of funguria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Humans; Male; Sex Factors; Urinary Catheterization; Urinary Tract Infections | 1999 |
Successful treatment of Candida albicans endocarditis in a child with leukemia--a case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Drug Therapy, Combination; Endocarditis; Fluconazole; Humans; Injections, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 1999 |
[Progress and new perspective treatments of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Forecasting; Humans; Itraconazole; Mycoses; Systemic Inflammatory Response Syndrome | 1999 |
Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida albicans; Female; Fluconazole; Humans; Male; Meningitis, Fungal; Reoperation; Treatment Outcome; Ventriculoperitoneal Shunt | 2000 |
Trichosporon beigelii infection: experience in a regional burn center.
Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial; Fatal Outcome; Female; Fluconazole; Flucytosine; Fungemia; Humans; Immunocompromised Host; Male; Mycoses; Opportunistic Infections; Sputum; Trichosporon; Wound Infection | 2000 |
Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
Topics: Amphotericin B; Antifungal Agents; Confidence Intervals; Fluconazole; Humans; Mycoses; Neoplasms; Neutropenia; Odds Ratio; Randomized Controlled Trials as Topic | 2000 |
Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Risk Factors | 2000 |
Changing strategies for treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Mycoses | 2000 |
Current approach to the acute management of cryptococcal infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Itraconazole; Lung Diseases, Fungal; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2000 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence | 2000 |
Current management of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Dermatomycoses; Fluconazole; Humans; Intestinal Absorption; Itraconazole; Onychomycosis | 2001 |
Therapy for fungal infections in leukemia.
Topics: Amphotericin B; Aspergillosis; Azoles; Candidiasis; Fluconazole; Humans; Immunotherapy; Leukemia; Mycoses; Neutropenia | 2001 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Time Factors | 2001 |
Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Neoplasms; Candida; Candidiasis; Catheterization, Central Venous; Child; Child, Preschool; Craniotomy; Cross Infection; Drug Resistance, Microbial; Equipment Contamination; Fluconazole; Fungemia; Hospitals, Pediatric; Humans; Microbial Sensitivity Tests; Postoperative Complications; Slovakia; Species Specificity; Ventriculoperitoneal Shunt | 2001 |
Disseminated Dactylaria constricta infection in a renal transplant recipient.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Fatal Outcome; Female; Fluconazole; Humans; Itraconazole; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Radiography | 2001 |
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2001 |
Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Fluconazole; Fungemia; Humans; Odds Ratio; Treatment Failure | 2001 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome | 2001 |
[Prevention of fungal infections in children and adolescents with cancer].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Child; Child, Preschool; Cohort Studies; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Infant, Newborn; Itraconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic; Respiratory Therapy; Risk Factors; Time Factors | 2001 |
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Neutropenia; Opportunistic Infections; Risk Factors | 2001 |
A brief review of antifungal therapy for deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Compounding; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Mycoses | 2001 |
Candida lusitaniae catheter-related sepsis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheters, Indwelling; Equipment Contamination; Female; Fluconazole; Humans; Middle Aged; Risk Factors | 2001 |
Management of systemic candidal infections in the intensive care unit.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluconazole; Humans; Intensive Care Units; Risk Factors | 2002 |
Fungal skin infections in organ transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Incidence; Itraconazole; Organ Transplantation; Risk Factors | 2002 |
Case report. Disseminated infection of Blastoschizomyces capitatus in a patient with acute myelocytic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Fatal Outcome; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Middle Aged; Mitosporic Fungi; Multiple Organ Failure; Mycoses | 2001 |
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment.
Topics: Adult; Aged; Amphotericin B; Cornea; Corneal Injuries; Drug Therapy, Combination; Eye Enucleation; Eye Infections, Fungal; Eye Injuries, Penetrating; Female; Fluconazole; Humans; Keratitis; Male; Mycetoma; Natamycin; Scedosporium | 2002 |
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Topics: Amphotericin B; Antifungal Agents; Confidence Intervals; Fluconazole; Humans; Mycoses; Neoplasms; Neutropenia; Odds Ratio; Randomized Controlled Trials as Topic | 2002 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Mycoses; Nystatin; Opportunistic Infections | 2002 |
[Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Resistance, Fungal; Drug Resistance, Multiple; Echinocandins; Fluconazole; Fungi; Incidence; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Polyenes; Spain; Terbinafine | 2002 |
Prevention of fungal infection in transplantation.
Topics: Amphotericin B; Antifungal Agents; Basement Membrane; Candida; Candidiasis; Cytomegalovirus Infections; Fluconazole; Humans; Mycoses; Organ Transplantation; Risk Factors | 2002 |
Overview of histoplasmosis.
Topics: Amphotericin B; Antifungal Agents; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole | 2002 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Mycoses; Nystatin; Opportunistic Infections; Randomized Controlled Trials as Topic | 2002 |
Candida lusitaniae infections in the era of fluconazole availability.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cell Culture Techniques; Child; Child, Preschool; Drug Resistance, Microbial; Female; Fluconazole; Humans; Infant; Infant, Newborn; Male; Middle Aged; Treatment Outcome | 2003 |
[Correlation between in vitro susceptibility to antifungal drugs and the clinical evolution of patients with candidiasis and cryptococcosis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 2002 |
[Cryptococcosis].
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Fluconazole; Humans; Immunity, Cellular; Immunocompromised Host; Melanins; Polysaccharides; Prognosis; Virulence Factors | 2003 |
[Antifungal drug].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Design; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fluorouracil; Fungi; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Polyenes; Pyrimidines | 2003 |
Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Corynebacterium Infections; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Retinal Diseases; Severity of Illness Index; Staphylococcal Infections | 2003 |
Molecular targeted treatments for fungal infections: the role of drug combinations.
Topics: Amphotericin B; Animals; Antifungal Agents; Cytokines; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluconazole; Humans | 2003 |
An unusual cause of vertebral osteomyelitis: Candida species.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Discitis; Female; Fluconazole; Follow-Up Studies; Fungemia; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Osteomyelitis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
[Controversy concerning optimal prophylaxis and empirical antifungal therapy in immunocompromised patients].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Administration Schedule; Fluconazole; Humans; Immunocompromised Host; Preventive Health Services | 2003 |
Update on antifungal therapy.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Cat Diseases; Cats; Dog Diseases; Dogs; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 2003 |
Current treatment approaches to leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine | 2003 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
Isolated native tricuspid valve Candida endocarditis in a non-drug-addicted patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Echocardiography; Endocarditis; Fluconazole; Humans; Male; Middle Aged; Parenteral Nutrition, Total; Substance-Related Disorders; Tomography, X-Ray Computed; Tricuspid Valve | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Side effects of systemic antimycotics].
Topics: Amphotericin B; Antifungal Agents; Chills; Fever; Fluconazole; Humans; Itraconazole; Meta-Analysis as Topic; Mycoses; Nausea; Vomiting; Water-Electrolyte Imbalance | 2003 |
Systemic antifungal drugs for invasive fungal infection in preterm infants.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Mycoses; Randomized Controlled Trials as Topic | 2004 |
[Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Female; Fever; Fluconazole; Hepatomegaly; Histoplasmosis; Humans; Itraconazole; Male; Recurrence; Respiration Disorders; Splenomegaly; Weight Loss | 2004 |
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2003 |
Antifungals in systemic neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Humans; Infant, Newborn; Peptides; Peptides, Cyclic | 2004 |
Empirical antifungal therapy in treating febrile neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Fever; Fluconazole; Fungemia; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections | 2004 |
Cerebral infarction related to cryptococcal meningitis in an HIV-infected patient: case report and literature review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebral Infarction; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Tomography, X-Ray Computed | 2004 |
[Emergent mycoses].
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biomarkers; Disease Progression; Fatal Outcome; Fluconazole; Glucans; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Otorhinolaryngologic Diseases; Risk Factors | 2004 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[Guidelines for the management of deep mycosis in neutropenic patients].
Topics: Amphotericin B; Aspergillosis; Candidiasis; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Micafungin; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole | 2004 |
Diagnosis and management of central nervous system histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Fluconazole; Histoplasmosis; Humans; Immunocompromised Host; Male; Meningitis, Fungal; Mycological Typing Techniques; Sensitivity and Specificity | 2005 |
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Chronic Disease; Fluconazole; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Time Factors | 2005 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
Cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunotherapy; Intracranial Pressure; Meningitis, Cryptococcal; Prognosis; Treatment Outcome | 2004 |
Cryptococcal meningitis in an immunocompetent child: a case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Child, Preschool; Cryptococcus neoformans; Female; Fluconazole; Humans; Malaysia; Meningitis, Cryptococcal | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Neonatal candidiasis: prophylaxis and treatment.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Infant, Low Birth Weight; Infant, Newborn; Randomized Controlled Trials as Topic; Risk Factors | 2005 |
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Mycoses; Neutropenia; Stem Cell Transplantation | 2005 |
Drug-drug interactions of antifungal agents and implications for patient care.
Topics: Acidosis, Renal Tubular; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Caspofungin; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Echinocandins; Enzyme Inhibitors; Fluconazole; Humans; Itraconazole; Lipopeptides; Liver; Mycoses; Patient Care; Peptides, Cyclic | 2005 |
Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Equipment Contamination; Female; Fluconazole; Fungemia; Humans; Parenteral Nutrition | 2005 |
Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Lipopeptides; Male; Mitral Valve; Peptides, Cyclic; Prosthesis-Related Infections | 2005 |
Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid Pressure; Cryptococcus neoformans; Deoxycholic Acid; Drainage; Drug Combinations; Female; Fluconazole; Flucytosine; HIV-1; Humans; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2005 |
An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Severity of Illness Index | 2005 |
Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cryptococcus neoformans; Female; Fluconazole; Humans; Lymphadenitis; Male; Meningitis, Cryptococcal | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Critical Illness; Fluconazole; Humans; Immunocompromised Host; Mycoses; Randomized Controlled Trials as Topic | 2006 |
Fungal infections in solid organ transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fluconazole; Humans; Incidence; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Postoperative Complications; Premedication | 2006 |
Systemic fungal infections in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Risk Factors | 2005 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Isolated intramedullary cryptococcal granuloma of the conus medullaris: case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Diagnosis, Differential; Fluconazole; Granuloma; Humans; Immunocompetence; Laminectomy; Male; Spinal Cord Diseases; Spinal Cord Neoplasms | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Neonatal invasive candidiasis.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Incidence; Infant, Newborn; Infant, Very Low Birth Weight; Prognosis; Risk Factors; Sensitivity and Specificity | 2006 |
Coccidioidal meningitis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Comorbidity; Fluconazole; Humans; Hydrocephalus; Itraconazole; Meningitis, Fungal; Treatment Outcome; Vasculitis | 2007 |
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Fungemia; Fungi; Health Status; Hospital Mortality; Humans; Male; Mycoses; Primary Prevention; Pyelonephritis; Risk Factors; Urinary Catheterization; Urinary Tract Infections; Urine | 2007 |
Fungal infections in neonates: update on prevention and treatment.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungal Proteins; Humans; Infant, Newborn; Mycoses; Peptides, Cyclic; Treatment Outcome | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Prevention and treatment of invasive fungal infection in very low birthweight infants.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Device Removal; Female; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Male; Microbial Sensitivity Tests | 2009 |
Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Topics: Acetazolamide; Acute Disease; Adult; Amphotericin B; Antifungal Agents; Antihypertensive Agents; Developing Countries; Fluconazole; Flucytosine; Health Resources; HIV Infections; Humans; Intracranial Hypertension; Meningitis, Cryptococcal | 2008 |
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment.
Topics: Amphotericin B; Antifungal Agents; Bacteremia; Candida albicans; Candidiasis; Fluconazole; Humans; Intensive Care Units | 2009 |
[Candidiasis].
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; beta-Glucans; Biomarkers; Candida; Candidiasis; Diabetes Complications; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Proteoglycans | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
Bladder irrigation with amphotericin B and fungal urinary tract infection--systematic review with meta-analysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Randomized Controlled Trials as Topic; Therapeutic Irrigation; Urinary Bladder; Urinary Tract Infections; Urine | 2009 |
Cryptococcal liver abscess: a case report of successful treatment with amphotericin-B and literature review.
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Humans; Liver Abscess; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Microbial Sensitivity Tests; Naphthalenes; Opportunistic Infections; Radiography; Terbinafine; Treatment Outcome | 2009 |
Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis; Echinocandins; Fluconazole; Humans; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2009 |
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic | 2008 |
Treatment of cryptococcal meningitis in resource limited settings.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Developing Countries; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal | 2009 |
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Aspergillus; Caspofungin; Ceftazidime; Clindamycin; Echinocandins; Fluconazole; Humans; Leukemia, Hairy Cell; Lipopeptides; Male; Middle Aged; Mouth; Ofloxacin; Pneumonia; Pulmonary Artery; Pulmonary Aspergillosis; Valacyclovir; Valine; Vancomycin | 2010 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Disseminated Penicillium marneffei infection in an SLE patient: a case report and literature review.
Topics: Amphotericin B; Antifungal Agents; China; Dermatomycoses; Female; Fluconazole; Humans; Itraconazole; Lupus Erythematosus, Systemic; Middle Aged; Mycoses; Opportunistic Infections; Penicillium | 2011 |
Candida tropicalis in human disease.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests | 2010 |
Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Clinical Trials as Topic; Echinocandins; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Yeasts | 2010 |
[Three cases of allergic bronchopulmonary mycosis due to Schizophyllum commune].
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Diagnosis, Differential; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Middle Aged; Prednisolone; Schizophyllum | 2010 |
Treatment of candidemia in adult patients without neutropenia--an inconvenient truth.
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Candidemia; Echinocandins; Fluconazole; Fungal Proteins; Humans; Kidney Diseases; Neutropenia; Practice Guidelines as Topic; Treatment Outcome | 2011 |
Candida infections in non-neutropenic children after the neonatal period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Child; Cross Infection; Deoxycholic Acid; Drug Combinations; Echinocandins; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units; Leukocyte Count; Mycological Typing Techniques; Neutrophils; Survival Rate; United States | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Bilateral polymicrobial osteomyelitis with Candida tropicalis and Candida krusei: a case report and an updated literature review.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida tropicalis; Cross Infection; Drug Combinations; Echinocandins; Fluconazole; Follow-Up Studies; Gallstones; Hospitalization; Humans; Male; Middle Aged; Osteomyelitis; Pancreatitis; Treatment Outcome | 2012 |
Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Comorbidity; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Osteomyelitis; Risk Factors; Sex Distribution; Treatment Outcome; Young Adult | 2012 |
Antifungal therapy for newborn infants with invasive fungal infection.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Mycoses; Randomized Controlled Trials as Topic | 2012 |
New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antihypertensive Agents; Developing Countries; Female; Fluconazole; Humans; Immunocompromised Host; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Prevalence | 2012 |
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Infant; Japan; Male; MEDLINE; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole; Young Adult | 2013 |
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida; Candidiasis; Carcinoma, Transitional Cell; Combined Modality Therapy; Disease Susceptibility; Drug Therapy, Combination; Endocarditis; Fatal Outcome; Female; Fluconazole; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pacemaker, Artificial; Postoperative Complications; Pregnancy; Pregnancy Complications, Infectious; Rheumatic Heart Disease; Sjogren's Syndrome; Spain; Tertiary Care Centers; Urinary Bladder Neoplasms | 2013 |
Candida cerebral abscesses: a case report and review of the literature.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Amphotericin B; Brain Abscess; Candida; Candidiasis; Child, Preschool; Diabetes Complications; Female; Fluconazole; Flucytosine; Humans; Infant; Male; Middle Aged; Substance Abuse, Intravenous; Young Adult | 2013 |
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole | 2013 |
Urinary tract infection.
Topics: Acute Disease; Aminoglycosides; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Catheters, Indwelling; Community-Acquired Infections; Cross Infection; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Male; Prognosis; Risk Factors; Shock, Septic; Urinary Tract; Urinary Tract Infections | 2013 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
Candida and candidaemia. Susceptibility and epidemiology.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Denmark; Echinocandins; Fluconazole; Humans; Incidence; Microbial Sensitivity Tests | 2013 |
Fungal prophylaxis in neonates: a review article.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidemia; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Malassezia; Nystatin; Zygomycosis | 2014 |
Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Coinfection; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Treatment Outcome | 2014 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Confidence Intervals; Fluconazole; Humans; Injections, Intravenous; Mycoses; Neoplasms; Neutropenia; Nystatin; Odds Ratio; Randomized Controlled Trials as Topic | 2014 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Liposomes; Mycoses; Nystatin; Opportunistic Infections; Randomized Controlled Trials as Topic | 2014 |
Antifungal drugs during pregnancy: an updated review.
Topics: Administration, Intravenous; Administration, Topical; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Teratogens | 2015 |
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
Topics: Amphotericin B; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Female; Fluconazole; Fungemia; Humans; Middle Aged; Mycoses; Risk Factors; Voriconazole; Yeasts | 2014 |
New antifungal and antiviral dosing.
Topics: Acyclovir; Amphotericin B; Antifungal Agents; Antiviral Agents; Candidiasis, Invasive; Cytomegalovirus Infections; Deoxycholic Acid; Drug Combinations; Fluconazole; Ganciclovir; Herpes Simplex; Humans; Infant; Infant, Newborn; Mycoses; Practice Guidelines as Topic; Pregnancy Complications, Infectious; Valganciclovir; Virus Diseases | 2015 |
Intracranial Fungal Granulomas: A Single Institutional Clinicopathologic Study of 66 Patients and Review of the Literature.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Child; Craniotomy; Drug Therapy, Combination; Emergency Treatment; Female; Fluconazole; Granuloma; Humans; Immunocompromised Host; Itraconazole; Male; Middle Aged; Neuroimaging; Recurrence; Renal Insufficiency; Reoperation; Retrospective Studies; Risk Factors; Survival Rate | 2015 |
Neonatal liver abscesses due to Candida infection in a preterm infant, secondary to malpositioned umbilical lines--a rare entity.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Liver Abscess; Male; Treatment Outcome; Umbilical Veins | 2015 |
[Cryptococcal meningitis].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompromised Host; Kidney Transplantation; Male; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2015 |
Coccidioidomycosis involving the cranium: a case report and review of current literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis, Rheumatoid; Coccidioides; Coccidioidomycosis; Drug Therapy, Combination; Female; Fluconazole; Humans; Osteomyelitis; Radiography; Risk Factors; Skull | 2015 |
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Fungemia; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pleural Effusion; Voriconazole | 2015 |
Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Echinocandins; Echocardiography; Endocarditis; Endophthalmitis; Fluconazole; Humans; Intensive Care Units; Magnetic Resonance Imaging; Osteomyelitis; Voriconazole | 2015 |
Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature.
Topics: Adolescent; Aged; Amphotericin B; Antifungal Agents; Base Sequence; DNA, Intergenic; Fluconazole; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; India; Male; Microbial Sensitivity Tests; Sequence Analysis, DNA; Shock, Septic | 2016 |
Dosing of antifungal agents in obese people.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles | 2016 |
Cryptococcus neoformans var. grubii Infection in HIV-Seronegative Patients from Northeast India: Report of Two Cases with Review of Literature.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Base Sequence; Cryptococcus neoformans; Dermatomycoses; DNA, Intergenic; DNA, Ribosomal Spacer; Female; Fluconazole; HIV Seronegativity; Humans; India; Male; Meningitis, Cryptococcal; Sequence Analysis, DNA; Young Adult | 2016 |
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Critical Illness; Fluconazole; Humans; Immunocompromised Host; Mycoses; Randomized Controlled Trials as Topic | 2016 |
Solid lipid nanoparticles for antifungal drugs delivery for topical applications.
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Fluconazole; Humans; Itraconazole; Lipids; Nanoparticles | 2016 |
Diagnosis and Treatment of Pythium Insidiosum Corneal Ulcer in a Chinese Child: A Case Report and Literature Review.
Topics: Amphotericin B; Animals; Antifungal Agents; Child; China; Corneal Transplantation; Corneal Ulcer; Diagnosis, Differential; Fluconazole; Humans; Male; Prognosis; Pythiosis; Pythium; Treatment Outcome; Vitrectomy | 2016 |
Physiological Differences in Cryptococcus neoformans Strains
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Fungal Capsules; Fungal Polysaccharides; Fungal Proteins; Gene Expression Regulation, Fungal; HIV Infections; Humans; Melanins; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pigmentation; Polyploidy | 2017 |
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.
Topics: Acanthamoeba; Amebiasis; Amebicides; Amphotericin B; Anti-Bacterial Agents; Antilymphocyte Serum; Biopsy; Cardiomyopathies; Drugs, Investigational; Endoscopy; Female; Fluconazole; Flucytosine; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Magnetic Resonance Imaging; Metacarpal Bones; Metronidazole; Middle Aged; Phosphorylcholine; Polymerase Chain Reaction; Radiography; Sinusitis; Skin | 2017 |
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Asymptomatic Diseases; Cost-Benefit Analysis; Cryptococcus neoformans; Developing Countries; Drug Administration Schedule; Fluconazole; Humans; Mass Screening; Meningitis, Cryptococcal; Sertraline | 2017 |
Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diseases in Twins; Female; Fluconazole; Gloves, Protective; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Pregnancy; Skin Diseases, Infectious | 2017 |
The Current Status of Feline Sporotrichosis in Malaysia.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malaysia; Naphthalenes; Prevalence; Sporothrix; Sporotrichosis; Terbinafine; Zoonoses | 2017 |
[Effect of bladder irrigation with amphotericin B for treatment of urinary tract fungal infection: a meta-analysis].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Mycoses; Randomized Controlled Trials as Topic; Therapeutic Irrigation; Urinary Bladder; Urinary Tract Infections | 2018 |
Topics: Adenine; Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cyclophosphamide; Doxorubicin; Empyema, Pleural; Fluconazole; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2018 |
Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Cause of Death; Drug Administration Schedule; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2018 |
Treatment for HIV-associated cryptococcal meningitis.
Topics: Acetazolamide; Acute Disease; Adult; Amphotericin B; Antifungal Agents; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Health Resources; HIV Infections; Humans; Induction Chemotherapy; Intracranial Hypertension; Meningitis, Cryptococcal; Network Meta-Analysis | 2018 |
Topical and systemic antifungal therapy for chronic rhinosinusitis.
Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Chronic Disease; Fluconazole; Humans; Quality of Life; Randomized Controlled Trials as Topic; Rhinitis; Sinusitis | 2018 |
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Topics: Africa; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcus neoformans; Developing Countries; Disease Management; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Guidelines as Topic; HIV Infections; Humans; Income; Meningitis, Cryptococcal; Survival Analysis | 2019 |
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles | 2019 |
Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Topics: Adolescent; Aged; Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Bronchoalveolar Lavage; Candida; Candidemia; Candidiasis; Caspofungin; DNA, Intergenic; Fatal Outcome; Female; Fluconazole; Genotype; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vagina; Voriconazole | 2019 |
Killer amoebas: Primary amoebic meningoencephalitis in a changing climate.
Topics: Amebicides; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiparasitic Agents; Azithromycin; Central Nervous System Protozoal Infections; Climate Change; Dexamethasone; Early Diagnosis; Early Medical Intervention; Fluconazole; Geography; Glucocorticoids; Humans; Hypothermia, Induced; Macrolides; Naegleria fowleri; Phosphorylcholine; Rifampin; United States; Ventriculostomy | 2019 |
Cryptococcus albidus Fungemia in an Immunosuppressed Child: Case Report and Systematic Literature Review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child, Preschool; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Immunocompromised Host; Infant, Newborn; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Takayasu Arteritis; Transplantation, Autologous | 2020 |
Candida auris and multidrug resistance: Defining the new normal.
Topics: 14-alpha Demethylase Inhibitors; Aminopyridines; Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Isoxazoles; Microbial Sensitivity Tests; Pyridines; Tetrazoles | 2019 |
Recent advances in managing HIV-associated cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2019 |
New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.
Topics: Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Deficiency Syndromes; Intracranial Hypertension; Meningitis, Cryptococcal; Risk Factors | 2019 |
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Cryptococcus neoformans; Deoxycholic Acid; Disease Management; Drug Combinations; Female; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Uganda; Young Adult | 2020 |
Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Antifungal Agents; Antigens, Fungal; China; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Opportunistic Infections; Treatment Outcome | 2019 |
Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis.
Topics: Adult; Africa South of the Sahara; Aged; Amphotericin B; Antifungal Agents; Female; Fluconazole; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic | 2020 |
Cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Immunocompromised Host; Lung Diseases, Fungal; Radiography | 2020 |
Treating progressive disseminated histoplasmosis in people living with HIV.
Topics: Amphotericin B; Anti-HIV Agents; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Administration Schedule; Fluconazole; Histoplasmosis; HIV Infections; Humans; Induction Chemotherapy; Itraconazole; Kidney; Liposomes; Maintenance Chemotherapy; Randomized Controlled Trials as Topic | 2020 |
Pseudozyma spp. human infections: A systematic review.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole; Yeasts | 2021 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole | 2020 |
Fungal infections in dentistry: Clinical presentations, diagnosis, and treatment alternatives.
Topics: Amphotericin B; Antifungal Agents; Dentistry; Drug Resistance, Fungal; Echinocandins; Fluconazole; Microbial Sensitivity Tests | 2020 |
Colonic cryptococcosis as a rare presentation in HIV infection: a case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; HIV Infections; Humans; Hypotension; Immunosuppression Therapy; Pain; Treatment Outcome | 2020 |
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Micafungin; Prevalence | 2020 |
Efficacy of different antifungal drugs as initial treatment for patients with talaromycosis: A systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses; Pharmaceutical Preparations; Randomized Controlled Trials as Topic; Retrospective Studies | 2021 |
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Mycoses; Nitriles; Phylogeny; Pneumonia; Pyridines; Saccharomycetales; Triazoles | 2021 |
Cryptococcal meningoencephalitis: time for action.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Databases, Factual; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningoencephalitis | 2021 |
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Glucocorticoids; HIV Infections; Humans; Meningitis, Cryptococcal; Sertraline; Tamoxifen | 2022 |
Distribution and antifungal susceptibility pattern of
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests | 2022 |
An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2023 |
Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests | 2022 |
Off-label treatments as potential accelerators in the search for the ideal antifungal treatment of cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Off-Label Use | 2023 |
Cryptococcal meningoencephalitis with Actinomyces odontolyticus sepsis: a case report and literature review.
Topics: Actinomyces; Actinomycosis; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Intracranial Hypertension; Meningitis, Cryptococcal; Meningoencephalitis; Penicillins; Sepsis | 2023 |
Searching for new antifungals for the treatment of cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans | 2023 |
89 trial(s) available for fluconazole and amphotericin b
| Article | Year |
|---|---|
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Method; Fluconazole; Humans; Immunocompromised Host; Neoplasms; Neutropenia; Survival Rate | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole; Follow-Up Studies; Humans; Injections, Intravenous; Male; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Recurrence | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluconazole; Humans; Injections, Intravenous; Male; Meningitis, Cryptococcal; Middle Aged; Random Allocation; Treatment Outcome | 1992 |
Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Child, Preschool; Chronic Disease; Female; Fluconazole; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Splenic Diseases; Superinfection | 1991 |
A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Amphotericin B; Female; Fluconazole; Humans; Leukemia; Male; Middle Aged; Mycoses; Prospective Studies; Remission Induction | 1991 |
[Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents].
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antineoplastic Agents; Female; Fluconazole; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia | 1990 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis; Opportunistic Infections; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Clinical Trials as Topic; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Male; Triazoles | 1988 |
Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.
Topics: Adult; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Bacteremia; Candidiasis, Oral; Double-Blind Method; Drug Therapy, Combination; Fever; Fluconazole; Humans; Incidence; Infusions, Intravenous; Leukemia; Lymphoma; Middle Aged; Mycoses; Neutropenia; Treatment Outcome | 1995 |
Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Bone Marrow Transplantation; Candidiasis, Oral; Child; Drug Combinations; Fellowships and Scholarships; Female; Fluconazole; Humans; Male; Middle Aged; Mouthwashes; Nystatin; Prospective Studies; Retrospective Studies | 1995 |
Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study.
Topics: Aged; Amphotericin B; Female; Fluconazole; Fungi; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Urine | 1995 |
Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever--preliminary observations from a pilot, exploratory study.
Topics: Adult; Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Female; Fever; Fluconazole; Humans; Leukemia; Male; Mycoses; Neutropenia; Pilot Projects; Prospective Studies; Treatment Outcome | 1995 |
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 1995 |
Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Reproducibility of Results | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind Method; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Middle Aged; Opportunistic Infections; Patient Compliance; Prospective Studies; Survival Analysis | 1995 |
A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group.
Topics: Administration, Oral; Adolescent; Amphotericin B; Candida; Child; Child, Preschool; Female; Fluconazole; Hematologic Diseases; Humans; Immunocompromised Host; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Nystatin | 1994 |
Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Candida; Candidiasis; Child; Child, Preschool; Colony Count, Microbial; Double-Blind Method; Female; Fluconazole; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Prospective Studies | 1994 |
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
Topics: Amphotericin B; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Follow-Up Studies; Fungemia; Humans; Male; Middle Aged; Neutropenia; Treatment Outcome | 1994 |
Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
Topics: Adolescent; Adult; Amphotericin B; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Patient Isolation; Prospective Studies; Transplantation, Autologous | 1994 |
Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antigens, Fungal; Biomarkers; Cryptococcus neoformans; Fluconazole; Fungemia; Humans; Meningitis, Cryptococcal; Polysaccharides; Prognosis; Treatment Outcome | 1994 |
Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients.
Topics: Administration, Oral; Amphotericin B; Female; Fluconazole; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1994 |
Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Blast Crisis; Female; Fluconazole; Humans; Kidney Diseases; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mycoses; Premedication; Prospective Studies; Remission Induction | 1994 |
Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Fluconazole; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Treatment Outcome | 1994 |
Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis, Oral; Erythema; Female; Fluconazole; Humans; Male; Middle Aged; Random Allocation; Stomatitis, Denture | 1993 |
Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.
Topics: Adult; Aged; Amphotericin B; Bacterial Infections; Candidiasis; Cause of Death; Colony Count, Microbial; Critical Illness; Cross Infection; Fluconazole; Fungemia; Hospital Mortality; Humans; Infection Control; Infusions, Intravenous; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; Severity of Illness Index; Superinfection; Therapeutic Irrigation; Urinary Tract Infections; Urine | 1993 |
Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Child; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Nystatin | 1993 |
Combined use of fluconazole and selective digestive decontamination in the prevention of fungal infection after adult liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Colistin; Digestive System; Drug Therapy, Combination; Fluconazole; Humans; Liver Transplantation; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Sputum; Tobramycin | 1995 |
A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Colony Count, Microbial; Cranial Irradiation; Dentures; Female; Fluconazole; Head and Neck Neoplasms; Humans; Middle Aged; Pharyngeal Diseases; Treatment Outcome | 1996 |
Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Costs and Cost Analysis; Female; Fluconazole; Follow-Up Studies; Humans; Male; Therapeutic Irrigation; Treatment Outcome; Urinary Bladder | 1995 |
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization; Fluconazole; Humans; Time Factors | 1995 |
Management of candida septicaemia in a regional burn unit.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Burn Units; Burns; Candidiasis; Child; Fluconazole; Fungemia; Humans; Middle Aged | 1995 |
Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Case-Control Studies; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Treatment Outcome | 1996 |
Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Combined Modality Therapy; Female; Fluconazole; Follow-Up Studies; Humans; Male; Therapeutic Irrigation; Treatment Outcome; Urinary Bladder; Urinary Tract Infections | 1996 |
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Female; Fluconazole; Humans; Male; Prospective Studies; Treatment Failure; Treatment Outcome | 1996 |
Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Developing Countries; Drug Administration Schedule; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Injections, Intravenous; Intensive Care Units, Neonatal; Male; Prospective Studies; South Africa; Survival Rate; Treatment Outcome | 1996 |
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; APACHE; Candidiasis; Critical Illness; Cross Infection; Data Interpretation, Statistical; Female; Fluconazole; Fungemia; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Prognosis; Prospective Studies; Spain | 1997 |
Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Female; Fever; Fluconazole; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Mycoses; Neoplasms; Opportunistic Infections; Prospective Studies; Treatment Outcome | 1996 |
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Survival Analysis | 1997 |
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Confidence Intervals; Female; Fluconazole; Fungemia; Humans; Immunocompetence; Male; Middle Aged; Survival Rate; Treatment Outcome | 1997 |
Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Delivery Systems; Drug Therapy, Combination; Fluconazole; Humans; Liposomes; Meningitis, Cryptococcal; Outcome Assessment, Health Care | 1997 |
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Prospective Studies; Recurrence; Risk Factors; Salvage Therapy | 1998 |
A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Female; Fever; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Treatment Outcome | 1998 |
Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Health Care Costs; Humans; Male; Middle Aged | 1998 |
Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Female; Fluconazole; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections | 1999 |
A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Consumer Product Safety; Female; Fluconazole; Humans; Male; Middle Aged; Risk Factors; Treatment Outcome | 2000 |
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Confidence Intervals; Female; Fever; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; North America; Prospective Studies; Renal Insufficiency; Survival | 2000 |
Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.
Topics: Adolescent; Adult; Aged; Amphotericin B; Bilirubin; Consumer Product Safety; Contraindications; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Middle Aged; Morphine; Mycoses; Neutropenia; Respiratory Tract Diseases; Shivering; Survival; Time Factors; Transaminases | 2000 |
Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Treatment Outcome | 2000 |
Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Mycoses; Neutropenia | 1999 |
A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
Topics: Amphotericin B; Antifungal Agents; Cause of Death; Female; Fever; Fluconazole; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Treatment Outcome | 2000 |
Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male | 2001 |
Antifungal therapy for treatment of cryptococcal meningitis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant; Injections, Intravenous; Injections, Spinal; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2000 |
A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Mucosa; Stomatitis; Treatment Outcome | 2002 |
Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycoses; Placebos; Postoperative Complications; Survival Analysis | 2002 |
Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Humans; Infant; Male; Middle Aged; Mycoses; Postoperative Complications; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Transplantation, Homologous | 2002 |
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Prospective Studies; Survival Analysis | 2003 |
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization; Double-Blind Method; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Neutropenia; Treatment Outcome | 2003 |
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Cohort Studies; Drug Administration Schedule; Female; Fluconazole; Fungemia; Humans; Infant; Male; Middle Aged; Prospective Studies; Survival Rate; United States | 2003 |
Cryptococcal meningitis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Treatment Outcome | 2002 |
Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study.
Topics: Acute Disease; Adult; Aged; Allyl Compounds; Amphotericin B; Antifungal Agents; Disulfides; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Mycoses; Pancreatitis; Prospective Studies; Treatment Outcome | 2003 |
Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Gingivitis, Necrotizing Ulcerative; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mouth; Mouthwashes; Nystatin; Polyenes; Severity of Illness Index; Time Factors; Treatment Outcome | 2004 |
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Colony Count, Microbial; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 2004 |
Initial treatment of cryptococcal meningitis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Enzyme Inhibitors; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Prospective Studies; Rifampin | 2005 |
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aerosols; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Safety; Transplantation, Homologous; Treatment Outcome | 2006 |
Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Prospective Studies; Thailand; Time Factors | 2006 |
Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anemia, Aplastic; Antibodies, Fungal; Antibody Specificity; Antifungal Agents; Antigens, Fungal; beta-Glucans; Candida albicans; Candidiasis; False Positive Reactions; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Hepatitis; Humans; Liposomes; Male; Middle Aged; Neutropenia; Patient Isolation; Predictive Value of Tests; Sensitivity and Specificity | 2006 |
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Itraconazole; Leukemia, Myelomonocytic, Acute; Male; Retrospective Studies | 2007 |
Amphotericin B: the higher the dose, the higher the toxicity.
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2008 |
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Female; Fluconazole; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Survival Analysis; Thailand; Treatment Outcome; United States | 2009 |
International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feasibility Studies; Fluconazole; Humans; International Cooperation; Meningitis, Cryptococcal; Patient Selection; Research Design; Thailand; United States | 2010 |
Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
Topics: Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Biological Availability; Chromatography, Gas; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal; Models, Biological; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Conjunctiva; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Injections; Keratitis; Middle Aged; Ophthalmic Solutions; Young Adult | 2010 |
Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Conjunctiva; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Follow-Up Studies; Fungi; Humans; Injections; Keratitis; Male; Middle Aged; Prospective Studies; Young Adult | 2010 |
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles | 2010 |
Ocular manifestations of candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cohort Studies; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Pilot Projects; Treatment Outcome; Uganda | 2012 |
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Malawi; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome; Young Adult | 2012 |
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Botswana; Clinical Protocols; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Meningitis, Cryptococcal; Research Design; Tanzania; Time Factors; Treatment Outcome | 2015 |
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.
Topics: Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Coinfection; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Female; Fluconazole; HIV; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Multilocus Sequence Typing; Treatment Outcome; Uganda | 2015 |
Oral care in a neonatal intensive care unit.
Topics: Amphotericin B; Anti-Bacterial Agents; Birth Weight; Chemoprevention; Cross Infection; Female; Fluconazole; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Mouth; Neonatal Sepsis; Oral Hygiene | 2017 |
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Topics: Administration, Oral; Adult; Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Male; Meningitis, Cryptococcal; Proportional Hazards Models | 2018 |
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Topics: Africa South of the Sahara; Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Cryptococcus neoformans; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Equivalence Trials as Topic; Fluconazole; Flucytosine; Humans; Induction Chemotherapy; Meningitis, Cryptococcal; Multicenter Studies as Topic; Time Factors; Treatment Outcome | 2018 |
Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cohort Studies; Drug Therapy, Combination; Female; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Retrospective Studies; Risk Factors; Uganda | 2019 |
Benefits of risk-adapted and mould-specific antifungal prophylaxis in childhood leukaemia.
Topics: Amphotericin B; Aspergillosis; Aspergillus; Child; Child, Preschool; Female; Fluconazole; Humans; Leukemia; Male; Retrospective Studies; Risk Factors | 2020 |
Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Body Weight; Cohort Studies; Coma; Dexamethasone; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Retrospective Studies; Risk Factors; Seizures; Uganda | 2020 |
An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Humans; Long QT Syndrome; Male; Meningitis, Cryptococcal; Tamoxifen | 2021 |
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Topics: Administration, Oral; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Meningitis, Cryptococcal | 2022 |
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?
Topics: Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Meningitis, Cryptococcal | 2023 |
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Treatment Outcome | 2023 |
1572 other study(ies) available for fluconazole and amphotericin b
| Article | Year |
|---|---|
Design and synthesis of 14 alpha-methyl-15-aza-D-homosterols as novel antimycotics.
Topics: Animals; Antifungal Agents; Candidiasis; Chemical Phenomena; Chemistry, Physical; Drug Design; Mice; NADH, NADPH Oxidoreductases; Oxidoreductases; Sterols | 1990 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bronchogenic Cyst; Candida albicans; Candidiasis; Disease Models, Animal; Echinocandins; Female; Fungal Proteins; Glucosyltransferases; Hemolysis; Membrane Proteins; Mice; Mice, Nude; Peptides; Peptides, Cyclic; Pneumonia, Pneumocystis; Schizosaccharomyces pombe Proteins; Solubility | 2001 |
Synthesis and biological activity of novel macrocyclic antifungals: acylated conjugates of the ornithine moiety of the lipopeptidolactone FR901469.
Topics: Animals; Antifungal Agents; Candidiasis; Depsipeptides; Hemolysis; Mice; Mice, Inbred ICR; Peptides, Cyclic; Structure-Activity Relationship | 2001 |
Three new phenolic compounds from a manipulated plant cell culture, Mirabilis jalapa.
Topics: Antifungal Agents; Candida albicans; Cells, Cultured; Magnetic Resonance Spectroscopy; Magnoliopsida; Microbial Sensitivity Tests; Phenols | 2001 |
Synthesis and biological activity of novel macrocyclic antifungals. modification of the tyrosine moiety of the lipopeptidolactone FR901469.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Depsipeptides; Erythrocytes; Hemolysis; Lactones; Mice; Microbial Sensitivity Tests; Peptides, Cyclic; Tyrosine | 2001 |
3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones: synthesis and biological activity of a novel group of potential antifungal drugs.
Topics: 4-Butyrolactone; Amphotericin B; Antifungal Agents; Fungi; Furans; Humans; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship | 2001 |
(+)-7S-Hydroxyxestospongin A from the marine sponge Xestospongia sp. and absolute configuration of (+)-xestospongin D.
Topics: Alkaloids; Animals; Antifungal Agents; Australia; Candida; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Macrocyclic Compounds; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxazoles; Porifera; Quinolizines; Stereoisomerism | 2002 |
Antifungal activity of bifunctional sphingolipids. Intramolecular synergism within long-chain alpha,omega-bis-aminoalcohols.
Topics: Amino Alcohols; Antifungal Agents; Binding Sites; Candida glabrata; Glycolipids; Microbial Sensitivity Tests; Molecular Structure; Sphingolipids | 2002 |
The activity of p-methoxybenzylisothiocyanate against Neisseria gonorrhoeae, Haemophilus ducreyi, and other microorganisms.
Topics: Bacteria; Cell Division; Haemophilus ducreyi; Isothiocyanates; Lepidium; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Plant Preparations | 2002 |
In vivo characterization of A-192411: a novel fungicidal lipopeptide (II).
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Drug Resistance, Fungal; Immunocompromised Host; Kidney; Mice; Oligopeptides; Rats; Survival Analysis | 2003 |
Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fatty Acids, Monounsaturated; Fluconazole; Gas Chromatography-Mass Spectrometry; Methylation; Microbial Sensitivity Tests; Molecular Structure; Peru; Plant Roots; Sphingolipids | 2003 |
Novel galbonolide derivatives as IPC synthase inhibitors: design, synthesis and in vitro antifungal activities.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Design; Hexosyltransferases; Lactones | 2004 |
Reversal of fluconazole resistance in multidrug efflux-resistant fungi by the Dysidea arenaria sponge sterol 9alpha,11alpha-epoxycholest-7-ene-3beta,5alpha,6alpha,19-tetrol 6-acetate.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Candida albicans; Cell Line, Tumor; Cholestenes; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Fluconazole; Humans; Inhibitory Concentration 50; Porifera | 2003 |
Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Candida albicans; Carcinoma 256, Walker; Cryptococcus neoformans; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Naphthoquinones; Pyrazoles; Rats; Structure-Activity Relationship | 2005 |
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Methyl Ethers; Molecular Structure; Naphthoquinones | 2005 |
Antifungal flavonoids from Hildegardia barteri.
Topics: Antifungal Agents; Candida; Chromones; Flavonoids; Isoflavones; Malvaceae; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Tanzania | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and antifungal activity of a novel series of alkyldimethylamine cyanoboranes and their derivatives.
Topics: Animals; Antifungal Agents; Boranes; Drug Resistance, Fungal; Fluconazole; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Structure-Activity Relationship | 2006 |
Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cryptococcus neoformans; Drug Design; Fluconazole; Gentamicins; Naphthoquinones; Sporothrix; Staphylococcus aureus; Structure-Activity Relationship; Thiazines; Trichophyton | 2006 |
Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Glucan 1,3-beta-Glucosidase; Microbial Sensitivity Tests | 2007 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
Synthesis, antifungal activity, and structure-activity relationships of coruscanone A analogues.
Topics: Animals; Antifungal Agents; Candida albicans; Cell Survival; Chlorocebus aethiops; Cryptococcus neoformans; Cyclopentanes; Drug Resistance, Fungal; Fluconazole; LLC-PK1 Cells; Miconazole; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Swine; Vero Cells | 2006 |
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzamides; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2007 |
Synthesis, antimicrobial activity, and QSAR studies of furan-3-carboxamides.
Topics: Amides; Antifungal Agents; Fungi; Furans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Electrospray Ionization | 2007 |
Synthesis of pseudopeptides based L-tryptophan as a potential antimicrobial agent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Fungi; Hemolysis; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Peptides; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Tryptophan | 2007 |
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antitubercular Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, Thin Layer; Estrone; Fungi; Heterocyclic Compounds; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles | 2007 |
Discovery of novel indazole-linked triazoles as antifungal agents.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillus; Candida; Disease Models, Animal; Indazoles; Mice; Microbial Sensitivity Tests; Rats; Stereoisomerism; Triazoles | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Chemistry, Pharmaceutical; Drug Design; Drug Resistance, Fungal; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Chemical; Time Factors; Triazoles | 2007 |
Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests | 2007 |
Synthesis, structure and biological activity of pseudopeptidic macrolides based on an amino alcohol.
Topics: Amino Alcohols; Anti-Infective Agents; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Macrolides; Microbial Sensitivity Tests; Structure-Activity Relationship | 2008 |
New guinea pig model of Cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2007 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Synthesis of chlorogenic acid derivatives with promising antifungal activity.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida; Chlorogenic Acid; Cryptococcus neoformans | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Protein Binding; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Tetrahydronaphthalenes; Vaginal Diseases | 2007 |
Voriconazole inhibits melanization in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
In vitro study of Candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin.
Topics: Antifungal Agents; Candida tropicalis; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Time Factors | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
Synthesis and biological activity of some new benzoxazoles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzoxazoles; Candida albicans; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Administration Schedule; Echinocandins; Humans; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
Topics: Antifungal Agents; Drug Resistance, Fungal; Gene Deletion; Gene Library; Genome, Fungal; Gliotoxin; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2008 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Specific Pathogen-Free Organisms; Treatment Outcome | 2008 |
Synthesis and antimicrobial activity of beta-lactam-bile acid conjugates linked via triazole.
Topics: Alkynes; Anti-Infective Agents; Antifungal Agents; beta-Lactams; Bile Acids and Salts; Copper; Crystallization; Cyclization; Escherichia coli; Fungi; Molecular Structure; Staphylococcus aureus; Triazoles | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
Topics: Amides; Anti-Bacterial Agents; Benzofurans; Benzoxazoles; Microbial Viability; Molecular Structure; Structure-Activity Relationship | 2008 |
Efficacy of SPK-843, a novel polyene antifungal, in a murine model of systemic cryptococcosis.
Topics: Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Polyenes | 2008 |
Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Humans; Microbial Sensitivity Tests; Regression Analysis | 2008 |
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation | 2008 |
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Kidney; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Potent in vitro antifungal activities of naturally occurring acetylenic acids.
Topics: Alkynes; Animals; Antifungal Agents; Candida albicans; Cell Line; Fatty Acids, Unsaturated; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Rubiaceae; Trichophyton | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Benzoxazoles; Candida albicans; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship | 2009 |
CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibility.
Topics: Base Sequence; Candida albicans; Cell Wall; Cytochrome P-450 Enzyme System; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Gene Deletion; Gene Expression; Genes, Fungal; Mutation; Phenotype; Recombinant Proteins; Tyrosine | 2008 |
Antifungal activity of synthetic di(hetero)arylamines based on the benzo[b]thiophene moiety.
Topics: Amines; Antifungal Agents; Arthrodermataceae; Aspergillus; Candida; Dose-Response Relationship, Drug; Flow Cytometry; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Thiophenes | 2008 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Fungal; Drug Resistance, Fungal; Ergosterol; Genes, Fungal; Guanine; Humans; Molecular Sequence Data; Polyenes | 2008 |
2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents.
Topics: Antifungal Agents; Antineoplastic Agents; Cell Proliferation; HeLa Cells; Humans; Hydroquinones; Phenothiazines; Sporothrix; Structure-Activity Relationship | 2009 |
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
Topics: Anti-Bacterial Agents; beta-Alanine; Cell Line; Cell Line, Tumor; Chemistry, Pharmaceutical; Cholic Acid; Drug Design; Erythromycin; Fluconazole; Glycine; Humans; Models, Chemical; Molecular Conformation; Peptides; Polymyxin B | 2008 |
2-Acylhydrazino-5-arylpyrrole derivatives: synthesis and antifungal activity evaluation.
Topics: Antifungal Agents; Candida; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyrroles; Species Specificity | 2009 |
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole | 2009 |
Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis.
Topics: Acetic Acid; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Benzimidazoles; beta-Glucans; Blotting, Western; Cell Wall; Drug Resistance, Fungal; Fungi; Glucose; Leucine; Microbial Sensitivity Tests; Pyridines; Saccharomyces cerevisiae; Uridine | 2009 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
One-pot synthesis of 5-phenylimino, 5-thieno or 5-oxo-1,2,3-dithiazoles and evaluation of their antimicrobial and antitumor activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Candida; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Humans; Thiazoles | 2009 |
Antifungal unsaturated cyclic Mannich ketones and amino alcohols: study of mechanism of action.
Topics: Amino Alcohols; Antifungal Agents; Candida albicans; Chitin; Chitin Synthase; Ergosterol; Hyphae; Ketones; Protein Biosynthesis; Quantitative Structure-Activity Relationship | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Triazoles | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Echinocandins; Kidney; Male; Mice | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Rhodamines | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
Exploration of click reaction for the synthesis of modified nucleosides as chitin synthase inhibitors.
Topics: Chitin Synthase; Crystallography, X-Ray; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Nucleosides | 2009 |
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Fungi; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur | 2009 |
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
Topics: Adult; Aerobiosis; Antifungal Agents; Azoles; Candida glabrata; Chromatography, High Pressure Liquid; Ergosterol; Female; Flow Cytometry; Genes, Fungal; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Polyenes | 2009 |
Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp.
Topics: Antifungal Agents; Aspergillus; Candida; Drug Design; Guanidine; Humans; Macrocyclic Compounds; Microbial Sensitivity Tests; Urea | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents.
Topics: Antifungal Agents; Benzothiazoles; Benzoxazines; Benzoxazoles; Candida; Fluconazole; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazines | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence | 2010 |
Antifungal 3,5-disubstituted furanones: From 5-acyloxymethyl to 5-alkylidene derivatives.
Topics: Antifungal Agents; Apoptosis; Cell Line; Cytostatic Agents; Furans; HeLa Cells; Humans; Microbial Sensitivity Tests | 2010 |
Design, synthesis and determination of antifungal activity of 5(6)-substituted benzotriazoles.
Topics: Antifungal Agents; Bacterial Proteins; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Drug Design; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Triazoles | 2010 |
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Green Chemistry Technology; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur; Water | 2010 |
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts | 2010 |
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction | 2010 |
T-2307 shows efficacy in a murine model of Candida glabrata infection despite in vitro trailing growth phenomena.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Male; Mice; Microbial Sensitivity Tests; Molecular Structure | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives.
Topics: Amides; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Fungal Proteins; Microbial Sensitivity Tests; Pyridines; Quinolines | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis of new antifungal peptides selective against Cryptococcus neoformans.
Topics: Amino Acid Sequence; Antifungal Agents; Antimicrobial Cationic Peptides; Circular Dichroism; Cryptococcus neoformans; Enzyme Inhibitors; Fungal Proteins; Microbial Sensitivity Tests; Protein Structure, Secondary | 2010 |
Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Topics: Antifungal Agents; Drug Discovery; Fungi; Microbial Sensitivity Tests; Phenothiazines; Structure-Activity Relationship | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one.
Topics: Antifungal Agents; Candida albicans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives.
Topics: Anti-Infective Agents; Antifungal Agents; Azo Compounds; Candida; Microbial Sensitivity Tests; Molecular Structure; Nitriles; Pyrazoles; Staphylococcus aureus | 2011 |
Stereoselective synthesis and antimicrobial activity of steroidal C-20 tertiary alcohols with thiazole/pyridine side chain.
Topics: Alcohols; Anti-Infective Agents; Bacteria; Chromatography, Liquid; Fungi; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Pyridines; Stereoisomerism; Thiazoles | 2011 |
High-throughput-screening-based identification and structure-activity relationship characterization defined (S)-2-(1-aminoisobutyl)-1-(3-chlorobenzyl)benzimidazole as a highly antimycotic agent nontoxic to cell lines.
Topics: Antifungal Agents; Antimitotic Agents; Benzimidazoles; Candida; Cell Line, Tumor; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Humans; Imidazoles; Microbial Sensitivity Tests; Mycology; Stereoisomerism; Structure-Activity Relationship; Transcription, Genetic | 2011 |
Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Binding Sites; Catalytic Domain; Computer Simulation; Hydrogen Bonding; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Natural Product Based 6-Hydroxy-2,3,4,6-tetrahydropyrrolo[1,2-a]pyrimidinium Scaffold as A New Antifungal Template.
Topics: | 2011 |
Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
Topics: Antifungal Agents; Candida; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Furans; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2011 |
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
Topics: Antifungal Agents; Candida; Catalysis; Drug Evaluation, Preclinical; Micelles; Microbial Sensitivity Tests; Naphthoquinones; Oxygen; Sporothrix; Trichophyton; Water | 2011 |
Semisynthesis and antimicrobial activity of novel guttiferone-A derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzophenones; Cell Survival; Dose-Response Relationship, Drug; Fungi; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship | 2012 |
New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies.
Topics: Antifungal Agents; Catalysis; Catalytic Domain; Click Chemistry; Computer Simulation; Copper; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles.
Topics: Candida albicans; Drug Resistance, Fungal; Fluconazole; Indoles; Signal Transduction | 2012 |
Synthesis and biological evaluation of vinyl ether-containing azole derivatives as inhibitors of Trichophyton rubrum.
Topics: Antifungal Agents; Azoles; Molecular Structure; Structure-Activity Relationship; Trichophyton; Vinyl Compounds | 2012 |
Total synthesis and antifungal activity of (2S,3R)-2-aminododecan-3-ol.
Topics: Antifungal Agents; Candida; Dodecanol; Molecular Structure | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and anti-Candida activity of novel 2-hydrazino-1,3-thiazole derivatives.
Topics: Animals; Antifungal Agents; Candida; Candida albicans; Cell Survival; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Structure-Activity Relationship; Thiazoles | 2013 |
Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship; Vero Cells | 2013 |
Antifungal ether diglycosides from Matayba guianensis Aublet.
Topics: Antifungal Agents; Candida; Glycosides; Humans; Leukocytes, Mononuclear; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Conformation; Plant Bark; Plant Roots; Sapindaceae | 2014 |
Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida; Drug Design; Drug Evaluation, Preclinical; Half-Life; Heterocyclic Compounds; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Rats; Solubility; Structure-Activity Relationship; Triazoles; Water | 2014 |
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Ethers; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2014 |
Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin h.
Topics: | 2012 |
Novel Macrocyclic Amidinoureas: Potent Non-Azole Antifungals Active against Wild-Type and Resistant Candida Species.
Topics: | 2013 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
Topics: Anti-Infective Agents; Carbamates; Cell Survival; Fungi; Gram-Positive Bacteria; Hep G2 Cells; Humans; Isocitrate Lyase; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium kansasii; Salicylanilides; Structure-Activity Relationship; Thiocarbamates | 2014 |
Ionic liquid catalyzed synthesis of 2-(indole-3-yl)-thiochroman-4-ones and their novel antifungal activities.
Topics: Antifungal Agents; Fungi; Indoles; Ionic Liquids; Molecular Structure; Structure-Activity Relationship | 2015 |
2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents.
Topics: Acetamides; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Morpholines; Species Specificity; Structure-Activity Relationship; Substrate Specificity | 2015 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
Topics: | 2015 |
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans | 2015 |
Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.
Topics: Animals; Antifungal Agents; Chlorocebus aethiops; Cryptococcus gattii; Cryptococcus neoformans; Dose-Response Relationship, Drug; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiazoles; Vero Cells | 2015 |
Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives.
Topics: 14-alpha Demethylase Inhibitors; Anti-Bacterial Agents; Antifungal Agents; Candida; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Fungal Proteins; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Small Molecule Libraries; Sterol 14-Demethylase; Structure-Activity Relationship; Thiazolidines | 2016 |
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Cell Line; Cell Survival; Drug Design; Drug Resistance, Microbial; Fungi; Hemolysis; Humans; Kanamycin; Mice; Mycoses; Surface-Active Agents | 2015 |
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Carbamates; Dose-Response Relationship, Drug; Fungi; Gram-Negative Bacteria; Microbial Sensitivity Tests; Molecular Structure; Salicylanilides; Structure-Activity Relationship | 2016 |
Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties.
Topics: Antifungal Agents; Antioxidants; Candida; Chelating Agents; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Thiazolidines; Toxicity Tests | 2016 |
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
Topics: Antifungal Agents; Benzimidazoles; Carbon-13 Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Reactive Oxygen Species; Yeasts | 2016 |
Synthesis of Natural Acylphloroglucinol-Based Antifungal Compounds against Cryptococcus Species.
Topics: Antifungal Agents; Cryptococcus gattii; Cryptococcus neoformans; Microbial Sensitivity Tests; Molecular Structure; Phloroglucinol | 2016 |
Synthesis of novel tetrazole derivatives and evaluation of their antifungal activity.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Species Specificity; Structure-Activity Relationship; Tetrazoles | 2017 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses | 2017 |
Diversity-oriented sustainable synthesis of antimicrobial spiropyrrolidine/thiapyrrolizidine oxindole derivatives: New ligands for a metallo-β-lactamase from Klebsiella pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Dose-Response Relationship, Drug; Indoles; Klebsiella pneumoniae; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Oxindoles; Protein Binding; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship; Substrate Specificity | 2017 |
Discovery of a Membrane-Active, Ring-Modified Histidine Containing Ultrashort Amphiphilic Peptide That Exhibits Potent Inhibition of Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Membrane; Chlorocebus aethiops; Cryptococcus neoformans; DNA Damage; Drug Stability; Fluconazole; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Oligopeptides; Structure-Activity Relationship; Surface-Active Agents; Swine; Vero Cells | 2017 |
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity.
Topics: Antifungal Agents; Candida; Carbon-13 Magnetic Resonance Spectroscopy; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Quantitative Structure-Activity Relationship; Thiazolidines | 2017 |
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water | 2018 |
Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.
Topics: 14-alpha Demethylase Inhibitors; Alkylation; Animals; Antifungal Agents; Aspergillus; Azoles; Candida albicans; Cell Line; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Protein Conformation; Sterol 14-Demethylase | 2018 |
Novel fluconazole derivatives with promising antifungal activity.
Topics: Animals; Antifungal Agents; Candida; Cell Line; Cell Survival; Drug Design; Erythrocytes; Fluconazole; Fungi; Hemolysis; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Voriconazole | 2018 |
New 1,5 and 2,5-disubstituted tetrazoles-dependent activity towards surface barrier of Candida albicans.
Topics: Antifungal Agents; Caco-2 Cells; Candida albicans; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2018 |
Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives.
Topics: Antifungal Agents; Candida; Candidiasis; Cryptococcosis; Cryptococcus; HEK293 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Paracoccidioides; Paracoccidioidomycosis; Structure-Activity Relationship; Thiazoles | 2018 |
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells | 2018 |
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus cereus; Dose-Response Relationship, Drug; Free Radicals; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fungal Proteins; HEK293 Cells; Hep G2 Cells; Humans; IMP Dehydrogenase; Models, Molecular; Oxadiazoles; Thiophenes | 2018 |
Chemical preparation, biological evaluation and 3D-QSAR of ethoxysulfuron derivatives as novel antifungal agents targeting acetohydroxyacid synthase.
Topics: Acetolactate Synthase; Animals; Antifungal Agents; Candida albicans; Enzyme Inhibitors; Herbicides; Mice; Molecular Docking Simulation; Nematoda; Quantitative Structure-Activity Relationship; Sulfonylurea Compounds | 2019 |
Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents.
Topics: Alkaloids; Antifungal Agents; Apoptosis; Biofilms; Cryptococcus neoformans; Drug Discovery; G1 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 4 or More Rings; Isoxazoles; Melanins; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Structure-Activity Relationship; Urease | 2019 |
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
Topics: Animals; Chlorocebus aethiops; Dioxanes; Drug Design; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Trypanocidal Agents; Vero Cells | 2019 |
Carvacrol prodrugs as novel antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Cymenes; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Monoterpenes; Prodrugs; Solubility; Structure-Activity Relationship | 2019 |
Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
Topics: Antifungal Agents; Azoles; Biofilms; Candida; Cell Line; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2019 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
Synthesis and biological evaluation of calycanthaceous alkaloid analogs.
Topics: Acetylcholinesterase; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cholinesterase Inhibitors; Fungi; Indole Alkaloids; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Protein Binding; Pyrroles; Structure-Activity Relationship; Torpedo | 2019 |
Design, synthesis and bio-evaluation of C-1 alkylated tetrahydro-β-carboline derivatives as novel antifungal lead compounds.
Topics: Alkylation; Amphotericin B; Antifungal Agents; Candida; Carbolines; Cell Survival; Cryptococcus neoformans; Drug Design; Drug Synergism; Fluconazole; HEK293 Cells; Humans; Kinetics; Microbial Sensitivity Tests; Structure-Activity Relationship | 2020 |
Oxadiazolylthiazoles as novel and selective antifungal agents.
Topics: Antifungal Agents; Aspergillus; Biofilms; Caco-2 Cells; Candida; Cryptococcus; Humans; Microbial Sensitivity Tests; Oxadiazoles; Stereoisomerism; Thiazoles | 2020 |
New azole antifungals with a fused triazinone scaffold.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazines | 2020 |
Azole Based Acetohydrazide Derivatives of Cinnamaldehyde Target and Kill
Topics: | 2020 |
A new 1-nitro-9-aminoacridine derivative targeting yeast topoisomerase II able to overcome fluconazole-resistance.
Topics: Aminacrine; Antifungal Agents; Candida albicans; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Molecular Structure; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2021 |
Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus neoformans; Depsipeptides; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Anti-protozoal and anti-fungal evaluation of 3,5-disubstituted 1,2-dioxolanes.
Topics: Antifungal Agents; Antiprotozoal Agents; Aspergillus; Candida; Dioxolanes; Dose-Response Relationship, Drug; Leishmania; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium; Structure-Activity Relationship | 2021 |
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.
Topics: Animals; Antifungal Agents; Cell Wall; Drug Evaluation, Preclinical; Drug Synergism; Female; Fungi; Humans; Male; Mice; Microbial Sensitivity Tests; Mycoses; Rats, Sprague-Dawley | 2021 |
Discovery of Novel Sertraline Derivatives as Potent Anti-
Topics: Antidepressive Agents; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Humans; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Sertraline | 2022 |
Development of Lipo-γ-AA Peptides as Potent Antifungal Agents.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Mice; Microbial Sensitivity Tests; Peptides | 2022 |
β-Nitrostyrene derivatives as broad range potential antifungal agents targeting fungal cell wall.
Topics: Antifungal Agents; Candida albicans; Cell Wall; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Styrenes | 2022 |
[Pulmonary cryptococcosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Diagnosis, Differential; Fluconazole; Humans; Incidence; Lung Diseases, Fungal; Male; Pulmonary Fibrosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
New antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
Fluconazole failure in a child with burns and candidemia.
Topics: Amphotericin B; Burns; Candidiasis; Fluconazole; Humans; Infant; Male | 1992 |
Successful second allogeneic bone marrow transplantation in a relapsed acute myeloid leukemia patient with fungal liver abscess.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Liver Abscess; Neoplasm Recurrence, Local; Recombinant Proteins | 1992 |
Failure of fluconazole in systemic candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Female; Fluconazole; Fungemia; Humans | 1992 |
Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.
Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Candidiasis; Child; Child, Preschool; Fluconazole; Humans; Infant; Liver Transplantation; Male; Opportunistic Infections; Pancreas Transplantation; Premedication | 1992 |
Sporothrix schenckii meningitis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dermatomycoses; Fluconazole; Humans; Male; Meningitis, Fungal; Sporothrix; Sporotrichosis | 1992 |
Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.
Topics: Amphotericin B; Candida albicans; Endothelium, Vascular; Fluconazole; Humans; Umbilical Veins | 1992 |
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
Topics: Adult; Aged; Amphotericin B; Animals; Antifungal Agents; Child, Preschool; Disease Models, Animal; Female; Fluconazole; Humans; Immunocompromised Host; Male; Mice; Miconazole; Middle Aged; Mycoses; Triazoles; Trichosporon | 1992 |
The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Echinocandins; Female; Fluconazole; Injections, Intraperitoneal; Kidney; Liver; Lung; Mice; Neutropenia; Peptides, Cyclic; Spleen | 1992 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Fluconazole; Humans; Meningitis, Cryptococcal | 1992 |
Saperconazole: in vitro and in vivo anticandidal activity.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles | 1992 |
Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Follow-Up Studies; Humans; Male; Middle Aged; Vitrectomy | 1992 |
[Fluconazole treatment of cryptococcal meningitis associated with HIV infection. Presentation of 4 cases].
Topics: Administration, Oral; Adult; Amphotericin B; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; HIV Infections; Humans; Length of Stay; Male; Meningitis, Cryptococcal; Time Factors | 1992 |
[Cryptococcosis and acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Prognosis | 1992 |
Amphotericin versus fluconazole in cryptococcal meningitis.
Topics: Amphotericin B; Fluconazole; Humans; Kidney; Meningitis, Cryptococcal | 1992 |
Amphotericin versus fluconazole in cryptococcal meningitis.
Topics: Amphotericin B; Cerebrospinal Fluid; Cryptococcus; Fluconazole; Humans; Meningitis, Cryptococcal | 1992 |
[Isolated Candida albicans meningitis after treatment of B lymphoma].
Topics: Abdominal Neoplasms; Adolescent; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Fluconazole; Follow-Up Studies; Humans; Immunosuppression Therapy; Lymphoma, B-Cell; Male; Meningitis; Neoplasm Recurrence, Local | 1992 |
In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B.
Topics: Amphotericin B; Blood; Candida; Fluconazole; Humans; Microbial Sensitivity Tests | 1992 |
Fluconazole: a position statement by the Society of Infectious Diseases Pharmacists.
Topics: Amphotericin B; Candidiasis; Drug Interactions; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Societies, Pharmaceutical | 1992 |
Fluconazole therapy in a child with Candida tropicalis fungemia.
Topics: Amphotericin B; Candidiasis; Child, Preschool; Fluconazole; Fungemia; Humans; Male; Risk Factors | 1992 |
[Cryptococcal meningitis in patients with AIDS: combined treatment with amphotericin B and fluconazole, and high levels of adenosine deaminase in cerebrospinal fluid].
Topics: Acquired Immunodeficiency Syndrome; Adenosine Deaminase; Adult; Amphotericin B; Drug Therapy, Combination; Fluconazole; Humans; Male; Meningitis, Cryptococcal | 1992 |
Chronic systemic candidiasis in acute leukemia.
Topics: Adolescent; Aged; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Child; Chronic Disease; Female; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV-1; Homosexuality; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Substance Abuse, Intravenous | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Fluconazole; Humans; Meningitis, Cryptococcal; Recurrence | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Amphotericin B; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Recurrence | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Amphotericin B; Fluconazole; Humans; Meningitis, Cryptococcal; Patient Dropouts; Research Design | 1992 |
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Leukemia; Mycoses; Opportunistic Infections; Postoperative Complications; Retrospective Studies | 1991 |
Fluconazole or amphotericin for candidosis in neutropenic patients.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Fluconazole; Humans; In Vitro Techniques; Neutropenia | 1991 |
Fluconazole or amphotericin for candidaemia in non-neutropenic patients?
Topics: Adult; Amphotericin B; Candidiasis; Fluconazole; Humans; Male; Neutropenia | 1991 |
Candida zeylanoides: another opportunistic yeast.
Topics: Amphotericin B; Candida; Catheterization, Central Venous; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Parenteral Nutrition, Total; Polymorphism, Restriction Fragment Length | 1991 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Opportunistic Infections; Recurrence; Time Factors; Zidovudine | 1991 |
Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Culture Media; Fluconazole; In Vitro Techniques; Macrophages; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests | 1991 |
Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis.
Topics: Amphotericin B; Animals; Candidiasis; Endocarditis, Bacterial; Female; Fluconazole; Half-Life; Injections, Intraperitoneal; Injections, Intravenous; Rabbits | 1991 |
Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii.
Topics: Amphotericin B; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mycoses; Prognosis; Prosthesis-Related Infections; Spain; Time Factors; Trichosporon | 1991 |
[Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Esophagitis; Female; Fluconazole; Flucytosine; HIV Infections; HIV-1; Humans; Male | 1991 |
Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Confidence Intervals; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Prospective Studies; Prostatic Diseases; Recurrence | 1991 |
Hepatosplenic candidiasis: successful treatment with fluconazole.
Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Candidiasis; Child; Child, Preschool; Fluconazole; Flucytosine; Humans; Leukemia; Liver Diseases; Remission Induction; Splenic Diseases; Tomography, X-Ray Computed | 1991 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Costs and Cost Analysis; Cryptococcosis; Delphi Technique; Drug Therapy, Combination; Fluconazole; Flucytosine; Hospitalization; Humans; Infusions, Intravenous; Meningitis; Models, Theoretical; Surveys and Questionnaires | 1991 |
Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole.
Topics: Amphotericin B; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans | 1991 |
Fluconazole failure in the treatment of invasive mycoses.
Topics: Amphotericin B; Candidiasis; Coccidioidomycosis; Fluconazole; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome | 1991 |
Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type.
Topics: Amphotericin B; Brain; Brain Abscess; Fluconazole; Flucytosine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitosporic Fungi; Mycoses; United States | 1991 |
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Esophagitis; Female; Fluconazole; Ganciclovir; Humans; Infusions, Intravenous; Ketoconazole; Male; Opportunistic Infections; Prospective Studies; Treatment Outcome | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
Amphotericin-resistant invasive hepatosplenic candidiasis controlled by fluconazole.
Topics: Adult; Amphotericin B; Candida albicans; Candidiasis; Drug Administration Schedule; Drug Resistance; Female; Fluconazole; Humans; Liver Diseases; Splenic Diseases | 1990 |
Treatment of refractory oral candidiasis with fluconazole. A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clotrimazole; Deglutition Disorders; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Ketoconazole; Male | 1991 |
Profound papilledema due to cryptococcal meningitis in acquired immunodeficiency syndrome: successful treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Papilledema | 1991 |
[Amphotericin B resistant severe hepato-splenic candidiasis, responding to fluconazole, in a patient following bone marrow transplantation].
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candidiasis; Female; Fluconazole; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Diseases; Splenic Diseases | 1991 |
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1991 |
Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits.
Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Kidney; Rabbits | 1991 |
Histoplasma capsulatum infection associated with continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Fluconazole; Flucytosine; Histoplasma; Histoplasmosis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1991 |
Successful treatment of Prototheca peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Diabetes Mellitus, Type 1; Fluconazole; Flucytosine; Humans; Infections; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prototheca | 1991 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin | 1991 |
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Chromatography, Gas; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Meningitis; Mice; Mice, Inbred BALB C | 1991 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Lung Diseases, Fungal; Miconazole; Mycoses | 1990 |
Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
Topics: Acute Disease; Agranulocytosis; Amphotericin B; Animals; Candidiasis; Chronic Disease; Disease Models, Animal; Female; Fluconazole; Flucytosine; Kidney; Liver; Rabbits; Specific Pathogen-Free Organisms | 1990 |
Infectious disease emergencies in persons with HIV/AIDS: an update.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Clindamycin; Communicable Diseases; Fluconazole; HIV Infections; Humans; Opportunistic Infections; Pentamidine; Pyrimethamine; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cells, Cultured; Colony Count, Microbial; Fluconazole; Itraconazole; Ketoconazole; Macrophages; Mice; Phagocytosis | 1990 |
Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fluconazole; Lung Diseases, Fungal; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles | 1990 |
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
Topics: Agranulocytosis; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Female; Fluconazole; Immunosuppression Therapy; Rabbits; Triazoles | 1990 |
[Identification and susceptibility of clinically isolated yeast-like fungi].
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Humans; Miconazole; Microbial Sensitivity Tests; Yeasts | 1990 |
Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male; Meningitis | 1990 |
Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Candida; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Mycoses; Yeasts | 1990 |
[Antifungal agents].
Topics: Administration, Oral; Amphotericin B; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Injections, Intraventricular; Injections, Spinal; Miconazole; Mycoses | 1990 |
In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
Topics: Amphotericin B; Candida; Drug Evaluation; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests; Species Specificity | 1990 |
In-vitro activity of SCH39304 in comparison with amphotericin B and fluconazole.
Topics: Amphotericin B; Culture Media; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis; Mycoses; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon | 1990 |
In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
Topics: Amphotericin B; Animals; Antifungal Agents; Female; Fluconazole; Histoplasma; Histoplasmosis; Leukopenia; Mice; Microbial Sensitivity Tests; Triazoles | 1990 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses | 1990 |
Coccidioidal meningitis acquired during holidays in Arizona.
Topics: Administration, Oral; Aged; Alberta; Amphotericin B; Arizona; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Humans; Injections, Spinal; Male; Meningitis; Travel | 1990 |
Severe systemic cryptococcal disease in a child: review of prognostic indicators predicting treatment failure and an approach to maintenance therapy with oral fluconazole.
Topics: Administration, Oral; Amphotericin B; Child; Cryptococcosis; Female; Fluconazole; Humans; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence | 1990 |
Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Fluconazole; Lung; Lung Diseases, Fungal; Male; Mice; Mice, Inbred BALB C; Triazoles | 1990 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles | 1989 |
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Humans; Male; Meningitis; Prostatic Diseases; Recurrence; Triazoles; Urine | 1989 |
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles | 1989 |
Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Diabetes Mellitus, Experimental; Fluconazole; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Saccharomyces cerevisiae; Triazoles | 1989 |
Efficacy of SCH39304 in murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Female; Fluconazole; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Spleen; Triazoles | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Colony Count, Microbial; Fluconazole; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains | 1989 |
Disseminated histoplasmosis in a Danish patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Denmark; Fluconazole; Histiocytes; Histoplasma; Histoplasmosis; Homosexuality; Humans; Immunity, Cellular; Male; Microscopy, Electron | 1989 |
CNS cryptococcosis: unusual aspects.
Topics: Adult; Aged; Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Triazoles | 1988 |
Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Female; Fluconazole; Histoplasmosis; Hydrocortisone; Immunosuppression Therapy; Mice; Mice, Inbred AKR; Triazoles | 1987 |
Treatment of two cases of cryptococcal meningitis with fluconazole.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Triazoles | 1988 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Ketoconazole; Mice; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1985 |
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Intestinal Diseases; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |
Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.
Topics: Amphotericin B; Animals; Fluconazole; Histoplasma; Histoplasmosis; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Triazoles | 1986 |
Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
Topics: Amphotericin B; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred ICR; Triazoles | 1986 |
Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Fluconazole; Male; Mice; Mice, Inbred BALB C; Triazoles | 1986 |
Treatment of cryptococcal meningitis in mice with fluconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Fluconazole; Ketoconazole; Kinetics; Meningitis; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Culture Techniques; Fluconazole; Histoplasma; Histoplasmosis; Ketoconazole; Male; Mice; Triazoles | 1987 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles | 1987 |
Candiduria as an early marker of disseminated infection in critically ill surgical patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Fluconazole; Humans; Surgical Procedures, Operative | 1995 |
In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Female; Fluconazole; Fluoroquinolones; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Quinolones; Spiro Compounds | 1995 |
Fluconazole therapy for candiduria.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Dose-Response Relationship, Drug; Fluconazole; Humans; Pyuria | 1995 |
Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Candida albicans; Candidiasis; Cytokines; Fluconazole; Inflammation; Interferons; Leukocyte Count; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Rabbits; Tumor Necrosis Factor-alpha | 1994 |
A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Candidiasis; Combined Modality Therapy; Female; Fluconazole; Fungemia; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Kidney Diseases; Liver Diseases; Middle Aged; Neutropenia; Retrospective Studies; Splenic Diseases; Syndrome; Tomography, X-Ray Computed; Transplantation, Autologous | 1994 |
Aspergillus brain abscess in a patient with normal immunity--case report.
Topics: Amphotericin B; Aspergillosis; Brain Abscess; Combined Modality Therapy; Fluconazole; Frontal Lobe; Humans; Lymphocyte Activation; Male; Middle Aged; Tomography, X-Ray Computed | 1994 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Therapy, Combination; Fluconazole; Itraconazole; Miconazole; Microbial Sensitivity Tests; Pseudallescheria | 1995 |
[The Candida infected hen's egg. An alternative test system for systemic anticandida activity].
Topics: Amphotericin B; Animal Testing Alternatives; Animals; Antifungal Agents; Candida albicans; Candidiasis; Chick Embryo; Fluconazole; Propylene Glycol; Propylene Glycols | 1995 |
Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
Topics: Amphotericin B; Animals; Candidiasis; Colony Count, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred ICR; Spleen | 1995 |
Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole.
Topics: Amphotericin B; Brain Abscess; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Tomography, X-Ray Computed | 1995 |
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1995 |
[Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: dependency on lipophilia].
Topics: Amphotericin B; Candida albicans; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Lipids; Miconazole; Microbial Sensitivity Tests; Structure-Activity Relationship | 1995 |
Disseminated cryptococcal infection despite treatment for cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Fatal Outcome; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Tomography, X-Ray Computed | 1995 |
Fluconazole in candida peritonitis in CAPD: an alternative proposal.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1995 |
In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
Topics: Amphotericin B; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Yeasts | 1995 |
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Silicones; Urinary Catheterization | 1995 |
Urinary tract candidiasis in neonates and infants.
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male; Urinary Tract Infections | 1995 |
In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mycoses; Yeasts | 1995 |
High prevalence of antifungal resistance in Candida spp. from patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests | 1994 |
Cryptococcosis after renal transplantation.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies | 1995 |
In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184.
Topics: Amphotericin B; Anthracyclines; Antibiotics, Antineoplastic; Antifungal Agents; Fluconazole; Microbial Sensitivity Tests; Yeasts | 1995 |
Percutaneous intracavitary antifungals for a patient with pulmonary aspergilloma; with a special reference to in vivo efficacies and in vitro susceptibility results.
Topics: Administration, Cutaneous; Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Fluconazole; Humans; Male; Middle Aged; Thorax | 1995 |
Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages.
Topics: Amphotericin B; Animals; Cells, Cultured; Cryptococcus neoformans; Drug Synergism; Fluconazole; Humans; Interferon-gamma; Macrophages; Mice; Microbial Sensitivity Tests; Nitric Oxide | 1994 |
Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cell Death; Dexamethasone; Female; Fluconazole; Flucytosine; Liposomes; Macrophages; Macrophages, Peritoneal; Mice; Pentoxifylline; Tumor Necrosis Factor-alpha | 1994 |
Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.
Topics: Amphotericin B; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluconazole; Formazans; Itraconazole; Microbial Sensitivity Tests; Mitochondria; Tetrazolium Salts; Thiazoles; Vitamin K | 1995 |
Cryptococcosis, AIDS, and clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 1995 |
Evaluation of a broth microdilution antifungal susceptibility test with a pH indicator: comparison with the broth macrodilution procedures.
Topics: Amphotericin B; Antifungal Agents; Bromcresol Purple; Candida; Culture Media; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Fluconazole; Fungi; Hydrogen-Ion Concentration; Indicators and Reagents; Microbial Sensitivity Tests; Nystatin; Saccharomyces cerevisiae | 1995 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Karyotyping; Microbial Sensitivity Tests; Molecular Epidemiology | 1995 |
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
Topics: Amphotericin B; Animals; Candidiasis; Cyclophosphamide; Drug Combinations; Female; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Neutropenia | 1995 |
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles | 1995 |
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts | 1995 |
When to use fluconazole.
Topics: Amphotericin B; Candidiasis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Humans; Mycoses | 1995 |
Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged | 1994 |
[A case of primary pulmonary cryptococcosis showing infiltrative shadows in the unilateral lung field].
Topics: Aged; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Lung Diseases, Fungal; Male; Miconazole; Tomography, X-Ray Computed | 1994 |
[Fungemia caused by Candida krusei in a female patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida; Candidiasis, Oral; Female; Fluconazole; Fungemia; Humans; Recurrence; Zidovudine | 1994 |
Zosteriform zygomycosis.
Topics: Adult; Amphotericin B; Dermatomycoses; Diagnosis, Differential; Female; Fluconazole; Herpes Zoster; Humans; Liver Transplantation; Mucormycosis; Rhizopus; Skin Diseases, Viral | 1995 |
Fluconazole and amphotericin B antifungal therapies do not negate the protective effect of endogenous tumor necrosis factor in a murine model of fatal disseminated candidiasis.
Topics: Amphotericin B; Animals; Candidiasis; Colony Count, Microbial; Female; Fluconazole; Immunoglobulin G; Interleukin-6; Kidney; Leukocyte Count; Liver; Lung; Macrophages, Peritoneal; Mice; Spleen; Survival Analysis; Tissue Distribution; Tumor Necrosis Factor-alpha | 1995 |
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Candidiasis, Oral; Cost-Benefit Analysis; Drug Resistance, Microbial; Fluconazole; Humans; Male; Treatment Outcome | 1994 |
[Treatment and prevention of main infections associated with HIV].
Topics: Adrenal Cortex Hormones; Amphotericin B; Controlled Clinical Trials as Topic; Cryptococcosis; Fluconazole; HIV Infections; Humans; Isoniazid; Pneumonia, Pneumocystis; Prospective Studies; Tuberculosis | 1994 |
[Obstructive candidiasis: a process with surgical solution].
Topics: Adolescent; Amphotericin B; Candidiasis; Fluconazole; Humans; Infant; Infant, Newborn; Intestinal Obstruction; Jejunal Diseases; Kidney Diseases; Male; Ultrasonography; Ureteral Obstruction | 1994 |
Renal fungus ball in a premature infant successfully treated with fluconazole.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Kidney Diseases; Male; Ultrasonography | 1994 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Catheterization; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Catheterization, Central Venous; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 1995 |
Efficacy of amphotericin B and fluconazole in removal of fungus contamination from human islet cultures: effects on hormone secretion.
Topics: Amphotericin B; Aspergillus; Candida; Cell Separation; Cells, Cultured; Culture Techniques; Fluconazole; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Pancreas; Somatostatin; Thyrotropin-Releasing Hormone; Time Factors; Tissue Donors | 1994 |
Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Candida; Colorimetry; Fluconazole; Humans; Microbial Sensitivity Tests; Observer Variation; Reproducibility of Results | 1994 |
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Quality Control; Reference Values; Saccharomyces cerevisiae; Yeasts | 1994 |
Management of candidemia.
Topics: Adult; Amphotericin B; Candidiasis; Fluconazole; Fungemia; Humans; Neutropenia | 1994 |
Gastrointestinal histoplasmosis presenting as hematochezia in human immunodeficiency virus-infected hemophilic patients.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Diagnosis, Differential; Fluconazole; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Hemophilia A; Histoplasmosis; Humans; Male; Middle Aged | 1994 |
Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Colorimetry; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Reference Standards; Reference Values; Yeasts | 1994 |
Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Synergism; Drug Therapy, Combination; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Spleen; Triazoles | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus neoformans; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Mycology; Oxidation-Reduction; Yeasts | 1994 |
Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Flucytosine; Humans; Infant, Newborn; Risk Factors | 1994 |
Successful peritransplant therapy in children with active hepatosplenic candidiasis.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Child, Preschool; Female; Fluconazole; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Splenic Diseases | 1994 |
Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Male; Mice; Microbial Sensitivity Tests | 1994 |
Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans.
Topics: Aged; Amphotericin B; Candidiasis; Coronary Artery Bypass; Drug Administration Schedule; Fluconazole; Humans; Male; Osteomyelitis; Postoperative Complications; Sternum | 1994 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies | 1994 |
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Administration Schedule; Drug Resistance, Microbial; Fluconazole; Humans; Pharyngitis; Treatment Failure | 1994 |
Case report: cutaneous manifestations of cryptococcosis.
Topics: Aged; Aged, 80 and over; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Fluconazole; Humans; Immunocompromised Host | 1994 |
[Percutaneous intracavitary treatment of pulmonary aspergilloma-clinical efficacy and prognosis].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Humans; Injections, Intralesional; Lung Diseases, Fungal; Male; Middle Aged; Prognosis | 1994 |
Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
Topics: Amphotericin B; Blood Physiological Phenomena; Candida albicans; Flow Cytometry; Fluconazole; Flucytosine; Humans | 1994 |
Mortality of hospitalized patients with Candida endophthalmitis.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Endophthalmitis; Fluconazole; Hospital Mortality; Humans; Middle Aged; Retrospective Studies; Treatment Outcome | 1994 |
Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro.
Topics: Amphotericin B; Antifungal Agents; Blood Proteins; Cryptococcus neoformans; Defensins; Drug Synergism; Fluconazole; Kinetics; Microbial Sensitivity Tests | 1993 |
Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.
Topics: Amphotericin B; Animals; Candidiasis; Deoxycholic Acid; Drug Carriers; Drug Combinations; Female; Fluconazole; Immunocompetence; Leukopenia; Liposomes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests | 1993 |
[Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia].
Topics: Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Bronchitis; Combined Modality Therapy; Female; Fluconazole; Humans; Incidence; Itraconazole; Lung Diseases, Fungal; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction | 1993 |
Case report: Candida meningitis with an intradural filling defect 1 year after candidemia.
Topics: Amphotericin B; Candida albicans; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Fungemia; Humans; Meningitis, Fungal; Middle Aged; Time Factors | 1994 |
Successful treatment of Candida prosthetic valve endocarditis with a combination of fluconazole and amphotericin B.
Topics: Amphotericin B; Candidiasis; Endocarditis, Bacterial; Fluconazole; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged | 1994 |
Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcus neoformans; Female; Fluconazole; Humans; Malawi; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies | 1994 |
Retropharyngeal abscess caused by Penicillium marneffei: an unusual cause of upper airway obstruction.
Topics: Adult; AIDS-Related Opportunistic Infections; Airway Obstruction; Amphotericin B; Biopsy; Combined Modality Therapy; Female; Fluconazole; Humans; Mycoses; Penicillium; Retropharyngeal Abscess; Tracheostomy | 1994 |
Disseminated lymphonodular cryptococcosis in a child with X-linked hyper-IgM immunodeficiency.
Topics: Agammaglobulinemia; Amphotericin B; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Genetic Linkage; Humans; Immunoglobulin M; Male; X Chromosome | 1994 |
Prevention of invasive fungal infection during chemotherapy-induced neutropenia in patients with acute leukemia.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Fluconazole; Humans; Leukemia; Middle Aged; Neutropenia; Retrospective Studies | 1994 |
Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Fungemia; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Recurrence | 1994 |
Development of Hansenula anomala infection in a child receiving fluconazole therapy.
Topics: Accidents, Traffic; Amphotericin B; Blood Transfusion; Candida albicans; Candidiasis; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Humans; Klebsiella Infections; Male; Microbial Sensitivity Tests; Mycoses; Pichia; Pseudomonas Infections; Wounds and Injuries | 1994 |
Effect of amphotericin B and fluconazole on platelet membrane glycoproteins.
Topics: Amphotericin B; Binding Sites, Antibody; Blood Platelets; Blood Preservation; Fluconazole; Humans; Leukocytes; Platelet Membrane Glycoproteins; Serum Albumin | 1994 |
Neonatal renal candidiasis.
Topics: Amphotericin B; Candidiasis; Diagnostic Imaging; Drug Therapy, Combination; Fluconazole; Humans; Infant; Ketoconazole; Male; Pyelonephritis; Ureteral Obstruction | 1994 |
Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Candida; Candidiasis; Female; Fluconazole; Humans; Incidence; Itraconazole; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lung Diseases; Male; Mycetoma; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Recurrence; Risk Factors | 1994 |
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Endocarditis; Female; Fluconazole; Fungemia; Heart Valve Diseases; Humans; Mitral Valve; Recurrence | 1994 |
Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Chronic Disease; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Vitreous Body | 1993 |
Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
Topics: Amphotericin B; Animals; Candidiasis; Fluconazole; Hematopoiesis; Immunosuppression Therapy; Liposomes; Male; Mice; Neutropenia; Survival Analysis | 1993 |
[In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses].
Topics: Amphotericin B; Aspergillus; Candida; Child; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Mycoses | 1993 |
A pseudocyst infected by Torulopsis glabrata: a unique problem.
Topics: Aged; Amphotericin B; Candida; Candidiasis; Drainage; Female; Fluconazole; Humans; Pancreatic Pseudocyst; Rupture, Spontaneous | 1993 |
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Topics: Amphotericin B; Bacterial Infections; Bone Marrow Transplantation; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Leukemia; Microbial Sensitivity Tests; Neutropenia | 1993 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Endocarditis; Female; Fluconazole; Heart; Injections, Intravenous; Microbial Sensitivity Tests; Rabbits | 1993 |
[Diagnosis and therapy of pulmonary mycoses].
Topics: Adolescent; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Fluorouracil; Humans; Lung Diseases, Fungal; Male; Middle Aged; Serologic Tests | 1993 |
Should all catheterized patients with candiduria be treated?
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Humans; Therapeutic Irrigation; Urinary Bladder; Urinary Catheterization; Urinary Tract Infections | 1993 |
Severe candidal infections in neutropenic patients.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Itraconazole; Ketoconazole; Neutropenia | 1993 |
Failure of therapy with fluconazole for candidal endophthalmitis.
Topics: Adult; Amphotericin B; Candidiasis; Cross Infection; Endophthalmitis; Female; Fluconazole; Fungemia; Humans; Pyelonephritis | 1993 |
[Hepatosplenic candidiasis in patients treated for hemato-oncological disorders].
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Leukemia, Myeloid, Acute; Liver Abscess; Male; Middle Aged; Splenic Diseases | 1994 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Penicillium; Phenotype | 1993 |
Peritoneal catheter colonization with Alternaria: successful treatment with catheter preservation.
Topics: Alternaria; Amphotericin B; Catheters, Indwelling; Equipment Contamination; Fluconazole; Humans; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory | 1994 |
Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Meningitis, Cryptococcal; Microbial Sensitivity Tests | 1993 |
Combination therapy in experimental invasive aspergillosis.
Topics: Amphotericin B; Animals; Antigens, Fungal; Aspergillosis; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Immunosuppression Therapy; Rabbits; Survival Analysis; Tissue Distribution | 1993 |
[The treatment of Candida peritonitis during peritoneal dialysis].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1993 |
Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
Topics: Amphotericin B; Animals; Candidiasis; Disease Models, Animal; Fluconazole; Flucytosine; Fungemia; Gastrointestinal Diseases; Mice | 1993 |
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Middle Aged; Retrospective Studies; Treatment Outcome | 1993 |
[Strategy for examination and therapy of mycotic keratitis].
Topics: Acremonium; Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Contact Lenses; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Keratitis; Ketoconazole; Mycoses; Ophthalmic Solutions; Therapeutic Irrigation | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1993 |
Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes.
Topics: Amphotericin B; Candida albicans; Cell Membrane; Centrifugation, Density Gradient; Culture Techniques; Fluconazole; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Neutrophils; Phagocytosis; Synovial Fluid; Temperature | 1993 |
Successful treatment of Candida albicans osteomyelitis with fluconazole.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Male; Middle Aged; Osteomyelitis | 1993 |
Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Female; Fluconazole; Flucytosine; Humans; Instillation, Drug; Lung; Lung Diseases, Fungal; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Radiography; Time Factors; Treatment Outcome | 1993 |
Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-beta-D-glucan synthase.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Glucosyltransferases; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Peptides, Cyclic; Schizosaccharomyces pombe Proteins; Species Specificity; Survival Analysis | 1993 |
Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Lung Diseases, Fungal; Male | 1993 |
The effects of amphotericin B, fluconazole and miconazole on neutrophil and lymphocyte function in a guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Chemotaxis, Leukocyte; Deoxyglucose; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Leukocyte Adherence Inhibition Test; Lymphocyte Activation; Lymphocytes; Miconazole; Neutrophils | 1995 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rhodotorula | 1995 |
Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage.
Topics: Amphotericin B; Animals; Antifungal Agents; Chromatography, Gas; Columbidae; Cryptococcus neoformans; Feces; Fluconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Sterols | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus neoformans; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Oxidation-Reduction; Species Specificity; Yeasts | 1995 |
Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Child; Endoscopy, Digestive System; Esophagitis; Esophagus; Fluconazole; Humans; Male; Mouth | 1995 |
In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Drug Combinations; Fluconazole; Flucytosine; Microbial Sensitivity Tests | 1995 |
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Culture Media; Drug Resistance, Microbial; Fluconazole; Fluoroquinolones; Microbial Sensitivity Tests; Quality Control | 1995 |
Candida endophthalmitis in Job syndrome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Chorioretinitis; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Fundus Oculi; Humans; Job Syndrome; Vitreous Body | 1996 |
Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cytomegalovirus Retinitis; Endophthalmitis; Eye; Eye Infections, Fungal; Fluconazole; Fungemia; Fusarium; Humans; Male; Middle Aged; Mycoses | 1996 |
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Incidence; Microbial Sensitivity Tests; Multivariate Analysis; Prospective Studies; Risk; Risk Factors | 1996 |
[Colorimetric broth microdilution for antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Evaluation Studies as Topic; Fluconazole; Flucytosine; Fungi; Indicator Dilution Techniques; Microbial Sensitivity Tests | 1996 |
Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case-Control Studies; Catheters, Indwelling; Female; Fluconazole; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Risk Factors; Treatment Outcome | 1996 |
Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Female; Fluconazole; France; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Treatment Outcome | 1996 |
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Peptides | 1996 |
In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomyces; Blastomycosis; Drug Evaluation, Preclinical; Fluconazole; Lethal Dose 50; Lung Diseases, Fungal; Male; Mice; Microbial Sensitivity Tests; Triazoles | 1996 |
Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole.
Topics: Administration, Inhalation; Amphotericin B; Biopsy; Candidiasis; Candidiasis, Oral; Diabetes Complications; Fluconazole; Fluorouracil; Humans; Male; Middle Aged; Osteomyelitis; Steroids; Zygoma | 1996 |
Obstructive jaundice due to Coccidioides immitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Choledochostomy; Cholestasis; Coccidioides; Coccidioidomycosis; Eosinophilia; Fluconazole; Humans; Male | 1996 |
Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Fluconazole; Genetic Variation; Hospitals; Humans; Microbial Sensitivity Tests | 1995 |
Aspergillus fumigatus scleritis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cryotherapy; Dura Mater; Eye Infections, Fungal; Eye Injuries; Fluconazole; Humans; Male; Scleritis | 1995 |
[Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Immunologic Deficiency Syndromes | 1996 |
Bilateral isolated adrenal coccidioidomycosis.
Topics: Adrenal Gland Diseases; Adrenal Glands; Adult; Amphotericin B; Antifungal Agents; Biopsy; Coccidioidomycosis; Cortisone; Fluconazole; Humans; Male; Sweden | 1996 |
Bruton's agammaglobulinaemia in a child presenting with cryptococcal empyema thoracis and periauricular pyogenic abscess.
Topics: Abscess; Agammaglobulinemia; Amphotericin B; Ceftazidime; Child, Preschool; Cloxacillin; Combined Modality Therapy; Cryptococcosis; Empyema, Pleural; Fluconazole; Humans; Immunization, Passive; Male; Opportunistic Infections; Otitis Externa | 1995 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Deoxyribonucleases, Type II Site-Specific; DNA, Fungal; Drug Resistance, Microbial; Fluconazole; Flucytosine; Genetic Variation; Humans; Itraconazole; Molecular Epidemiology | 1996 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Endocarditis; Fluconazole; Heart; Injections, Intraperitoneal; Kidney; Rabbits | 1996 |
[New antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole | 1996 |
[A case of acquired immunodeficiency syndrome associated with cryptococcemia and cryptococcal meningitis].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; HIV-1; Humans; Male; Meningitis, Cryptococcal; Middle Aged | 1996 |
Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Humans; Microbial Sensitivity Tests; Reference Standards; Reproducibility of Results | 1996 |
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Administration Schedule; Endocarditis; Fluconazole; Microbial Sensitivity Tests; Rabbits | 1996 |
Editorial response: management of cryptococcal meningitis--have we answered all the questions?
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Meningitis, Cryptococcal | 1996 |
Treatment of non-meningeal cryptococcosis in patients with AIDS. Centre d'Informations et de Soins de l'Immunodéficience Humaine de l'Est Parisien.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Female; Fluconazole; Follow-Up Studies; Humans; Male; Middle Aged | 1996 |
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.
Topics: Adult; Age Factors; Amphotericin B; Antifungal Agents; Bacterial Infections; Candidiasis; Diabetes Mellitus, Type 1; Female; Fluconazole; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Pancreas Transplantation; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Tissue Donors; Treatment Outcome | 1996 |
Pancreatic transplantation after thirty years: still room for improvement.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Pancreas Transplantation; Postoperative Complications; Staphylococcal Infections; Staphylococcus epidermidis | 1996 |
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Blood; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Rabbits; Triazoles | 1996 |
[Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests | 1996 |
Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Enzyme Inhibitors; Ergosterol; Fluconazole; Intramolecular Transferases; Isomerases; Pyridinium Compounds | 1996 |
Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Birth Weight; Candidiasis; Congenital Abnormalities; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies | 1996 |
Peripheral thrombophlebitis caused by Candida.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Prospective Studies; Thrombophlebitis | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Multiple; Drug Therapy, Combination; Fluconazole; Flucytosine; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Microbial Sensitivity Tests | 1996 |
Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and flucona
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Flucytosine; Glucose; Humans; Indicator Dilution Techniques; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Quality Control | 1996 |
In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp.
Topics: Amphotericin B; Anthracyclines; Antibiotics, Antineoplastic; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests | 1996 |
Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Resistance, Multiple; Esophagitis; Fluconazole; Humans; Male; Microbial Sensitivity Tests | 1996 |
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Indicator Dilution Techniques; Microbial Sensitivity Tests | 1996 |
Empyema following the percutaneous instillation of antifungal agents in patients with aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Empyema; Fluconazole; Humans; Injections; Lung Diseases, Fungal; Male; Middle Aged; Pleural Diseases | 1996 |
Serum cryptococcal antigen in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Animals; Antifungal Agents; Antigens, Fungal; CD4 Lymphocyte Count; Cryptococcosis; Diagnosis, Differential; Disease Progression; Drug Resistance, Microbial; False Positive Reactions; Fluconazole; Humans; Latex Fixation Tests; Mice; Polysaccharides | 1996 |
Successful treatment of fungus ball in a patient with allergic bronchopulmonary aspergillosis: continuous percutaneous instillation of antifungal agents into the cavity.
Topics: Administration, Inhalation; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Prednisolone; Remission Induction | 1996 |
Suspected drug eruption in seven dogs during administration of flucytosine.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cryptococcosis; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Itraconazole; Male | 1996 |
Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Fungemia; Humans; Middle Aged | 1996 |
Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Microbial Sensitivity Tests | 1996 |
Postantifungal effect and effects of low concentrations of amphotericin B and fluconazole on previously treated Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Microbial Sensitivity Tests | 1996 |
Fluconazole and amphotericin B for cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Meningitis, Cryptococcal | 1996 |
Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests | 1997 |
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Multiple; Female; Fluconazole; Flucytosine; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Mice; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Virulence | 1997 |
In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon | 1996 |
Cryptococcal cellulitis in an immunocompetent host.
Topics: Aged; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Dermatomycoses; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Leg Dermatoses | 1997 |
Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxidoreductases; Sterols | 1997 |
[Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 1996 |
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles | 1997 |
Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Cell Line; Cell Survival; Cryptococcus neoformans; Drug Resistance, Microbial; Drug Synergism; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1997 |
[Focusing on therapy of systemic mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Mycoses | 1995 |
In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; France; Humans; Itraconazole; Microbial Sensitivity Tests | 1996 |
The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
Topics: Amphotericin B; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses | 1997 |
Hospital-acquired candidaemia: experience from a developing country.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Cross Infection; Female; Fluconazole; Fungemia; Humans; Infant; Male; Middle Aged; Qatar; Risk Factors | 1997 |
A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Antagonism; Fluconazole; Ketoconazole; Microbial Sensitivity Tests | 1996 |
Update on treatment of coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Pneumonia | 1997 |
Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Flucytosine; Gingival Diseases; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Neutropenia | 1997 |
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance; Fluconazole; Microbial Sensitivity Tests; Oxidoreductases; Sterol 14-Demethylase; Sterols | 1997 |
A case of primary cutaneous cryptococcosis.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Fingers; Fluconazole; Humans; Immunocompromised Host; Lung Diseases, Obstructive; Male; Steroids | 1997 |
Coccidioidomycosis in liver transplant patients.
Topics: Adult; Aged; Amphotericin B; Coccidioidomycosis; Female; Fluconazole; Humans; Liver Transplantation; Male; Middle Aged | 1997 |
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Indicator Dilution Techniques; Itraconazole; Miconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1997 |
Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; CD4 Lymphocyte Count; Fluconazole; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity | 1997 |
[Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV Seropositivity; Humans; Male; Treatment Failure | 1996 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Echinocandins; Fluconazole; Microbial Sensitivity Tests; Peptides, Cyclic | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
Bilateral Candida parapsilosis endophthalmitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Humans; Injections; Lens Capsule, Crystalline; Lenses, Intraocular; Male; Phacoemulsification; Visual Acuity; Vitrectomy | 1997 |
Detection and identification of fungal pathogens in blood by using molecular probes.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; DNA, Fungal; Fluconazole; Fungemia; Fungi; Humans; Molecular Sequence Data; Neutropenia; Oligonucleotide Probes; Polymerase Chain Reaction; RNA, Ribosomal, 18S; Sensitivity and Specificity | 1997 |
Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Fluconazole; Microbial Sensitivity Tests; Morpholines; Time Factors | 1997 |
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Endocarditis; Female; Fluconazole; Male; Mice; Mice, Inbred BALB C; Neutropenia; Rabbits | 1997 |
Candida norvegensis: a fluconazole-resistant species.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged | 1997 |
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Fluconazole; Kinetics; Microbial Sensitivity Tests; Time Factors | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
[Maternofetal disseminated candidiasis and high-grade prematurity].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intrauterine Devices; Pregnancy; Pregnancy Complications, Infectious | 1997 |
Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Interferon-gamma; Interleukin-4; Mice; Mice, Inbred BALB C; Th1 Cells | 1997 |
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biological Transport; Candida albicans; Drug Resistance, Microbial; Fluconazole; Genes, Fungal; Genes, MDR; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; RNA, Messenger | 1997 |
Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 1996 |
Rapid flow cytometric susceptibility testing of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cell Membrane Permeability; Flow Cytometry; Fluconazole; Microbial Sensitivity Tests; Propidium; Reproducibility of Results; Sensitivity and Specificity | 1997 |
A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Middle Aged; Prosthesis-Related Infections; Recurrence | 1997 |
Disseminated miliary cerebral candidiasis.
Topics: Amphotericin B; Antifungal Agents; Brain; Candidiasis; Child, Preschool; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluconazole; Heart Defects, Congenital; Humans; Hydrocephalus; Meningitis, Fungal; Opportunistic Infections; Postoperative Complications; Ventriculoperitoneal Shunt | 1997 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Fungemia; Humans; Incidence; Infant; Injections, Intravenous; Male; Middle Aged; Retrospective Studies | 1997 |
Apophysomyces elegans limb infection with a favorable outcome: case report and review.
Topics: Adult; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Therapy, Combination; Fluconazole; Humans; Male; Mucorales; Mucormycosis; Thigh | 1997 |
Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient.
Topics: Abnormalities, Multiple; Adult; Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Humans; Infant, Newborn; Male; Meningitis, Fungal; Osteochondrodysplasias; Pregnancy; Pregnancy Complications, Infectious | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum | 1997 |
Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Candidiasis; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Fluconazole; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Naphthyridines; Topoisomerase II Inhibitors | 1997 |
Treatment of cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Research Design; Selection Bias | 1997 |
[Evaluation of effective treatment drugs against Acanthamoeba cyst].
Topics: Acanthamoeba; Amphotericin B; Animals; Anti-Infective Agents, Local; Antifungal Agents; Antiprotozoal Agents; Cornea; Fluconazole; Humans; Keratitis; Miconazole; Natamycin; Pentamidine | 1997 |
Prediction of relapse after treatment of coccidioidomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Cohort Studies; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Predictive Value of Tests; Recurrence; Retrospective Studies | 1997 |
Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Saccharomyces cerevisiae | 1995 |
In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Culture Media; Fluconazole; Fungi; Griseofulvin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 1997 |
Fusarium solani infection in a patient with acute myelogenous leukemia--a case report.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Female; Fluconazole; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Necrosis; Skin | 1997 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection.
Topics: Adult; Aged; Amphotericin B; Amputation, Surgical; Antifungal Agents; Arthrodesis; Candidiasis; Diplopia; Fatal Outcome; Female; Fluconazole; Flucytosine; Hemofiltration; Hernia, Inguinal; Humans; Male; Meningococcal Infections; Osteomyelitis; Pulmonary Ventilation; Vitrectomy | 1997 |
Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Colorimetry; Fluconazole; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Reproducibility of Results | 1997 |
[Candidemia: a never ceasing challenge].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Retrospective Studies; Risk Factors | 1997 |
[Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Candidiasis; Catheterization; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Time Factors | 1997 |
Delayed-onset fungal keratitis after endophthalmitis.
Topics: Acremonium; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cataract Extraction; Corneal Stroma; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Fusarium; Humans; Keratitis; Keratoplasty, Penetrating; Lenses, Intraocular; Male; Mycoses; Retrospective Studies; Vitrectomy | 1998 |
Endogenous cryptococcal endophthalmitis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Fluorescein Angiography; Humans; Middle Aged; Retina; Vitreous Body | 1998 |
[Pulmonary cryptococcosis during HIV infection. 15 cases].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pneumonia, Pneumocystis; Radiography, Thoracic; Retrospective Studies | 1997 |
Cryptococcosis, epileptic seizures and encephalopathy in a HIV-infected patient.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcus neoformans; Epilepsy, Tonic-Clonic; Fatal Outcome; Fluconazole; HIV Infections; Humans; Injections, Intravenous; Male; Meningoencephalitis; Pneumonia, Bacterial; Sepsis | 1997 |
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1998 |
[Fungus-ball in a preterm infant successfully treated with fluconazole].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Kidney Diseases; Male; Ultrasonography | 1998 |
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Body Weight; Brain; Drug Therapy, Combination; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Specific Pathogen-Free Organisms; Survival Analysis | 1998 |
Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Yeasts | 1998 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Humans; Incidence; Itraconazole; Ketoconazole; Male; Mitosporic Fungi; Neoplasms; Pichia; Retrospective Studies; Risk Factors; Slovakia; Treatment Outcome | 1998 |
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Culture Media, Conditioned; Dose-Response Relationship, Drug; Fluconazole; Humans; Microbial Sensitivity Tests; Species Specificity; Time Factors | 1998 |
[Exophytic papillomatous space-occupying lesions of the larynx as a rare manifestation of candidiasis. Diagnostic and therapeutic consequences].
Topics: Amphotericin B; Antifungal Agents; Biopsy; Candidiasis; Diagnosis, Differential; Fluconazole; Follow-Up Studies; Humans; Hyperplasia; Laryngeal Diseases; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Papilloma; Vocal Cords | 1998 |
Intraocular coccidioidomycosis diagnosed by skin biopsy.
Topics: Adult; Amphotericin B; Biopsy; Bone Diseases; Brain Diseases; Chorioretinitis; Coccidioidomycosis; Dermatomycoses; Eye Infections, Fungal; Female; Fluconazole; Humans; Iridocyclitis; Lung Diseases, Fungal; Male; Radiography; Radionuclide Imaging; Retrospective Studies; Skin; Technetium Tc 99m Pyrophosphate | 1998 |
Candidemia: a nosocomial complication in adults with late-stage AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; CD4 Lymphocyte Count; Cross Infection; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors | 1998 |
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluconazole; Health Surveys; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests | 1998 |
Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluconazole; Immunity, Cellular; Interferon-gamma; Interleukin-4; Mice; Mice, Inbred BALB C; Receptors, Interleukin-4; Specific Pathogen-Free Organisms; Th1 Cells | 1998 |
[Gas chromatography in express diagnosis of candidiasis and monitoring of antifungal therapy efficacy by D-arabinitol and mannose levels in pediatric patients].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Chromatography, Gas; Female; Fluconazole; Humans; Infant; Male; Mannose; Sugar Alcohols | 1998 |
[Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Middle Aged; Mycoses; Nystatin; Retrospective Studies; Severity of Illness Index | 1998 |
Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluconazole; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Molecular Epidemiology | 1998 |
[A case of rhinocerebral mucormycosis presenting orbital apex syndrome].
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Craniotomy; Diagnosis, Differential; Fluconazole; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mucormycosis; Orbital Diseases; Paranasal Sinus Diseases; Syndrome | 1998 |
Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Fluconazole; Microbial Sensitivity Tests | 1998 |
Infectious crystalline keratopathy caused by Candida guilliermondii.
Topics: Aged; Amphotericin B; Biopsy; Candida; Candidiasis; Cornea; Corneal Diseases; Drug Resistance, Microbial; Eye Infections, Fungal; Fluconazole; Humans; Keratoplasty, Penetrating; Male; Recurrence; Reoperation | 1998 |
Recurrent cryptococcal choroiditis in a renal transplant patient: clinicopathologic study.
Topics: Adult; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Choroiditis; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Eye Enucleation; Eye Infections, Fungal; Fluconazole; Humans; Kidney Transplantation; Male; Meningitis, Cryptococcal; Recurrence; Vitrectomy; Vitreous Body | 1998 |
[Prospective study of Candida-related sepsis in the neonate].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Infant, Newborn; Prospective Studies; Sepsis | 1998 |
Association between facial cutaneous coccidioidomycosis and meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Confidence Intervals; Dermatomycoses; Facial Dermatoses; Female; Fluconazole; Humans; Male; Meningitis, Fungal; Odds Ratio; Retrospective Studies | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin | 1998 |
Idiopathic CD4+ T-lymphocytopenia in a child with disseminated cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Bone Marrow; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Liver; Lung; Lymph Nodes; T-Lymphocytopenia, Idiopathic CD4-Positive | 1998 |
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Laboratories; Microbial Sensitivity Tests; Quality Control; Time Factors | 1998 |
[Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Middle Aged; Prosthesis-Related Infections | 1998 |
Treatment of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Itraconazole; Mycoses | 1998 |
Blastomycosis in dogs: 115 cases (1980-1995).
Topics: Age Distribution; Amphotericin B; Animals; Antibodies, Fungal; Antifungal Agents; Blastomyces; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluconazole; Housing, Animal; Immunodiffusion; Itraconazole; Ketoconazole; Louisiana; Male; Radiography, Thoracic; Retrospective Studies; Seasons; Treatment Outcome | 1998 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
Case report of long-term survival in a patient with acquired immunodeficiency syndrome and cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Fatal Outcome; Fluconazole; HIV Antibodies; Humans; Male; Meningitis, Cryptococcal; Time Factors | 1998 |
Pradimicin therapy of disseminated Candida tropicalis infection in the mouse.
Topics: Amphotericin B; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Injections, Intravenous; Kidney; Mice; Microbial Sensitivity Tests; Spleen | 1998 |
In vitro activity of voriconazole against selected fungi.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Evaluation Studies as Topic; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test | 1998 |
Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Fungemia; Humans; Male; Middle Aged; Primary Myelofibrosis | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences.
Topics: Amphotericin B; Animals; Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Candida albicans; Candidiasis; Drug Resistance, Microbial; Endocarditis; Fluconazole; Humans; Postoperative Complications | 1998 |
Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents.
Topics: Administration, Inhalation; Adult; Aged; Amphotericin B; Anastomosis, Surgical; Antifungal Agents; Biopsy; Bronchi; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Infusions, Intravenous; Lung Transplantation; Male; Middle Aged; Surgical Wound Infection | 1998 |
Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Blindness; Candidiasis; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Heroin Dependence; Humans; Injections, Intravenous; Male; Visual Acuity; Vitrectomy | 1998 |
Treatment options for candidal endophthalmitis [editoria; comment].
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Humans; Vitrectomy | 1998 |
Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Fluconazole; Glucose; Humans; Itraconazole; Microbial Sensitivity Tests; Spectrophotometry; Time Factors | 1999 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors | 1998 |
In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Fluconazole; Microbial Sensitivity Tests; Mycology; Time Factors | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Child; Female; Fluconazole; Fungemia; Humans; Incidence; Male; Microbial Sensitivity Tests; Neoplasms; Risk Factors | 1998 |
Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations.
Topics: Amphotericin B; Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Macrophages; Mice; Microscopy, Electron, Scanning; Phagocytosis; Polysaccharides | 1999 |
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Cross Infection; Fluconazole; Hospitals, University; Humans; Incidence; Intensive Care Units; Iowa; Ketoconazole; Medical Records; Postoperative Complications | 1999 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Fungi; Histatins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides; Salivary Proteins and Peptides | 1999 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Drug Combinations; Drug Evaluation; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Leukemia; Lymphoma; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Neutropenia | 1999 |
Fluconazole therapy in Candida albicans spondylodiscitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Discitis; Drug Therapy, Combination; Female; Fluconazole; Humans; Liver Transplantation | 1998 |
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 1999 |
Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Liposomes; Osteomyelitis; Recurrence | 1999 |
Candida krusei sinusitis.
Topics: Alcoholism; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fatal Outcome; Fluconazole; Humans; Infection Control; Intubation, Intratracheal; Male; Maxillary Sinusitis; Middle Aged; Respiratory Distress Syndrome; Risk Factors; Serotyping | 1998 |
Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infections.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Cost-Benefit Analysis; Decision Trees; Drug Carriers; Fluconazole; Humans; Liposomes; Models, Economic; Mycoses; Oropharynx; Polyenes; Probability; United Kingdom | 1995 |
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin | 1998 |
[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].
Topics: Acute Disease; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agents; Cohort Studies; Cryptococcosis; Data Interpretation, Statistical; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Spain; Treatment Outcome | 1999 |
[Neurologic cryptococcosis: meningitis of the immunosuppressed patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcus neoformans; Diabetes Complications; Diabetes Mellitus; Female; Fluconazole; Hodgkin Disease; Humans; Male; Meningitis, Cryptococcal; Treatment Outcome | 1999 |
Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Postoperative Period; Survival Rate | 1999 |
Midbrain infarction: a rare presentation of cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cerebral Infarction; Chronic Disease; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Mesencephalon; Tomography, X-Ray Computed | 1999 |
Activities of sordarins in murine histoplasmosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Histoplasma; Histoplasmosis; Indenes; Kidney; Lung; Male; Mice; Mice, Inbred ICR | 1999 |
Management of asymptomatic candiduria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Humans; Urinary Catheterization; Urinary Tract Infections | 1999 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Preschool; Female; Fluconazole; France; Fungemia; Hospitals, University; Humans; Infant; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Postoperative Complications; Saccharomyces cerevisiae | 1999 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
Clinicians' reaction to positive urine culture for Candida organisms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Attitude of Health Personnel; Candida; Candidiasis; Catheters, Indwelling; Colony Count, Microbial; Female; Fluconazole; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections | 1999 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sex Factors; Spain; Yeasts | 1999 |
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Glucose; Microbial Sensitivity Tests; Pyrimidines; Spectrophotometry; Time Factors; Triazoles; Voriconazole | 1999 |
Disseminated cutaneous sporotrichosis in an AIDS patient receiving maintenance therapy with fluconazole for previous cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Female; Fluconazole; Humans; Meningitis, Cryptococcal; Sporotrichosis | 1999 |
Hepatosplenic candidiasis after neutropenic phase of acute leukaemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Female; Fluconazole; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Liver Diseases; Male; Middle Aged; Neutropenia; Opportunistic Infections; Splenic Diseases | 1999 |
The prognostic factors of cryptococcal meningitis in HIV-negative patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Prognosis; Taiwan; Treatment Outcome | 1999 |
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
Topics: Amphotericin B; Analysis of Variance; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Dose-Response Relationship, Drug; Echinocandins; Female; Fluconazole; Metabolic Clearance Rate; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic; Potassium; Rabbits | 1999 |
Cytokines in sepsis due to Candida albicans and in bacterial sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Bacteremia; Candidiasis; Cell Adhesion Molecules; Cytokines; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged | 1999 |
[Role of Candida allergen in atopic dermatitis and efficacy of oral therapy with various antifungal agents].
Topics: Administration, Oral; Adult; Allergens; Amphotericin B; Antifungal Agents; Antigens, Fungal; Candida albicans; Dermatitis, Atopic; Female; Fluconazole; Humans; Itraconazole; Male; Nystatin | 1999 |
Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Drug Carriers; Fluconazole; Liposomes; Nystatin; Rabbits; Treatment Outcome | 1999 |
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Liposomal amphotericin B for fever and neutropenia.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Drug Carriers; Fluconazole; Humans; Liposomes; Mycoses; Neutropenia | 1999 |
The influence of subinhibitory concentrations of conventional and experimental antifungal drugs on the expression of the iC3b binding protein in Candida albicans strains during filamentation.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Clotrimazole; Complement C3b; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Fluconazole; Humans; Immunoblotting; Microbial Sensitivity Tests; Nystatin; Receptors, Complement 3b; Rosette Formation; Sheep; Species Specificity; Thiazoles; Tunicamycin | 1999 |
Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Topics: Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Candida; Candida albicans; Candidiasis; Catheterization; Chi-Square Distribution; Cross Infection; Fluconazole; Fungemia; Humans; Incidence; Neoplasms; Neutropenia; Outcome Assessment, Health Care; Prospective Studies; Risk Factors; Slovakia | 1999 |
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Synergism; Fluconazole; Flucytosine; Humans; Lactoferrin; Microbial Sensitivity Tests | 1999 |
[Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts | 1999 |
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Meta-Analysis as Topic; Mycoses; Neoplasms; Neutropenia; Nystatin; Opportunistic Infections; Publication Bias; Randomized Controlled Trials as Topic; Research Design | 1999 |
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis; Endophthalmitis; Fluconazole; Flucytosine; Kidney; Male; Microbial Sensitivity Tests; Myocardium; Pyelonephritis; Rabbits; Survival Analysis; Time Factors; Vitreous Body | 1999 |
Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Female; Fluconazole; Kidney; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests | 1999 |
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Topics: Amphotericin B; Animals; Fluconazole; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Spleen; Time Factors; Triazoles; Trypanocidal Agents | 1999 |
Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clotrimazole; Community-Acquired Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Fungemia; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged | 1999 |
Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunocompetence; Male; Meningitis | 1999 |
Value of Ga-67 SPECT in monitoring the effects of therapy in invasive aspergillosis of the sphenoid sinus.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Diagnosis, Differential; Fluconazole; Follow-Up Studies; Gallium Radioisotopes; Humans; Male; Paranasal Sinus Diseases; Pituitary Neoplasms; Radiopharmaceuticals; Sella Turcica; Sphenoid Sinus; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 1999 |
Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Inbred C3H; Neutrophils | 2000 |
Penicillium peritonitis in an adolescent receiving chronic peritoneal dialysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Kidney Failure, Chronic; Penicillium; Peritoneal Dialysis; Peritonitis | 1999 |
Determination of antifungal MICs by a rapid susceptibility assay.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Glucose; Microbial Sensitivity Tests; Molecular Sequence Data; Time Factors | 2000 |
Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Topics: Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Combinations; Fluconazole; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Randomized Controlled Trials as Topic | 2000 |
Survival following fulminant hepatic failure from fluconazole induced hepatitis.
Topics: Amphotericin B; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cryptococcosis; Female; Fluconazole; Humans; Kidney; Liver Failure; Middle Aged | 1999 |
Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis.
Topics: Amphotericin B; Antifungal Agents; Ascitic Fluid; Candidiasis; Drug Combinations; Drug Therapy, Combination; Fluconazole; Humans; Infant; Infusions, Intravenous; Male; Peritoneal Dialysis; Peritonitis; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Fungal peritonitis in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Fluconazole; Humans; Infant; Infant, Newborn; Peritoneal Dialysis; Peritonitis | 1998 |
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Leprostatic Agents; Rifampin; Time Factors | 2000 |
Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis.
Topics: Amphotericin B; Animals; Antibodies, Monoclonal; Antifungal Agents; Candida albicans; Candidiasis; Combined Modality Therapy; Cytokines; Female; Fluconazole; Humans; Immunocompromised Host; Immunotherapy; Interleukin-10; Interleukin-12; Kidney; Mice; Mice, Inbred BALB C; Receptors, Interleukin-4; Recombinant Proteins; RNA, Messenger; Th1 Cells | 2000 |
Miliary coccidioidomycosis in the immunocompetent.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunocompetence; Lung Diseases, Fungal; Male; Middle Aged; Respiration, Artificial; Survival Rate | 2000 |
Central nervous system pneumocystosis in AIDS: antemortem diagnosis and successful treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Central Nervous System Fungal Infections; Drug Therapy, Combination; Fluconazole; Follow-Up Studies; Homosexuality, Male; Humans; Male; Pneumonia, Pneumocystis; Spinal Puncture; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 2000 |
Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Candida; Cross Infection; Fluconazole; Humans; Microbial Sensitivity Tests; Species Specificity; Trichosporon | 1999 |
Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Polyenes | 2000 |
Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Seasons; Taiwan | 2000 |
Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Colony Count, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sensitivity and Specificity | 2000 |
Case report of three Candida albicans infections detected at delivery.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Delivery, Obstetric; Electrophoresis; Enzymes; Female; Fluconazole; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Microbial Sensitivity Tests | 2000 |
Cryptococcal meningitis in acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; India; Male; Meningitis, Cryptococcal | 1999 |
Cryptococcal meningitis in non-HIV-infected patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Female; Fever; Fluconazole; Headache; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Recurrence; Survival Rate; T-Lymphocytes; Taiwan; Vomiting | 2000 |
Comparative efficacy of fluconazole and amphotericin B in the parenteral treatment of experimental paracoccidioidomycosis in the rat.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Female; Fluconazole; Humans; Paracoccidioides; Paracoccidioidomycosis; Rats; Rats, Wistar | 1999 |
Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2000 |
A comparative study of changes in fecal flora in patients preconditioned with either amphotericin B or fluconazole for allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Feces; Fluconazole; Humans; Middle Aged; Tobramycin; Transplantation Conditioning; Transplantation, Homologous; Vancomycin | 2000 |
Improving the conduct and reporting of clinical trials.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Meta-Analysis as Topic | 2000 |
Improving the conduct and reporting of clinical trials.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Meta-Analysis as Topic | 2000 |
Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Paracoccidioides; Sterols | 2000 |
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
Topics: Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cross Reactions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Germany; HIV Seropositivity; Humans; Itraconazole; Mycoses; Penicillium; Thailand; Travel | 1999 |
Durable cure of mucormycosis involving allograft and native lungs.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Administration Routes; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Mucormycosis; Transplantation, Homologous | 2000 |
Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Recurrence; Retrospective Studies; Time Factors | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Treatment Outcome | 2000 |
[Four cases of pulmonary aspergilloma successfully treated with drug therapy].
Topics: Administration, Inhalation; Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Humans; Infusions, Intravenous; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Treatment Outcome | 2000 |
Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Digestive System; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Neutropenia; Oropharynx; Phenotype; Urogenital System | 2000 |
Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis.
Topics: Amphotericin B; Animals; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Histoplasmosis; Itraconazole; Mice; Microbial Sensitivity Tests | 2000 |
Clinical utility of in vitro antifungal susceptibility testing.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Incidence; Microbial Sensitivity Tests; Mycoses; Practice Guidelines as Topic | 2000 |
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles | 2000 |
Disseminated histoplasmosis in a non-immunocompromised child.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow; Child, Preschool; Disseminated Intravascular Coagulation; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Immune System; Pancytopenia | 1999 |
Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; Drug Resistance, Microbial; Female; Finland; Fluconazole; Hematologic Neoplasms; Hospital Units; Humans; Infection Control; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Saccharomyces cerevisiae | 2000 |
Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida; Candida albicans; Drug Combinations; Drug Resistance, Microbial; Female; Fluconazole; Humans; Liver Transplantation; Male; Medical Audit; Microbial Sensitivity Tests; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Care; Postoperative Complications; Prospective Studies | 2000 |
Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Interferon-gamma; Liver; Male; Mice; Mice, Inbred BALB C | 2000 |
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Echinocandins; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic | 2000 |
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Fluconazole; Immunocompromised Host; Male; Mice; Microbial Sensitivity Tests; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test.
Topics: Amphotericin B; Antifungal Agents; Flow Cytometry; Fluconazole; Fluorescence; Microbial Sensitivity Tests; Mycoses; Quality Control; Scattering, Radiation; Yeasts | 2000 |
Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candida albicans; Case-Control Studies; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Drug Resistance, Microbial; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Immunosuppressive Agents; Infant; Logistic Models; Male; Middle Aged; Neutropenia; Prognosis; Retrospective Studies; Risk Factors; Shock, Septic; Treatment Outcome | 2000 |
Persistently positive cultures and outcome in invasive neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cell Division; Colony Count, Microbial; Female; Fluconazole; Humans; Infant, Newborn; Male; Predictive Value of Tests; Prognosis; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2000 |
Successful treatment of bilateral renal fungal balls with liposomal amphotericin B and fluconazole in an extremely low birth weight infant.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Kidney Diseases; Remission Induction | 2000 |
Management of persistent fever in the neutropenic patient.
Topics: Amphotericin B; Antifungal Agents; Fever; Fluconazole; Humans; Mycoses; Neutropenia | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Humans; Itraconazole; Lactoferrin; Mouthwashes; Muramidase | 2000 |
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies | 2000 |
In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Fluconazole; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests; Periapical Periodontitis; Periodontitis | 2000 |
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Resistance, Microbial; Echinocandins; Esophageal Diseases; Esophagus; Female; Fluconazole; Immunosuppression Therapy; Peptides, Cyclic; Pharyngeal Diseases; Rabbits; Saliva | 2001 |
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Endocarditis; Fluconazole; Heart; Kidney; Kidney Function Tests; Male; Microbial Sensitivity Tests; Pyelonephritis; Rabbits; Time Factors | 2001 |
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Bone Marrow Transplantation; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Neutropenia; Prospective Studies; Retrospective Studies | 2001 |
Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candida; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasms; Neutropenia; Treatment Failure | 2001 |
Empirical antifungal therapy for persistent fever in patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Deoxycholic Acid; Drug Combinations; Fever; Fluconazole; Humans; Mycoses; Neutropenia | 2001 |
Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Prospective Studies; Treatment Outcome | 2001 |
Coccidioidomycosis in adolescents with lupus nephritis.
Topics: Abscess; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Amphotericin B; Child; Coccidioidomycosis; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Female; Fluconazole; Humans; Immunosuppressive Agents; Injections, Intravenous; Liposomes; Lung Diseases; Lupus Nephritis; Radiography, Thoracic; Tomography, X-Ray Computed | 2001 |
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 2000 |
[Successful allogeneic bone marrow transplantation following fungal liver abscess treatment in a patient with chronic myeloid leukemia in blastic crisis].
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Transplantation; Fluconazole; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Abscess; Male; Mycoses; Transplantation, Homologous | 2000 |
Chronic systemic (hepatosplenic) candidiasis in a patient with granulocytic sarcoma.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Chronic Disease; Female; Fluconazole; Humans; Liver Diseases; Opportunistic Infections; Ovarian Neoplasms; Sarcoma; Splenic Diseases; Tomography, X-Ray Computed | 2000 |
Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillus; Candida; Cryptococcus; Drug Resistance, Microbial; Drug Synergism; Fluconazole; Flucytosine; Fungi; Histatins; Humans; Magainins; Microbial Sensitivity Tests; Salivary Proteins and Peptides; Xenopus Proteins | 2000 |
[Current problems in etiotropic therapy of mycoses].
Topics: Amphotericin B; Antifungal Agents; Candicidin; Candida; Fluconazole; Humans; Itraconazole; Miconazole; Mycoses; Nystatin | 2001 |
Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Vagina | 2001 |
Fungal left ventricular assist device endocarditis.
Topics: Amphotericin B; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Endocarditis; Fluconazole; Heart-Assist Devices; Humans; Mycoses; Prosthesis Design; Prosthesis-Related Infections; Reoperation; Risk Factors | 2001 |
Candidal endophthalmitis in a renal transplant patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Female; Fluconazole; Humans; Immunosuppression Therapy; Kidney Transplantation; Visual Acuity | 2001 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
Treatment for coccidioidomycosis in pregnancy?
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Erythema Nodosum; Female; Fluconazole; Humans; Ketoconazole; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Risk Factors | 2001 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Culture Media; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Reproducibility of Results | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
[Candida antigen and antibody kinetics during antifungal therapy in non-neutropenic intensive care patients].
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Intensive Care Units; Neutrophils | 2000 |
Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Cell Culture Techniques; Culture Media; Fluconazole; Humans; Immunodiffusion; Microbial Sensitivity Tests; Reproducibility of Results | 2001 |
Fungaemia in elderly patients.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Flucytosine; Fungemia; Humans; Male; Postoperative Complications; Risk Factors; Slovakia; Survival Rate | 2001 |
Fungal infection overview.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Fluconazole; Histoplasmosis; Humans; Itraconazole; Meningitis, Cryptococcal; Mycoses | 1995 |
Cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Meningitis, Cryptococcal | 1996 |
Coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; HIV Infections; Humans; Itraconazole; Risk Factors; Southwestern United States | 1997 |
Histoplasmosis: update 1998.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Clinical Trials as Topic; Dosage Forms; Fluconazole; Histoplasmosis; Itraconazole; Ketoconazole; Remission Induction | 1998 |
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.
Topics: Acrylic Resins; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Chlorhexidine; Colony Count, Microbial; Denture Bases; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluconazole; Galactose; Glucose; Humans; Indicators and Reagents; Nystatin; Polymethyl Methacrylate; Saliva; Statistics as Topic; Stomatitis, Denture; Sucrose; Tetrazolium Salts; Time Factors | 2001 |
[Endemic mycotic infections].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Travel | 2001 |
[Visceral mycotic infections. In clinical practice].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Immunosuppression Therapy; Mycology; Mycoses; Neutropenia; Prognosis; Risk Factors; Travel | 2001 |
[Fungal infections in intensive care units: a cross-survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucytosine; France; Humans; Intensive Care Units; Mycoses; Surveys and Questionnaires | 2001 |
Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Echocardiography; Endocarditis; Fluconazole; Heart Failure; Humans; Male; Time Factors; Tricuspid Valve; Tricuspid Valve Insufficiency | 2001 |
Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Female; Fluconazole; Humans; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Neoplasms; Nystatin; Treatment Failure; Treatment Outcome | 2001 |
Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests | 2001 |
Standardization of antifungal susceptibility variables for a semiautomated methodology.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dimethyl Sulfoxide; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Spectrophotometry | 2001 |
Cryptococcal meningitis in renal transplant patients associated with environmental exposure.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Meningitis, Cryptococcal; Middle Aged; Ohio; Postoperative Complications; Rural Population | 1999 |
Treatment of invasive Candida infection in neonates with congenital cutaneous Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Dermatomycoses; Drug Administration Schedule; Fluconazole; Humans; Infant, Newborn; Liposomes | 2001 |
Clinical presentation, radiological findings, and treatment results of coccidioidomycosis involving the spine: report on 23 cases.
Topics: Adolescent; Adult; Amphotericin B; Child; Coccidioidomycosis; Debridement; Drainage; Drug Therapy, Combination; Female; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Postoperative Complications; Psoas Abscess; Reoperation; Spinal Fusion; Spondylitis; Tomography, X-Ray Computed; Treatment Failure | 2001 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; China; Cohort Studies; Drug Resistance, Microbial; Ethnicity; Female; Fluconazole; Follow-Up Studies; HIV Infections; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Recurrence | 2001 |
Candida albicans spinal epidural abscess secondary to prosthetic valve endocarditis.
Topics: Amphotericin B; Candida albicans; Candidiasis; Endocarditis; Epidural Abscess; Female; Fluconazole; Follow-Up Studies; Heart Valve Prosthesis; Humans; Lumbar Vertebrae; Middle Aged; Spondylolisthesis; Treatment Outcome | 2001 |
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Cell Count; Colorimetry; Fluconazole; Humans; Microbial Sensitivity Tests; Reproducibility of Results | 2001 |
Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Device Removal; Equipment Failure; Female; Fluconazole; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Risk Factors | 2001 |
Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients.
Topics: Adolescent; Adult; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Naphthalenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Steroids; Terbinafine; Tinea; Treatment Outcome; Trichophyton | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence | 2001 |
Clinicopathological report of Candida granuloma from an endogenous candidal endophthalmitis.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Female; Fluconazole; Granuloma; Humans; Middle Aged | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
Scedosporium endophthalmitis: two fatal disseminated cases of Scedosporium infection presenting with endophthalmitis.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fatal Outcome; Female; Fluconazole; Fungemia; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycetoma; Neutropenia; Scedosporium | 2001 |
Bilateral endogenous Candida endophthalmitis after induced abortion.
Topics: Abortion, Induced; Adult; Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Pregnancy; Visual Acuity; Vitrectomy; Vitreous Body | 2001 |
Case report. Hepatic abscesses due to Aspergillus terreus in an immunodeficient child.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Liposomes; Liver Abscess; Lung Diseases; Male; Treatment Outcome | 2001 |
Case report. Cutaneous cryptococcosis in a patient with systemic erythematous lupus.
Topics: Adult; Agglutination Tests; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Fatal Outcome; Female; Fluconazole; Fungemia; Humans; Injections, Intravenous; Lupus Erythematosus, Systemic; Renal Insufficiency | 2001 |
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Microbial Sensitivity Tests | 2002 |
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genetic Heterogeneity; HIV Infections; Humans; Itraconazole; Karyotyping; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Triazoles | 2002 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Fluconazole; Flucytosine; Gingival Diseases; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Leukocyte Count; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
Keratitis caused by Verticillium species.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Humans; Keratitis; Male; Middle Aged; Mycoses; Verticillium | 2002 |
Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests | 2002 |
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
Topics: Amphotericin B; Antifungal Agents; APACHE; Bone Marrow Transplantation; Candida albicans; Candidiasis; Case-Control Studies; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Postoperative Complications; Regression Analysis; Treatment Outcome | 2002 |
In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Drug Resistance, Fungal; Fluconazole; Humans; Liposomes; Microbial Sensitivity Tests; Nystatin | 2002 |
Candida endophthalmitis after tattooing in an asplenic patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Fluorescein Angiography; Fundus Oculi; Humans; Male; Splenectomy; Tattooing; Vitreous Body | 2002 |
SDT1/SSM1, a multicopy suppressor of S-II null mutant, encodes a novel pyrimidine 5'-nucleotidase.
Topics: 5'-Nucleotidase; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Escherichia coli; Fluconazole; Flucytosine; Fluorouracil; Fungal Proteins; Molecular Sequence Data; Nucleotidases; Phosphorylation; Protein Binding; Recombinant Proteins; Ribosomal Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Substrate Specificity | 2002 |
Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Fluconazole; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Risk Factors | 2002 |
Risk factors for breakthrough candidemia.
Topics: Amphotericin B; Anti-Bacterial Agents; Candidiasis; Fluconazole; Fungemia; Humans; Multivariate Analysis; Neoplasms; Neutropenia; Odds Ratio; Retrospective Studies; Risk Factors | 2002 |
Prophylaxis with oral fluconazole and an oral solution of amphotericin B in liver transplant patients.
Topics: Administration, Oral; Amphotericin B; Candidiasis; Female; Fluconazole; Humans; Liver Transplantation; Male; Middle Aged; Postoperative Complications | 2002 |
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Female; Fluconazole; Humans; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Phosphoproteins; Treatment Outcome; Virulence | 2002 |
Candida dubliniensis infection, Singapore.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fatal Outcome; Female; Fluconazole; Humans; Immunosuppression Therapy; Middle Aged; Singapore | 2002 |
Nosocomial candidemia in a tertiary care hospital in Saudi Arabia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Fungemia; Hospital Bed Capacity, 300 to 499; Hospitals; Humans; Infant, Newborn; Male; Middle Aged; Risk Factors; Saudi Arabia | 2002 |
[Mycotic endophthalmitis: management and treatment (9 year study)].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Combined Modality Therapy; Endophthalmitis; Eye; Female; Fluconazole; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Retreatment; Retrospective Studies; Vitrectomy | 2002 |
Post-antifungal effect and effects of sub-MIC concentrations on previously treated Candida spp.: influence of exposure time and concentration.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 2002 |
Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Fluconazole; Histoplasmosis; Mice; Spleen | 2002 |
Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sensitivity and Specificity; Trichosporon | 2002 |
Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Colorimetry; Coloring Agents; Dermatomycoses; Drug Resistance, Fungal; Epidermophyton; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Oxazines; Sensitivity and Specificity; Trichophyton; Xanthenes | 2002 |
[Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Fluconazole; Growth Inhibitors; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2002 |
Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brain Abscess; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Male | 2002 |
Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Topics: Aged; Aged, 80 and over; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Endocarditis; Fluconazole; Flucytosine; Heart Valve Prosthesis; Humans; Male; Middle Aged; Swine | 2002 |
Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
Topics: Adult; Amphotericin B; Anemia, Aplastic; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fatal Outcome; Female; Fluconazole; Humans; Itraconazole; Larynx; Methylprednisolone; Opportunistic Infections | 2002 |
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Caspofungin; Chemoprevention; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Trichosporon | 2002 |
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Candida; Drug Interactions; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Models, Biological | 2002 |
Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Risk Factors; Spleen; Splenectomy; Treatment Failure | 2002 |
Clinical microbiological case: fever and headache in a heavy consumer of eucalyptus extract.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Eucalyptus; Fever; Fluconazole; Headache; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Plant Extracts; Risk Factors | 2002 |
Cryptococcus neoformans infection.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Organ Transplantation | 2002 |
The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Culture Media; DNA-Binding Proteins; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Transcription Factors | 2002 |
Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole.
Topics: Amphotericin B; Analysis of Variance; Anti-Infective Agents; Antifungal Agents; Candida albicans; Candida tropicalis; Colony Count, Microbial; Fluconazole; Humans; Lactoferrin; Microbial Sensitivity Tests; Mouth; Muramidase; Nystatin; Species Specificity; Statistics as Topic | 2002 |
Xanthomonas maltophilia endophthalmitis following penetrating corneal injury.
Topics: Amphotericin B; Cornea; Corneal Injuries; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Fluconazole; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ofloxacin; Stenotrophomonas maltophilia; Visual Acuity | 2002 |
In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement.
Topics: Amphotericin B; Antifungal Agents; Arthroplasty, Replacement; Bone Cements; Candida; Colony Count, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoses; Polymethyl Methacrylate; Postoperative Complications | 2002 |
Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B.
Topics: Amphotericin B; Arthritis, Infectious; Blast Crisis; Candidiasis; Drug Combinations; Drug Resistance; Fatal Outcome; Female; Fluconazole; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Cryptococcal meningitis in a patient with systemic immunosuppression 13 years after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Germany; Humans; Immunocompromised Host; Liver Transplantation; Male; Meningitis, Cryptococcal | 2002 |
Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B.
Topics: Adult; Age Distribution; Aged; Amphotericin B; Ascitic Fluid; Candida; Cohort Studies; Female; Fluconazole; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer Perforation; Peritonitis; Probability; Prospective Studies; Risk Factors; Sex Distribution; Statistics, Nonparametric; Survival Rate; Taiwan | 2002 |
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half-Life; Microbial Sensitivity Tests; Microscopy, Electron; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Colony Count, Microbial; Colorimetry; Coloring Agents; Echinocandins; Fluconazole; Indicators and Reagents; Lipopeptides; Peptides; Peptides, Cyclic; Reproducibility of Results; Tetrazolium Salts; Time Factors | 2002 |
Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Flucytosine; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Rate | 2002 |
[A clinical study of 26 cases of cryptococcal meningitis].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Child; Cryptococcus; Drainage; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Lupus Erythematosus, Systemic; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2002 |
PCR-aided diagnosis of fungal chorioretinitis following ingestion of traditional Chinese medication.
Topics: Aged; Amphotericin B; Antifungal Agents; Chorioretinitis; DNA, Fungal; Drug Therapy, Combination; Drugs, Chinese Herbal; Eye Infections, Fungal; Female; Fluconazole; Fluorescein Angiography; Humans; Immunocompromised Host; Medicine, Chinese Traditional; Opportunistic Infections; Polymerase Chain Reaction; Prednisolone; Vitreous Body | 2002 |
Prevalence of dermatomycoses in Mal de Meleda patients: a field study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Biopsy, Needle; Comorbidity; Dermatomycoses; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Keratoderma, Palmoplantar; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Risk Assessment; Sampling Studies; Skin; Treatment Outcome; Turkey | 2002 |
Clinical cases in transplantation.
Topics: Adult; Aged; Amphotericin B; Aspergillus fumigatus; Candida; Candida glabrata; Female; Fluconazole; Humans; Kidney; Leukemia, Myeloid, Acute; Lung Transplantation; Male; Middle Aged; Mycoses; Sinusitis; Transplantation | 2002 |
[Pseudozyma sp.: colonizer of the respiratory tract in critical patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Critical Care; Female; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Spain; Trichosporon | 2003 |
Prevalence and antifungal susceptibilities of yeast isolates during one year at a university hospital in Turkey.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Fluconazole; Hospitals, University; Humans; Ketoconazole; Microbial Sensitivity Tests; Prevalence; Turkey | 2002 |
[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case Management; Consensus Development Conferences as Topic; Critical Care; Data Collection; Drug Utilization; Fever; Fluconazole; Fungemia; Guideline Adherence; Humans; Internship and Residency; Intestinal Perforation; Mycoses; Peritonitis; Practice Guidelines as Topic; Practice Patterns, Physicians'; Spain; Surveys and Questionnaires; Urinary Tract Infections | 2003 |
Peritoneal infection with multiple species of Candida: a case report.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Candidiasis; Child, Preschool; Digestive System Surgical Procedures; Female; Fluconazole; Gastrins; Humans; Peritonitis; Reoperation; Rupture, Spontaneous; Stomach Rupture; Treatment Outcome | 2002 |
Hairy cell leukemia with concurrent cryptococcus infection.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cladribine; Cryptococcosis; Fluconazole; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction | 2003 |
Candida glabrata spinal osteomyelitis involving two contiguous lumbar vertebrae: a case report and review of the literature.
Topics: Amphotericin B; Candida glabrata; Candidiasis; Fluconazole; Humans; Lumbar Vertebrae; Male; Osteomyelitis; Radiography | 2003 |
Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Canavanine; Cryptococcosis; Cryptococcus neoformans; Diabetes Mellitus; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Male; Middle Aged | 2003 |
Caspofungin versus amphotericin B for invasive candidiasis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Peptides; Peptides, Cyclic | 2003 |
Aspergillosis: a rare case of secondary delayed mandibular involvement.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Humans; Mandibular Diseases; Maxillary Sinusitis; Recurrence; Tooth Extraction | 2003 |
An unusual native tricuspid valve endocarditis caused by Candida colliculosa.
Topics: Aged; Amphotericin B; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Male; Tricuspid Valve | 2003 |
Evaluation of semisolid agar screening tests for determining fluconazole and amphotericin B susceptibilities of Candida strains by using three different media.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Culture Media; Fluconazole; Microbial Sensitivity Tests | 2003 |
[Invasive cerebral aspergillosis in an immunocompetent patient: a case report].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Female; Fluconazole; Humans; Immunocompetence | 2003 |
[Infections by Candida sp. in intensive care. Survey of French practices].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Cross-Sectional Studies; Equipment Contamination; Female; Fluconazole; France; Fungemia; Humans; Incidence; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors | 2003 |
Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Fungemia; Humans | 2003 |
Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candida albicans; Candidiasis; Chemoprevention; Drug Resistance, Microbial; Female; Fluconazole; Fungemia; Humans; Leukemia; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia | 2003 |
Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
Topics: Amphotericin B; Antifungal Agents; Chemoprevention; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Mycoses; Postoperative Complications; Transplantation, Autologous; Transplantation, Homologous | 2003 |
Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Fungemia; Humans; Infusions, Intravenous; Lipopeptides; Male; Neutropenia; Opportunistic Infections; Peptides; Peptides, Cyclic; Pleural Effusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[Antifungal susceptibility of yeasts by Etest. Comparison of 3 media].
Topics: Amphotericin B; Antifungal Agents; Candida; Colony Count, Microbial; Cryptococcus neoformans; Culture Media; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Mitosporic Fungi | 2003 |
Effects of melanin upon susceptibility of Cryptococcus to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Fluorescent Dyes; Melanins; Microbial Sensitivity Tests | 2003 |
Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus neoformans; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2003 |
Oral candidosis in patients with removable dentures.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Candida; Candidiasis, Oral; Female; Fluconazole; Humans; Jordan; Male; Middle Aged; Prevalence; Stomatitis, Denture | 2003 |
A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Chlorpromazine; Disease Models, Animal; Female; Fluconazole; Immunocompromised Host; Mice; Mice, Inbred ICR; Prednisolone; Tetracycline; Virulence | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt | 2003 |
A deeply invasive Phoma species infection in a renal transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Female; Fluconazole; Humans; Kidney Transplantation; Middle Aged; Mycoses; Postoperative Complications; Treatment Outcome | 2003 |
A very low birth weight infant with Candida nephritis with fungus balls. Full recovery after pyelotomy and antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Combined Modality Therapy; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Kidney; Male; Nephritis; Urologic Surgical Procedures | 2003 |
Cryptococcal meningitis in pediatric systemic lupus erythematosus.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Fluconazole; Humans; Lupus Erythematosus, Systemic; Meningitis, Cryptococcal | 2003 |
Successful medical treatment of Candida albicans in mechanical prosthetic valve endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Prognosis; Prosthesis-Related Infections; Risk Assessment; Treatment Outcome | 2003 |
[Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; CD4 Lymphocyte Count; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pharyngeal Diseases | 2003 |
Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
Topics: Amphotericin B; Antifungal Agents; Atropine; Bucladesine; Candida albicans; Chromatography, Gas; Cryptococcus neoformans; Cyclic AMP; Drug Synergism; Ergosterol; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Phosphodiesterase Inhibitors | 2003 |
[Architecture, influencing factors, and sensitivity to antifungal agents of Candida biofilm].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microscopy, Confocal | 2002 |
[Optic disk neovascularization in fungal endophthalmitis].
Topics: Adult; Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Neovascularization, Pathologic; Optic Disk; Retinal Detachment; Vitrectomy | 2003 |
Fluconazole-resistant cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Male; Meningitis, Cryptococcal | 2003 |
Antifungal susceptibility testing of Candida albicans by flow cytometry.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Flow Cytometry; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 2003 |
Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Bacteroides fragilis; Combined Modality Therapy; Drug Therapy, Combination; Fluconazole; Glomerulonephritis, IGA; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mucormycosis; Peritoneal Dialysis; Peritonitis; Recurrence | 2003 |
Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Inpatients; Itraconazole; Microbial Sensitivity Tests | 2003 |
In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects.
Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Exophiala; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine | 2003 |
Scedosporium apiospermum keratitis treated with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Keratitis; Male; Microbial Sensitivity Tests; Mycetoma; Scedosporium; Treatment Outcome | 2003 |
[Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic | 2003 |
Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient.
Topics: Abscess; Adult; Amphotericin B; Antifungal Agents; Antimetabolites, Antineoplastic; Candida glabrata; Candidiasis; Diagnosis, Differential; Fallopian Tubes; Female; Fever; Fluconazole; Genital Diseases, Female; Granulocyte Colony-Stimulating Factor; Humans; Hydatidiform Mole; Magnetic Resonance Imaging; Methotrexate; Neutropenia; Pregnancy | 2003 |
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Treatment Outcome | 2003 |
Antifungal combinations against Candida albicans biofilms in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Combinations; Echinocandins; Fluconazole; Lipopeptides; Peptides; Peptides, Cyclic; Tetrazolium Salts | 2003 |
In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil.
Topics: Adolescent; Adult; Agglutination Tests; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Serotyping | 2003 |
Fungal infection of sutureless self-sealing incision for cataract surgery.
Topics: Aged; Aged, 80 and over; Amphotericin B; Aspergillosis; Candidiasis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Humans; Ketoconazole; Male; Minimally Invasive Surgical Procedures; Natamycin; Phacoemulsification; Retrospective Studies; Scleritis; Surgical Wound Infection; Suture Techniques | 2003 |
Back pain in a 22-year-old man.
Topics: Amphotericin B; Antifungal Agents; Back Pain; Biopsy; Braces; Coccidioidomycosis; Combined Modality Therapy; Diagnosis, Differential; Disease Progression; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Patient Isolation; Spinal Fusion; Spondylitis; Thoracic Vertebrae; Treatment Outcome | 2003 |
Images in pathology: birefringent cryptococcus.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Birefringence; Cellulitis; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Male; Middle Aged; Pemphigus; Prednisone; Skin | 2003 |
Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Liposomes; Male | 2003 |
Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.
Topics: Abdominal Abscess; Adjuvants, Immunologic; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cytokines; Female; Fluconazole; Granulocyte Colony-Stimulating Factor; Lymphocytes; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recombinant Proteins; Spleen; Treatment Outcome | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
Disseminated trichosporonosis in China.
Topics: Adult; Amphotericin B; Antifungal Agents; China; Dermatomycoses; DNA, Ribosomal; Drug Therapy, Combination; Female; Fluconazole; Humans; Mycological Typing Techniques; Mycoses; RNA, Ribosomal; Sequence Analysis, DNA; Trichosporon | 2003 |
Effect of antifungal drugs on pathogenic Naegleria spp isolated from natural water sources.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Ketoconazole; Naegleria; Water Microbiology | 2003 |
Recurrent scleral abscess after uncomplicated cataract extraction.
Topics: Abscess; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Therapy, Combination; Female; Fluconazole; Humans; Natamycin; Recurrence; Scleral Diseases | 2004 |
Therapy for severe histoplasmosis: what's best?
Topics: Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Drug Combinations; Fluconazole; Histoplasmosis; Humans; Itraconazole; Male | 2004 |
[Vitrectomy in the treatment of endogenous fungal endophthalmitis in a patient after renal transplantation].
Topics: Amphotericin B; Antifungal Agents; Endophthalmitis; Fluconazole; Fusarium; Humans; Kidney Transplantation; Mycoses; Postoperative Complications; Vitrectomy | 2003 |
Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida tropicalis; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Prospective Studies; Taiwan | 2004 |
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Topics: Amphotericin B; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sampling Studies; Sensitivity and Specificity | 2004 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Body Weight; Brain; Colony Count, Microbial; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Combinations; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Analysis | 2004 |
Surgical treatment of multiple skull abscesses associated with coccidioidomycosis.
Topics: Abscess; Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluconazole; Humans; Liposomes; Osteomyelitis; Skull | 2004 |
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors | 2003 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Fungal; Flow Cytometry; Fluconazole; Humans; Microbial Sensitivity Tests | 2004 |
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
Topics: Africa; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcosis; Cryptococcus neoformans; Developing Countries; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Assessment; Sampling Studies; Triazoles; Voriconazole | 2004 |
Caspofungin: new indication. No progress in invasive candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; France; Humans; Peptides; Pyrimidines; Triazoles | 2004 |
Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Treatment Outcome | 2004 |
Endogenous endophthalmitis due to alternaria in an immunocompetent host.
Topics: Adult; Alternaria; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Immunocompetence; Immunocompromised Host; Mycoses; Vitreous Body | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2004 |
Patterns of antifungal prescribing in general dental practice.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Prescriptions; Fluconazole; General Practice, Dental; Humans; Miconazole; Nystatin; Practice Patterns, Dentists'; Surveys and Questionnaires; United Kingdom | 2004 |
Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA Primers; DNA, Complementary; Drug Resistance, Fungal; Ergosterol; Fluconazole; Gene Expression Profiling; Genes, Fungal; Genome, Fungal; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Oxidoreductases; Phenotype; Protein Folding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; Saccharomyces cerevisiae; Sterol 14-Demethylase; Sterols | 2004 |
[Antifungal susceptibility of Acremonium species using E-test and Sensititre].
Topics: Acremonium; Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 2004 |
Alternatives to amphotericin B for Candida rugosa infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2004 |
Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Serotyping; Taiwan; Triazoles; Voriconazole | 2004 |
[The 'bull's eye' pattern in hepatic tomography].
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Child, Preschool; Drug Therapy, Combination; Entamoeba histolytica; Feces; Female; Fluconazole; Humans; Liver Abscess; Tomography, X-Ray Computed | 2004 |
Prosthetic valve endocarditis due to Candida albicans treated successfully with medical treatment alone.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Candida albicans; Candidiasis; Endocarditis, Bacterial; Female; Fluconazole; Heart Valve Prosthesis; Humans; Middle Aged; Treatment Outcome | 2004 |
Denture stomatitis: a role for Candida biofilms.
Topics: Acrylic Resins; Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Cell Adhesion; Denture, Complete, Upper; Fluconazole; Humans; Microbial Sensitivity Tests; Stomatitis, Denture | 2004 |
Antifungal penetration into normal rabbit nucleus pulposus.
Topics: Amphotericin B; Animals; Antifungal Agents; Biological Availability; Dimyristoylphosphatidylcholine; Drug Carriers; Fluconazole; Infusions, Intravenous; Intervertebral Disc; Male; Phosphatidylglycerols; Rabbits | 2004 |
Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Population Surveillance; Quality Control; Serotyping | 2004 |
Candida parapsilosis keratitis following treatment of epithelial ingrowth after laser in situ keratomileusis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Drug Therapy, Combination; Epithelium, Corneal; Eye Infections, Fungal; Female; Fluconazole; Humans; Keratitis; Keratomileusis, Laser In Situ; Middle Aged; Ofloxacin; Postoperative Complications; Retrospective Studies; Surgical Flaps | 2004 |
Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chile; Critical Care; Drug Resistance, Fungal; Fluconazole; Humans; Inpatients; Intensive Care Units; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2004 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Oropharynx | 2004 |
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Thiazoles | 2004 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamethasone; Disease Progression; Drug Therapy, Combination; Fluconazole; Flucytosine; Headache; Humans; Hydrocephalus; Immunocompetence; Male; Meningitis, Cryptococcal; Prednisone; Ventriculoperitoneal Shunt | 2004 |
Penetration of Candida biofilms by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole | 2004 |
Balamuthia mandrillaris from soil samples.
Topics: Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Azithromycin; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Fluconazole; Flucytosine; Fluorescent Antibody Technique, Indirect; Genes, rRNA; Lobosea; Microscopy; Molecular Sequence Data; Parasitic Sensitivity Tests; Pentamidine; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Soil; Sulfadiazine | 2004 |
Sequestration and late activation of lenticular Candida abscess in premature infants.
Topics: Abscess; Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Eye Infections, Fungal; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Lens Diseases; Male; Vitrectomy | 2004 |
Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Lipopeptides; Male; Peptides, Cyclic; Treatment Failure | 2004 |
Fluconazole-resistant pathogens Candida inconspicua and C. norvegensis: DNA sequence diversity of the rRNA intergenic spacer region, antifungal drug susceptibility, and extracellular enzyme production.
Topics: Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Base Sequence; Candida; DNA, Ribosomal Spacer; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genetic Variation; Lipopeptides; Lipoproteins; Lysophospholipase; Micafungin; Molecular Sequence Data; Peptides, Cyclic; RNA, Ribosomal; Virulence | 2004 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Candidiasis; Caspofungin; Colony-Forming Units Assay; Echinocandins; Female; Fluconazole; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Survival Analysis; Treatment Outcome | 2004 |
Systemic humicolus cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Fluconazole; Humans; Male | 2004 |
Fungal granuloma of the brain caused by Cladosporium bantianum--a case report and review of literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Diseases; Cladosporium; Fluconazole; Granuloma; Headache; Humans; Magnetic Resonance Imaging; Male; Review Literature as Topic; Staining and Labeling | 2005 |
Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echinocandins; Fluconazole; HSP90 Heat-Shock Proteins; Humans; Lipopeptides; Microbial Sensitivity Tests; Nitric Oxide; Peptides, Cyclic; Recombinant Proteins | 2005 |
Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Cyclophosphamide; Drug Therapy, Combination; Echinocandins; Fluconazole; Immunosuppressive Agents; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Peptides, Cyclic; Trichosporon | 2005 |
[Amphotericin B: the end of an era].
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Mycoses; Treatment Outcome | 2005 |
In vitro method to study antifungal perfusion in Candida biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biological Assay; Candida; Candida albicans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Micropore Filters; Microscopy, Electron, Scanning | 2005 |
[Disseminated cryptococcosis as inaugural manifestation of AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Diagnosis, Differential; Female; Fluconazole; HIV Seropositivity; Humans; Skin | 2005 |
Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles | 2005 |
Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Costa Rica; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Retrospective Studies; Risk Factors | 2005 |
[Primary cutaneous cryptococcosis in transplant recipients: a report of two cases].
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Dermatomycoses; Fluconazole; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome | 2005 |
Molecular epidemiology of Candida species isolated from urine at an intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique; Turkey; Urine | 2005 |
Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Microbial Sensitivity Tests | 2005 |
In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida; Candida albicans; Chlorocebus aethiops; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Thiosemicarbazones; Vero Cells | 2005 |
Phototherapeutic keratectomy in treating keratomycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Cornea; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Keratitis; Lasers, Excimer; Male; Middle Aged; Ophthalmic Solutions; Photorefractive Keratectomy; Retrospective Studies; Secondary Prevention; Treatment Outcome; Visual Acuity; Wound Healing | 2005 |
Successful allogeneic bone marrow transplantation in a patient with active Coccidioidomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Coccidioidomycosis; Female; Fluconazole; Humans; Myelodysplastic Syndromes; Tomography, X-Ray Computed; Transplantation, Homologous | 2005 |
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole | 2005 |
Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida tropicalis; Candidiasis; Drug Resistance, Microbial; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Taiwan | 2005 |
DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy.
Topics: Aerosols; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Base Sequence; Candida albicans; Candidiasis; Candidiasis, Oral; Carcinoma, Squamous Cell; DNA, Fungal; Fatal Outcome; Female; Fluconazole; Humans; Miconazole; Mouth Neoplasms; Pneumonia, Aspiration; Random Amplified Polymorphic DNA Technique | 2005 |
Bilateral Candida chorioretinitis: involvement of the second eye after 3 years.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Fluconazole; Fluorescein Angiography; Humans; Male; Visual Acuity | 2005 |
[Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Memory; Lamivudine; Lopinavir; Male; Meningitis, Cryptococcal; Pyrimidinones; Recurrence; Ritonavir; Syndrome; T-Lymphocyte Subsets; Zidovudine | 2005 |
In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Hospitals, University; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Turkey | 2005 |
Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Female; Fluconazole; HIV Infections; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Oropharynx; Polymerase Chain Reaction; Turkey | 2005 |
Candidal arthritis after complete treatment of systemic candidiasis.
Topics: Amphotericin B; Antifungal Agents; Arthritis; Candidiasis; Diabetes, Gestational; Female; Fluconazole; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Knee; Magnetic Resonance Imaging; Male; Pregnancy; Radiography; Treatment Outcome | 2005 |
In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Topics: Amphotericin B; Antifungal Agents; Candida; Cardiac Care Facilities; Cohort Studies; Female; Fluconazole; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Species Specificity; Turkey; Yeasts | 2005 |
Candida albicans lung abscess sensitive to fluconazole and responding only to amphotericin B in a non-immunocompromised critically ill patient.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Critical Illness; Fluconazole; Humans; Male; Middle Aged | 2005 |
Renal ultrasonography and detection of pseudomycelium in urine as means of diagnosis of renal fungus balls in neonates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Mycelium; Ultrasonography; Urinary Bladder; Urinary Tract Infections; Urine | 2005 |
Necrotic ulcer on the thumb of a teenager with leukemia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dermatomycoses; Fatal Outcome; Female; Fluconazole; Humans; Leukemia; Thumb | 2005 |
Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans | 2005 |
Potential of plant oils as inhibitors of Candida albicans growth.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Plant Oils | 2005 |
The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Intracranial Hypertension; Lateral Ventricles; Meningitis, Cryptococcal; Middle Aged; Neurosurgical Procedures; Tomography, X-Ray Computed; Treatment Outcome; Ventriculoperitoneal Shunt | 2005 |
Two cases of cutaneous cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Fluconazole; Granuloma; Humans; Itraconazole; Male; Neck; Spores, Fungal; Thigh | 2005 |
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Case-Control Studies; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Cryptococcal meningitis in a patient with X-linked hyper-IgM1 syndrome.
Topics: Adult; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Genetic Diseases, X-Linked; Humans; Hypergammaglobulinemia; Immunoglobulin M; Male; Meningitis, Cryptococcal | 2005 |
Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida tropicalis; Candidiasis; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Fluconazole; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Mice; Mice, Inbred Strains; Neutropenia; Survival Rate; Treatment Outcome | 2005 |
Transplantation of yeast-infected cardiac allografts: a report of 2 cases.
Topics: Adult; Amphotericin B; Candida albicans; Candidiasis; Fluconazole; Follow-Up Studies; Graft Survival; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Risk Assessment; Severity of Illness Index; Tissue Donors; Transplantation, Homologous; Transplants; Treatment Outcome; Yeasts | 2005 |
Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Peptide Hydrolases | 2005 |
Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Fungi; Humans; Keratitis; Ketoconazole; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Treatment Outcome | 2006 |
Diffusion-weighted and conventional magnetic resonance imaging in cerebral cryptococcoma.
Topics: Amphotericin B; Antifungal Agents; Brain; Brain Edema; Brain Mapping; Cryptococcus neoformans; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Facial Paralysis; Female; Fluconazole; Headache; Humans; Image Enhancement; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Experience with caspofungin in the treatment of persistent fungemia in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Flucytosine; Fungemia; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lipopeptides; Male; Peptides, Cyclic; Retrospective Studies | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
[A patient with coccidioidal meningoencephalitis].
Topics: Adult; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Brain; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Meningoencephalitis; Tomography, X-Ray Computed | 2005 |
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Fluconazole; Flucytosine; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Peptides, Cyclic | 2005 |
The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
Topics: Amphotericin B; Antifungal Agents; Biological Evolution; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Taiwan | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Cryptococcosis in human immunodeficiency virus-negative patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diabetes Complications; Female; Fluconazole; Health Surveys; HIV Infections; HIV Seronegativity; Hospitals, University; Humans; Immunosuppression Therapy; Lupus Erythematosus, Systemic; Male; Middle Aged; Neoplasms; Retrospective Studies; Thailand; Treatment Outcome | 2006 |
Intracerebral CSF collection mimicking cerebral abscess in a patient suffering from cryptococcal meningitis.
Topics: Acyclovir; Aged; Amphotericin B; Anti-Infective Agents; Brain Abscess; Ceftriaxone; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Diagnosis, Differential; Drainage; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Metronidazole; Spinal Puncture; Teicoplanin | 2005 |
Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient.
Topics: Abscess; Amphotericin B; Animals; Antifungal Agents; Combined Modality Therapy; Cryptococcosis; Debridement; Diagnosis, Differential; Ducks; Environmental Exposure; Facial Injuries; Fluconazole; Graft Rejection; Granuloma; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Osteitis; Osteolysis; Parietal Bone; Postoperative Complications; Remission Induction; Seminoma; Skull Neoplasms; Subcutaneous Tissue; Testicular Neoplasms | 2005 |
Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Epithelial Cells; Fixatives; Fluconazole; HIV; HIV Infections; Humans; Lipopeptides; Mouth Mucosa; Peptides, Cyclic; Smoking | 2005 |
Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in immunocompromised host.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptococcosis; Female; Fluconazole; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Lupus Erythematosus, Systemic | 2006 |
Late-onset donor-to-host transmission of Candida glabrata following corneal transplantation.
Topics: Aged; Amphotericin B; Anterior Chamber; Candida glabrata; Candidiasis; Cornea; Corneal Ulcer; Disease Transmission, Infectious; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Humans; Keratoplasty, Penetrating; Male; Tissue Donors; Tissue Plasminogen Activator | 2006 |
Influence of sub-inhibitory concentrations of antimicrobial agents on biofilm formation in indwelling medical devices.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida; Cefazolin; Dicloxacillin; Fluconazole; Humans; Staphylococcus epidermidis; Vancomycin | 2005 |
Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Caspofungin; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Echinocandins; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Microbiological Techniques; Peptides, Cyclic; Prevalence; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2005 |
Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Device Removal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Kidney Transplantation; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Reoperation; Stents; Therapeutic Irrigation; Treatment Outcome; Urography | 2006 |
Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Argentina; Candida; Catheterization; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Fungemia; Health Surveys; Humans; Incidence; Infant; Intensive Care Units, Pediatric; Itraconazole; Malassezia; Microbial Sensitivity Tests; Species Specificity | 2006 |
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Lipopeptides; Middle Aged; Mycoses; Peptides, Cyclic; Risk Factors | 2006 |
Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Communicable Diseases, Emerging; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Itraconazole; Male | 2005 |
[Pulmonary infection caused by Blastoschizomices capitatus].
Topics: Aged; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Fatal Outcome; Female; Fluconazole; Humans; Immunocompromised Host; Lung Diseases, Fungal; Myositis | 2005 |
[Cerebral Aspergillus abscess in immunocompetent patient].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus; Brain Abscess; Female; Fluconazole; Follow-Up Studies; Humans; Immunocompetence; Intracranial Aneurysm; Neuroaspergillosis; Postoperative Complications; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Flucytosine; Fluoresceins; Fluorometry; Miconazole; Microbial Sensitivity Tests | 2006 |
Tzanck smear as a rapid diagnostic tool for disseminated cryptococcal infection.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Cytodiagnosis; Dermatomycoses; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Humans; Male; Middle Aged; Skin | 2006 |
[Rhinofacial entomophthoromycosis. About two new cases in Mayotte].
Topics: Adult; Amphotericin B; Antifungal Agents; Conidiobolus; Face; Female; Fluconazole; Humans; Itraconazole; Male; Nose Diseases; Soft Tissue Infections; Treatment Outcome; Zygomycosis | 2005 |
[Cryptococcal meningitis disclosed by visual loss in HIV negative patient with ventriculo-atrial shunting].
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cerebrospinal Fluid Shunts; Diagnosis, Differential; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Flucytosine; Fludrocortisone; Follow-Up Studies; HIV Seronegativity; Humans; Hydrocephalus; Hydrocortisone; Male; Meningitis, Cryptococcal; Middle Aged; Prednisolone; Sarcoidosis; Time Factors; Treatment Outcome | 2006 |
The first reported cases of disseminated histoplasmosis in Cambodia, complicated by multiple opportunistic infections.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cambodia; Female; Fluconazole; Histoplasmosis; Humans; Male | 2005 |
Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cohort Studies; Cost-Benefit Analysis; Echinocandins; Fluconazole; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides, Cyclic | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Echinocandins; Enzyme-Linked Immunosorbent Assay; Fluconazole; Formazans; Lipopeptides; Melanins; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides, Cyclic; Plankton; Pyrimidines; Triazoles; Voriconazole | 2006 |
Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptide Hydrolases; Prevalence; Risk Factors; Turkey | 2006 |
[Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Japan; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Minimally Invasive Surgical Procedures; Peptides, Cyclic | 2005 |
Effect of antifungal agents on protein composition of Candida albicans studied by capillary electrophoresis and chip technology.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Electrophoresis, Capillary; Electrophoresis, Microchip; Fluconazole; Fungal Proteins; Molecular Weight; Protein Array Analysis | 2006 |
Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; APACHE; Candida; Candidiasis; Catheterization, Central Venous; Community-Acquired Infections; Cross Infection; Diabetes Complications; Female; Fluconazole; Fungemia; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; Shock; Statistics as Topic; Taiwan | 2006 |
Fluconazole-resistant pseudomembranous oral candidiasis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; HIV Infections; Humans | 2006 |
Disseminated cryptococcosis in a patient with nephrotic syndrome.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Forearm; Humans; Male; Nephrotic Syndrome; Skin; Treatment Outcome | 2006 |
[Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycology | 2006 |
Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan.
Topics: Adolescent; Adult; Age Factors; Aged; Amphotericin B; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Middle Aged | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
Candida pseudohaemulonii Sp. Nov., an amphotericin B-and azole-resistant yeast species, isolated from the blood of a patient from Thailand.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Fungemia; Microbial Sensitivity Tests; Phylogeny | 2006 |
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Predictive Value of Tests; Prognosis; Treatment Outcome | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Polymers; Polyvinyl Chloride; Staphylococcus epidermidis | 2006 |
Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
[Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Venezuela | 2006 |
In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2006 |
[Mycotic complications of shunt infection in children with primary hydrocephalus].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cerebrospinal Fluid; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Hydrocephalus; Infant; Injections, Intravenous; Injections, Intraventricular; Male; Ventriculoperitoneal Shunt | 2002 |
Disseminated crytococcosis with extensive cutaneous involvement in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Fluconazole; Humans; Male | 2006 |
Zygomycosis in the immunocompromised patient: a case report.
Topics: Absidia; Acute Disease; Aerosols; Amphotericin B; Amsacrine; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Debridement; Drug Resistance, Fungal; Drug Resistance, Neoplasm; Etoposide; Fluconazole; Humans; Immunocompromised Host; Leukemia; Liposomes; Middle Aged; Mucormycosis; Sinusitis; Tomography, X-Ray Computed | 2006 |
Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; In Vitro Techniques; India; Meningitis, Cryptococcal; Opportunistic Infections | 2006 |
Epidemiology of candidemia in a Turkish tertiary care hospital.
Topics: Amphotericin B; Antifungal Agents; Blotting, Southern; Candida; Candidiasis; Cross Infection; DNA Fingerprinting; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Hospital Units; Humans; Microbial Sensitivity Tests; Turkey | 2006 |
Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
Topics: Algorithms; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida glabrata; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Echinocandins; Female; Fluconazole; Mice; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic | 2006 |
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Meningitis, Cryptococcal; Recurrence; South Africa | 2006 |
Free fluconazole for cryptococcal meningitis: too little of a good thing?
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Developing Countries; Fluconazole; Humans; Meningitis, Cryptococcal; Secondary Prevention | 2006 |
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole | 2006 |
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Combined antifungal therapy in a murine infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic; Spleen; Survival Analysis | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole | 2006 |
Molluscum or a mimic?
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcosis; Diagnosis, Differential; Fluconazole; Flucytosine; HIV Seropositivity; Humans; Male; Molluscum Contagiosum | 2006 |
Long-term outcome of therapy for 59 cats and 11 dogs with cryptococcosis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cat Diseases; Cats; Cryptosporidiosis; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Fluconazole; Itraconazole; Male; Prognosis; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Effect of antifungal treatment in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2007 |
A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.
Topics: Amino Acid Sequence; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Combinatorial Chemistry Techniques; Cryptococcus neoformans; Drug Synergism; Erythrocytes; Fluconazole; Flucytosine; Fungi; Hemolysis; Inhibitory Concentration 50; Microbial Sensitivity Tests; Oligopeptides; Rabbits | 2007 |
Scytalidium keratitis: case report in a human eye.
Topics: Administration, Oral; Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Ascomycota; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Humans; Mycoses | 2006 |
Successful treatment of Paecilomyces lilacinus keratitis in a patient with a history of herpes simplex virus keratitis.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Cornea; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Humans; Keratitis, Herpetic; Keratoplasty, Penetrating; Male; Miconazole; Middle Aged; Mycoses; Paecilomyces; Reoperation; Retrospective Studies | 2006 |
In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Eye Diseases; Fluconazole; Keratitis; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses | 2006 |
The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
Topics: Amphotericin B; Animal Structures; Animals; Antibiotic Prophylaxis; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Fluconazole; Fungemia; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Survival Analysis; Treatment Outcome; Trichosporon | 2007 |
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
[A case of cryptococcal meningitis with nephrotic syndrome and renal insufficiency under immunosuppressive therapy].
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Cyclosporine; Drug Administration Schedule; Female; Fluconazole; Humans; Immunosuppressive Agents; Meningitis, Cryptococcal; Nephrotic Syndrome; Prednisolone; Renal Insufficiency | 2007 |
Coccidioides immitis: an unexpected fungal pathogen causing retropharyngeal abscess.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Follow-Up Studies; Humans; Male; Pharyngitis; Retropharyngeal Abscess | 2007 |
[Rowell syndrome].
Topics: Adult; Amphotericin B; Anti-Inflammatory Agents; Drug Combinations; Erythema Multiforme; Female; Fluconazole; Humans; Lupus Erythematosus, Systemic; Neck; Prednisolone; Syndrome | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Endogenous ocular candidiasis: changes in epidemiology and factors associated with poor functional outcome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Female; Fluconazole; Humans; Incidence; Male; Prognosis; Retrospective Studies; Spain; Substance Abuse, Intravenous; Treatment Outcome; Visual Acuity | 2007 |
Paecilomyces lilacinus fungemia in a Jamaican neonate.
Topics: Amphotericin B; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Fungemia; Humans; Jamaica; Paecilomyces | 2006 |
Bilateral pulvinar thalamic calcification in a patient with chronic cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Calcinosis; Fluconazole; Hearing Loss; Humans; Hydrocephalus; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Pulvinar; Tomography, X-Ray Computed | 2007 |
Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Outbreaks; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Itraconazole; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
A case of malignant otitis externa caused by Candida glabrata in a patient receiving haemodialysis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Gallium Radioisotopes; Humans; Male; Otitis Externa; Radiography; Recurrence; Renal Dialysis; Tomography, Emission-Computed, Single-Photon | 2007 |
[Two cases of spondylodiscitis due to Candida sp].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Discitis; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Spine | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2007 |
Petrous apex aspergillosis as a long-term complication of cholesterol granuloma.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Basilar Artery; Cerebrospinal Fluid Rhinorrhea; Cholesterol; Fatal Outcome; Fluconazole; Granuloma, Foreign-Body; Headache; Humans; Magnetic Resonance Imaging; Male; Methicillin Resistance; Middle Aged; Neuroaspergillosis; Ofloxacin; Otorhinolaryngologic Surgical Procedures; Petrous Bone; Sphenoid Sinus; Subarachnoid Space | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Retroviral Agents; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2007 |
Endophthalmitis due to Trichosporon beigelii in acute leukemia.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Female; Fluconazole; Flucytosine; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon | 2007 |
Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Combinations; Echinocandins; Female; Fluconazole; Fungemia; Humans; Ileostomy; Lipopeptides; Middle Aged; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Practice Guidelines as Topic | 2007 |
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Arteritis; Body Temperature; Brain; Cisterna Magna; Coccidioides; Drug Combinations; Fluconazole; Granuloma; Injections, Intravenous; Male; Meningitis, Fungal; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Spinal Cord; Survival Analysis | 2007 |
Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Immunocompetence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
[In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 2007 |
[Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungemia; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests | 2007 |
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Cryptococcus neoformans; Dipeptides; Drug Synergism; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2007 |
Candida lusitaniae arthritis in an intravenous drug user.
Topics: Adult; Amphotericin B; Arthritis, Infectious; Blood Sedimentation; Candida; Candidiasis; Fluconazole; Heroin; Humans; Injections, Intra-Articular; Knee Joint; Male; Protein C; Substance Abuse, Intravenous; Synovial Fluid; Treatment Outcome | 2007 |
Drug-drug interactions with systemic antifungals in clinical practice.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Creatinine; Cyclosporine; Drug Interactions; Female; Fluconazole; France; Furosemide; HIV Infections; Hospitals, University; Humans; Hydrocortisone; Hypokalemia; Intensive Care Units; Itraconazole; Kidney Diseases; Leukemia; Male; Middle Aged; Neoplasms; Retrospective Studies | 2007 |
Cryptococcal meningoencephalitis diagnosed by blood culture.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Fungemia; HIV Seropositivity; Humans; Male; Meningoencephalitis; Middle Aged | 2007 |
Disseminated cryptococcosis in a case of idiopathic CD 4 + lymphocytopenia.
Topics: Adult; Amphotericin B; Cryptococcosis; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Male; T-Lymphocytopenia, Idiopathic CD4-Positive; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Direct comparison of the pharmacodynamics of four antifungal drugs in a mouse model of disseminated candidiasis using microbiological assays of serum drug concentrations.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Fluconazole; Itraconazole; Kidney; Mice; Microbial Sensitivity Tests | 2007 |
Survival time of HIV-infected patients with cryptococcal meningitis.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; CD4 Lymphocyte Count; Comorbidity; Female; Fluconazole; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Retrospective Studies; Risk Factors; Survival; Time Factors | 2007 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Antifungal chemotherapy for fungal keratitis guided by in vivo confocal microscopy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Fungi; Humans; Itraconazole; Male; Microscopy, Confocal; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions | 2008 |
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Peptides | 2007 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA Primers; DNA, Fungal; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique | 2008 |
Evaluation of glucose-methylene-blue-mueller-hinton agar for E-test minimum inhibitory concentration determination in Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests | 2007 |
The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Cells, Cultured; Coculture Techniques; Culture Media; Fluconazole; Galactose; Humans; Itraconazole; Mannans; Monocytes | 2007 |
Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Endocarditis; Female; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Liposomes; Male; Mycetoma | 2008 |
Characteristics of biofilm formation by Candida tropicalis and antifungal resistance.
Topics: Amphotericin B; ATP-Binding Cassette Transporters; Biofilms; Candida tropicalis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Microscopy, Electron, Scanning; Sterol 14-Demethylase | 2008 |
Palatal zygomycosis: experience of 21 cases.
Topics: Absidia; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Child; Diabetic Ketoacidosis; Drug Combinations; Female; Fluconazole; Humans; Itraconazole; Male; Mouth Diseases; Mucormycosis; Nose Diseases; Opportunistic Infections; Oral Ulcer; Palate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Rhizopus; Treatment Outcome; Zygomycosis | 2008 |
Systemic illnesses unexpectedly presenting as acute appendicitis: case studies.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Appendicitis; Candidiasis; Female; Fluconazole; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Splenic Diseases | 2008 |
Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
[Fungal necrotizing external otitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Male; Necrosis; Otitis Externa; Tomography, X-Ray Computed | 2008 |
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Colony Count, Microbial; False Positive Reactions; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reagent Strips; Reproducibility of Results | 2008 |
Antifungal prophylaxis for the prevention of neonatal candidiasis?
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Very Low Birth Weight; Nystatin; Practice Patterns, Physicians' | 2008 |
Cryptococcal meningitis in patients with glioma: a report of two cases.
Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebrospinal Fluid; Cryptococcus neoformans; Dacarbazine; Dexamethasone; Fatal Outcome; Fluconazole; Flucytosine; Glioma; Humans; Immunosuppression Therapy; Lomustine; Male; Meningitis, Cryptococcal; Opportunistic Infections; Temozolomide; Treatment Outcome | 2008 |
Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; DNA Primers; DNA, Fungal; Fluconazole; Humans; India; Microbial Sensitivity Tests; Molecular Epidemiology; Mycological Typing Techniques; Random Amplified Polymorphic DNA Technique | 2008 |
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Cohort Studies; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors | 2008 |
Acremonium spp. peritonitis in an infant.
Topics: Acremonium; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Down Syndrome; Fluconazole; Heart Defects, Congenital; Humans; Infant; Male; Mycoses; Peritoneal Dialysis; Peritonitis | 2008 |
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Diffusion; Fluconazole; Microbial Sensitivity Tests | 2008 |
Neonatal Candida parapsilosis meningitis and empyema related to epidural migration of a central venous catheter.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Empyema; Epidural Space; Fluconazole; Foreign-Body Migration; Humans; Infant, Newborn; Male; Meningitis, Fungal; Radiography | 2008 |
Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzaldehydes; Catechols; Cell Membrane; Cell Wall; Drug Resistance, Fungal; Fluconazole; Gene Deletion; Humans; Ketoconazole; Microbial Sensitivity Tests; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Oxidative Stress; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sorbitol; Thymol | 2008 |
In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined by the time-kill method.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Time Factors | 2008 |
In vitro susceptibility of Cryptococcus gattii clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Triazoles | 2008 |
Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Humans; Microbial Sensitivity Tests; Polyendocrinopathies, Autoimmune; Time Factors | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Cryptococcus meningitis and skin lesions in an HIV negative child.
Topics: Amphotericin B; Antifungal Agents; Child, Preschool; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; HIV Seronegativity; Humans; Meningitis, Cryptococcal; Skin | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult | 2009 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Utilization; Fluconazole; Hospitals; Humans; Itraconazole; Korea; Microbial Sensitivity Tests | 2009 |
Candida species: species distribution and antifungal susceptibility patterns.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; South Africa | 2008 |
In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Topics: Amphotericin B; Antifungal Agents; Corneal Diseases; Drug Evaluation; Drug Synergism; Eye; Eye Infections, Fungal; Fluconazole; Fusarium; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Natamycin; Terbinafine | 2008 |
Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus; Female; Fluconazole; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Peru; Risk Factors; Treatment Outcome; Urine | 2008 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Double-blind active-control trials: beware the comparator you keep.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Double-Blind Method; Echinocandins; Fever; Fluconazole; HIV Infections; Humans; Lipopeptides; Randomized Controlled Trials as Topic | 2008 |
Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Candida albicans; Candida tropicalis; Candidiasis, Oral; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Phospholipases | 2009 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Diagnostic Errors; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Substance Abuse, Intravenous; Young Adult | 2008 |
[Cryptococcus neoformans meningitis in a HIV negative miliary tuberculosis-suspected patient].
Topics: Aged; Amphotericin B; Antifungal Agents; Antitubercular Agents; CD4-CD8 Ratio; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; HIV Seronegativity; Humans; Leukocyte Count; Male; Tuberculosis, Miliary | 2008 |
Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Intensive Care Units, Pediatric; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Turkey | 2008 |
Review of risk factors in four cases of cryptococcosis after heart transplantation.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Meningitis, Cryptococcal; Middle Aged; Postoperative Complications; Risk Factors | 2008 |
[Neuromeningeal cryptococcosis in non-HIV patients to CHU ward of Point G in Bamako (Mali): 3 case report].
Topics: Adult; Amphotericin B; Antifungal Agents; Ceftriaxone; Cryptococcus neoformans; Fatal Outcome; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2008 |
[Neuromeningeal cryptococcosis in patients apparently non-immunodeficient: report of 3 cases in Dakar, Senegal].
Topics: Adult; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Fatal Outcome; Female; Fluconazole; HIV Seronegativity; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Middle Aged; Senegal; Treatment Outcome | 2008 |
Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Female; Fluconazole; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Nausea; Retrospective Studies; Risk Factors; Safety; Vomiting; Young Adult | 2008 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Flucytosine; Humans; Immunocompetence; Intracranial Hypertension; Itraconazole; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Spinal Puncture; Ventriculoperitoneal Shunt | 2008 |
Cutaneous expression of systemic candidiasis.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Candidiasis, Cutaneous; Female; Fluconazole; Humans; Immunocompromised Host; Male; Middle Aged; Risk Factors; Sepsis | 2009 |
[A case of colonic cryptococcosis].
Topics: Adult; Amphotericin B; Antifungal Agents; Colonic Diseases; Colonoscopy; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Humans; Injections, Intravenous; Tomography, X-Ray Computed | 2008 |
A closer look at coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Itraconazole; United States | 2009 |
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Pulmonary cryptococcosis in non-AIDS patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Fluconazole; Male; Mice; Mycoses; Random Allocation; Trichosporon | 2008 |
Prevalence and outcome of fungal infection in patients with severe acute pancreatitis.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Female; Fluconazole; Humans; Hypotension; Length of Stay; Logistic Models; Male; Middle Aged; Mycoses; Odds Ratio; Pancreatectomy; Pancreatitis, Acute Necrotizing; Parenteral Nutrition, Total; Prevalence; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Gene expression and evolution of antifungal drug resistance.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Evolution, Molecular; Fluconazole; Gene Expression Profiling; Gene Expression Regulation, Fungal; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
Chronic meningitis by histoplasmosis: report of a child with acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Chronic Disease; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Histoplasmosis; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Meningitis, Fungal; Treatment Outcome | 2008 |
An unusual cause of haemoptysis and headache: cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Fluconazole; Headache; Hemoptysis; Humans; Lung Diseases, Fungal; Lung Neoplasms; Recurrence | 2008 |
Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Fatal Outcome; Fluconazole; HIV Seropositivity; HIV-1; Humans; Male; Meningitis, Cryptococcal; Recurrence | 2009 |
Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Ciclopirox; Deferiprone; Drug Combinations; Fluconazole; Iron Chelating Agents; Ketoconazole; Microbial Sensitivity Tests; Pyridones | 2009 |
Cardiac mucormycosis with T-cell immunodeficiency.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunologic Deficiency Syndromes; Infant; Mitral Valve; Mitral Valve Insufficiency; Mucormycosis; T-Lymphocytes; Ultrasonography | 2009 |
[Twenty-two cases of neuromeningeal cryptococcosis in Tunisia].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Comorbidity; Female; Fluconazole; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Middle Aged; Tunisia; Young Adult | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Prosthetic hip infection due to Cryptococcus neoformans: case report.
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Arthroplasty, Replacement, Hip; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Hip; Humans; Male; Prosthesis-Related Infections; Radiography | 2009 |
Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Culture Media; DNA, Fungal; DNA, Ribosomal Spacer; Drainage; Female; Fluconazole; Flucytosine; Humans; Meningoencephalitis; Middle Aged; Molecular Sequence Data; Phylogeny; Sequence Analysis, DNA; Switzerland; Travel | 2009 |
[A case report of severe hepatitis patient complicated with hemo-disseminated lung aspergillosis].
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Glucocorticoids; Hepatitis B, Chronic; Humans; Male; Pulmonary Aspergillosis; Tomography, X-Ray Computed | 2009 |
Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Australia; Candida albicans; Candidiasis; Child; Child, Preschool; Comorbidity; DNA Fingerprinting; Female; Fluconazole; Humans; Incidence; Infant, Newborn; Infant, Premature; Male; Neoplasms; Risk Factors; Seroepidemiologic Studies; Systemic Inflammatory Response Syndrome | 2009 |
Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Cyclooxygenase Inhibitors; Cysteine; Drug Resistance, Fungal; Fluconazole; Isoindoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Organoselenium Compounds; Proton-Translocating ATPases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2009 |
Intraocular cryptococcoma.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Eye Diseases; Eye Infections, Fungal; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Ultrasonography; Vitrectomy; Vitreous Body | 2009 |
Amphotericin B plus fluconazole for HIV-associated cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal; Treatment Outcome | 2009 |
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cross Infection; Echinocandins; Female; Fluconazole; Fungemia; Humans; Incidence; Infant; Infant, Newborn; Male; Middle Aged; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Dose-Response Relationship, Drug; Doxycycline; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Candida; Chickens; Chromatography, Affinity; Cystatins; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Histatins; Membrane Transport Proteins; Microbial Sensitivity Tests; Ovum | 2010 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; HIV Seropositivity; Humans; Male; Microbial Sensitivity Tests; Time Factors | 2009 |
[Cryptococcus neoformans meningoencephalitis in immunocompetent schoolchildren].
Topics: Amphotericin B; Animals; Animals, Domestic; Antifungal Agents; Blindness; Cerebrospinal Fluid; Child; Columbidae; Cryptococcus neoformans; Fatal Outcome; Female; Fluconazole; Humans; Immunocompetence; Intracranial Hypertension; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Venezuela | 2009 |
Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Antiretroviral Therapy, Highly Active; Clinical Trials, Phase II as Topic; Fluconazole; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Incidence; Kaplan-Meier Estimate; Logistic Models; Meningitis, Cryptococcal; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2009 |
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole | 2010 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization; Cell Adhesion; Cells, Cultured; Enzymes; Epithelial Cells; Equipment and Supplies; Fluconazole; Fungal Proteins; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Urine; Virulence Factors; Voriconazole | 2010 |
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Statistics as Topic; Triazoles; Voriconazole | 2010 |
The role of an Ommaya reservoir in the management of children with cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus neoformans; Drug Delivery Systems; Female; Fluconazole; Flucytosine; Humans; Intracranial Hypertension; Male; Meningitis, Cryptococcal | 2010 |
Cryptococcal meningitis with an antecedent cutaneous Cryptococcal lesion.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Carbon; Coloring Agents; Cryptococcosis; Cryptococcus gattii; Dermatomycoses; Fluconazole; Foot Ulcer; Fungemia; Gentian Violet; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Phenazines; Staining and Labeling; Toes | 2009 |
A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans.
Topics: Actins; Adenosine Triphosphatases; Amphotericin B; Animals; Antifungal Agents; Bacteriocins; Cell Membrane; Cryptococcosis; Cryptococcus neoformans; Endocytosis; Female; Fluconazole; Fungal Proteins; Genetic Complementation Test; Humans; Macrophages; Melanins; Mice; Mice, Inbred BALB C; Oxidative Stress; Peptides, Cyclic; Phospholipid Transfer Proteins; Virulence Factors | 2010 |
Intraventricular fungus ball: a unique manifestation of refractory intracranial candidiasis in an immunocompetent neonate.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Brain Diseases; Candidiasis; Caspofungin; Echinocandins; Endoscopy; Ependyma; Female; Fluconazole; Humans; Immunocompetence; Infant, Newborn; Injections, Spinal; Lipopeptides; Magnetic Resonance Imaging; Postoperative Care; Recurrence; Reoperation; Ventriculoperitoneal Shunt | 2009 |
Management of old world cutaneous leishmaniasis in refugee children.
Topics: Amphotericin B; Animals; Antifungal Agents; Australia; Child; Female; Fluconazole; Humans; Infant; Leishmaniasis, Cutaneous; Liposomes; Male; Refugees; Renal Insufficiency; Treatment Outcome | 2010 |
Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Blood-Brain Barrier; Capillary Permeability; Cattle; Cell Line, Tumor; Cells, Cultured; Cytokines; Endothelial Cells; Fluconazole; Immunologic Factors; Rats; Tight Junctions | 2010 |
Candida parapsilosis meningitis associated with shunt infection in an adult male.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida; Candidiasis; Drainage; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Injections, Intravenous; Male; Meningitis, Bacterial; Middle Aged; Recurrence; Treatment Outcome; Ventriculoperitoneal Shunt | 2010 |
The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis.
Topics: Amino Acid Sequence; Amphotericin B; Animals; Antifungal Agents; Antimicrobial Cationic Peptides; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Fluorescein-5-isothiocyanate; Meningitis, Cryptococcal; Molecular Sequence Data; Nanoparticles; Rabbits; Tissue Distribution; Treatment Outcome | 2010 |
Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis.
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Intrauterine Devices; Microbial Sensitivity Tests; Recurrence | 2010 |
Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Prospective Studies; South Africa; Survival Analysis | 2010 |
The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Population Surveillance; Taiwan | 2010 |
Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Transcription, Genetic | 2010 |
Fungal cerebral abscess in a diabetic patient successfully treated with surgery followed by prolonged antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Combined Modality Therapy; Craniotomy; Deoxycholic Acid; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Fluconazole; Humans; Hyphae; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Parietal Lobe; Psoas Abscess | 2010 |
A case of fungal arthritis caused by Hansenula anomala.
Topics: Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Fluconazole; Humans; Knee Joint; Male; Mycoses; Pichia | 2010 |
Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracellular Matrix Proteins; Fluconazole; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Lipopeptides; Luciferases; Membrane Glycoproteins; Transcription, Genetic | 2010 |
Explosive nasofacial cryptococosis.
Topics: Acids; Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Automobiles; Burns, Chemical; Cryptococcosis; Cryptococcus neoformans; Facial Injuries; Fluconazole; HIV-1; Humans; Immunocompromised Host; Male; Medication Adherence; Meningoencephalitis; Middle Aged; Recurrence | 2010 |
Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Catheter-Related Infections; Catheters, Indwelling; Echinocandins; Extracellular Matrix; Fluconazole; Lipopeptides; Microbial Viability; Microscopy, Confocal; Microscopy, Electron, Scanning; Time Factors | 2010 |
Correlation of Etest and Neo-Sensitabs diffusion assays on Mueller-Hinton-methylene blue agar with broth microdilution reference method (CLSI-M27-A2) for testing susceptibilities of Cryptococcus neoformans to amphotericin B and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests; Mycology | 2010 |
[Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
Topics: Amphotericin B; Antifungal Agents; Benzylamines; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Naphthalenes; Natamycin | 2010 |
Primary pulmonary coccidioidomycosis in China.
Topics: Adolescent; Amphotericin B; Asian People; Coccidioides; Coccidioidomycosis; Cough; Fluconazole; Humans; Lung Diseases, Fungal; Male; Treatment Outcome | 2010 |
Characterization of yeasts colonizing in healthy individuals.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Carrier State; Female; Fluconazole; Human Experimentation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Taiwan; Triazoles; Voriconazole; Yeasts; Young Adult | 2011 |
Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Bird Diseases; Brazil; Candida; Candidiasis; Cockatoos; Feces; Fluconazole; Gastrointestinal Diseases; Itraconazole; Microbial Sensitivity Tests; Phospholipases; Statistics, Nonparametric; Zoonoses | 2010 |
Aureobasidium pullulans var. melanigenum fungemia in a pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Blood; Catheter-Related Infections; Child; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Sequence Analysis, DNA | 2011 |
Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Synergism; Fluconazole; Oils, Volatile; Plant Components, Aerial; Thymus Plant | 2010 |
Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing.
Topics: Amphotericin B; Candida; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole | 2011 |
Structural and functional study of YER067W, a new protein involved in yeast metabolism control and drug resistance.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Carbon; Drug Resistance, Microbial; Energy Metabolism; Fluconazole; Genes, Fungal; Membrane Proteins; Molecular Sequence Data; Phylogeny; Protein Conformation; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid | 2010 |
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Bone Cements; Candidiasis; Fluconazole; Humans; Infusions, Parenteral; Knee Joint; Knee Prosthesis; Male; Prosthesis-Related Infections; Radiography; Reoperation | 2011 |
Meningoencephalitis caused by a zygomycete fungus (Basidiobolus) associated with septic shock in an immunocompetent patient: 1-year follow-up after treatment.
Topics: Aged; Amphotericin B; Antifungal Agents; Entomophthorales; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Male; Meningoencephalitis; Shock, Septic; Treatment Outcome; Zygomycosis | 2010 |
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers' mouths and nipples.
Topics: Amphotericin B; Antifungal Agents; Baccharis; Breast Feeding; Candida; Drug Resistance, Fungal; Endopeptidases; Female; Fluconazole; Fungal Proteins; Humans; Infant; Microbial Sensitivity Tests; Mouth; Nipples; Oils, Volatile; Phospholipases | 2011 |
Drug susceptibility of 64 strains of Rhodotorula sp.
Topics: Amphotericin B; Antifungal Agents; Feces; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Rhodotorula; Skin; Species Specificity; Vagina | 2010 |
Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2011 |
Disseminated Cryptococcosis in an HIV-negative patient in South Africa: the elusive differential diagnosis.
Topics: Acute Kidney Injury; Adult; Amphotericin B; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Fluconazole; Humans; Male; South Africa; Tomography, X-Ray Computed | 2010 |
Coccidioidal meningitis: clinical presentation and management in the fluconazole era.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Coccidioides; Coccidioidomycosis; Enzyme-Linked Immunosorbent Assay; Female; Fluconazole; Humans; Hydrocephalus; Male; Meningitis; Middle Aged; Radiography, Thoracic; Young Adult | 2010 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pyrimidines; Rodent Diseases; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole; Yeasts | 2011 |
Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Fluconazole; Gentian Violet; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Staining and Labeling; Tetrazolium Salts | 2011 |
In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Lipoproteins; Microbial Sensitivity Tests | 2011 |
[Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluconazole; Gestational Age; Humans; Incidence; Infant, Newborn; Microbial Sensitivity Tests; Retrospective Studies; Turkey | 2010 |
A Case of Cryptococcal Lymphadenitis in an HIV-Infected Child.
Topics: Abdomen; Amphotericin B; Antifungal Agents; Antigens, Fungal; Brain; Child; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Histocytochemistry; HIV Infections; Humans; Lymphadenitis; Male; Microscopy; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2011 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Tunisia; Voriconazole | 2011 |
Clinical microbiology of neonatal candidiasis in Hungary.
Topics: Amphotericin B; Candida; Candida albicans; Candida glabrata; Candidiasis; Cesarean Section; Female; Fluconazole; Gestational Age; Humans; Hungary; Infant, Extremely Low Birth Weight; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Male; Parenteral Nutrition | 2010 |
Two squalene synthase inhibitors, E5700 and ER-119884, interfere with cellular proliferation and induce ultrastructural and lipid profile alterations in a Candida tropicalis strain resistant to fluconazole, itraconazole, and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Cell Proliferation; Drug Resistance, Multiple, Fungal; Farnesyl-Diphosphate Farnesyltransferase; Fatty Acids; Fluconazole; Gas Chromatography-Mass Spectrometry; Histocytochemistry; Inhibitory Concentration 50; Itraconazole; Lipid Metabolism; Microscopy, Electron, Transmission; Pyridines; Quinuclidines | 2011 |
Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Echinocandins; Fluconazole; Hospitals; Humans; Lipopeptides; Long-Term Care; Male; Phylogeny | 2011 |
One case of Candidemia developed after surgery for tongue cancer in a young adult.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Gallium Radioisotopes; Humans; Postoperative Complications; Radionuclide Imaging; Tongue Neoplasms; Treatment Outcome; Young Adult | 2009 |
Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Cryptococcus neoformans; Drug Synergism; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Phenols; Saccharomyces cerevisiae | 2011 |
[Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Female; Fluconazole; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique; Turkey; Urinary Tract Infections; Urine | 2011 |
Chromogenic medium for direct susceptibility testing of Candida spp. isolated from urine.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests; Urine | 2011 |
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; South Africa; Time Factors | 2011 |
Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Humans; Incidence; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Neutropenia; Retrospective Studies; Risk Factors; Treatment Outcome | 2011 |
Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cyclophosphamide; Doxorubicin; Female; Fluconazole; Flucytosine; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Neutropenia; Prednisolone; Rituximab; Treatment Outcome; Vincristine | 2011 |
Candida urinary tract infections--treatment.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Candidiasis, Invasive; Causality; Echinocandins; Fluconazole; Flucytosine; Humans; Urinary Tract Infections | 2011 |
Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Diagnosis and treatment of fungal infection after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Development of a high-throughput Candida albicans biofilm chip.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Fluconazole; Microscopy, Confocal; Microscopy, Electron, Scanning | 2011 |
[Invasive candidiasis in neonatal intensive care units].
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Catheters; Fluconazole; France; Humans; Incidence; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Risk Factors; Treatment Outcome | 2011 |
Osteoarticular infection by Candida albicans in an infant with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidemia; Candidiasis, Invasive; Cystic Fibrosis; Female; Fluconazole; Flucytosine; Humans; Infant; Osteoarthritis; Treatment Outcome | 2011 |
Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Deoxyribonucleases; Drug Combinations; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Mitochondria; Reproducibility of Results; Tetrazolium Salts | 2012 |
Unusual cause of cellulitis in a patient with hepatitis C and cirrhosis.
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Hepatitis C; Humans; Liver Cirrhosis; Middle Aged; Perineum; Pneumonia; Radiography; Suppuration; Vulva | 2011 |
Use of antifungal agents in pediatric and adult high-risk areas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Child, Preschool; Drug Utilization; Echinocandins; Female; Fluconazole; Humans; Immunocompromised Host; Inappropriate Prescribing; Infant; Intensive Care Units; Lipopeptides; Male; Middle Aged; Mycoses; Prospective Studies; Transplantation; Young Adult | 2012 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids.
Topics: Administration, Inhalation; Aged; Amphotericin B; Anti-Asthmatic Agents; Asthma; Candidemia; Candidiasis, Oral; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Glucocorticoids; Humans; Nystatin; Risk Factors | 2011 |
Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cymbopogon; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Humans; Microbial Sensitivity Tests; Oils, Volatile | 2012 |
Cryptococcal meningitis in immunocompetent children.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Child; Child, Preschool; Cryptococcus neoformans; Drug Administration Schedule; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Male; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome | 2012 |
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; ATP-Binding Cassette Transporters; Biological Transport, Active; Candida albicans; Drug Resistance, Multiple, Fungal; Drug Synergism; Farnesol; Fluconazole; Fungal Proteins; Ketoconazole; Kinetics; Membrane Transport Proteins; Miconazole; Microbial Sensitivity Tests; Quorum Sensing; Reactive Oxygen Species; Rhodamines; Saccharomyces cerevisiae | 2011 |
Poor long-term outcomes for cryptococcal meningitis in rural South Africa.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Prognosis; Rural Population; South Africa; Treatment Outcome | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus).
Topics: Amphotericin B; Animals; Animals, Zoo; Antifungal Agents; Carrier State; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Female; Fluconazole; Fungemia; Itraconazole; Male; Nasal Cavity; Phascolarctidae; Treatment Outcome | 2012 |
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Colony Count, Microbial; Dental Caries; Drug Resistance, Fungal; Female; Fluconazole; Head and Neck Neoplasms; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Radiation Injuries; Saliva; Salivary Glands; Secretory Rate; Triazoles; Voriconazole; Xerostomia | 2012 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
Candida parapsilosis complex water isolates from a haemodialysis unit: biofilm production and in vitro evaluation of the use of clinical antifungals.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Fluconazole; Hemodialysis Solutions; Microbial Sensitivity Tests; Renal Dialysis; Species Specificity; Water Microbiology | 2011 |
Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates.
Topics: Acids; Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Candida glabrata; Caspofungin; Drug Synergism; Echinocandins; Fluconazole; Hepcidins; Humans; Hydrogen-Ion Concentration; Lipopeptides; Microbial Sensitivity Tests; Peptide Fragments | 2011 |
Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; beta-Glucans; Echinocandins; Female; Fluconazole; Fungemia; Hematologic Diseases; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Miconazole; Middle Aged; Proteoglycans; Retrospective Studies; Treatment Outcome; Trichosporon; Young Adult | 2012 |
[In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Resistance, Fungal; Ecosystem; Female; Fluconazole; Humans; Intrauterine Devices, Copper; Itraconazole; Microbial Sensitivity Tests; Vagina | 2011 |
Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal; Prognosis; Survival Analysis; Thailand; Treatment Outcome; United States | 2011 |
Invasive fungal bezoar requiring partial cystectomy.
Topics: Aged; Amphotericin B; Antifungal Agents; Bezoars; Candidiasis; Combined Modality Therapy; Cystectomy; Cystoscopy; Dysuria; Electrocoagulation; Fluconazole; Humans; Laser Therapy; Lasers, Solid-State; Lithotripsy; Male; Postoperative Complications; Prostatic Hyperplasia; Recurrence; Urinary Bladder; Urinary Tract Infections | 2012 |
Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
Topics: Acrolein; Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Synergism; Eugenol; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Scanning; Plant Extracts; Staining and Labeling; Tetrazolium Salts | 2012 |
Antifungal therapy and outcomes in infants with invasive Candida infections.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Infant; Infant Mortality; Infant, Newborn; Intensive Care Units, Neonatal; Logistic Models; Male; Treatment Outcome; United States | 2012 |
Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane; Cryptococcus gattii; Culture Media; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Ergosterol; Fluconazole; Humans; Microbial Sensitivity Tests; Species Specificity; Spectrophotometry | 2012 |
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2012 |
Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Taiwan; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2012 |
Cryptococcus neoformans: the model organism for yeast antifungal drug susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Culture Media; Drug Combinations; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests | 2012 |
Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cell Membrane; Cymbopogon; Drug Resistance; Fluconazole; Microbial Sensitivity Tests; Microscopy; Oils, Volatile; Phytotherapy; Plant Extracts; Syzygium | 2012 |
Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Fluconazole; Genotype; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Soil Microbiology; Time Factors | 2012 |
[Neuromeningeal cryptococcosis and AIDS: an 11-case series from Libreville, Gabon].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Young Adult | 2010 |
A retrospective study of AIDS-associated cryptomeningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Distribution; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Fluconazole; Follow-Up Studies; Humans; India; Male; Medical Records; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Sex Distribution; Young Adult | 2012 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cell Adhesion; Epithelial Cells; Female; Fluconazole; Fungal Proteins; Hemolysis; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Phospholipases; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Saccharomyces cerevisiae; Vagina; Virulence Factors; Young Adult | 2012 |
Candidiasis caused by Candida kefyr in a neonate: case report.
Topics: Amphotericin B; Antifungal Agents; Anus, Imperforate; Candida; Candidiasis; Congenital Abnormalities; Enterococcus faecalis; Fluconazole; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kidney; Kidney Diseases; Sepsis; Treatment Outcome; Urinary Tract Infections; Urine; Vesico-Ureteral Reflux | 2012 |
Auditory neuropathy secondary to cryptococcal central nervous system infection in 2 immunocompromised patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Therapy, Combination; Evoked Potentials, Auditory; Fluconazole; Hearing Loss, Central; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Otoacoustic Emissions, Spontaneous; Reflex, Acoustic; Tomography, X-Ray Computed | 2012 |
Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.
Topics: Amphotericin B; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Meningitis, Fungal; Middle Aged; Recurrence; Retinal Diseases; Tomography, X-Ray Computed; Vitreous Body | 2012 |
[Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Prescriptions; Drug Utilization; Echinocandins; Female; Fluconazole; Hospital Bed Capacity; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Registries; Spain | 2012 |
Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings.
Topics: Africa South of the Sahara; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Developing Countries; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Practice Guidelines as Topic | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
Diffuse mucocutaneous leishmaniasis.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Biopsy; Fluconazole; Humans; Leishmania tropica; Leishmaniasis, Diffuse Cutaneous; Male; Skin; Treatment Outcome | 2011 |
Photo quiz. Lip lesion in a solid organ transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fluconazole; Humans; Kidney Transplantation; Lip Diseases; Male; Middle Aged; Pancreas Transplantation; Ulcer | 2012 |
Nonspecific effect of Mycograb on amphotericin B MIC.
Topics: Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Candida albicans; Caspofungin; Drug Interactions; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests | 2012 |
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2013 |
In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Imidazoles | 2012 |
Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis; Endocarditis; Fluconazole; Gallbladder Diseases; Humans; Infant, Newborn; Male | 2012 |
The first Korean case of candidemia due to Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Diagnosis and treatment of postpartum Candida endophthalmitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Intravitreal Injections; Postpartum Period | 2012 |
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Base Sequence; Biological Transport; Candida glabrata; Drug Resistance, Multiple, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation, Missense; Pyrimidines; Saccharomyces cerevisiae; Sequence Analysis, DNA; Sterol 14-Demethylase; Sterols; Triazoles; Voriconazole | 2012 |
Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Caspofungin; Disease Models, Animal; Echinocandins; Female; Fluconazole; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cohort Studies; Creatinine; Fluconazole; Humans; Hypokalemia; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Kidney; Kidney Diseases; Kidney Function Tests; Mycoses; Premature Birth; Retrospective Studies; Sepsis | 2012 |
[Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
Topics: Amphotericin B; Antifungal Agents; Candida; Chile; Cohort Studies; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Farnesol; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests | 2013 |
Candida colonization in urine samples of ICU patients: determination of etiology, antifungal susceptibility testing and evaluation of associated risk factors.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Trichosporon; Trichosporonosis; Urine; Young Adult | 2012 |
Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane Permeability; Chitosan; Drug Resistance, Fungal; Fluconazole; Gene Expression Profiling; Gene Expression Regulation, Fungal; Haploinsufficiency; Monomeric GTP-Binding Proteins; Naphthalenes; Oxidative Stress; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Terbinafine; Vesicular Transport Proteins | 2012 |
Cryptococcosis in an immunocompetent pregnant woman.
Topics: Adult; Amphotericin B; Antifungal Agents; Apgar Score; Brain; Cryptococcosis; Female; Fluconazole; Humans; Immunocompetence; Infant, Newborn; Intracranial Hypertension; Magnetic Resonance Imaging; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome | 2013 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Terbinafine inhibits Cryptococcus neoformans growth and modulates fungal morphology.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2012 |
Prototheca wickerhamii as a cause of neuroinfection in a child with congenital hydrocephalus. First case of human protothecosis in Poland.
Topics: Amphotericin B; Antifungal Agents; DNA, Plant; Fluconazole; Head; Humans; Hydrocephalus; Infant; Ketoconazole; Male; Meningoencephalitis; Microscopy, Electron; Molecular Sequence Data; Poland; Prototheca; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Outcome; Ventriculoperitoneal Shunt | 2012 |
In vitro efficacy of continuous mild heat stress on the antifungal susceptibility of Candida albicans biofilm formation.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Echinocandins; Fluconazole; Hot Temperature; Lipopeptides; Micafungin; Stress, Physiological | 2012 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole | 2012 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole | 2013 |
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pyrimidines; Saccharomyces cerevisiae; Steroid Isomerases; Sterols; Triazoles; Voriconazole | 2012 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Disease Outbreaks; Female; Fluconazole; Genotype; Humans; Infant; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Mycological Typing Techniques; Random Amplified Polymorphic DNA Technique; Treatment Outcome | 2013 |
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
Topics: Africa; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2012 |
Challenges in diagnosis and management of Cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Disease Management; Fatal Outcome; Fluconazole; Health Resources; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Recurrence; Uganda | 2012 |
Disseminated cryptococcosis in an HIV-positive boy.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Child; Cryptococcosis; Cryptococcus neoformans; Fluconazole; HIV; HIV Seropositivity; Humans; Male | 2012 |
[A study for candidemia during the six year period from 1993 to 1999 in St. Luke's International Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Central Venous Catheters; Cross Infection; Fluconazole; Hospitals; Humans; Prognosis; Risk Factors | 2012 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Fluconazole; Meningitis, Cryptococcal; Meningoencephalitis; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Survival | 2013 |
Candida parapsilosis : an emerging fungal pathogen.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Child; Disk Diffusion Antimicrobial Tests; Female; Fluconazole; Humans; India; Male; Middle Aged; Species Specificity | 2012 |
An atypical, pigment-producing Metschnikowia strain from a leukaemia patient.
Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; DNA, Ribosomal; Fluconazole; Humans; Italy; Leukemia; Male; Metschnikowia; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Phylogeny; Pigments, Biological; Pyrazines; Sequence Analysis, DNA; Sputum; Voriconazole | 2013 |
Preshipment testing success: resolution of a nasal sinus granuloma in a captive koala (Phascolarctos cinereus) caused by Cryptococcus gattii.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Female; Fluconazole; Granuloma; Itraconazole; Phascolarctidae; Sinusitis | 2012 |
Application of chip-based flow cytometry for amphotericin B and fluconazole susceptibility testing on Candida strains.
Topics: Amphotericin B; Candida; Drug Resistance, Fungal; Flow Cytometry; Fluconazole; Microbial Sensitivity Tests; Microchip Analytical Procedures | 2013 |
Disseminated Cryptococcosis presenting as cellulitis in a renal transplant recipient.
Topics: Adult; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Diagnosis, Differential; Fluconazole; Humans; Immunocompromised Host; Kidney Transplantation; Male; Treatment Outcome | 2013 |
Two rare cases of central nervous system opportunistic mycoses.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Neuroaspergillosis; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Rare Diseases; Treatment Outcome; Voriconazole | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Cryptococcus humicolus meningitis: first case report in Malaysia.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Fluconazole; Humans; Hydrocephalus; Immunocompetence; Malaysia; Male; Meningitis, Fungal; Middle Aged | 2012 |
Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Administration Schedule; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Incidence; Male; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome | 2013 |
Diffuse skeletal coccidioidomycosis in an AIDS patient.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Male; Pelvic Bones; Spine; Treatment Outcome | 2013 |
Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Creatinine; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Practice Patterns, Physicians'; Renal Insufficiency | 2013 |
Histopathological evaluation of the efficacy of antifungals for experimental Trichosporon bloodstream infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Fluconazole; Fungemia; Histocytochemistry; Kidney; Macrolides; Male; Mice; Microbial Viability; Polyenes; Trichosporon; Trichosporonosis | 2013 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Kidney Transplantation; Lymphoma; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Postoperative Complications; Serbia | 2012 |
Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Environmental Microbiology; Fluconazole; Hemolysin Proteins; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence | 2013 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans.
Topics: Adenosine Triphosphate; Amphotericin B; Antifungal Agents; Biological Transport; Cryptococcus neoformans; Fluconazole; Glutathione; Microbial Sensitivity Tests; Microbial Viability; Pyruvates; Time Factors | 2013 |
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazole; Lepidoptera; Pyrimidines; Triazoles; Voriconazole | 2013 |
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2013 |
Treating cryptococcal meningitis in people with HIV.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2013 |
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Base Sequence; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyenes; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Triazoles; Tunisia; Voriconazole | 2013 |
Bilateral endogenous fungal endophthalmitis.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Humans; Intravitreal Injections; Male; Middle Aged; Treatment Outcome; Vitrectomy | 2014 |
A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs.
Topics: Adverse Drug Reaction Reporting Systems; Amphotericin B; Antifungal Agents; Databases, Factual; Drug Interactions; Drug Overdose; Fluconazole; Heart Failure; Humans; Itraconazole; Propranolol | 2013 |
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
Topics: Adult; Amphotericin B; Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Male; Time Factors; Treatment Outcome | 2013 |
Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Child; Colombia; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Health Surveys; Humans; Incidence; Male; Middle Aged; Population Surveillance; Retrospective Studies; Symptom Assessment; Young Adult | 2012 |
Simultaneous cryptococcal and tuberculous meningitis in a patient with systemic lupus erythematosus.
Topics: Administration, Intravenous; Amphotericin B; Antifungal Agents; Antitubercular Agents; Female; Fluconazole; Humans; Infusions, Intraventricular; Lupus Erythematosus, Systemic; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome; Tuberculosis, Meningeal | 2016 |
Antifungal activities of diphenyl diselenide alone and in combination with fluconazole or amphotericin B against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Candida glabrata; Drug Interactions; Fluconazole; Microbial Sensitivity Tests; Organoselenium Compounds | 2013 |
Use of isothermal microcalorimetry to quantify the influence of glucose and antifungals on the growth of Candida albicans in urine.
Topics: Amphotericin B; Antifungal Agents; Calorimetry; Candida albicans; Fluconazole; Flucytosine; Glucose; Humans; Imidazoles; Microbial Sensitivity Tests; Urinary Tract Infections; Urine | 2013 |
Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Chromosomes, Fungal; Echinocandins; Fluconazole; Flucytosine; Lipopeptides | 2013 |
Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Conjunctiva; Eurotium; Female; Fluconazole; Fungi; Horses; Itraconazole; Male; Miconazole; Microbial Sensitivity Tests; Switzerland; Voriconazole | 2014 |
[Treatment of invasive fungal diseases in children].
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Mycoses; Practice Guidelines as Topic | 2013 |
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis; Coinfection; Deoxycholic Acid; DNA, Fungal; DNA, Ribosomal Spacer; Drug Combinations; Drug Users; Echocardiography; Endocarditis; Fatal Outcome; Fluconazole; Humans; Male; Molecular Sequence Data; Mycological Typing Techniques; Sequence Analysis, DNA; Substance-Related Disorders; Tricuspid Valve | 2013 |
Endocarditis caused by Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Endocarditis; Fluconazole; Humans; Lipopeptides; Male; Micafungin; Middle Aged | 2013 |
Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.
Topics: Amphotericin B; Antifungal Agents; Canada; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Genetic Complementation Test; Humans; Microbial Sensitivity Tests; Mutation; Northwestern United States; Saccharomyces cerevisiae; Sterol 14-Demethylase | 2013 |
Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Disease Models, Animal; Fluconazole; Flucytosine; Larva; Moths | 2013 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Drug Resistance, Fungal; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2013 |
Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis, Oral; Caspofungin; Diabetes Mellitus; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Stomatitis, Denture | 2013 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult | 2013 |
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2013 |
Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Fluconazole; Injections, Intraperitoneal; Kidney; Liver; Male; Mice; Mice, Inbred BALB C; Spleen; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis | 2014 |
In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluconazole; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome | 2014 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Enterococcus; Female; Fluconazole; Fungemia; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Multivariate Analysis; Neutropenia; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Time Factors; Transplantation, Homologous; Viridans Streptococci; Young Adult | 2014 |
Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Child; Cryptococcus; Female; Fluconazole; Flucytosine; Hepatitis B; Hepatitis B virus; Humans; Liver Cirrhosis; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia | 2014 |
Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.
Topics: Amphotericin B; Anidulafungin; Biofilms; Calorimetry; Candida; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Plankton | 2014 |
Adrenocortical insufficiency is not a problem in preterm infants treated with antifungal prophylaxis with fluconazole.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Apgar Score; Bronchoalveolar Lavage Fluid; Candida; Chemoprevention; Female; Fluconazole; Humans; Hypoaldosteronism; Infant, Extremely Low Birth Weight; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Logistic Models; Male; Mycoses; Outcome Assessment, Health Care; Retrospective Studies | 2014 |
[Clinical analysis of invasive laryngeal mycosis].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Chemical and Drug Induced Liver Injury; Fluconazole; Humans; Itraconazole; Laryngeal Diseases; Mycoses | 2013 |
A case of cryptococcal lymphadenitis in an HIV-lnfected woman.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy, Fine-Needle; Botswana; Cryptococcus neoformans; Female; Fluconazole; HIV Infections; Humans; Lymph Nodes; Lymphadenitis; Neck; Treatment Outcome | 2014 |
Cryptococcal necrotizing fasciitis in a patient after renal transplantation--a case report.
Topics: Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Fasciitis, Necrotizing; Fluconazole; Humans; Kidney Transplantation; Male; Middle Aged | 2014 |
Candida pelliculosa endophthalmitis after cataract surgery: a case report.
Topics: Amphotericin B; Anterior Chamber; Antifungal Agents; Candida; Cataract; Cataract Extraction; Contraindications; Endophthalmitis; Fluconazole; Humans; Injections, Intraocular; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Middle Aged; Postoperative Complications; Vitrectomy | 2014 |
[Case 136th--intermittent fever for over 20 days and coughing for 2 days].
Topics: Amphotericin B; Antifungal Agents; Biomarkers; Child; Cough; Cryptococcosis; Fever; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Radiography, Thoracic; Tomography, X-Ray Computed | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
Cryptococcal meningitis post autologous stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Male; Meningitis, Cryptococcal; Stem Cell Transplantation; Transplantation, Autologous | 2014 |
Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals.
Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Incidence; Male; Mexico; Middle Aged; Proportional Hazards Models; Prospective Studies; Regression Analysis; Risk Factors; Tertiary Care Centers; Treatment Outcome | 2014 |
Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Cells, Cultured; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Mycology; Nephelometry and Turbidimetry | 2015 |
Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2014 |
First case of continuous ambulatory peritoneal dialysis-related peritonitis caused by Cryptococcus arboriformis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus; DNA, Ribosomal; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Phylogeny; Saccharomyces cerevisiae; Sequence Homology, Nucleic Acid | 2014 |
Complicated and protracted cryptococcal disease in HIV-infected children.
Topics: Adolescent; Age Distribution; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Child; Cryptococcosis; Female; Fluconazole; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Retrospective Studies | 2015 |
Case report of a ureteral obstruction by Candida albicans fungus balls detected by magnetic resonance imaging in kidney transplant recipient.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Bezoars; Candida albicans; Candidiasis; Fluconazole; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Therapeutic Irrigation; Treatment Outcome; Ureteral Obstruction | 2014 |
In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Finasteride; Fluconazole | 2014 |
Intrastromal antifungal injection with secondary lamellar interface infusion for late-onset infectious keratitis after DSAEK.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Corneal Stroma; Corneal Ulcer; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Fungal; Fluconazole; Humans; Infusions, Intralesional; Injections, Intraocular; Male; Microscopy, Confocal; Voriconazole | 2014 |
Disseminated coccidioidomycosis of the spine in an immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Coccidioidomycosis; Fluconazole; Humans; Male; Osteomyelitis; Spinal Fractures; Spinal Fusion; Treatment Outcome | 2014 |
Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis, Oral; Fluconazole; Hemolysin Proteins; HIV Infections; Humans; Microbiological Techniques; Nystatin; Virulence Factors | 2014 |
Invasive mycosis due to species of Blastobotrys in immunocompromised patients with reduced susceptibility to antifungals.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Immunocompromised Host; Infant, Newborn; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Saccharomycetales; Sequence Analysis, DNA | 2014 |
Hyperphosphatemia in a patient with Candida sepsis.
Topics: Amphotericin B; Antifungal Agents; Blood Chemical Analysis; Candida; Candidiasis; Fluconazole; Humans; Hyperphosphatemia; Male; Middle Aged; Sepsis | 2014 |
Migratory skin lesions in a renal transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Biopsy; Child; Cryptococcosis; Dermatomycoses; Drug Therapy, Combination; Fluconazole; Humans; Kidney Transplantation; Male; Skin; Time Factors; Transplant Recipients; Treatment Outcome | 2014 |
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole | 2014 |
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Fluconazole; Flucytosine; Humans; South Africa; Voriconazole | 2014 |
Cerebral aspergillosis in a patient with leprosy and diabetes: a case report.
Topics: Amphotericin B; Anticonvulsants; Antifungal Agents; Aspergillus fumigatus; Biopsy; Carbamazepine; Cerebrum; Diabetes Mellitus; Fluconazole; Humans; Leprosy, Lepromatous; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Predictive Value of Tests; Seizures; Treatment Outcome | 2014 |
Pathology in practice. Cryptococcus sp in a dog.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Dog Diseases; Dogs; Fatal Outcome; Fluconazole; Male | 2014 |
Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.
Topics: Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Biofilms; Candida albicans; Caspofungin; Drug Combinations; Drug Repositioning; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endocytosis; Fluconazole; Hydrogen-Ion Concentration; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Plankton; Quinacrine | 2014 |
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Dose-Response Relationship, Drug; Drug Interactions; Farnesol; Fluconazole; Humans; Microbial Sensitivity Tests; Microscopy, Confocal | 2015 |
Kinetics of oral colonization by Candida spp. during topical corticotherapy for oral lichen planus.
Topics: Administration, Topical; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Clobetasol; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; Glucocorticoids; Humans; Lichen Planus, Oral; Male; Middle Aged; Mouth; Peptide Hydrolases; Phospholipases | 2014 |
Invasive fungal infection in neonatal intensive care units: a multicenter survey.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Gestational Age; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Invasive Fungal Infections; Microbial Sensitivity Tests; Portugal; Pregnancy; Surveys and Questionnaires | 2016 |
Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Artemisinins; Artesunate; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fluconazole; Hexachlorophene; Lipopeptides; Miconazole; Microbial Sensitivity Tests; Pyrvinium Compounds; Reactive Oxygen Species | 2015 |
Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Nystatin | 2016 |
Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Fluconazole; Hospitals; Humans; Infant; Infant, Newborn | 2015 |
A case of lung mass: a common association between uncommon diseases.
Topics: Adult; Amphotericin B; Antifungal Agents; Chest Pain; Cough; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Hemoptysis; Humans; Lung Diseases, Fungal; Male | 2014 |
Management of infected non-union of the proximal femur: a combination of therapeutic techniques.
Topics: Adult; Amoxicillin; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Cements; Candidiasis; Fluconazole; Fracture Fixation, Intramedullary; Fracture Healing; Fractures, Ununited; Hip Fractures; Humans; Male; Recovery of Function; Staphylococcal Infections; Treatment Outcome; Vancomycin; Wound Infection | 2014 |
Pulmonary cryptococcosis with endobronchial lesions and meningitis.
Topics: Amphotericin B; Animals; Bronchi; Bronchoscopy; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Lung; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2014 |
Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).
Topics: Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2015 |
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult | 2015 |
Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma.
Topics: Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cryptococcosis; Cryptococcus; Fluconazole; Hodgkin Disease; Humans; Male | 2015 |
Hidden in a headache: cryptococcal meningitis in a septuagenarian.
Topics: Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Headache; Humans; Meningitis, Cryptococcal | 2015 |
Determination of MICING: a new assay for assessing minimal inhibitory concentration for invasive growth.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Culture Media; Fluconazole; Itraconazole; Microbiological Techniques; Saccharomyces cerevisiae; Temperature; Virulence; Yeasts | 2015 |
Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Candidiasis; Child; Child, Preschool; Cross Infection; Cytokines; Female; Fluconazole; Free Radicals; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units; Interleukin-10; Interleukin-1beta; Male; Microbial Sensitivity Tests; Nitric Oxide; Nitric Oxide Synthase; Sepsis; Tumor Necrosis Factor-alpha; Voriconazole | 2015 |
The role of antifungal and antiviral agents in primary dental care.
Topics: Acyclovir; Amphotericin B; Antifungal Agents; Antiviral Agents; Candidiasis, Oral; Cheilitis; Dental Care; Fluconazole; Glossitis; Guanine; Herpes Zoster; Humans; Miconazole; Mouth Diseases; Nystatin; Primary Health Care; Stomatitis, Herpetic | 2014 |
Patterns of Candida biofilm on intrauterine devices.
Topics: Amphotericin B; Biofilms; Candida; Cross-Sectional Studies; Culture Media; Female; Fluconazole; Humans; Intrauterine Devices; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy, Electron, Scanning; Staining and Labeling | 2015 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aortic Valve; Candida; Candidiasis; Endocarditis; Fluconazole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Treatment Outcome | 2015 |
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Fluconazole; Immunocompromised Host; Kidney; Larva; Lipopeptides; Mice; Microbial Sensitivity Tests; Moths; Trichosporon; Trichosporonosis; Voriconazole | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Exogenous tyrosol inhibits planktonic cells and biofilms of Candida species and enhances their susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Synergism; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Phenylethyl Alcohol | 2015 |
Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Gene Expression Regulation, Fungal; Gene Knockout Techniques; Mice; Saccharomyces cerevisiae; Virulence; Voriconazole | 2015 |
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole | 2015 |
Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2015 |
Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fluconazole; Humans; Malaysia; Microbial Sensitivity Tests; Urinary Tract Infections | 2014 |
Chronic candida endophthalmitis as a cause of intermediate uveitis.
Topics: Administration, Oral; Amphotericin B; Candida albicans; Cataract Extraction; Diagnostic Errors; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Intravitreal Injections; Middle Aged; Pars Planitis; Postoperative Complications; Steroids; Treatment Outcome; Uveitis, Intermediate; Vitrectomy | 2015 |
Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Fabaceae; Fluconazole; Microbial Sensitivity Tests; Plant Extracts; Proanthocyanidins; Tannins; Tetrazolium Salts | 2015 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |
[Fungal infectivities of implanted catheters due to Candida sp. Biofilms formation and resistance].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Catheter-Related Infections; Catheters, Indwelling; Cross Infection; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests | 2015 |
Mycetoma Caused by Aspergillus nidulans.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Biopsy; DNA, Fungal; Drug Substitution; Fluconazole; Humans; Male; Middle Aged; Mycetoma; Sequence Analysis, DNA | 2016 |
Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Chlorhexidine; Echinocandins; Fluconazole; Hemolysin Proteins; Humans; Ketoconazole; Kuwait; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Sri Lanka; Time Factors | 2016 |
Voriconazole: a novel treatment option for cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Carbon; China; Cryptococcus neoformans; Diagnostic Errors; Drug Therapy, Combination; Female; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Time Factors; Voriconazole | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole | 2015 |
In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida glabrata; Candida tropicalis; Echinocandins; Fluconazole; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests | 2015 |
Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.
Topics: Administration, Topical; Adult; Aged; Amphotericin B; Antifungal Agents; Attitude of Health Personnel; Candidiasis, Oral; Cross-Sectional Studies; Drug Prescriptions; Female; Fluconazole; Humans; Jordan; Male; Miconazole; Middle Aged; Nystatin; Practice Patterns, Dentists'; Private Practice; Professional Practice; Public Health Dentistry; Referral and Consultation; Sex Factors; Workplace | 2015 |
Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hemolysis; Humans; Hydrolases; Mycotoxins; Virulence Factors | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Management of cryptococcal meningitis in a district hospital in KwaZulu-Natal: a clinical audit.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Flucytosine; Hospitals, Urban; Humans; Male; Medical Audit; Meningitis, Cryptococcal; Retrospective Studies; South Africa; Treatment Outcome | 2014 |
Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
Topics: Amphotericin B; Anilides; Antifungal Agents; Biofilms; Candida; Catechin; Drug Synergism; Fluconazole; Miconazole; Microbial Sensitivity Tests; Polyphenols; Tetrazolium Salts | 2015 |
Evidence of Fluconazole-Resistant Candida Species in Tortoises and Sea Turtles.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Cloaca; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mouth; Turtles | 2015 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Cryptococcus uniguttulatus Meningitis.
Topics: Administration, Intravenous; Aged; Amphotericin B; Antifungal Agents; Cryptococcus; Drug Substitution; Female; Fluconazole; Glucocorticoids; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome; Voriconazole | 2015 |
Changing trends of Candidemia and antifungal susceptibility pattern in a tertiary health care centre.
Topics: Adolescent; Adult; Age Factors; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Intensive Care Units; Male; Microbial Sensitivity Tests; Risk Factors; Tertiary Care Centers; Young Adult | 2015 |
Comparison of two antifungal susceptibility testing of Candida sp. isolates using agar diffusion method: Neo-sensitabs® tablets and Bio-rad® disks.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Immunodiffusion; Microbial Sensitivity Tests; Prospective Studies; Tablets; Voriconazole | 2016 |
Candida albicans osteomyelitis as a cause of chest pain and visual loss.
Topics: Adult; Amphotericin B; Antifungal Agents; Blindness; Candida albicans; Candidiasis; Chest Pain; Fluconazole; Humans; Male; Osteomyelitis; Ribs | 2015 |
Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Species Specificity; United Kingdom; Urinary Tract Infections | 2016 |
Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidemia; Cohort Studies; Echinocandins; Female; Fluconazole; Fungal Proteins; Hospitalization; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Severity of Illness Index; Systemic Inflammatory Response Syndrome | 2016 |
Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Ergosterol; Fluconazole; HSP90 Heat-Shock Proteins; Humans; Itraconazole; Melanins; Microbial Sensitivity Tests; Plankton; Voriconazole | 2016 |
Cryptococcosis Presenting as a Colonic Ulcer in a Kidney Transplant Recipient: A Case Report.
Topics: Amphotericin B; Antifungal Agents; Colonic Diseases; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Fluconazole; Humans; Kidney Transplantation; Middle Aged; Ulcer | 2015 |
Comparative effectiveness of fungicidal vs. fungistatic therapies for the treatment of paediatric candidaemia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidemia; Caspofungin; Child; Child, Preschool; Cohort Studies; Echinocandins; Fluconazole; Humans; Infant; Inpatients; Lipopeptides; Retrospective Studies; Treatment Outcome | 2016 |
Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs.
Topics: Alternaria; Aminoglycosides; Amphotericin B; Antifungal Agents; Caspofungin; Cell Wall; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Melanins; Microbial Sensitivity Tests; Naphthols; Pyrroles; Quinolines | 2015 |
[Brain Abscess due to Infection with Dematiaceous Fungi Cladophialophora bantiana Associated with Hypogammaglobulinemia Following Gastrectomy: A Case Report].
Topics: Agammaglobulinemia; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Brain Abscess; Drug Combinations; Fluconazole; Gastrectomy; Humans; Male; Mycoses | 2016 |
Epidemiology of Candida Infections in HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Prospective Studies; United States | 2015 |
[Successful treatment for cryptococcal meningoencephalitis complicated by cerebral salt-wasting syndrome in a patient with chronic lymphocytic leukemia: A clinical case].
Topics: Aged; Amphotericin B; Antifungal Agents; Comorbidity; Fluconazole; Humans; Hyponatremia; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Meningitis, Cryptococcal; Syndrome | 2015 |
Coccidioidomycosis in infants: A retrospective case series.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Coccidioidomycosis; Cough; Diagnosis, Differential; Echinocandins; Endemic Diseases; Female; Fever; Fluconazole; Humans; Infant; Lipopeptides; Lung Diseases, Fungal; Male; Retrospective Studies; Treatment Outcome; Voriconazole | 2016 |
Antifungal therapies in murine infections by Candida kefyr.
Topics: Amphotericin B; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis, Invasive; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluconazole; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Microbial Viability; Proteoglycans; Survival Analysis; Treatment Outcome | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Cryptococcemia in primary HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diabetes Mellitus; Fluconazole; Hepatitis B; HIV Infections; Humans; Liver Function Tests; Male; Syphilis; Treatment Outcome | 2016 |
Bilateral Rhizopus keratitis in a cocaine user.
Topics: Adult; Amphotericin B; Antifungal Agents; Cocaine-Related Disorders; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Humans; Male; Mucormycosis; Natamycin; Rhizopus | 2016 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillus; Child; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Voriconazole | 2016 |
[Clinical analysis of 8 cases of neonatal septicemia caused by Candida haemulonii in neonatal intensive care unit].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; C-Reactive Protein; Candida; Candidiasis; Fluconazole; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2016 |
[Multiple facial nodules revealing disseminated cryptococcosis in an immunocompetent patient].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Facial Dermatoses; Fatal Outcome; Fluconazole; Fungemia; Humans; Immunocompetence; Male; Meningitis, Cryptococcal | 2016 |
Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidemia; Echinocandins; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies | 2016 |
Naegleria fowleri That Induces Primary Amoebic Meningoencephalitis: Rapid Diagnosis and Rare Case of Survival in a 12-Year-Old Caucasian Girl.
Topics: Amebiasis; Amphotericin B; Antiprotozoal Agents; Azithromycin; Central Nervous System Protozoal Infections; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Child; Early Diagnosis; Female; Fluconazole; Humans; Hypothermia, Induced; Meningoencephalitis; Naegleria fowleri; Phosphorylcholine; Rifampin | 2016 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Birds; Brazil; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Reservoirs; Environmental Microbiology; Feces; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Typing; Mycological Typing Techniques; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Trees | 2016 |
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; United States | 2016 |
Highly Dynamic and Specific Phosphatidylinositol 4,5-Bisphosphate, Septin, and Cell Wall Integrity Pathway Responses Correlate with Caspofungin Activity against Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Benzenesulfonates; Candida albicans; Caspofungin; Cell Cycle Proteins; Cell Wall; Echinocandins; Fluconazole; Fungal Proteins; Green Fluorescent Proteins; Hydrogen Peroxide; Lipopeptides; Luminescent Proteins; Microbial Sensitivity Tests; Mitogen-Activated Protein Kinases; Phosphatidylinositol 4,5-Diphosphate; Phosphorylation; Protein Domains; Protein Kinase C; Red Fluorescent Protein; Septins | 2016 |
Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
Topics: Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Biofilms; Candida albicans; Drug Combinations; Drug Synergism; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Glycolipids; Hyphae; Membrane Glycoproteins; Microbial Sensitivity Tests; Microbial Viability; Saccharomycetales; Surface-Active Agents | 2016 |
Discrepancy between immunosuppressive status and extensiveness of fungal infections?
Topics: Amphotericin B; Antifungal Agents; Evidence-Based Medicine; Fluconazole; Humans; Immunocompromised Host; Immunosuppressive Agents; Mycoses; Risk Factors | 2016 |
Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Denmark; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Genotype; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Serotyping | 2016 |
Management of temporomandibular joint Coccidioidomycosis.
Topics: Abscess; Adult; Amphotericin B; Coccidioidomycosis; Drug Therapy, Combination; Fluconazole; Humans; Infusions, Intravenous; Long-Term Care; Male; Osteomyelitis; Temporomandibular Joint Disorders; Tomography, X-Ray Computed | 2016 |
Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients.
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Therapeutic Irrigation; Treatment Outcome; Urinary Bladder; Urinary Tract Infections | 2017 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Chromatography, Liquid; Colony Count, Microbial; Cryptococcosis; Cryptococcus gattii; Disease Models, Animal; Drug Resistance, Fungal; Fluconazole; Lung; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Models, Biological; Spectrometry, Mass, Electrospray Ionization | 2016 |
Immunological Consequences of Intestinal Fungal Dysbiosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Bacteria; Base Sequence; Colitis; Dietary Supplements; Drug Hypersensitivity; Dysbiosis; Fluconazole; Fungi; Gastrointestinal Microbiome; Hypersensitivity; Intestines; Mice; Mice, Inbred C57BL | 2016 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole | 2016 |
Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspirin; Cell Death; Cell Line; Cryptococcosis; Cryptococcus; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Ibuprofen; Mice; RAW 264.7 Cells | 2016 |
Probiotic yeast Saccharomyces boulardii (nom. nud.) modulates adhesive properties of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Cell Adhesion; Fluconazole; Gentian Violet; Humans; Hydrogen-Ion Concentration; Itraconazole; Lacticaseibacillus casei; Lacticaseibacillus rhamnosus; Microbial Interactions; Saccharomyces boulardii; Staining and Labeling; Temperature | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
Antifungal susceptibilities of Candida species isolated from urine culture.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Middle Aged; Urinary Tract Infections; Young Adult | 2016 |
Challenges in the development of novel anticryptococcal agents.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; HIV Infections; Humans | 2016 |
[A pediatric case of HIV who diagnosed by virtue of disseminated cryptococcus infection].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Child; Cryptococcosis; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; Humans; Tuberculosis, Pulmonary | 2016 |
Cryptococcal cellulitis on the shin of an immunosuppressed patient.
Topics: Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Flucytosine; Fungemia; Glomerulosclerosis, Focal Segmental; Humans; Immunocompromised Host; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Prednisone; Skin | 2016 |
Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
Topics: Agar; Amphotericin B; Antifungal Agents; Culture Media; Fluconazole; Itraconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Immunocompromised Host; Lung; Mice; Microbial Sensitivity Tests; Spleen; Voriconazole | 2017 |
Pulmonary Cryptococcoma Masquerading as Lung Cancer.
Topics: Amphotericin B; Antifungal Agents; Chest Pain; Cough; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Hemoptysis; Humans; Lung Diseases, Fungal; Male; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Synergistic activity of doped zinc oxide nanoparticles with antibiotics: ciprofloxacin, ampicillin, fluconazole and amphotericin B against pathogenic microorganisms.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nanoparticles; Zinc Oxide | 2016 |
Use of Intra-Articular Amphotericin B in the Treatment of Candida parasilosis and albicans in Prosthetic Joint Infections (PJI): A Novel Approach to this Difficult Problem.
Topics: Aged; Amphotericin B; Antifungal Agents; Arthroplasty, Replacement, Knee; Candida; Candidiasis; Communicable Diseases; Female; Fluconazole; Humans; Injections, Intra-Articular; Knee Prosthesis; Male; Prosthesis-Related Infections; Synovial Fluid; Treatment Failure | 2017 |
White-opaque Switching in Different Mating Type-like Locus Gene Types of Clinical
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Fluconazole; Genotype; Humans; Microbial Sensitivity Tests; Phylogeny | 2016 |
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole | 2016 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole | 2017 |
DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug.
Topics: Amino Acid Motifs; Amphotericin B; Antifungal Agents; Biofilms; Candida; Candida tropicalis; Cell Survival; Drug Combinations; Drug Synergism; Erythrocytes; Fluconazole; HEK293 Cells; Humans; Microbial Sensitivity Tests; Peptides; Solid-Phase Synthesis Techniques; Species Specificity | 2017 |
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles | 2017 |
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Echinocandins; Female; Fluconazole; Fungemia; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Registries; Saccharomycetales; Voriconazole; Young Adult | 2017 |
Utilizing online-dual-SPE-LC with HRMS for the simultaneous quantification of amphotericin B, fluconazole, and fluorocytosine in human plasma and cerebrospinal fluid.
Topics: Amphotericin B; Antifungal Agents; Chromatography, Liquid; Drug Monitoring; Fluconazole; Flucytosine; Humans; Online Systems; Solid Phase Extraction; Tandem Mass Spectrometry | 2017 |
Troponoids Can Inhibit Growth of the Human Fungal Pathogen Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Tropolone | 2017 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Topics: Amidines; Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Models, Animal; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Mice; Microbial Sensitivity Tests; Voriconazole | 2017 |
In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Farnesol; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Naphthalenes; Terbinafine | 2017 |
Candida auris candidaemia in Indian ICUs: analysis of risk factors.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Echinocandins; Female; Fluconazole; Humans; India; Intensive Care Units; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Risk Factors; Young Adult | 2017 |
Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Voriconazole | 2017 |
Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Biofilms; Candida; Caspofungin; Conjunctiva; Echinocandins; Eye Infections, Fungal; Fluconazole; Horse Diseases; Horses; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests | 2017 |
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2017 |
Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus.
Topics: Amphotericin B; Animals; Antifungal Agents; Biodiversity; Biofilms; Caspofungin; Chickens; Colony Count, Microbial; Drug Resistance, Fungal; Echinocandins; Fluconazole; Gastrointestinal Microbiome; Lipopeptides; Microbial Sensitivity Tests; Nepal; Poultry; Virulence; Virulence Factors; Voriconazole; Yeasts | 2017 |
Candidiasis: Prevalence and resistance profiling in a tertiary care hospital of Pakistan.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; Kidney Failure, Chronic; Kidney Transplantation; Microbial Sensitivity Tests; Pakistan; Prevalence; Prospective Studies; Tertiary Care Centers; Voriconazole | 2017 |
Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidemia; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Neoplasms; Polyenes; Retrospective Studies | 2017 |
Isolation of potentially pathogenic fungi from selected pigeons' feeding sites in Karachi: A new dimension to health hazard.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Columbidae; Drug Resistance, Fungal; Fluconazole; Fusarium; Microbial Sensitivity Tests; Pakistan; Penicillium; Rhizopus; Soil Microbiology | 2017 |
Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Cross Infection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, Teaching; Humans; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Retrospective Studies; Young Adult | 2017 |
Synthetic antimicrobial peptides of the halictines family disturb the membrane integrity of Candida cells.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Cell Membrane; Fatty Acids, Monounsaturated; Fluconazole; Imines; Lipids; Microbial Sensitivity Tests; Naphthalenes; Peptides; Pyridines; Sterols; Terbinafine | 2017 |
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Defensins; Fluconazole; Glucosyltransferases; Humans; Microbial Sensitivity Tests; Microscopy, Atomic Force; Microscopy, Confocal; Mutation; Plant Proteins | 2017 |
Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Recurrence; Serum; Treatment Outcome | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Fungemia associated with Schizophyllum commune in Brazil.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungemia; Humans; Male; Middle Aged; Schizophyllum | 2017 |
Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Female; Fluconazole; Humans; Hypoglycemic Agents; Hypoxia; Insulin; Lung Diseases, Fungal; Male; Middle Aged; Mucor; Mucormycosis; Respiratory Function Tests | 2017 |
High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus gattii; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Humans; Lung; Mice; Microbial Sensitivity Tests; Treatment Outcome | 2017 |
Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Topics: Amphotericin B; Antifungal Agents; Biological Transport; Candida; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Lipopeptides; Micafungin; Microbial Sensitivity Tests | 2017 |
Central nervous system infection due to Cryptococcus gattii sensu lato in India: Analysis of clinical features, molecular profile and antifungal susceptibility.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Cryptococcosis; Cryptococcus gattii; Female; Fluconazole; Genes, Mating Type, Fungal; Humans; India; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Young Adult | 2017 |
A Cationic Polymer That Shows High Antifungal Activity against Diverse Human Pathogens.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Arabidopsis; Candida; Cryptococcus; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Humans; Immunity, Innate; Microbial Sensitivity Tests; Nylons; Plant Roots; Polymers | 2017 |
In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Topics: Adult; Amphotericin B; Antifungal Agents; Burkina Faso; Candida albicans; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged | 2017 |
Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis; Candidiasis, Vulvovaginal; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Infant, Newborn; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Outpatients; Pakistan; Prevalence; Prospective Studies; Respiratory Tract Infections; Tertiary Care Centers; Urinary Tract Infections; Voriconazole; Young Adult | 2017 |
Cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Brain; Cryptococcus gattii; Cryptococcus neoformans; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Early Diagnosis; Fluconazole; HIV Infections; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Patient Care Management | 2017 |
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Hydrolysis; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Virulence | 2017 |
Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Coinfection; Fluconazole; Humans; Polymerase Chain Reaction | 2018 |
What Is Your Neurologic Diagnosis?
Topics: Amphotericin B; Animals; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cat Diseases; Cats; Fluconazole; Male; Meningitis, Cryptococcal; Prednisolone | 2017 |
Necrotic ulcer on the thigh.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Diagnosis, Differential; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Ulcer; Thigh | 2017 |
Adjuvant Stromal Amphotericin B Injection for Late-Onset DMEK Infection.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Chemotherapy, Adjuvant; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections, Intraocular; Middle Aged; Postoperative Complications | 2017 |
Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Child; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Treatment Outcome; Voriconazole | 2018 |
Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Castleman Disease; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Risk Factors | 2018 |
Cryptococcal cerebellitis in no-VIH patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Cerebellar Diseases; Cryptococcosis; Fatal Outcome; Fluconazole; Humans; Magnetic Resonance Spectroscopy; Male | 2017 |
Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Management; Endocarditis; Female; Fluconazole; France; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Prosthesis-Related Infections; Registries; Retrospective Studies; Spain | 2018 |
Bilateral Candida endophthalmitis accompanying Candida lusitaniae bloodstream infection: A case report.
Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candida; Candidemia; Candidiasis; Catheter-Related Infections; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Rectal Neoplasms; Risk Factors | 2018 |
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
Topics: Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Denmark; Drug Resistance, Multiple, Fungal; Echinocandins; Epidemiological Monitoring; Female; Fluconazole; Fungemia; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Sex Factors | 2018 |
Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Topics: Adult; Amphotericin B; Antifungal Agents; Chloramphenicol; Cote d'Ivoire; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; DNA, Fungal; Environmental Microbiology; Female; Fluconazole; Flucytosine; Genotype; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Prospective Studies; Serotyping; Young Adult | 2018 |
Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amphotericin B; Fluconazole; Humans; Metal Nanoparticles; Microscopy, Atomic Force; Nystatin; Silver; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2018 |
Follicular papules and pustules in a patient with pulmonary symptoms.
Topics: Aged; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fatal Outcome; Fluconazole; Folliculitis; Humans; Lung Diseases, Fungal; Male | 2018 |
Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Electrophoresis, Agar Gel; Female; Fluconazole; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Urinary Tract Infections; Voriconazole; Young Adult | 2017 |
A case of Candida septic arthritis with rice body formation in a 2-month-old infant.
Topics: Amphotericin B; Antifungal Agents; Arthritis, Infectious; Candidiasis; Female; Fluconazole; Humans; Hypertrophy; Infant; Joint Loose Bodies; Knee Joint; Synovial Membrane | 2017 |
Enhanced Efflux Pump Activity in Old Candida glabrata Cells.
Topics: Amphotericin B; Antifungal Agents; ATP-Binding Cassette Transporters; Biological Transport; Candida glabrata; Cell Division; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, MDR; Glucosyltransferases; Micafungin; Microbial Sensitivity Tests | 2018 |
Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Cohort Studies; Drug Resistance, Fungal; Female; Fluconazole; Gestational Age; Humans; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Male; Micafungin; Microbial Sensitivity Tests; Neurodevelopmental Disorders; Prospective Studies; Sepsis; Treatment Outcome | 2018 |
Three cases of Candida fermentati fungemia following hematopoietic stem cell transplantation.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; DNA, Ribosomal; Echinocandins; Fatal Outcome; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Lymphoproliferative Disorders; Male; Middle Aged; Sequence Analysis, DNA | 2018 |
A Rare Presentation of Cryptococcal Meningitis and Cerebellitis in an Asplenic Patient, Seronegative for Human Immunodeficiency Virus (HIV).
Topics: Aged; Amphotericin B; Antifungal Agents; Cerebellar Diseases; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Flucytosine; Follow-Up Studies; HIV Seronegativity; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Rare Diseases; Risk Assessment; Severity of Illness Index; Splenectomy; Treatment Outcome | 2018 |
Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Clotrimazole; Diosgenin; Erythrocytes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Saponins | 2018 |
Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Mycoses; New Zealand; Pichia | 2018 |
The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Infant, Newborn; Infant, Premature; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Voriconazole | 2018 |
Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Bilateral Asymptomatic Cryptococcal Retinitis without Choroiditis or Vitritis.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococcosis; Cryptococcus gattii; Drug Therapy, Combination; Eye Diseases; Eye Infections, Fungal; Fluconazole; Flucytosine; HIV Infections; Humans; Infusions, Intravenous; Male; Meningitis, Cryptococcal; Retinitis; Tomography, Optical Coherence; Vitreous Body | 2018 |
Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Catheter-Related Infections; Drug Evaluation, Preclinical; Female; Fluconazole; Luminescent Measurements; Mice, Inbred BALB C | 2018 |
A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Caspofungin; Echinocandins; Fluconazole; Histoplasma; Histoplasmosis; HIV; HIV Infections; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2018 |
Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Synergism; Fluconazole; Lactic Acid; Male; Mice; Microbial Sensitivity Tests; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2018 |
Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Phenylethyl Alcohol; Vulvovaginitis | 2018 |
Intracranial Cryptococcoma-Clinicopathologic Correlation and Surgical Outcome: A Single-Institution Experience.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcus gattii; Female; Fluconazole; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Invasive; Caspofungin; Child; Child, Preschool; Cohort Studies; Female; Fluconazole; Fungemia; Hospital Mortality; Humans; Incidence; Infant; Infant, Newborn; Male; Risk Factors; Taiwan; Treatment Outcome | 2018 |
Risk assessment for the spread of Candida sp. in dental chair unit waterlines using molecular techniques.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Cross Infection; Dental Equipment; Drug Resistance, Fungal; Equipment Contamination; Fluconazole; Humans; Risk Assessment; Sequence Analysis, DNA | 2018 |
The first isolate of Candida auris in China: clinical and biological aspects.
Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Bronchoalveolar Lavage Fluid; Candida; Candidemia; Caspofungin; China; Copper Sulfate; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moths | 2018 |
Multifocal verrucous plaques in an apparently immunocompetent female.
Topics: Adult; Amphotericin B; Antifungal Agents; Dermatomycoses; Female; Fluconazole; Hand Dermatoses; Humans; Immunocompetence; Meningitis, Cryptococcal; Neck | 2018 |
Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Brazil; Candida; Candida glabrata; Candidiasis, Vulvovaginal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications; Prevalence; Schools; Young Adult | 2018 |
Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Fungi; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Mycoses | 2018 |
Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Incidence; Iran; Itraconazole; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Prevalence; Young Adult | 2018 |
Overexpression or Deletion of Ergosterol Biosynthesis Genes Alters Doubling Time, Response to Stress Agents, and Drug Susceptibility in
Topics: Amphotericin B; Antifungal Agents; Biosynthetic Pathways; Drug Resistance, Fungal; Ergosterol; Fluconazole; Gene Deletion; Gene Expression Regulation, Fungal; Genes, Fungal; Saccharomyces cerevisiae | 2018 |
Case of cryptococcal choroiditis in adult with T-cell leukemia/lymphoma.
Topics: Aged; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococcosis; Cryptococcus neoformans; Eye; Eye Infections, Fungal; Fatal Outcome; Female; Fluconazole; Humans; Intravitreal Injections; Leukemia-Lymphoma, Adult T-Cell; Multifocal Choroiditis; Organophosphates; Tomography, Optical Coherence | 2019 |
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole | 2018 |
Outcomes in patients with fungal endocarditis: A multicenter observational cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Echinocandins; Endocarditis; Female; Fluconazole; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Azithromycin; Central Nervous System Protozoal Infections; Disease Models, Animal; Drug Combinations; Drug Discovery; Drug Synergism; Female; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Naegleria fowleri; Phenotype; Time Factors; Triazoles; United States; United States Food and Drug Administration | 2019 |
Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus gattii; DNA, Fungal; Female; Fluconazole; Genotype; Humans; Invasive Fungal Infections; Male; Meningitis; Middle Aged; Polymorphism, Restriction Fragment Length; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B.
Topics: Acanthamoeba castellanii; Amebicides; Amphotericin B; Cell Survival; Fluconazole; Gold; HeLa Cells; Humans; Metal Nanoparticles; Nanomedicine; Nystatin | 2019 |
Disseminated cryptococcosis in two boys with novel mutation of CD40 Ligand-Associated X-linked hyper-IgM syndrome.
Topics: Amphotericin B; Antifungal Agents; CD40 Ligand; Child; Cryptococcosis; Fluconazole; Humans; Hyper-IgM Immunodeficiency Syndrome; Immunoglobulins, Intravenous; Male; Mutation | 2021 |
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Topics: Aminopyridines; Amphotericin B; Animals; Antifungal Agents; Coccidioides; Disease Models, Animal; Female; Fluconazole; Isoxazoles; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia; Prodrugs; Triazoles | 2019 |
Impact of Antifungal Compounds on Viability and Anti-
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole | 2019 |
Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; Candida albicans; Caspases; Catalase; Cell Membrane; Cell Membrane Permeability; Drug Combinations; Drug Synergism; Enzyme Activation; Fluconazole; Flucytosine; Free Radical Scavengers; Microbial Sensitivity Tests; Oxidative Stress; Quercetin; Reactive Oxygen Species; Superoxide Dismutase | 2019 |
Clinical Significance of the Floral Shift in Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Nystatin; Oils, Volatile; Voriconazole | 2018 |
Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Catalytic Domain; Drug Combinations; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Binding; Schiff Bases; Sterol 14-Demethylase | 2019 |
Disseminated cryptococcosis in Crohn's disease: a case report.
Topics: Amphotericin B; Antifungal Agents; Crohn Disease; Cryptococcosis; Disease Progression; Female; Fluconazole; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Invasive Fungal Infections; Middle Aged; Tomography, X-Ray Computed | 2018 |
Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Child; Cryptococcus; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; HIV Infections; Humans; Maintenance Chemotherapy; Meningitis, Cryptococcal; Practice Guidelines as Topic; World Health Organization | 2018 |
High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Patient Compliance; Retrospective Studies; Salvage Therapy; Young Adult | 2018 |
Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fresh Water; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Sequence Analysis, DNA; Voriconazole; Yeasts | 2019 |
In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Cryptococcosis; Cryptococcus; Drug Synergism; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Organoselenium Compounds | 2019 |
The influence of N and S poles of static magnetic field (SMF) on Candida albicans hyphal formation and antifungal activity of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Fluconazole; Hyphae; Magnetic Fields; Microbial Sensitivity Tests; Microbial Viability | 2019 |
Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Bone Marrow; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Fluconazole; Genotype; HIV Infections; Humans; Male; Meningitis; Middle Aged | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Successful Treatment of Cutaneous Blastomycosis in a Renal Transplant Patient With BK Virus Infection: A Case Report.
Topics: Amphotericin B; Antifungal Agents; BK Virus; Blastomycosis; Coinfection; Fluconazole; Humans; Immunocompromised Host; Kidney Transplantation; Male; Polyomavirus Infections; Tumor Virus Infections; Turkey | 2019 |
Health care-associated invasive Candida infections in children.
Topics: Amphotericin B; Candida; Candidiasis, Invasive; Child; Child, Preschool; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Risk Factors | 2019 |
Disseminated
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Cryptococcosis; Cryptococcus neoformans; Extracorporeal Membrane Oxygenation; Fluconazole; Flucytosine; Heart-Assist Devices; Humans; Immunocompetence; Intra-Aortic Balloon Pumping; Male; Middle Aged; Shock, Septic; ST Elevation Myocardial Infarction | 2019 |
Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Topics: Amphotericin B; Antifungal Agents; Brazil; DNA, Fungal; DNA, Ribosomal; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Tertiary Care Centers; Trichosporon; Trichosporonosis; Voriconazole | 2019 |
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Caspofungin; Catheter-Related Infections; Catheters; Citric Acid; Ethanol; Fluconazole; Micafungin; Nitroglycerin; Pharmaceutical Solutions; Voriconazole | 2019 |
Acinetobacter sp. mediated synthesis of AgNPs, its optimization, characterization and synergistic antifungal activity against C. albicans.
Topics: Acinetobacter; Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Synergism; Fluconazole; Metal Nanoparticles; Plankton; Reactive Oxygen Species; Silver | 2019 |
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompetence; Male; Meningitis, Cryptococcal; Middle Aged; Organ Transplantation; Retrospective Studies; Treatment Outcome | 2019 |
Rare presentation of cryptococcal meningitis in an immunocompetent patient.
Topics: Agricultural Workers' Diseases; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Diplopia; Drug Therapy, Combination; Eye Pain; Fluconazole; Humans; Immunocompetence; Male; Meningitis, Cryptococcal; Meningoencephalitis; Middle Aged; Opportunistic Infections; Rare Diseases | 2019 |
In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspartic Acid Proteases; Candida; Deoxyribonucleases; Echinocandins; Esterases; Fluconazole; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Phospholipases; Virulence Factors; Yeasts | 2019 |
Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Combined Modality Therapy; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Humans; Kidney Transplantation; Lung Diseases, Fungal; Radiography, Thoracic; Treatment Outcome; Voriconazole; Young Adult | 2019 |
The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Synergism; Estrogen Antagonists; Fluconazole; Humans; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Tamoxifen | 2019 |
Successful treatment of a
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cartilage, Articular; Caspofungin; Drug Therapy, Combination; Female; Fluconazole; Humans | 2019 |
Synergistic effects of geldanamycin with fluconazole are associated with reactive oxygen species in
Topics: Amphotericin B; Antifungal Agents; Azoles; Benzoquinones; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Lactams, Macrocyclic; Microbial Sensitivity Tests; Mitochondria; Oxidative Stress; Reactive Oxygen Species | 2019 |
Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Topics: Amphotericin B; Animal Structures; Animals; Antifungal Agents; Antipsychotic Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Fluconazole; Fluphenazine; Gene Expression Profiling; Gene Expression Regulation, Fungal; Mice; Treatment Outcome | 2019 |
Evaluation of Candida colonization and use of the Candida Colonization Index in a paediatric Intensive Care Unit: a prospective observational study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Preschool; Disease Susceptibility; Feasibility Studies; Female; Fluconazole; Humans; Infant; Intensive Care Units, Pediatric; Itraconazole; Male; Microbial Sensitivity Tests; Organ Specificity; Prospective Studies; Sensitivity and Specificity; Voriconazole | 2019 |
Rare
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Cornea; Corneal Injuries; Corneal Stroma; Eye Infections, Fungal; Female; Fluconazole; Humans; Immunocompromised Host; Keratitis; Middle Aged; Pichia; Plant Leaves; Treatment Outcome; Visual Acuity | 2019 |
Candida species isolated from pigeon (Columbia livia) droppings may express virulence factors and resistance to azoles.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Brazil; Candida; Columbidae; Cryptococcosis; Drug Resistance, Fungal; Feces; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Virulence Factors | 2019 |
Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform.
Topics: Amphotericin B; Fluconazole; Humans; Leishmania; Leishmaniasis; Microbial Sensitivity Tests; Parasitic Sensitivity Tests | 2019 |
Disseminated cryptococcosis with granuloma formation in idiopathic CD4 lymphocytopenia.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; CD4 Lymphocyte Count; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Granuloma; Humans; Lung; Sjogren's Syndrome; T-Lymphocytopenia, Idiopathic CD4-Positive; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Infection of Aortic Endograft Caused by Coccidioidomycosis.
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aortic Aneurysm, Abdominal; Aortitis; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Clostridium Infections; Coccidioidomycosis; Device Removal; Enterobacter cloacae; Enterobacteriaceae Infections; Fluconazole; Humans; Magnetic Resonance Angiography; Male; Pneumonia, Bacterial; Postoperative Complications; Prosthesis-Related Infections | 2020 |
Study of the activity of Punica granatum-mediated silver nanoparticles against Candida albicans and Candida glabrata, alone or in combination with azoles or polyenes.
Topics: Amphotericin B; Antifungal Agents; Azoles; Biofilms; Candida albicans; Candida glabrata; Fluconazole; Metal Nanoparticles; Microbial Sensitivity Tests; Nystatin; Polyenes; Pomegranate; Silver | 2020 |
Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida parapsilosis; Candida tropicalis; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Sterol 14-Demethylase; Voriconazole | 2020 |
Characterization of virulence factors, antifungal resistance with ERG-11 gene among Candida species isolated from pulmonary samples.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillus; Bacteria; Biofilms; Candida; Candida albicans; Coagulase; Drug Resistance, Fungal; Fluconazole; Genotype; Humans; Microbial Sensitivity Tests; Middle Aged; Transcriptional Regulator ERG; Virulence Factors; Voriconazole; Young Adult | 2019 |
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Severe primary cutaneous Cryptococcus gattii causing ulcerative cellulitis in an immunocompetent patient.
Topics: Administration, Intravenous; Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cellulitis; Cryptococcosis; Cryptococcus gattii; Debridement; Fluconazole; Humans; Immunocompromised Host; Male; Treatment Outcome | 2019 |
Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain; Cerebrospinal Fluid; Female; Fluconazole; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Pilot Projects; Sertraline; Uganda | 2019 |
The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Peptide Fragments; Triazoles | 2020 |
[Forty cases of neuromeningeal cryptococcosis diagnosed at the Mycology-Parasitology Department of the Ibn Sina hospital in Rabat, over a 21-year period].
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Fluconazole; HIV Infections; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Middle Aged; Morocco; Young Adult | 2019 |
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
Topics: Adult; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Follow-Up Studies; Genetic Variation; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mycological Typing Techniques | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Carrier Proteins; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests | 2019 |
Cryptococcosis in Patients following Kidney Transplantation: A 9-Year Retrospective Clinical Analysis at a Chinese Tertiary Hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; China; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tertiary Care Centers; Voriconazole | 2019 |
Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Cryptococcosis; Cryptococcus gattii; Disease Models, Animal; Fluconazole; Humans; Larva; Microbial Sensitivity Tests; Moths; Voriconazole | 2020 |
A case report of catheter-related bloodstream infection due to Trichosporon coremiiforme in a patient with secondary neutropenia to HIV.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Bacteremia; Catheter-Related Infections; Central Venous Catheters; Drug Therapy, Combination; Female; Fluconazole; HIV; HIV Infections; Humans; Immunocompromised Host; Middle Aged; Neutropenia; Trichosporon; Trichosporonosis; Tuberculosis, Pulmonary | 2020 |
Cutaneous and pulmonary cryptococcosis in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Dermatomycoses; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunocompetence; Lung; Lung Diseases, Fungal; Tomography, X-Ray Computed; Young Adult | 2019 |
Antibiotic saving effect of combination therapy through synergistic interactions between well-characterized chito-oligosaccharides and commercial antifungals against medically relevant yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chitosan; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Microbial Sensitivity Tests; Polymerization; Proton Magnetic Resonance Spectroscopy | 2019 |
Necessity to identify candida species accurately with minimum inhibitory concentration determination in each case of bloodstream infections.
Topics: Amphotericin B; Antifungal Agents; Bacteremia; Candida; Candida tropicalis; Candidiasis; Caspofungin; Cross-Sectional Studies; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Voriconazole | 2020 |
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials.
Topics: Amphotericin B; Antifungal Agents; Biomarkers; Cerebrospinal Fluid; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal | 2020 |
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Itraconazole; Lebanon; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vaginal Discharge; Voriconazole | 2020 |
An exceptional case report of disseminated cryptococcosis in a hitherto immunocompetent patient.
Topics: Adenocarcinoma; Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Immunocompromised Host; Male; Prostatic Neoplasms | 2020 |
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole | 2020 |
Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome.
Topics: Adult; Aged; Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Candida; Candidemia; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Length of Stay; Male; Middle Aged; Molecular Typing; Phylogeny; Prevalence; Prospective Studies; Respiration, Artificial; Risk Factors; Treatment Outcome | 2020 |
Nitrogen concentration affects amphotericin B and fluconazole tolerance of pathogenic cryptococci.
Topics: Ammonium Chloride; Amphotericin B; Antifungal Agents; Biosynthetic Pathways; Cryptococcus; Cryptococcus gattii; Cryptococcus neoformans; Culture Media; Ergosterol; Fluconazole; Melanins; Microbial Sensitivity Tests; Nitrogen | 2020 |
Optimum Inhibition of Amphotericin-B-Resistant
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Terpenes | 2020 |
Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report.
Topics: Acyclovir; Amphotericin B; Autoantibodies; Coinfection; Cryptococcosis; Fluconazole; Herpesvirus 3, Human; Humans; Immunologic Deficiency Syndromes; Interferon-gamma; Lymphadenopathy; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Varicella Zoster Virus Infection | 2020 |
The Added Value of Longitudinal Imaging for Preclinical
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Meningitis, Cryptococcal; Mice | 2020 |
Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidemia; Drug Resistance, Multiple, Fungal; Echinocandins; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Turkey; Voriconazole | 2020 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents; Antifungal Agents; Arachnoid; Arachnoiditis; Biopsy; Brain; Brain Abscess; Brain Edema; Cerebellar Diseases; Empyema, Subdural; Fluconazole; Flucytosine; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Prednisone; Recurrence | 2020 |
Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Resistance, Fungal; Farnesol; Fluconazole; Microbial Sensitivity Tests; Quorum Sensing; South Africa | 2020 |
Development and characterization of a novel liquid crystalline system containing sodium alginate for incorporation of
Topics: Alginates; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Delivery Systems; Emulsions; Fluconazole; Hydrophobic and Hydrophilic Interactions; Liquid Crystals; Mouth Mucosa; Nanotechnology; Resveratrol; Surface-Active Agents | 2020 |
The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo.
Topics: Alcohol Dehydrogenase; Amphotericin B; Animals; Antibodies, Monoclonal; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Fungal Proteins; Hyphae; Larva; Microbial Sensitivity Tests; Moths; Virulence | 2020 |
Cryptococcal meningitis in an immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Culture Techniques; Delayed Diagnosis; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompetence; Intensive Care Units; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Papilledema; Respiratory Insufficiency; Spinal Puncture; Ventriculoperitoneal Shunt | 2020 |
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Phylogeny; Saccharomyces cerevisiae; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2021 |
Fungal arthritis with adjacent osteomyelitis caused by Candida pelliculosa: a case report.
Topics: Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Candida; Candidemia; Candidiasis; Deoxycholic Acid; Device Removal; Drug Combinations; Female; Fluconazole; Humans; Intraoperative Care; Joint Prosthesis; Knee; Micafungin; Osteomyelitis | 2020 |
Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cell Membrane Permeability; Cell Wall; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Microbial Sensitivity Tests; Moths; Pore Forming Cytotoxic Proteins | 2020 |
Candida duobushaemulonii sepsis and Candida auris co-isolation following hospitalisation in Vietnam.
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Candidiasis, Cutaneous; Coinfection; Drug Resistance, Multiple, Fungal; Fluconazole; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Saccharomycetales; Vietnam | 2020 |
A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.
Topics: Amphotericin B; Animals; Antifungal Agents; Bombyx; Disease Models, Animal; Fluconazole; Green Fluorescent Proteins; Hyphae; Microbial Sensitivity Tests; Optical Imaging; Organisms, Genetically Modified; Survival Analysis; Trichosporon; Trichosporonosis; Voriconazole | 2020 |
Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candida parapsilosis; Candidemia; China; Female; Fluconazole; Hospitals, Teaching; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Treatment Outcome | 2020 |
[Candida hellenica Candidemia Occurred After Esophagus Surgery].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Esophagus; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Postoperative Complications; Young Adult | 2020 |
Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromatography, Liquid; Depsipeptides; Drug Resistance, Multiple, Fungal; Fatty Acids, Monounsaturated; Fluconazole; Glucosylceramides; Humans; Lipidomics; Tandem Mass Spectrometry | 2021 |
First case report of Cryptococcus laurentii knee infection in a previously healthy patient.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Cryptococcosis; Cryptococcus; Debridement; Diagnostic Errors; Fluconazole; Focal Infection; Humans; Knee; Male; Skin Diseases, Bacterial; Voriconazole | 2020 |
Prevalence and susceptibility profile of Candida spp. isolated from patients in cancer therapy.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Mouthwashes; Neoplasms; Prevalence; Saliva | 2020 |
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Missouri; Treatment Outcome | 2021 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
Synergistic Antifungal Activity of Chitosan with Fluconazole against
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Chitosan; Drug Resistance, Fungal; Fluconazole | 2020 |
Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas.
Topics: Amphotericin B; Animals; Biomarkers; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Meningitis, Cryptococcal; Mice; Middle Aged; Trehalose | 2021 |
Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Hypertension; Length of Stay; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Spinal Puncture; Treatment Outcome; Ventriculoperitoneal Shunt | 2020 |
Recognizing mucormycosis in an immunocompromised patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Debridement; Dexamethasone; Diagnosis, Differential; Fluconazole; Humans; Immunocompromised Host; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Lymphohistiocytosis, Hemophagocytic; Male; Mucormycosis; Paranasal Sinuses; Prognosis; Sinusitis; Therapeutic Irrigation; Tomography, X-Ray Computed | 2020 |
Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Biofilms; Candida parapsilosis; Candida tropicalis; Caspofungin; Cathelicidins; Drug Combinations; Fluconazole; Humans; Muramidase | 2021 |
HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
Topics: Adult; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Referral and Consultation; Retrospective Studies | 2021 |
Amphotericin B, fluconazole, and nystatin as development inhibitors of Candida albicans biofilms on a dental prosthesis reline material: Analytical models in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Dental Prosthesis; Fluconazole; Nystatin | 2022 |
Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Topics: Amphotericin B; Antifungal Agents; Basidiomycota; Fluconazole; Fungemia; Humans; Lymphoma, Follicular; Middle Aged; Trichosporon; Trichosporonosis | 2021 |
Categorizing Susceptibility of Clinical Isolates of
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Fluconazole; Humans; Microbial Sensitivity Tests | 2021 |
Investigation of the Physiological, Biochemical and Antifungal Susceptibility Properties of Candida auris.
Topics: Amphotericin B; Antifungal Agents; Asia; Candida; Fluconazole; Microbial Sensitivity Tests | 2021 |
The role of Cryptococcus neoformans histone deacetylase genes in the response to antifungal drugs, epigenetic modulators and to photodynamic therapy mediated by an aluminium phthalocyanine chloride nanoemulsion in vitro.
Topics: Amphotericin B; Antifungal Agents; Bacterial Proteins; Butyric Acid; Cryptococcosis; Cryptococcus neoformans; Drug Synergism; Emulsions; Epigenesis, Genetic; Fluconazole; Gene Expression Regulation, Bacterial; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Nanoparticles; Organometallic Compounds; Photochemotherapy; Sulfamethoxazole | 2021 |
Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Otomycosis | 2021 |
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B.
Topics: Amphotericin B; ATP-Binding Cassette Transporters; Candida albicans; Cell Membrane; Cell Membrane Permeability; Decanoic Acids; Drug Resistance, Multiple; Fluconazole; Humans; Saccharomyces boulardii; Saccharomyces cerevisiae Proteins | 2021 |
Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Antioxidants; Cryptococcus neoformans; Culture Media; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Nutrients; Temperature | 2021 |
Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; HIV; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Myanmar; Phlebitis; Primary Health Care; Retrospective Studies; Treatment Outcome; Young Adult | 2021 |
Disseminated coccidioidomycosis in a patient with juvenile idiopathic arthritis receiving infliximab.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antirheumatic Agents; Arthritis; Arthritis, Juvenile; Choroid Diseases; Coccidioides; Coccidioidomycosis; Disease Progression; Female; Fluconazole; Humans; Immune Tolerance; Infliximab; Meningitis, Fungal; Monitoring, Immunologic; Pneumonia, Necrotizing; Treatment Outcome | 2021 |
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole | 2021 |
Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Middle Aged; Polymorphism, Restriction Fragment Length; Vagina; Virulence; Voriconazole; Young Adult | 2021 |
In vitro anti-Cryptococcus activity of diphenyl diselenide alone and in combination with amphotericin B and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Organoselenium Compounds | 2021 |
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antimicrobial Stewardship; Candida; Caspofungin; Child; Child, Preschool; Colony Count, Microbial; Disease Susceptibility; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Triazoles | 2021 |
Antifungal activity of nitroxoline against Candida auris isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida auris; Fluconazole; Humans; Microbial Sensitivity Tests; Nitroquinolines | 2021 |
Biodirected Synthesis of Silver Nanoparticles Using Aqueous Honey Solutions and Evaluation of Their Antifungal Activity against Pathogenic
Topics: Amphotericin B; Antifungal Agents; Apitherapy; Candida; Candida albicans; Fluconazole; Honey; Metal Nanoparticles; Microbial Sensitivity Tests; Silver | 2021 |
Arginine-phenylalanine and arginine-tryptophan-based surfactants as new biocompatible antifungal agents and their synergistic effect with Amphotericin B against fluconazole-resistant Candida strains.
Topics: Amphotericin B; Antifungal Agents; Arginine; Biofilms; Candida; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Phenylalanine; Surface-Active Agents; Tryptophan | 2021 |
Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Topics: Adaptation, Physiological; Amphotericin B; Aneuploidy; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Serogroup | 2021 |
The gut commensal fungus, Candida parapsilosis, promotes high fat-diet induced obesity in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida parapsilosis; Diet, High-Fat; Fluconazole; Flucytosine; Male; Mice; Mice, Inbred C57BL; Obesity; Symbiosis | 2021 |
Antifungal Treatment Aggravates Sepsis through the Elimination of Intestinal Fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dysbiosis; Feces; Fluconazole; Fungi; Gastrointestinal Microbiome; Lipopolysaccharides; Mannans; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Mice, Knockout; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Sepsis; Staphylococcal Infections | 2021 |
Evaluation of bisphenylthiazoles as a promising class for combating multidrug-resistant fungal infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Resistance, Multiple; Fluconazole; Humans; Microbial Sensitivity Tests; Mycoses; Thiazoles | 2021 |
Antifungal susceptibility profile of invasive
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Pakistan; Retrospective Studies; Tertiary Care Centers | 2021 |
Successful fluconazole combined with caspofungin treatment of candida bloodstream infection in preterm infant: A case report.
Topics: Amphotericin B; Antifungal Agents; Candida parapsilosis; Candidemia; Caspofungin; Female; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Male; Microbial Sensitivity Tests; Treatment Outcome | 2021 |
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries.
Topics: Amphotericin B; Animals; Antifungal Agents; Antigens, Fungal; CD4 Lymphocyte Count; Cost-Benefit Analysis; Developing Countries; Fluconazole; HIV Infections; Meningitis, Cryptococcal; Prospective Studies; Uganda | 2022 |
Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1α related IL-17 signaling.
Topics: Acetophenones; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluconazole; Interleukin-17; Mice; Microbial Sensitivity Tests | 2022 |
Antifungal activity of [K
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Candida albicans; Fluconazole; Microbial Sensitivity Tests; Yeasts | 2022 |
Comparison of Six Antifungal Susceptibilities of 11
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Drug Resistance, Fungal; Fluconazole; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2022 |
Prevalence and susceptibility profiles of oral yeast species isolated from a healthy adult Thai cohort.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Prevalence; Thailand; Voriconazole | 2022 |
Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; COVID-19; Critical Illness; Fluconazole; Humans; Lung; Microbial Sensitivity Tests; Pneumonia; SARS-CoV-2 | 2022 |
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida parapsilosis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Genotype; Humans; Microbial Sensitivity Tests; Spain | 2022 |
Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Prevalence; Retrospective Studies | 2022 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
High MICs for antifungal agents in yeasts from an anthropized lagoon in South America.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Ecosystem; Fluconazole; Microbial Sensitivity Tests; Pesticides; Tandem Mass Spectrometry; Terbinafine; Yeasts | 2022 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Malassezia species: the need to establish epidemiological cutoff values.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Voriconazole | 2022 |
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Hypokalemia; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome; Voriconazole | 2022 |
Antifungal use via outpatient parenteral antimicrobial therapy.
Topics: Ambulatory Care; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Echinocandins; Fluconazole; Humans; Outpatients; Retrospective Studies | 2022 |
Antifungal prescription practices and consumption in a tertiary care hospital of a developing country.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Developing Countries; Fluconazole; Humans; Prescriptions; Tertiary Care Centers; Voriconazole | 2022 |
Single-Dose Amphotericin B for Cryptococcal Meningitis.
Topics: Amphotericin B; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2022 |
Single-Dose Amphotericin B for Cryptococcal Meningitis. Reply.
Topics: Amphotericin B; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2022 |
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole | 2022 |
Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Fluconazole; Humans; Japan; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2022 |
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2023 |
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Topics: Amphotericin B; Animals; Antifungal Agents; Calmodulin; Cat Diseases; Cats; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Thailand; Tubulin | 2022 |
A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Japan; Longitudinal Studies; Micafungin; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2022 |
Antifungal efficacy of pure boron on yeast and mold isolates causing superficial mycosis.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Boron; Candida; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Trichophyton; Water | 2022 |
A critical role of calcineurin in stress responses, hyphal formation, and virulence of the pathogenic fungus Trichosporon asahii.
Topics: Amphotericin B; Antifungal Agents; Basidiomycota; Caffeine; Calcineurin; Calcium; Calcium Chloride; Congo Red; Cornea; Corneal Diseases; Dithiothreitol; Eye Diseases, Hereditary; Fluconazole; Monensin; Sodium Chloride; Sodium Dodecyl Sulfate; Sorbitol; Trichosporon; Tunicamycin; Virulence; Voriconazole | 2022 |
Cryptococcus neoformans Presenting as a Lung Mass in an Immunocompromised Patient.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Headache; Humans; Immunocompromised Host; Lung; Middle Aged | 2022 |
Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candida parapsilosis; Candida tropicalis; DNA, Intergenic; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Voriconazole; Yeasts | 2023 |
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda.
Topics: Antifungal Agents; Botswana; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Uganda | 2022 |
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia.
Topics: Adult; Antifungal Agents; Candidemia; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Echinocandins; Ethiopia; Fluconazole; Humans; Lipopeptides | 2022 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antifungal Agents; Fluconazole; HIV; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Inflammation; Male; Meningitis, Cryptococcal | 2023 |
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
Topics: Amphotericin B; Anidulafungin; Biofilms; Caspofungin; Echinocandins; Fluconazole; Micafungin | 2023 |
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Topics: Adult; Amphotericin B; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Middle Aged; Natamycin; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult | 2022 |
Malassezia spp. and Candida spp. from patients with psoriasis exhibit reduced susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Psoriasis; Saccharomyces cerevisiae; Terbinafine | 2023 |
Antifungal drug resistance in oral Candida isolates from HIV-infected and healthy individuals and efficacy of chitosan as an alternative antifungal agent.
Topics: Amphotericin B; Antifungal Agents; Candida; Chitosan; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests | 2023 |
Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidemia; Deoxycholic Acid; Fluconazole; Humans | 2023 |
Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Caspofungin; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Trichosporon; Trichosporonosis | 2023 |
Intermittent bladder irrigation with liposomal amphotericin B for the treatment of fluconazole-resistant Meyerozyma guilliermondii cystitis in an immunosuppressed adolescent.
Topics: Adolescent; Cystitis; Fluconazole; Humans; Urinary Bladder | 2023 |
Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimalarials; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Fluconazole; Mice; Microbial Sensitivity Tests | 2023 |
Identification and susceptibility testing of oral candidiasis in advanced cancer patients.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Neoplasms | 2023 |
Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Humans; Larva; Mammals; Microbial Sensitivity Tests; Voriconazole | 2023 |
Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Virulence; Voriconazole | 2023 |
A 3-year study of
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Neoplasms | 2023 |
Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests | 2023 |
Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Democratic Republic of the Congo; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fluorouracil; HIV Infections; Humans; Microbial Sensitivity Tests; Polymorphism, Genetic | 2023 |
In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents
Topics: Amphotericin B; Animals; Antifungal Agents; Dermatitis, Seborrheic; Fluconazole; HIV Infections; Humans; Itraconazole; Malassezia; Saccharomyces cerevisiae; Voriconazole | 2023 |
Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of
Topics: Aged; Amphotericin B; Candida; Candida glabrata; Cross Infection; Fluconazole; Humans; Kuwait; Multilocus Sequence Typing; Phylogeny; Voriconazole | 2023 |
The alternating 50 Hz magnetic field depending on the hydrophobicity of the strain affects the viability, filamentation and sensitivity to drugs of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Fields; Microbial Sensitivity Tests | 2023 |